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Thesis Summary 
Aston University 
Tonometry and Biomechanics of the Cornea in Contact Lens Wear 
Dirk Johan Booysen 
Doctor of Optometry  
May 2016 
Aims 
Research on use of contact lenses as drug delivery systems continues. Disposable lenses are often 
used to treat corneal injuries. Accurate intraocular pressure (IOP) measurements with lenses in situ 
will enhance patient care and save valuable chair time. 
Inter- and intraobserver reliability of rebound tonometer (RBT) and intraobserver reliability of ocular 
response analyser (ORA) with and without contact lenses of 50 (15 male, 35 female) healthy well 
adapted contact lens wearers between 18 – 55 years (M = 38.90, SD = 9.23) were examined. Clinical 
comparisons of IOP measurements with ORA and RBT were done. Accuracy of IOP measurements 
with four commonly prescribed disposable contact lenses (Acuvue Oasys, Frequency XC, Acuvue 1-
Day Moist, and Pure Vision with powers -6.00 − +6.00 D) in situ was evaluated. Physiological and 
physical factors influencing IOP measurements with both instruments were determined. 
Findings 
Intraobserver reliability of RBT without and with lenses was excellent (ICC > 0.88; > 0.92 
respectively). Interobserver reliability of RBT was excellent without or with lenses (ICC 0.81; 0.88 
respectively). Intraobserver reliability of ORA was good for all metrics measured except for corneal 
hysteresis (CH) (ICC: CH 0.63; corneal resistance factor (CRF) 0.79; corneal compensated IOP (IOPcc) 
0.77; IOPg 0.87).  
RBT and ORA IOPg (Goldmann equivalent IOP) measurements were clinically and statistically 
comparable without or with lenses (differences < 0.6 mmHg). ORA IOPcc and RBT were less 
comparable (differences < 1.45 mmHg).  
Accurate RBT and ORA tonometry (within 2 mmHg) was possible with low minus power (range -0.50 
to -6.00 D); moderate modulus of elasticity (< 0.75 MPa); thin silicone hydrogel (Acuvue Oasys) and 
hydrogel (Frequency XC; Acuvue 1-Day Moist) contact lenses in situ.  
Multiple regression analyses showed biomechanical metrics CRF and CH affected RBT and ORA (IOPcc 
and IOPg) measurements strongly (p < 0.0001). Therefore, cornea’s biomechanical properties had 
greater influence on accuracy of IOP measurements with these two instruments than other variables 
examined. 
Key words 
Intraocular pressure, disposable contact lenses, modulus of elasticity, rebound tonometry, and ocular 
response analyser.  
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Chapter 1 
Intraocular pressure measurements and factors influencing its 
accuracy 
1.1 General introduction 
Tonometry refers to the measurement of intraocular pressure (IOP) with various instruments 
(tonometers) with each tonometer employing at least one or combinations of the following four 
physical principles: indentation, applanation, contour matching, and rebound tonometry (Kniestedt 
et al., 2008). The accuracy of all tonometers is affected by specific characteristics of the eye being 
measured. These characteristics include, but are not limited to, central corneal thickness (CCT), 
corneal curvature, corneal and scleral elasticity and viscoelasticity, biomechanics of the eye, ocular 
pulse amplitude (OPA), and tear film surface tension (Kniestedt et al., 2008).   
It has been suggested that measurements of the CCT should be a mandatory investigation in patients 
with glaucoma and ocular hypertension (Brandt, 2004) and several correction formulae have been 
produced to account for the variation in corneal thickness and its influence on IOP measurements 
(Ehlers et al., 1975; Whitacre et al., 1993; Stodtmeister, 1998; Doughty and Zaman, 2000; Shimmyo 
et al., 2003). Significant among these formulae are the Ehlers model which corrects IOP for errors 
induced by corneal thickness and the mathematical or theoretical model of Orssengo & Pye which 
corrects IOP for errors induced by corneal thickness as well as corneal curvature (Ehlers et al., 1975; 
Orssengo and Pye, 1999). Gunvant et al. (2005), investigated the efficacy of the Ehlers and the 
Orssengo & Pye formulae to correct IOP measured by the Goldman applanation tonometer (GAT) for 
CCT and found that both these models overestimated the effect of corneal parameters on GAT IOP 
measurements (Gunvant et al., 2005). This effect of CCT on measured IOP reported by Gunvant et al. 
(2005) was found to be consistent with other studies in literature (Herndon et al., 1997; Wolfs et al., 
1997; Singh et al., 2001; Bhan et al., 2002) thereby indicating other intrinsic and extrinsic factors may 
also influence the accuracy of IOP measurements. Corneal characteristics such as CCT, corneal 
curvature, and biomechanics can be altered by using soft contact lenses on the eye when measuring 
IOP. This makes it possible to clinically evaluate the effects of these changes on the accuracy of the 
IOP measurements with different instruments, techniques and contact lens materials. Recent 
research posits that contact lenses will be used as drug delivery systems to the eye (Maddox and 
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Bernstein, 1972; Peng et al., 2010; Jung et al., 2013) and that accurate measurements of IOP with 
these lenses in situ would greatly benefit clinicians treating patients with glaucoma, corneal trauma, 
and other eye disease.  
The literature review covered the following topics: intraocular pressure (IOP); the importance of IOP 
in the diagnosis and management of the glaucomas; measurements of IOP; prevalence of glaucoma 
worldwide as well as in South Africa; the Goldmann applanation tonometer (GAT); noncontact 
tonometry (NCT) and the ocular response analyser (ORA); rebound tonometry or ICare tonometry 
(RBT); Scheimpflug or Pentacam corneal tomography; and the impact of soft contact lenses on the 
accuracy of IOP measurements. 
1.2 Intraocular pressure 
The vertebrate eye is a fluid-filled sphere with flexible and partially elastic walls. Intraocular pressure 
(IOP) maintains a stable shape necessary for the important optical properties of the eye (Hart, 1992). 
IOP is maintained within a fairly narrow range by a complex, dynamic equilibrium in which aqueous 
production is matched by a constant rate of aqueous escape from the eye through the drainage 
pathways. Flow rates vary between 2 µl/min and 3 µl/min with higher flow rates during waking hours  
than during sleep (Lawrenson, 2007). Although small variations in either the production or rate of 
outflow from the eye can result in large changes in IOP, a remarkably stable homeostasis is 
maintained in the healthy eye (Hart, 1992). Aqueous is produced in the ciliary body epithelia by a 
complex, energy-dependent metabolic pump. The pump operates at a constant rate which is not 
sensitive to IOP. A semipermeable membrane blocks all macromolecules (ensuring high optical 
quality), resulting in a blood aqueous barrier similar to the blood-brain barrier (Hart, 1992). The 
metabolic needs (mainly oxygen and glucose) of the lens epithelium, corneal endothelium, and other 
structures in the anterior chamber are provided by the aqueous humour (Hart, 1992).  
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Figure 1.1 Aqueous flows from the posterior chamber, between the lens and the posterior surface of the iris, through the 
pupil into the anterior chamber of the eye to drain mainly through the trabecular meshwork into Schelmm’s canal. Note 
the iris-lens channel. (Drawing courtesy of Gerrie Kruger) 
From the ciliary body the aqueous moves from the posterior chamber, across the anterior surface of 
the lens, past the narrow space between the posterior surface of the iris and the anterior surface of 
the lens (iris-lens channel), through the pupil and into the anterior chamber of the eye. From the 
anterior chamber the vast majority of the aqueous then exits the eye via the trabecular meshwork 
into Schelmm’s canal as well as the collector channels into the network of episcleral veins (Hart, 
1992) (Figure 1.1). A secondary, non-pressure dependent, drainage passage exists via the uveoscleral 
outflow. At normal IOP levels, the aqueous slowly weeps through the face of the ciliary body (just 
posterior to the scleral spur in the apex of the anterior chamber) into the supraciliary and 
suprachoroidal spaces and surrounding periocular tissues to be absorbed into the blood vessels 
draining the uvea (Hart, 1992; Lawrenson, 2007). It is estimated that 15% − 20%  of total aqueous 
outflow is via this route (Freddo, 1993; Lawrenson, 2007). Although uveoscleral outflow is not 
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pressure dependent, contraction of the ciliary muscle − while beneficial for trabecular outflow − can 
significantly alter the amount of uveoscleral outflow by compressing the intracellular spaces within 
the muscle that constitutes the drainage pathway (Freddo, 1993).   
Resistance to aqueous flow occurs between the iris and the lens due to the close approximation 
between the posterior surface of the iris and the anterior capsule of the lens (iris-lens channel); 
additionally, a pressure gradient is also present from the cornea to the cerebrospinal fluid. This leads 
to a small but significant difference in pressure between the posterior and anterior chambers of the 
eye (Hart, 1992; Robert, 2007). Normally the anterior-posterior chamber pressure differential is 
around 1 mmHg (higher pressure in the posterior chamber) but this can be significantly affected by 
variations in the iris-lens channel dimensions and viscous forces within the aqueous resulting in 
clinically significant pressure differences (Silver and Quigley, 2004). Tonometry on the cornea 
measures the anterior chamber pressure and does not estimate the true pressure in the posterior 
chamber and vitreous cavity. Hence, the pressure at the optic nerve head may be significantly 
different in some eyes from the pressure measured at the cornea obscuring an additional risk factor 
in glaucoma damage (Silver and Quigley, 2004). However, the principal resistance to aqueous flow in 
the eye is encountered in the trabecular meshwork. Resistance to flow rises gradually through the 
progressively smaller spaces of the mesh with the juxtacanalicular tissue being responsible for the 
highest resistance to aqueous outflow and the generation and fluctuation of the IOP in the normal 
eye (Hart, 1992; Lawrenson, 2007; Robert, 2007). IOP is dependent on the vascular and respiratory 
properties of the body and the eye. Therefore, the pulse also affects the eye pressure (more 
specifically the ocular pulse amplitude); hence, IOP is only correctly measured when this effect on 
the measurements is considered (Robert, 2007).  
Although IOP is relatively constant, long-term variations associated with age, blood pressure, and 
calendar seasons as well as short-term variations associated with body posture, exercise, eye 
movement, and drug effects can occur (Hart, 1992; Spry and Harper, 2010). For example, IOP is 
usually measured during office hours which are generally from between 08h00 to 17h00 in South 
Africa. The normal diurnal variation (short-term fluctuation) during this timeframe is about 5mmHg 
(Harper and Henson, 2007; Spry and Harper, 2010). Conversely, the nocturnal IOP can be significantly 
higher in part due to the supine body position, and can consequently lead the clinician to 
underestimate peak IOP (Harper and Henson, 2007; Spry and Harper, 2010). The measurements of 
IOPs during routine office hours can miss up to 62% of IOP peaks found if testing is done outside 
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office hours and up to 88% of IOP troughs (Hughes et al., 2003; Mosaed et al., 2005; Barkana et al., 
2006). Yet, supine IOP measurements can be used to estimate nocturnal peak IOPs better than sitting 
IOP measurements thereby providing valuable information to the clinician when evaluating ocular 
hypertension (OHT) patients (Mosaed et al., 2005). The relative importance of IOP peaks remain 
unclear even though several studies have demonstrated that IOP peaks tend to be associated with 
visual field loss as well as short-term fluctuation in IOP of more than 5 mmHg (Sultan et al., 2009). 
Long-term IOP fluctuation (between office visits on separate days) is also associated with a greater 
risk of progression of visual field loss but is not considered an independent risk factor (Sultan et al., 
2009). 
1.3 The importance of IOP in the diagnosis and management of the 
glaucomas 
Although historically there has been a great deal of emphasis on intraocular pressure, IOP is no 
longer included in the definition of glaucoma but is rather seen as a primary risk factor for the 
development of glaucoma (Rudnicka and Owen, 2007). Glaucomatous optic nerve head and/or visual 
field changes can occur in the presence of “low, normal or elevated” IOP (Anderson et al., 2001). 
More recently glaucoma has been defined as “a group of diseases of the optic nerve which result in a 
loss of retinal ganglion cells in a characteristic pattern of optic neuropathy or an optic neuropathy 
which causes characteristic optic nerve head cupping and visual field loss”(Coleman, 1999). 
Nowadays, glaucoma is recognised as a chronic non-curable condition which is often symptom free. 
Unfortunately, if left untreated it eventually leads to severe loss of vision and quality of life (Rudnicka 
and Owen, 2007; Heijl et al., 2008; Spry and Harper, 2010). Treatment, which consist mainly of drugs 
or surgical procedures to lower IOP, attempt to avoid significant vision loss during the patient’s 
lifetime (Heijl et al., 2008; Heijl et al., 2013).  
The classification of glaucoma includes primary (mechanism of the disease is unknown) and 
secondary (secondary to another ocular or systemic disease) glaucoma. Primary glaucoma is further 
subdivided into primary open angle glaucoma and primary closed angle glaucoma. Primary open 
angle glaucoma (POAG) is subdivided into normal tension glaucoma (NTG), high tension glaucoma 
(HTG), and ocular hypertension (OHT) (Rudnicka and Owen, 2007). 
OHT can be defined as IOP above 21 mmHg with no evidence of optic nerve damage, visual field loss 
and/or symptoms (Rudnicka and Owen, 2007). Normal IOP is considered as 15 to 16 mmHg with a 
standard deviation of 2.5 mmHg. The upper limit is given as 2 standard deviations higher at 21 mmHg 
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(Harper and Henson, 2007; Rudnicka and Owen, 2007). The distribution is not strictly Gaussian 
(positively skewed) thus resulting in considerable overlapping of IOP between normal and 
glaucomatous patients (Harper and Reeves, 1999). Approximately 6.6% of the normal population will 
have an IOP > 21 mmHg (Harper and Reeves, 1999).  
The prevalence of OHT is estimated to be between 4 and 7% in the over 40-year-old population in 
the United States of America (USA) (Kass et al., 2010).  The Roscommon study examined an Irish 
population over 50 years of age and found the prevalence of OHT at 4.2% and POAG at 1.87% (Coffey 
et al., 1993) while the Blue Mountains eye study in Australia looked at Caucasian males and females 
over the age of 49 and found the prevalence of OHT at 3.7% and POAG at 2.4% (Mitchell et al., 1996). 
Bonomi et al. (1998) also evaluated Caucasian males and females between 40 and 70 years of age in 
a closed population in Egna-Neumarkt, Northern Italy and found the prevalence of OHT at 2.1% and 
POAG at 1.4% (Bonomi et al., 1998). Wormald et al. (1994) determined the prevalence of OHT among 
a Black African Caribbeans (35 – 60+ years old) to be 2.18%. The prevalence of POAG in African 
Americans, Hispanics, and Latinos over the age of 40 years was around 4 to 5 times that of the 
Caucasian population therefore indicating a higher prevalence of OHT as well (Sommer, Tielsch, Katz, 
Quigley, et al., 1991; Tielsch, Sommer, et al., 1991).  
Elevated intraocular pressure remains the leading risk factor for developing glaucoma and 
glaucomatous visual field loss. Davanger et al. (1991) did an investigation to determine the 
probability of glaucoma in a large population-based study of older Norwegians. Their data show at an 
IOP of 18 mmHg or lower the probability of having POAG was near zero; at 28 mmHg the probability 
was 60%; and at 35 mmHg the probability approached 100% (Davanger et al., 1991). A further cross-
sectional study in Europeans with IOPs ranging from 25 to 29 mmHg and 30 to 34 mmHg estimated 
the prevalence of glaucoma at 7% and 14% respectively (Pohjanpelto and Palva, 1974). Sommer et al. 
(1991) found in a multiracial population the risk of optic nerve damage increased nonlinearly when 
the IOP was higher than 22 mmHg. They calculated at IOPs of 22 to 29 mmHg and 30 mmHg or more, 
patients were 12.8 times and 39 times more likely to develop glaucoma respectively. Finally, the 
overall risk of glaucomatous field loss is 5 times higher in patients with an IOP higher than 21 mmHg 
than in patients with an IOP lower than 21 mmHg (Leske, 1983). Table 1.1 summarises the 
prevalence of POAG at different screening IOP levels and the relative risk at specific IOP levels from 
the population-based Baltimore Eye Survey data (Sommer, Tielsch, Katz and et al., 1991; Tielsch, 
Katz, et al., 1991). 
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IOP (mmHg) Cumulative % with POAG Prevalence of eyes with 
POAG (%) 
Relative Risk (RR) 
<15 13 0.65 1.0 
16-18 37 1.31 2.0 
19-21 59 1.82 2.8 
22-24 78 8.30 12.8 
25-29 88 8.33 12.8 
30-34 97 25.37 39.0 
≥ 35 100 26.09 40.1 
Table 1.1 Data from the Baltimore Eye Survey indicating the prevalence and relative r isk of POAG at 
different IOP screening levels and specific IOP levels respectively  (Sommer, Tielsch, Katz and et al., 1991; Tielsch, 
Katz, et al., 1991) 
Lowering IOP has been shown to slow or halt the onset of primary open angle glaucoma in patients 
with OHT by 50 to 60% (Kass et al., 2002). This seems to firstly confirm that the pathophysiological 
basis for glaucoma is an elevated IOP and, secondly, it supports the mechanical theory of the 
pathogenesis of optic nerve neuropathy in glaucoma (Quigley and Addicks, 1981; Lusky et al., 1993; 
Cartwright and Anderson, 1998; Quigley, 2001; Maier et al., 2005).  
It is estimated that 3 to 6 million people in the USA alone have elevated IOP (OHT) without detectible 
glaucomatous damage on standard clinical tests (Kass et al., 2010). In fact, in 2006 Quigley and 
Broman estimated the number of people with glaucoma (POAG and PACG) in 2010 would be about 
60.5 million which would increase to 79.6 million by 2020. Although these authors do not provide 
separate estimates for OHT, their estimates for people suffering from POAG worldwide were 44.7 
million in 2010 increasing to 58.6 million by 2020 (Quigley and Broman, 2006). At this point it is 
important to reiterate that population-based prevalence studies such as the Roscommon, Blue 
Mountains and Egna-Neumarkt studies affirm that the prevalence of OHT is known to be nearly 
double that of POAG. Therefore, it can be argued that in 2010 about 50% of the estimated 110 
million people with OHT worldwide would probably go undiagnosed. Of further significance is the 
conclusion of Quigley and Broman (2006) that glaucoma is the second leading cause of blindness 
worldwide (Quigley and Broman, 2006). Table 1.2 summarises their 2010 worldwide estimates for 
POAG according to geographic locations.  
In a systematic review and meta-analysis entitled Global Prevalence of Glaucoma and Projections of 
Glaucoma Burden Through 2040: A Systematic Review and Meta-analysis, Tham et al. (2014) 
addressed, estimated and evaluated the worldwide burden of glaucoma. According to these authors’ 
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evaluation, their review projected the worldwide prevalence of glaucoma burden up until 2040 for 
populations aged 40 to 80 years is 3.54% (95% CI [2.09 to 5.82]). The prevalence of POAG is higher in 
Africa at 4.20% (95% CI [2.08 to 7.35]), and the prevalence of PACG is higher in Asia at 1.09% (95% CI 
[0.43 to 2.32]). According to the review, in 2013 the number of people between 40- and 80-years old 
with glaucoma (both POAG and PACG) was 64.3 million worldwide. The projected increase in 
numbers is 76 million by 2020 and 111.8 million by 2040. Of further note is that after adjusting for 
age, gender, habitation type, response rate, and year of study, people of African ancestry are more 
likely to have glaucoma than people of European ancestry (OR, 2.80: 95% CI [1.83 to 4.06]). The 
review further indicated that people living in urban areas are more likely to have POAG than those 
living in rural areas (OR, 1.58; 95% CI [1.19 to 2.04]) (Tham et al., 2014). 
Table 1.2 Number of people with POAG 2010 (POAG – Primary open angle Glaucoma)(Quigley and Broman, 2006) 
 
1.4 Glaucoma in South Africa 
Kyari et al. (2009) suggests that the differences between the prevalence of blindness in different 
countries in Africa and Asia could be due to a number of factors and the criteria used for the 
definition and collection of the data. These include the causes of blindness, access to eye care 
services, or even differences in life expectancy of the various populations. They found a national 
 Total POAG 95% Confidence levels % Worldwide 
Europe 10,693,335 7,599,188 to 14,040,703 23.9% 
China 8,309,001 6,695,433 to 10,423,439 18.6% 
India 8,211,276 6,812,711 to 9,937,413 18.4% 
Africa 6,212,179 4,992,103 to 7,722,626 13.9% 
Latin America 5,354,354 2,943,534 to 9,697,792 12.0% 
Japan 2,383,802 2,106,534 to 2,697,623 5.3% 
SE Asia 2,116,036 1,744,523 to 2,580,354 4.7% 
Middle East 1,440,849 1,001,315 to 2,082,944 3.2% 
World 44,720,832 33,895,340 to 60,182,894  
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prevalence of 4.19% for the blind or visually impaired in Nigeria (Kyari et al., 2009). Ntim-Amponsah 
et al. (2004) also found that West African and people of African descent also had a high prevalence of 
glaucoma (Ntim-Amponsah et al., 2004).  
 
In 2004 Resinkoff et al. (2004) observed that in sub-Saharan Africa 27 million people were visually 
impaired of which 6.8 million were blind (Resnikoff et al., 2004). According to the World Health 
Organization (WHO), the main causes of preventable blindness in Africa are cataract (50%);  
glaucoma (12%); corneal opacity (5%); diabetes (5%); trachoma (4%); vitamin A deficiency, measles 
and neonatal conjunctivitis (4%); and onchocerciasis (0.8%). Other causes include low vision and 
refractive errors (14%) (WHO, 2007). The major causes of blindness in children in Africa vary widely 
from region to region as it is largely determined by socioeconomic development and the availability 
of primary health care and eye care services. Furthermore, corneal scarring from measles, vitamin A 
deficiency, using harmful traditional eye remedies, ophthalmia neonatorum, and rubella cataract are 
the leading causes in low-income countries whereas in high-income countries lesions of the optic 
nerve and higher visual pathways predominate as the cause of blindness (WHO, 2007). Retinopathy 
of prematurity is an important cause in middle-income countries. Other significant causes in all 
countries are congenital abnormalities such as cataract, glaucoma, and hereditary retinal dystrophies 
(WHO, 2007).  
However, the WHO (2007) also points out that the majority of the causes of childhood blindness are 
preventable or treatable; indeed, 75% of all cases of blindness in Africa are preventable (WHO, 
2007). As part of the strategy for reducing these statistics, the WHO emphasises the urgency for early 
diagnosis and treatment and recommends strengthening of the capabilities of eye care providers 
(WHO, 2007). It was also concluded by Bastawrous et al. (2014) that posterior segment eye diseases 
“are likely to grow in importance as causes of visual impairment and blindness in sub-Saharan Africa 
in the coming years as populations grow, age and become more urban in lifestyle” (Bastawrous et al., 
2014). While children (less than 16 years of age) contribute to a minority in the glaucoma 
epidemiology estimates, in the late nineties it was found that glaucoma (6.7%) was the major cause 
of blindness in pupils in the majority (16 out of 17) schools for the blind in South Africa (O'Sullivan et 
al., 1997). Of further importance is the fact that the proportion of previously undiagnosed glaucoma 
was found to be as high as 87% in South Africa (Table 1.3) (Shaarawy et al., 2009). In South Africa, 
±5% of the Black population over 40 years have primary open angle glaucoma while the prevalence in 
the white populations is around 1.5%.   (Salmon et al., 1993; Rotchford and Johnson, 2002; Rotchford 
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et al., 2003). Similar numbers are reported for Black Cameroonians (Ellong et al., 2006) but the 
prevalence is lower than the estimate of ±7% for Blacks in Ghana and in Barbados (Ntim-Amponsah 
et al., 2004; Kyari et al., 2013). According to South African Government statistics (2014), 43,333,700 
Blacks reside in South Africa, 10.5 million of them are older than 40 years. Considering a POAG 
prevalence of ±5% (over 40 year old group) the number of Black citizens in South Africa with 
diagnosed glaucoma is therefore ±525 000  
A review of publications in PubMed on glaucoma specifically in sub-Saharan Africa was done by Cook 
(2009) to investigate the priority need for inclusion into Vision 20/20 planning. Cook’s conclusion 
reads: “Glaucoma should be included as a priority disease in Vision 2020 programs” (Cook, 2009). 
Further suggestions included “cases could be followed up after surgery by mid-level eye care 
workers, using the intraocular pressure as the indicator for adequacy of control, and using a 
glaucoma register to identify and trace defaulters” because follow-up requirements for treatment 
were often disregarded (Cook, 2009). 
Additionally, in the 2003 Temba glaucoma study (Rotchford et al., 2003) it was determined that a 
large number of the African Black population in an urban South African population had blindness due 
to glaucoma (Table 1.3) and the majority was undiagnosed and untreated. Blindness also occurred at 
a young age. The prevalence in the urban African Black population was much higher than in the 
urban white population (Rotchford et al., 2003). In a previous population-based study conducted by 
Rotchford and Johnson (2002) with a Zulu ethnic population in a rural region in South Africa, the 
blindness prevalence was found to be relatively high: 4.7% with POAG contributing 2.7%. While this 
study attempted to only include data relevant to the Zulu ethnicity in a rural region, some other 
ethnicities were included by default, possibly due to the impact of migrant working conditions and 
multiple partners. Nevertheless, the finding that the prevalence of glaucoma was found to be high 
carries significant implications for the already struggling rural health care districts in KwaZulu-Natal 
(KZN), (one of the nine provinces in South Africa). The findings of researchers like Rotchford and 
Johnson (2002) and Cook (2009) confirm the varied prevalence of glaucoma in African Black 
populations in sub-Saharan Africa as well as in South Africa (Rotchford and Johnson, 2002; Cook, 
2009).  
Investigating the possible differences due to glaucoma variations in different ethnic races, a study 
was conducted in a community of mixed ethnic backgrounds in the Western Cape, another province 
in South Africa (Salmon et al., 1993). The findings were idiosyncratic and indicated that across all 
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ages, females were affected four times more frequently than males. Bilateral blindness occurred with 
a prevalence of 0.5% for both primary glaucomas in this community. The implications for the rural 
health care districts of both KZN (Rotchford and Johnson, 2002) and the study done in the Western 
Cape (Salmon et al., 1993) are of significance. Due to the different ethnic backgrounds of 
populations, Salmon et al. (1993) are of the opinion that similar findings may result in the 
populations of Southeast Asia (Salmon et al., 1993).   
Population Studied Percentage of cases previously undiagnosed (POAG) 
South Africa (Temba) 87% 
Chennai −  Southern India 98.5% 
Los Angeles Latinos (LALES) 75% 
Australia – Blue Mountains Eye Study  
    
51% 
Melbourne (Visual Impairment Project)  
   
50% 
Rotterdam 53% 
Table 1.3 Proportion of people with glaucoma cases detected in population-based surveys that were 
previously undiagnosed(Shaarawy et al., 2009) 
1.5 Summary 
Given the hypothesis that elevated IOP causes glaucoma one can postulate that the only way to treat 
glaucoma effectively is to lower IOP. But, not all patients with elevated IOP do develop glaucomatous 
optic nerve head and visual field changes; conversely, other patients with low or normal IOP can 
develop these changes. Risk factors for the development of primary open angle glaucoma include: 
elevated IOP; myopia > 3.00D; older age; male gender; African American/Hispanic/Latino ethnicity; 
low socioeconomic status; alcohol drinking and smoking; positive family history; genetic factors; 
systemic hypertension; type 2 diabetes; cholesterol and coronary heart disease; and vasospastic 
disease (Rudnicka and Owen, 2007). However, multicentre trials have shown the most important 
predictive risk factors for the development of POAG in individuals with OHT may be higher baseline 
IOP; thinner central corneal thickness; older age; higher vertical cup to disc ratios; and higher pattern 
standard deviation values with standard automated perimetry (Gordon et al., 2002; Coleman and 
Miglior, 2008). 
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The Ocular Hypertension Treatment Study (OHTS) conclusively demonstrated a 20% reduction in IOP 
reduced the incidence of POAG between 50 and 60% (Kass et al., 2002). Consequently, the 
prevalence and severity of POAG can be significantly reduced by treating OHT individuals before they 
develop glaucoma. However, the treatment of all OHT individuals is neither medically indicated nor 
economically justified because of the high prevalence of the condition, the low conversion rate to 
POAG, and the cost, inconvenience as well as possible adverse effects of treatment (Heijl et al., 
2008). By carefully evaluating specific baseline risk factors, OHT individuals at high risk for developing 
POAG can be identified and appropriately treated or observed depending on their specific risk 
profiles (Heijl et al., 2008).  
Ultimately, clinicians are faced with the difficult decision of who to treat and who not to treat. As our 
understanding of glaucoma improves, technology to evaluate the structural and functional changes 
earlier in the disease process becomes available while medical treatment (neuroprotective or 
conventional IOP lowering) is also refined to further reduce unwanted side effects. Subsequently, the 
management and the prevention of the progression of OHT will be simplified. In the meantime it 
makes sense that younger patients with several high risk factors should receive prophylaxis while 
elderly patients with few risk factors should not (Heijl et al., 2008; Sommer, 2010).  
Global and regional epidemiological studies are required to support community ocular health care to 
subsequently reduce the risk of preventable blindness. Research is progressing on various aspects of 
the aetiology and management of glaucoma, particularly with the development of newer 
technologies. Clinically useful measurements of intraocular pressure, besides contributing to better 
patient management, may contribute to bringing epidemiology studies up to date and current; a 
desideratum that is long overdue. Accuracy and reliability of intraocular pressure measurements as 
well as an understanding of the factors influencing the accuracy of the measurements with the 
different techniques is imperative in the treatment and diagnosis of glaucoma. With the predicted 
increase in the prevalence of glaucoma worldwide and the already high prevalence and proportion of 
undiagnosed glaucoma in South Africa, more streamlined screening, treatment and public health 
strategies (including the use of mid-level eye care workers) will be needed in future (Cook, 2009; 
Shaarawy et al., 2009; Tham et al., 2014). The measurement of IOP forms an integral part of an 
effective screening and treatment strategy for glaucoma. A simple, safe, non-invasive, accurate, and 
cost-effective instrument to measure IOP would benefit these health care initiatives. 
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1.6 Measurement of intraocular pressure 
IOP can be measured in three ways: palpation, manometry, and tonometry. Palpation of the eye is 
the oldest, least expensive, simplest, and least accurate method of estimating IOP (Baum et al., 
1995). This technique involves the patient closing their eyes in a downward gaze while the redundant 
skin of the upper lid is displaced and the central area of the eye ball is palpated with the tips of each 
index finger. By comparing palpation estimates of IOP with actual measured pressures, the clinician 
can “calibrate” his/her sense of touch to a limited extent (Baum et al., 1995). Palpation correlates 
poorly with Goldmann applanation tonometry (GAT) and should be avoided in eyes with significant 
trauma (Feldman et al., 1987; Baum et al., 1995; Kniestedt et al., 2008).  
Manometry is an invasive technique which accurately measures the pressure in the eye; it is used as 
the reference pressure whereby all tonometers are judged and calibrated (Kniestedt et al., 2004; 
Kniestedt et al., 2005; Kniestedt et al., 2008). Manometry is used most commonly as a laboratory 
technique to measure IOP measurements over time as well as to study aqueous humour dynamics in 
post-mortem eyes (Ellingsen and Grant, 1971; Blumenthal et al., 1992). Ethically, the use of 
manometry in living human eyes is restricted to eyes undergoing enucleation or intraocular surgery 
(Blumenthal et al., 1992).  
Tonometers are instruments used for performing IOP measurements with the least disturbance to 
the eye. In clinical practice the following four physical principles apply: indentation, applanation, 
contour matching, and rebound tonometry (Kniestedt et al., 2008). Indentation and applanation 
tonometry use force to deform the eye, more specifically the cornea, in order to measure the IOP 
(Robert, 2007; Kniestedt et al., 2008). Contour matching tonometers use an external piezo-electric 
pressure sensor to measure the pressure in the eye when the tangential forces on the cornea are 
cancelled by the concave tip of the instrument without applanation of the cornea (Robert, 2007; 
Kniestedt et al., 2008). The rebound tonometer probe has a small footprint (1.7 mm diameter plastic 
end-tip) and there is no applanating of the cornea (contact time approximately 0.2 m/s) (Beasley et 
al., 2013). Therefore the rules applying to applanation tonometry cannot be applied to this 
tonometer. It has an induction coil to magnetize a metal probe with a polymer tip. The probe 
contacts the cornea and bounces back resulting in an induction current being generated. IOP is then 
calculated from the generated induction current (Lim et al., 2012). The rebound response of the 
probe may be affected by the viscoelastic properties of the cornea as well as the central corneal 
thickness (Chihara, 2008).  
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Although many tonometers are used in clinical practice today, this review will only elaborate on the 
theories, principles, and factors influencing the accuracy of the most commonly used tonometers in 
South African optometric practices. This includes applanation tonometry − specifically Goldmann 
applanation tonometry (GAT), and noncontact tonometry (NCT) as used in the ocular response 
analyser (ORA), and rebound or ICare tonometry (RBT).  
1.6.1 Goldmann applanation tonometry − GAT 
The Goldmann applanation tonometer (GAT) is a fixed area tonometer measuring the force 
necessary to flatten a fixed area of the cornea (Goldmann and Schmidt, 1957; Kniestedt et al., 2008). 
The applanating surface has a diameter of 3.06 mm and an applanating an area of 7.354 mm² 
displacing a volume of 0.44 mm³. The area and volume are always the same regardless of the IOP or 
the force necessary for its measurement (Robert, 2007).  
Applanation tonometry is based on the Imbert-Fick law which, when applied to the eye, states the 
IOP is equal to the weight (grams) applied to the cornea divided by the applanated area (mm²) 
(Goldmann and Schmidt, 1957; Liu and Roberts, 2005; Harper and Henson, 2007; Kniestedt et al., 
2008). In other words, pressure is defined as force per unit area (pressure = force/area) providing a 
nearly direct method of IOP measurement (Schmidt, 1960; Hart, 1992; Kniestedt et al., 2008).  
However, the law is correct only for a spherical container with an infinitely thin, flexible, elastic and 
dry membrane which will create no resistance to flattening and will allow for expansion elsewhere so 
that the pressure will not increase/decrease with applanation (Liu and Roberts, 2005; Harper and 
Henson, 2007). In the living eye the anterior corneal curvature is not equal to that of the posterior 
corneal curvature, the cornea is not sufficiently soft, has a thickness of ±520 µm, and resists a force 
that applanates the cornea. Furthermore, the corneal modulus of elasticity can differ among 
individuals, and different amounts and characteristics of the tear film can affect surface tension, 
intermolecular force of the tear film and, therefore, the IOP readings (Chihara, 2008).  
Goldmann and Schmidt (1965) expected an empirical balance between the surface tension and a 
force to deform the cornea. The surface tension of the tears creates a capillary attraction that pulls 
the tonometer towards the cornea, lowering the force required to applanate the cornea (Chihara, 
2008). However, Goldmann found that with an applanation diameter of 3.06 mm and an assumed 
corneal thickness of 500 µm (measured optically), the forces of tear surface tension and corneal 
rigidity cancelled out so that the force of 1/10th gram on an area of 7.354 mm² is equivalent to 1 
mmHg (Schmidt, 1960; Goldmann and Schmidt, 1965; Kniestedt et al., 2008) (Figure 1.2). Although 
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the surface tension may be nearly constant among individuals, the force needed to deform the 
cornea varies with the corneal thickness and modulus of elasticity of the cornea thereby causing a 
cornea-dependent error in the IOP reading (Chihara, 2008).  
Although Goldmann used a value of 500 µm to calibrate the applanation tonometer (Schmidt, 1960; 
Goldmann and Schmidt, 1965), a major review on corneal thickness and IOP by Dougthy and Zaman 
(2000) describes a chronological shift in the average central corneal thickness (CCT) values as a result 
of changes in pachymeter use. Optical pachymetry measured consistently lower CCT values (20-30 
µm) compared to ultrasound pachymetry; therefore, the average reported CCT across all 300 
included data sets in their review was 534 µm (Doughty and Zaman, 2000). More recent population-
based studies using ultrasound pachymetry give a range of 537 - 567µm in healthy eyes (Argus, 1995; 
Bron et al., 1999; Shah et al., 1999; La Rosa et al., 2001; Nemesure et al., 2003). Other methodologies 
to measure CCT such as specular microscopy, optical coherence tomography, slit-scanning systems, 
and Scheimpflug camera systems added to the confusion and possibly obscured the relationship 
between CCT and IOP (Chihara, 2008).  
It has been suggested that pachymetry should be a mandatory investigation in patients with 
glaucoma or ocular hypertension (Brandt, 2004). Several nomograms or correction formulae have 
been produced to account for the variation in corneal thickness and its influence on IOP 
measurements (Ehlers et al., 1975; Whitacre et al., 1993; Stodtmeister, 1998; Doughty and Zaman, 
2000; Shimmyo et al., 2003). Among these formulae is the Ehlers model which states the correction 
value is equal to the measured corneal thickness in microns minus a mean corneal thickness of 578 
microns (from their measurement series) times a factor of 5/70. Also, included in these models is the 
mathematical or theoretical model of Orssengo & Pye which corrects IOP for errors induced by 
corneal thickness as well as corneal curvature (Ehlers et al., 1975; Orssengo and Pye, 1999).  
Gunvant et al. (2005) investigated the efficacy of the Ehlers and the Orssengo & Pye models to 
correct IOP measured by GAT for CCT. They found that both these models overestimated the effect 
of corneal parameters on GAT IOP measurements (Gunvant et al., 2005). The effect of CCT on 
measured IOP reported by Gunvant et al. (2005) was consistent with other studies in literature 
(Herndon et al., 1997; Wolfs et al., 1997; Singh et al., 2001; Bhan et al., 2002). If correction factors 
overestimate the effect of CCT on IOP, then the reclassification of subjects with ocular hypertension 
with thicker than average corneas as “normal”, and individuals with normal tension glaucoma and 
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thinner CCT as “primary open angle glaucoma” may, in fact, be questionable as it may result in the 
inappropriate management of these subjects (Gunvant et al., 2005).  
Liu and Roberts (2005) developed a model whereby the influence of individual corneal variables 
influencing corneal biomechanical properties (Young’s modulus, corneal thickness, and corneal 
curvature) as well as true IOP can be adjusted one at a time while the other variables were kept 
constant. Keeping Young’s modulus constant at 0.19 MPa, and corneal curvature at 7.8 mm and true 
IOP at 10, 15, and 20 mmHg respectively, the difference in predicted IOP readings in a normal 
population with CCT M = 536, SD = 0.031 µm would be 2.87 mmHg lower for thinner corneas but 
higher for thicker corneas (Liu and Roberts, 2005). The influence of CCT on predicted IOP in normal 
eyes is nearly linear (Liu and Roberts, 2005). In their review Douhty and Zaman (2000) found for 
normal eyes any differences in CCT between individuals are unlikely to have a clinically significant 
effect on measured IOP due to the fact that a tonometer will generally measure to the nearest 1 
mmHg. This generalisation is applicable over a wide range of CCT values (model generated from data 
sets with average CCTs ranging from 488 µm to 584 µm) (Doughty and Zaman, 2000). However, for 
eyes with chronic disease even moderate changes in CCT can have a measurable impact on 
tonometry measures (Doughty and Zaman, 2000).  
Although GAT demonstrated poor agreement with dynamic contour tonometry (DCT), adjustment 
with published correction formulae did not improve agreement. This suggests that correction 
formulae for GAT IOP are unsuitable to clinically approximate “true IOP” in Caucasian glaucoma and 
glaucoma suspect patients (Ang et al., 2011). This suggestion was confirmed in a later study by Park 
et al. (2012) who found that adjusted IOP using CCT-based formulae resulted in poorer agreement 
between DCT and GAT if compared with unadjusted GAT IOP. This suggests that although CCT may be 
useful in population-based analysis, CCT-based formulae should not be applied to individuals (Park et 
al., 2012). The question thus arising is: ‘Is it therefore justified to routinely correct tonometry 
measures for differences or changes in CCT?’ According to Brubaker (1997) “it is doubtful that such 
an adjustment, except in rare cases, will alter the weight of evidence that leads a clinician to treat or 
not to treat a given case” (Brubaker, 1997).  
In addition to CCT and scleral rigidity there are other ocular sources of error that may influence the 
accuracy of applanation tonometry (Whitacre and Stein, 1993; Kniestedt et al., 2008). Corneal 
curvature can affect the accuracy of IOP measurements possibly due to volume changes with 
changes in corneal curvature after a given area has been applanated (Liu and Roberts, 2005). Using  
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Liu and Roberts’ model and varying only the corneal radius of curvature, the difference in predicted 
IOP readings in a normal population with a radius of curvature M = 7.8, SD = 0.27 mm is 1.76 mmHg 
lower in flatter corneas and higher in steeper corneas (Liu and Roberts, 2005).   
 
Figure 1.2 Goldmann applanation tonometer.(Drawing Gerrie Kruger) 
Corneal elasticity and viscoelasticity can also affect the accuracy of IOP measurements. It is 
important to differentiate viscoelastic properties from the elastic modulus (Young’s modulus). 
Elasticity refers to how a material deforms in response to an external force. Elastic materials regain 
its original form when the stress is removed (Kotecha, 2007). Young’s modulus or the modulus of 
elasticity, calculated from the stress-strain relationship, is a function of the applied force and is not 
rate- and time-dependent (Roberts, 2012). The elastic modulus of the cornea varies directionally and 
regionally: a high modulus is exhibited meridionally at the centre and para-central areas as well as 
circumferentially at the limbus due to the specific arrangement of the corneal collagen fibrils. A high 
modulus indicates a stiffer material (Hjortdal, 1996; Kotecha, 2007). Young’s modulus varies with IOP 
in that a stiffer cornea is manifested at higher levels of true IOP (Kotecha, 2007). Young’s modulus 
can currently only be measured ex vivo (Kerautret et al., 2008). Viscous materials flow when an 
external force is applied and, unlike materials with elastic properties, do not regain their original 
shape when stress is removed.  
The cornea is viscoelastic, having elements of both elasticity and viscosity. When stress is applied to a 
viscoelastic material energy is dissipated (Kotecha, 2007; Chen et al., 2008; Fontes et al., 2010; Terai 
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et al., 2012). Liu and Roberts’ model predicts that varying Young’s modulus between 0.1-0.9 MPa 
[normal human cornea range 0.01-10 MPa (Jue and Maurice, 1986; Liu and Roberts, 2005)] while 
keeping corneal curvature and CCT constant at 7.8 mm and 536 µm respectively, the difference in 
the predicted IOP readings between the low and high modulus can be 17.26 mmHg (Liu and Roberts, 
2005). Combining changes in CCT with different values for Young’s modulus substantially influenced 
the predicted IOP values. A 10% change in the value of Young’s modulus from an assumed population 
mean of 0.19 MPa leads to an error in IOP readings of ±0.41 mmHg (Liu and Roberts, 2005). 
However, Young’s modulus can vary from 0.01 – 10 MPa in human corneas; differences in 
biomechanical properties may have a significant impact on IOP measurement error (Liu and Roberts, 
2005). 
Data from the Ocular Hypertension Treatment Study (OHTS) revealed that central corneal thickness 
is an important and powerful independent risk factor for progression from OHT to POAG. Thinner 
corneas have consistently been associated with a higher risk of developing POAG. It seems that this 
effect in the OHTS is independent of the effect of CCT on the measurement of IOP (Gordon et al., 
2002). Other studies by Medeiros et al. (2003) and Medeiros and Weinreb (2008) indicated that thin 
central corneas are associated with more frequency-doubling technology perimetry field defects, are 
risk factors for pre-perimetric glaucoma progression to field loss, and are also risk factors for the 
development of short wavelength automated perimetry (SWAP) test defects in ocular hypertension 
(Medeiros, Sample and Weinreb, 2003; Medeiros and Weinreb, 2008). According to the OHTS, the 
risk of progression to POAG is statistically higher among African Americans (16%) despite similar 
baseline and follow-up IOPs. The increased risk seems to be largely related to other baseline risk 
factors including vertical cup to disc ratio and, importantly, central corneal thickness which were 
respectively larger and thinner in the African American participants taking part in the OHTS (Kass et 
al., 2010). Adjusting for these factors in a multivariate analysis, race is no longer a statistically 
significant predictor of progression to POAG (Gordon et al., 2002). 
Non-ocular sources that may influence the accuracy of GAT include: the quantity and concentration 
of fluorescein which may produce wider mires and lead to underestimation of the IOP (Grant, 1963; 
Kniestedt et al., 2008); incorrect alignment of the semicircles can also result in erroneous 
measurements (Harper and Henson, 2007); pressure on the globe by the eye lids or clinician can lead 
to overestimation of the IOP (Harper and Henson, 2007); prolonged contact between the probe and 
the cornea can cause an apparent decrease in IOP due to the effect of aqueous massage (Harper and 
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Henson, 2007); the ocular pulse amplitude (OPA) can also affect the time dependent IOP 
measurement (Robert, 2007); and corneal astigmatism or an irregular cornea can also lead to 
erroneous measurements (Harper and Henson, 2007). Dielemans et al. (1994) found a mean 
intraobserver variation of 1.64 mmHg and interobserver variation of 1.79 mmHg with GAT 
(Dielemans et al., 1994). Thorburn (1978) found a difference of 2 mmHg or more in 40% of eyes and 
3 mmHg in 17% of eyes measured using GAT by two experienced ophthalmologists (Thorburn, 1978). 
Phelps and Phelps (1976) reported differences between GAT measurements between two examiners 
of at least 2 mmHg in 50% of eyes and 3 mmHg in 30% of eyes (Phelps and Phelps, 1976). Kotecha et 
al. (2005) reported high intraobserver reliability (within 1.7 mmHg) and interobserver variability 
(equal to 0.4 mmHg) with GAT (Kotecha et al., 2005).  
Considering the above information it is difficult to understand what a single IOP measurement 
actually means and how it should be interpreted. While research into the measurement of true IOP 
continues, it still remains a vital measurement in clinical practice and the only modifiable risk factor 
in the management of glaucoma. According to the International Standards Organization (ISO) (2001), 
GAT corrected for CCT remains the reference instrument for clinical measurements of  IOP; in other 
words, the gold standard for tonometry (ISO, 2001). However, tonometric correction factors attempt 
to give GAT a degree of precision that is not warranted and should therefore be used with caution 
(Brubaker, 1997; Herndon et al., 1997; Wolfs et al., 1997; Singh et al., 2001; Bhan et al., 2002; 
Gunvant et al., 2005; Ang et al., 2011; Park et al., 2012).   
1.6.2 Noncontact air puff tonometry and the ocular response analyser 
The noncontact air puff tonometer (NCT) works on the same basic principle as the GAT (Forbes et al., 
1973; Harper and Henson, 2007; Kniestedt et al., 2008). A puff of air is directed at the cornea with 
the force of the air stream rising linearly over several milliseconds (Forbes et al., 1973; Kniestedt et 
al., 2008). The air puff is designed so that it hits the cornea within a known and reproducible area, 
much like the GAT. The air puff then progressively flattens/applanates the cornea over the 
predetermined area (Forbes et al., 1973; Harper and Henson, 2007; Kniestedt et al., 2008). The area 
of the column of air is known and the force of the air puff increases linearly over a period of ±8 ms. 
An illumination and detection system identifies the point at which the cornea is in its flattened state 
and acts like a mirror to reflect the illumination maximally to the detector. The force of the air puff is 
monitored by a microcomputer and recorded at the moment of applanation. The IOP is calculated 
either from the force of the air puff and the known predetermined area of applanation or time to 
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applanation and then displayed digitally (Forbes et al., 1973; Harper and Henson, 2007; Kniestedt et 
al., 2008). Although noncontact tonometry is affected by the same ocular sources of error including 
CCT, scleral rigidity, corneal curvature, and corneal biomechanics (Kniestedt et al., 2008), data have 
been presented that show that noncontact tonometry is influenced more than conventional 
applanation tonometry by the corneal thickness. Starting from a central thickness of 0.51 mm, the 
NCT is assumed to underestimate the actual intraocular pressure in eyes with thinner and to 
overestimate it in eyes with thicker cornea by 1 mmHg per 0.01 mm difference of corneal thickness. 
This value changes with individual corneal tissue qualities and is not valid especially in presence of 
corneal oedema (Graf, 1991). Compared to GAT, NCT is the tonometer with the least amount of 
variability in IOP. Sixty-six per cent (66%) of measurements with NCT were estimated to be within 2 
mmHg of the GAT measurement (Cook et al., 2012). 
 
Figure 1.3 The Reichert Ocular Response Analyser used in this study.(Photo D Booysen) 
The ocular response analyser (ORA) was developed by Reichert, Inc. in Depew, New York (NY), USA. It 
measures the response of the cornea to indentation by a rapid air pulse (Reichert, 2013) using the 
delay of corneal response after the applanation process to estimate the amount of energy absorbed 
and to derive the viscous as well as viscoelastic properties of the cornea (Jorge, Gonzales-Meijome, 
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et al., 2008). The principles of the ORA are based on those of the noncontact tonometer (Luce, 2005; 
Kotecha, 2007; Kniestedt et al., 2008) (Figure 1.3). A controlled amount of air pulse lasting 20 ms 
deforms the central 3 mm of the cornea inward, past the applanation point (P1), and into a concave 
shape. The air pulse is then reduced in an inverse time-symmetrical profile, and the corneal shape 
returns back to normal, through the applanation point (P2) (Figure 1.6) (Luce, 2005; Kotecha, 2007; 
Kniestedt et al., 2008; Lau and Pye, 2011; Wolffsohn et al., 2012). According to Reichert, P2 occurs at 
a lower pressure than P1 due to the viscoelastic dampening effects of the cornea. The average of 
these two pressure values provides the Goldmann-correlated IOP value (IOPg): 
Equation 1.1 IOPg 
 𝑰𝑶𝑷𝒈 = (𝑷𝟏 + 𝑷𝟐)/𝟐  (Kniestedt et al., 2008; Lau and Pye, 2011)  
 
The difference between the two pressures is termed corneal hysteresis (CH):  
Equation 1.2 CH 
 𝑪𝑯 = 𝑷𝟏 − 𝑷𝟐  (Luce, 2005; Kotecha, 2007; Kniestedt et al., 2008; Lau and Pye, 2011)  
 
Equation 1.3 IOPCC 
Corneal compensated IOP (IOPcc) utilises information of individual corneal elasticity and viscosity 
and is less affected by corneal properties such as CCT which does affect IOPg significantly:  
In addition to CH, the ORA also measures the corneal resistance factor (CRF) which is derived from 
the formula (P1-kP2) where ‘k’ is a constant derived from an empirical analysis of the relationship 
between P1, P2 and the central corneal thickness (CCT): 
Equation 1.4 CRF 
 𝑪𝑹𝑭 = (𝑷𝟏 − 𝟎. 𝟕𝟎𝒙𝑷𝟐) − 𝟑. 𝟎𝟖  (Lau and Pye, 2011)  
 
 𝑰𝑶𝑷𝒄𝒄 = 𝟏. 𝟓𝟏(𝑷𝟏 − 𝟎. 𝟒𝟑𝒙𝑷𝟏) + 𝟏𝟑. 𝟖𝟐  
 (Luce, 2005; Kniestedt et al., 2008; Lau and Pye, 2011) 
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CRF is therefore more closely associated with CCT than CH and offers a measurement of the corneal 
viscoelastic resistance (Luce, 2005; Kotecha, 2007; Kniestedt et al., 2008; Lau and Pye, 2011). Unlike 
CH, CRF is unaffected by changes in the IOP (Luce, 2005; Kotecha, 2007). It has been shown that CH 
and CRF are reduced in patients with keratoconus; Fuchs endothelial dystrophy; glaucoma; high 
myopia; and in conditions which may cause changes in the CCT (Luce, 2005; Kotecha, 2007; Ortiz et 
al., 2007; Shen et al., 2008).  
The morphological signal or waveform produced by the Ocular Response Analyser is a unique 
“signature” for the eye being measured. The waveform signal is complex and stores considerably 
more information than just the interrelation of the inward and outward applanation pressure 
conveyed by CH and CRF (Galletti et al., 2015). The ORA software provides 37 additional descriptors 
that further describe each signal (Mikielewicz et al., 2011). The prospect of improved diagnosis by 
multivariate waveform analysis is attractive and have been explored by researchers (Mikielewicz et 
al., 2011; Wolffsohn et al., 2012; Galletti et al., 2015). In terms of diagnosing keratoconus 
characteristics of the waveform profile (Wolffsohn et al., 2012) and indices describing the second 
peak in the ORA waveform signal had excellent performance (Mikielewicz et al., 2011).  
 
In glaucoma patients with low hysteresis there is greater backward bowing of the lamina cribrosa in 
response to transient IOP elevation (Wells et al., 2008). The low CH and CRF in keratoconic corneas 
(Figures 1.4 and 1.5) are due to the reduced ability of the cornea to dissipate energy which, in turn, is 
a function of both viscosity and elasticity (Roberts, 2012). Although the low CH and CRF may be 
partially caused by a decrease in corneal thickness, it is primarily due to the altered structure of 
keratoconic PGs (proteoglycans) and GAGs (glycosaminoglycans) which leads to lower lamellar 
adhesion and a lower shear modulus (Terai et al., 2012). It is important to consider that the ORA 
screens only the central 3 to 4 mm of the cornea which could result in an incorrect analysis of the 
corneal biomechanics in the early stages of off-centre corneal ectasia (Touboul et al., 2011). 
Furthermore, it has been observed that CH and CRF were markedly reduced following Laser assisted 
keratomeulesis (LASIK); this was possibly due to the creation of the LASIK flap and the subsequent 
alteration of the anterior stromal lamellae (Luce, 2005; Kotecha, 2007; Ortiz et al., 2007; Chen et al., 
2008). (Figures 1.4 and 1.5). 
 
37 
 
 
Figure 1.4 Comparison of the CH distribution in normal, post LASIK, and keratoconic eyes(Note the lower CH values in 
post LASIK and keratoconus eyes. Reproduced from the original paper with written permission, [Appendix 2.1]) (Ortiz et 
al., 2007) 
 
Figure 1.5 Comparison of the CRF distribution in normal, post LASIK, and keratoconic eyes(Note the lower CHF values in 
post LASIK and keratoconus eyes. Reproduced from the original paper with written permission [Appendix 2.1]) (Ortiz et 
al., 2007) 
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Factors influencing the CH and CRF include diurnal variation; tear film (a dry cornea leads to false CH 
values); IOP (the higher the IOP the lower the CH and higher the CRF); age (CH and CRF decrease on 
average by  0.24 to 0.28 mmHg and 0.31 mmHg per decade of life respectively); corneal curvature 
(flatter corneas have lower CH and CRF values); and corneal swelling (corneal thickness increases but 
CH decreases due to the modified matrix viscosity and reduced dampening capacity of the cornea) 
(Moreno-Montanes et al., 2008; Sullivan-Mee et al., 2009; Kotecha et al., 2010; Terai et al., 2012; 
Wang et al., 2013).  
As mentioned, CH is dependent on IOP and measured IOP is dependent on CH. Interestingly, 
lowering IOP with topical prostaglandin therapy [and trabeculectomy (Sun et al., 2009)] increased the 
CH, but the magnitude of IOP reduction seems to be associated with the baseline CH. In other words, 
lower CH values prior to therapy tend to be associated with larger treatment effects. CH may 
therefore be a useful measure to predict IOP change and treatment effect in clinical settings 
(Agarwal et al., 2012). Hence, CH can be seen as a dynamic corneal property indicating how much 
energy the cornea can absorb under stress. Studies suggest that along with IOP, CH and age are good 
indicators of glaucoma progression manifested in visual field changes as well as ONH damage 
(Medeiros et al., 2013). Xu et al. (2008) found that long-term soft contact lens wear leads to changes 
in corneal viscoelastic properties. Lower CH and CRF were apparent the first day after contact lens 
removal as well as two weeks after discontinuing contact lens wear while CCT remained constant (Xu 
et al., 2008).  
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Figure 1.6 Typical ORA display showing the wave score, IOPcc, IOPg, CH, and CRF values recorded in this study.(The green 
curve represents the pressure of air on the cornea; the red curve indicates the raw signal of the applanation detection 
system. The blue curve is a filtered version of the red curve designed to identify the optimum point of applanation. The 
blue squares indicate the inward (P1) and outward (P2) applanation pressures on the green pressure curve. Ideally the 
peak-amplitude of the applanation signals (blue and red spikes) should be above the green pressure curve, similar in 
height, free of noise and the pressure curve should be fairly symmetrical) (Photo D. Booysen) 
According to Kerautret et al. (2008), normal CH is considered to be between 8 and 12 mmHg 
(Kerautret et al., 2008). In a study conducted by Luce (2005) it was found that the CH in a normal 
population (339 eyes; average age was 28 years) was 9.6 mmHg and in keratoconic eyes (60 eyes; 
average age was 31 years) it was 8.1 mmHg (Luce, 2005). However, in different studies on normal 
eyes the CH ranged between 9.6 and 12.7 mmHg and the CRF between 9.5 and 11 mmHg (Ortiz et al., 
2007; Shehadeh-Mashor et al., 2012). In other studies involving at least 100 normal eyes, the mean 
CH and CRF ranged between 10.0 and 11.0 mmHg with the standard deviation (SD) lying between 1.3 
and 2.0 and 1.5 and 2.0 mmHg respectively (Lau and Pye, 2011). It was observed that ORA 
measurements during a single test series were highly reproducible with interclass correlation 
coefficients (ICC) for a CH and CRF of 0.73 and 0.881 respectively. Moreover, the reproducibility of 
measurements between two examinations showed an ICC of 0.799 indicating highly consistent 
measurements during a series of repeated tests (Terai et al., 2012).  
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The ORA allows an in vivo measurement of the viscoelastic and corneal resistance properties in 
addition to corneal compensated (IOPcc) and Goldmann-correlated IOP (IOPg). According to Reichert 
(2013), CH represents ocular resistance due to the combined effects of CCT, ocular rigidity, and the 
cornea’s elastic properties. CRF is dominated by the viscous and elastic properties of the cornea and 
appears to be an indicator of the overall resistance of the cornea (Reichert, 2013). However, unlike 
true corneal properties such as CCT and Young’s modulus which are invariant to the measurement 
technique, CH and CRF are specific responses to the ORA measurement process and can therefore 
not be considered corneal properties (Lau and Pye, 2011).  
Although GAT IOP has a significant association with CCT, IOPcc produced by the ORA was found to 
have no significant association with ocular variables such as CCT, corneal curvature, and axial length 
(Medeiros and Weinreb, 2006; ElMallah and Asrani, 2008). Studies of the ORA have produced 
conflicting results; two studies with untreated patients show promising results with the ORA, IOPcc 
seeming to compensate for corneal factors (Kotecha et al., 2006; Medeiros and Weinreb, 2006). In 
another study of glaucoma patients undergoing therapy with topical medication, the ORA IOPcc and 
IOPg consistently overestimated GAT IOP by 8.3 mmHg and 7.2 mmHg respectively. In this group of 
patients the ORA IOP measurements were not independent of CCT (Martinez-de-la-Casa, Garcia-
Feijoo, Fernandez-Vidal, et al., 2006). Medeiros and Weinreb (2006) reported a difference of M = 
0.068, SD = 2.77 mmHg between ORA IOPcc and GAT IOP. The difference was significantly influenced 
by CCT. Thicker CCT resulted in higher GAT compared to ORA IOPcc and thinner CCT resulted in lower 
GAT compared to ORA IOPcc (Medeiros and Weinreb, 2006). Kotecha et al. (2006) reported that ORA 
IOPcc overestimates GAT by 1.7 mmHg (Kotecha et al., 2006). In a study by Lam et al. (2007), 80% 
(100 of 125 eyes) in IOPg and 79% (99 of 125 eyes) in IOPcc could achieve this ±3 mmHg agreement 
with GAT. The 95% limits of agreement with GAT are similar from IOPg and IOPcc respectively. Lam et 
al. (2007) found good agreement between GAT and ORA and the mean difference was just 0.33 
mmHg between IOPg and GAT, and 0.24 mmHg between IOPcc and GAT respectively. The conclusion 
of the study was that in general, ORA is comparable with GAT findings in normal subjects when IOP is 
in the teens (Lam et al., 2007).  
Vandewalle et al. (2009) found that although the ORA overestimated IOP compared to GAT, 41.8% of 
ORA IOPg and 35.2% of IOPcc measurements were within 3 mmHg of GAT (Vandewalle et al., 2009). 
Studies conducted by Carbonaro et al. (2010) and Kotecha et al. (2010) also found that the ORA IOPg 
and IOPcc overestimated GAT by ±2 mmHg and that the differences were independent of CCT 
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(Carbonaro et al., 2010; Kotecha et al., 2010). Ehrlich et al. (2010) reported that ORA IOPg 
overestimated GAT by 0.1 mmHg. Of the ORA IOPg measurements 53.9% were within 2 mmHg and 
92.3% within 5 mmHg of GAT (Ehrlich et al., 2010). 
Lau and Pye (2011) observed that the IOPg and IOPcc overestimate GAT IOP by 3.2 to 3.7 mmHg (Lau 
and Pye, 2011). In a more recent systematic review of agreement between different tonometers and 
GAT, 42 % of the measurements with the ORA were estimated to be within 2 mmHg of the GAT 
measurement (Cook et al., 2012). However, it is not clear from the review of Cook et al. (2012) 
whether the ORA’s corneal corrected IOP (IOPcc) or Goldmann IOP (IOPg) was used in the 
comparison.  
It is clear from the literature that the ORA (IOPg and IOPcc) tend to overestimate GAT IOP (Table 1.4). 
The exact magnitude of this difference is not clear and depends on the biomechanical properties of 
the cornea. However, differences of more than 3 mmHg are rare. The suitability of the NCT process 
used by the ORA for determining corneal biomechanics and the “true” IOP have not been 
demonstrated with traditional biomechanical testing and manometry in human subjects. Validation 
of the ORA IOP measurements using manometric data needs to be performed (Lau and Pye, 2011).  
 
 
Study Subjects IOP: ORA compared to GAT. Mean(M), 
Standard deviation(SD) 
Marinez-de-la-Casa et al.(2006)  48 eyes of 48 patients with 
glaucoma. 
IOPcc overestimated GAT by 8.3 mmHg 
IOPg overestimated GAT by 7.2 mmHg 
ORA IOP measurements were not 
independent of CCT 
Medeiros and Weinreb, (2006)  153 eyes of 78 subjects without 
prior intraocular or refractive 
surgery, secondary causes of high 
intraocular pressure, or other 
intraocular disease 
ORA IOPcc and GAT measurement 
difference was M = 0.068, SD = 2.77 
mmHg. The difference was significantly 
influenced by CCT. Thicker CCT resulted in 
higher GAT compared to IOPcc and 
thinner CCT resulted in lower GAT 
compared to IOPcc  
Kotecha et al. (2006) ORA and GAT IOP and CCT were 
measured in 144 eyes of 144 
ORA overestimated GAT by 1.7mmHg 
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untreated subjects. 
Lam et al. (2007)   125 subjects free of glaucoma and 
any ocular symptoms not taking 
any medication. Subjects had no 
history of ocular surgery. Subjects 
with a family history of glaucoma 
were excluded. 
IOPg 0.33 mmHg higher and IOPcc 0.24 
mmHg higher than GAT. ORA IOP is 
comparable with GAT findings in normal 
subjects when IOP is in the teens. 
Study Subjects IOP: ORA compared to GAT.  Mean(M), 
Standard deviation(SD) 
Vandewalle et al. (2009)   92 patients, 72 with primary open 
angle glaucoma, 6 secondary 
glaucoma, 5 chronic angle closure 
glaucoma, and 2 ocular 
hypertension 
ORA IOPg overestimated GAT by > 3.1 
mmHg and ORA IOPcc overestimated GAT 
by > 3.6 mmHg 
41.8% of ORA IOPg and 35.2% of IOPcc 
measurements were within 3mmHg of 
GAT. 
Carbonaro et al. (2010)   694 individuals were recruited 
from the TwinsUK (UK Adult Twin 
Registry), based at St Thomas’ 
Hospital, London. The subjects 
were twin volunteers from the 
general population, and were part 
of a twin study on glaucoma 
heritability. 
ORA IOP measurements significantly 
higher than GAT independent of CCT. GAT 
− M = 14.1, SD = 2.8 mmHg, IOPcc - M = 
15.9, SD = 3.2 mmHg, IOPg – M = 16.6, SD 
= 3.2 mmHg 
Kotecha et al. (2010)   100 patients comprising a mixture 
of normal volunteers, glaucoma 
suspects, and glaucoma patients 
attending the Glaucoma Research 
Unit at Moorfields Eye Hospital. 
ORA IOPcc overestimated GAT by 2 
mmHg. IOP differences were predicted 
better by CRF than CCT. IOP 
measurements with each device are not 
interchangeable. 
Ehrlich et al. (2010)   260 consecutive patients over the 
age of 18 years undergoing 
glaucoma evaluation at the Weill 
Cornell Medical College. 
ORA IOPg overestimated GAT by 0.1 
mmHg. 
53.9% of ORA IOPg measurements were 
within 2mmHg and 92.3% within 5 mmHg 
of GAT 
Lau and Pye, (2011)   99 subjects (age, 21 ± 2 years) who 
were free of ocular and systemic 
disease. 
IOPg overestimated GAT by 3.2 mmHg 
IOPcc overestimated GAT by 3.7 mmHg 
Cook et al. (2012)  Variety of individuals: both patient 
and non-diseased cases, some with 
treatment and others untreated 
Systematic review of 12 studies. 42% of 
the IOP measurements with the ORA 
were estimated to be within 2 mmHg of 
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cases of ocular hypertension and 
glaucoma. 
the GAT. Mean difference 1.5 mmHg 
Not clear if this refers to IOPcc or IOPg.  
Table 1.4 Comparison of ORA IOPg and IOPcc with GAT.Both ORA IOPg and IOPcc overestimate GAT IOP. 
(Differences of more than 3.5 mmHg are rare. In a systematic review 42% of the overestimation was within 2 mmHg and 
the mean difference was 1.5 mmHg) (Cook et al., 2012) 
1.6.3 Rebound tonometry or ICare tonometry 
The ICare tonometer (TA01, Tiolat Oy, Helsinki, Finland) was developed, validated and successfully 
used on animal eyes before use on human eyes (Goldblum et al., 2002; Danias et al., 2003; Wang et 
al., 2005). It showed good correlation with the IOP measurements manometrically obtained on the 
eyes of mice and rats but so far no manometric comparison on human eyes has been done (Kontiola 
et al., 2001; Danias et al., 2003).  
The ICare rebound tonometer uses a probe of stainless steel with one end covered by a small plastic 
cap with a radius of 0.90 mm, total length of 50 mm, and total weight of 26.5 mg (Chihara, 2008; 
Kniestedt et al., 2008). A magnetic field holds the one end of the probe in place in the tonometer. 
The tonometer is held 4 - 8 mm from the cornea before pressing a button that releases an extension 
spring shooting the probe toward the cornea. A microprocessor analyses the deceleration or bounce 
of the probe after it has impacted the cornea and a digital reading displays the IOP (Chihara, 2008; 
Kniestedt et al., 2008). Deceleration is less at low than high IOPs and therefore the higher the IOP the 
shorter the duration of the corneal impact (Kniestedt et al., 2008). No topical anaesthetics are used 
and the probes are exchanged after every patient (Chihara, 2008).  
The ICare tonometer is pre-programmed for six measurements. The IOPs measured are displayed for 
each measurement and the software discards the highest and lowest value to calculate the average 
IOP from the remaining measurements (Kontiola and Puska, 2004). The software can also detect 
erroneous measurements that may occur when the probe speed was too high or too low, if the 
probe did not move, if the probe hit the lid, or if the probe did not hit the central cornea. In these 
cases the tonometer displays an error message and does not accept the measurement as correct 
(Kontiola and Puska, 2004). Furthermore, the software considers the relationship between all the 
measures taken by estimating the standard deviation to ensure a coherent final result. If the 
instrument detects a discrepancy an error sign (‘-‘) is displayed. If the standard deviation of the 
measurements is higher than normal the ‘P’ blinks: 
 ‘P_’ (P bottom) indicates a slightly higher than normal standard deviation but the effect will 
most likely not affect the final result;  
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 ‘P-’ (P middle) indicates the standard deviation is clearly higher than normal, but a new 
measurement is only recommended if the IOP is higher than 19 mmHg; 
  ‘P¯’(P top) indicates the standard deviation of the measurements is large and a new set of 
measurements is recommended (Fernandes et al., 2005). (Figure 1.7)   
 
Figure 1.7 ICare rebound tonometer.If the instrument detects a discrepancy an error sign [‘-‘]is displayed.  The most 
reliable measurement is indicated by P solid and the least reliable measurement by ¯P top. (Photo  D. Booysen) 
(Fernandes et al., 2005). 
IOPs measured at the central cornea as well as 3 mm from the periphery have been shown to be 
similar (Chui et al., 2008). IOP measurements with the ICare tonometer are reproducible when used 
in humans. Furthermore, intra- and interobserver correlation coefficients are high and close to those 
of GAT as long as the device is correctly positioned (Martinez-de-la-Casa et al., 2005; Detry-Morel et 
P  P solid  
P_ P Bottom 
P- P middle 
P¯ P top 
Most 
reliable 
Least 
reliable 
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al., 2006; Sahin, Basmak, et al., 2007). With the rebound tonometer (RBT) the small tip of the probe 
impacts the cornea and energy is absorbed due to the biomechanical properties of the cornea which 
may influence the measurements (Jorge, Gonzales-Meijome, et al., 2008). From the researcher’s 
personal experience, when measuring IOP over a rigid gas permeable (RGP) lens, RBT shows a zero 
value (reproducible). Therefore, the effects of biomechanics on this measurement should not be 
underestimated. ICare or RBT is thus affected by the same physical properties of the eye that affects 
GAT. These properties include CCT, corneal curvature, corneal biomechanics as well as refractive 
error with RBT overestimating GAT IOP in myopic eyes, but it is not influenced by the ocular pulse 
amplitude (OPA) (Detry-Morel et al., 2006; Lopez-Caballero et al., 2007; Avitabile et al., 2010; 
Hohmann et al., 2012; Rao et al., 2012). In the higher IOP range (> 18 mmHg) the ICare tonometer 
tends to significantly overestimate IOP when compared to GAT (Lopez-Caballero et al., 2007; 
Munkwitz et al., 2008; Avitabile et al., 2010). It has also been shown that RBT may be more sensitive 
to CCT than GAT and that a CCT change of 10 µm can result in a measurement deviation of 0.7 mmHg 
(Brusini et al., 2006; Nakamura et al., 2006; Sahin, Niyaz, et al., 2007; Avitabile et al., 2010). Salvetat 
et al. (2011) also found that CCT in subjects with normal corneas significantly affected IOP 
measurements with GAT and RBT, an increase of 0.41 mmHg and 0.50 mmHg respectively for a 10 
µm increase in CCT was observed. These authors further found that although corneal curvature did 
not seem to influence GAT, it significantly affected RBT. RBT tends to underestimate IOP in healthy 
steep corneas and overestimate IOP in healthy flat corneas by 0.76 mmHg per 1.00 D change in 
corneal curvature. Steep corneas may therefore hypothetically decrease the probe velocity leading to 
the underestimation of the IOP (Salvetat et al., 2011).  
Chui et al. (2008) found that other biomechanical “corneal” (ORA − specific) properties such as CH 
and CRF were more important than CCT in influencing IOP measurements with the RBT (Chui et al., 
2008). Although their study considered the influence of CCT, CH and CRF on IOP measured with the 
RBT, it did not report or comment on the correlation between the RBT IOP, GAT IOP (IOPg), and the 
corneal corrected IOP (IOPcc) measured with the ORA (Chui et al., 2008). In a 2008 a study by Jorge 
et al. the influence of CCT and corneal biomechanical properties of the cornea (measured by the 
ORA) on ICare tonometry was evaluated. In the study ICare tonometry and ultrasound pachymetry 
were measured centrally, nasally and peripherally and the ICare IOP measurements were correlated 
with corneal thickness as well as ORA CH, CRF, IOPg, and IOPcc (Jorge, Gonzales-Meijome, et al., 
2008). The findings showed that, although CCT plays a role in the accuracy of RBT measurements, the 
elastic and viscous properties of the cornea seem to play a more significant role in the interaction of 
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the tonometer probe with the ocular surface. CRF showed a higher correlation with ICare RBT than 
CCT or CH (Jorge, Gonzales-Meijome, et al., 2008). They also found a high correlation between ICare 
RBT and IOPg but a lower correlation with IOPcc which suggests that ICare RBT measurements are 
affected by corneal properties including viscosity and viscoelasticity, and not only by the actual IOP 
of the eye (Jorge, Gonzales-Meijome, et al., 2008). Currently studies comparing the IOP measured 
with GAT and RBT have somewhat divergent results (Table 1.5). ICare tonometry measurements 
were similar to GAT measures in pathologic corneas, and in some cases could obtain measurements 
where GAT could not (Moreno-Montanes et al., 2007).  
It seems as if the ICare RBT is able to estimate IOP within a range of ±3.00 mmHg in more than 80% 
of the population (Fernandes et al., 2005; Iliev et al., 2006; Munkwitz et al., 2008). It is influenced by 
CCT, corneal curvature, and corneal biomechanics (Brusini et al., 2006; Nakamura et al., 2006; Sahin, 
Niyaz, et al., 2007; Chui et al., 2008; Jorge, Gonzales-Meijome, et al., 2008; Salvetat et al., 2011) and 
although RBT measurements are highly correlated with GAT measurements, they are not 
interchangeable (Salvetat et al., 2011). 
Not many studies compare ICare RBT with ORA IOP measurements (Table 1.6). Jorge et al. 2008 
found that the ICare RBT overestimated ORA IOPg and IOPcc while Vandewalle et al. (2009) found 
the opposite (Jorge, Gonzales-Meijome, et al., 2008; Vandewalle et al., 2009). Theoretically, due to 
the dependence of the RBT on the cornea’s biomechanics, IOP measurements with this instrument 
should correlate well with ORA IOPg while poorly with IOPcc (Chui et al., 2008; Jorge, Gonzales-
Meijome, et al., 2008).  
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Study/Subjects IOP: RBT compared to GAT. Mean(M), Standard deviation 
(SD)  
Kontiola and Vesti, (2003) 
 114 subjects  
Of all the IOP readings 55% were between ± 2 mmHg and 75% 
were between ±3 mmHg from the mean GAT readings 
Fernandes et al. (2005)  
46 subjects, left eye only 
Higher than GAT by M = 1.34, SD = 2.03 mmHg 
Van der Jagt and Jansonius (2005) 
103 subjects 
Higher than GAT by +0.6 (95% CI -0.0 to +1.2) mmHg  
Martinez-de-la-Casa et al. (2005) 
85 subjects, 147 eyes     
Higher than GAT by M = 1.8, SD = 2.8 mmHg 
Kumar et al. (2006) 
107 subjects, 213 eyes  
Higher than GAT by ±2.2mmHg 
Martinez-de-la-Casa et al. (2006) 
90 subjects, 146 eyes       
Higher than GAT by M = 1.4, SD = 2.7 mmHg 
Garcia-Resua et al. (2006) 
65 young subjects  
Higher by M = 3.35, SD = 2.28 mmHg than Perkins applanation 
tonometry 
Brusini et al. (2006)  
 178 subjects, 89 eyes 
RBT highly correlated with corrected GAT, M = 18.4, SD = 5.2 
mmHg and M = 18.5, SD = 5.7 mmHg respectively 
Davies et al. (2006) 
42 eyes  
Higher by M = 0.5, SD = 2.33 mmHg and M = 0.52, SD = 1.92 
mmHg than GAT 
Detry-Morel et al. (2006) 
138 subjects 
Higher on average by 1.5 mmHg than GAT 
Nakamura et al. (2006) 
45 subjects      
Higher by M = 1.4, SD = 2.9 mmHg than GAT 
Iliev et al. (2006) 
28 subjects, 52 eyes  
Higher by M = 1.0, SD = 2.7 mmHg than GAT 
Moreno-Montanes et al. (2007)  
258 corneas  
Higher by ±2 mmHg in 73-77.4% of normal and abnormal 
corneas than GAT   
Lopez-Caballero et al. (2007) 
68 subjects,132 eyes 
Higher by M = 3.4, SD = 3.6mmHg than GAT  
Ruokonen et al. (2007)  
 243 subjects, 445 eyes 
Higher by M = 2.5, SD = 1.1 mmHg than GAT 
Sahin et al. (2007)  
61 subjects, 61 eyes  
Higher by M = 0.43, SD = 2.33 mmHg than GAT 
Schreiber et al. (2007)   
102 eyes 
Comparable to GAT. GAT M = 13.2, SD = 3.1 mmHg & RBT M = 
13.4, SD = 3.1 mmHg 
Abraham et al. (2008) 
100 subjects – experienced clinician 
In experienced hands, higher than GAT by M = 0.2, SD = 2.15 
mmHg 
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58 subjects – inexperienced technician   In inexperienced hands, lower by M =-0.5, SD = 2.8 mmHg 
Study/Subjects IOP: RBT compared to GAT. Mean(M), Standard 
deviation(SD)  
Rehnman and Martin (2008) 
45 subjects  
Higher by M = 1.5, SD = 3 mmHg than GAT 
Johannesson et al.(2008)  
150 eyes 
Higher by 2 mmHg than GAT 
Chui et al.(2008)    
125 normal subjects   
Higher by M = 1.94, SD = 2.75 mmHg than GAT 
Munkwitz et al. (2008)  
75 subjects, 75 eyes  
Higher by M = 0.79, SD = 4.73 mmHg than GAT, in 62.7% the 
measurement was within ±3 mmHg of the GAT 
Vandewalle et al. (2009) 
93 subjects, 93 eyes  
No significant difference between the mean IOP with RBT and 
GAT. GAT M = 15.1, SD = 4.8 mmHg & RBT M = 15.7, SD = 5.7 
mmHg 
Avitabile et al. (2010)  
78 emmetropes 
83 hyperopes 
87 myopes 
79 astigmats 
Higher than GAT by: 
Emmetropic M = 0.6, SD = 1.5 mmHg 
Hyperopic M = 0.7, SD = 1.5 mmHg 
Myopic M = 1.6, SD = 1.8 mmHg 
Astigmatic M = 0.6, SD = 1.2 mmHg 
Flemmons et al. (2010) 
71 subjects, 71 eyes  
Higher by M = 2.9, SD = 3.6 mmHg than GAT. 67% of RBT 
measurements were within 3 mmHg of GAT 
Scuderi et al. (2011)  
97 subjects  
Higher by M = 0.78, SD = 3.55 mmHg than GAT. Not clinically 
relevant 
Flemmons et al. (2011)  
71 eyes of 71 subjects     
Higher by M = 2.3, SD = 3.7 mmHg than GAT 
Salvetat et al. (2011) 
58 normal, 43 glaucoma, 90 post keratoplasty, 34 
penetrating keratoplasty, 20 ALK, 19 DASEK, and 17 
corneal graft subjects one eye only 
Lower in all groups by M = 3.5, SD = 3.5 mmHg than GAT 
Hohmann et al. (2012) 
150 subjects, 150 eyes  
Higher by M = 0.84, SD =2.63mmHg than GAT 
Rao et al. (2012) 
102 subjects  
Higher by 1 mmHg than GAT 
Cook et al., 2012 
Meta-analysis, 11582 subjects, 15525 eyes  
Approximately 52% of measurements with RBT were 
estimated to be within 2 mmHg of GAT measurements 
Gandhi et al. (2012) Higher by M = 3.3, SD = 4.0 mmHg than GAT 
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60 subjects, 60 eyes      
Study/Subjects IOP: RBT compared to GAT. Mean(M), Standard 
deviation(SD)  
Kim et al. (2013)  
86 subjects, 72 eyes 
Higher by M = 1.92, SD = 3.29mmhg than GAT 
Beasly et al. (2013) 
36 subjects, right eye only  
Higher by M = 2.7, SD = 2.8mmHg than GAT 
Suman et al. (2013) 
71 subjects, 142 eyes   
Higher by 2-3 mmHg than GAT 
Rosentreter et al. (2013) 
99 subjects   
Significantly underestimates IOP in pathologic corneas in 
relation to GAT by 1-3 mmHg  
Table 1.5 Comparison of RBT with GAT.(ICare RBT overestimates GAT IOP, however some studies [indicated by 
shaded cells] found that ICare RBT underestimated GAT IOP. From the studies listed ICare RBT is able to estimate IOP 
within a range of ±3.00 mmHg in more than 80% of the population) 
Study/Subjects ICare RBT compared to ORA IOPg and IOPcc. Mean(M), 
Standard deviation (SD) 
Jorge et al. (2008) 
 
76 subjects, right eye only 
ICare RBT measured higher more variable IOP than ORA 
IOPg and IOPcc  
ICare central M = 17.17, SD = 4.04 mmHg 
ICare nasal M = 16.83, SD = 3.89 mmHg 
ICare temporal M = 18.57, SD = 4.28 mmHg 
ORA IOPg M = 15.61, SD = 3.06 mmHg 
ORA IOPcc M = 15.47, SD = 3.43 mmHg 
Vandewalle et al. (2009)   
 
93 subjects, 93 eyes 
ORA IOPg M = 18.30, SD = 6.60 mmHg 
ORA IOPcc M = 18.70, SD = 6.30 mmHg 
ICare RBT M = 15.7, SD = 5.7 mmHg 
ORA overestimates ICare RBT by > 2.5mmhg 
Table 1.6 Comparison of ICare RBT with ORA IOPcc and IOPg.(ICare RBT is dependent on the corneal 
biomechanics. IOP measurement with this instrument should correlate well with ORA IOPg and poorly with IOPcc. The 
results of the listed studies are not conclusive) 
1.7 Scheimpflug or Pentacam corneal tomography 
Theodor Scheimpflug (1865 − 1911) was a pioneer of aerial photography and mapping. He used land 
surveying instruments to create aerial photographs. The Scheimpflug rule describes the orientation 
of the plane of focus of an optical system, such as a camera, when the lens plane is not parallel to the 
image plane (Wegener and Laser-Junga, 2009). Normally in photography the image and film or 
sensor planes are parallel and the plane of focus (PoF) is parallel to the lens and image (film) planes. 
If the subject plane is not parallel to the image (film) plane, it will be in focus only along a line where 
it intersects the PoF (Figures 1.8, 1.9 and 1.10). By tilting the lens plane to lie parallel to the image 
plane the depth of field extends between the parallel planes on either side of the plane of focus 
resulting in distortion-free images (Figure 1.9 and figure 1.10) (Wegener and Laser-Junga, 2009; 
Erdkamp, 2012). Initially Scheimpflug took photos from kites and balloons, deskewing the oblique 
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views with his device to create “photo-perspectographs” or distortion-free images in order to create 
aerial maps (Figure 1.10 and figure 1.11) (Erdkamp, 2012). He published his work, The making of 
maps and plans using photography, in 1907 and to this day his geometric rule on camera position to 
enhance depth and focus when displaying oblique views without distortion is of major significance 
not only in architectural but also in diagnostic ophthalmology imaging. Recently this 100-year-old 
rule was used again by Google-Earth to produce undistorted images of landscapes and cities 
(Neuhann, 2007; Wegener and Laser-Junga, 2009).  
 
Figure 1.8 Diagram illustrating the positions of the PoF, lens plane, and film plane where the film plane and lens planes 
are not parallel.(Drawing courtesy of Gerrie Kruger) 
 
Figure 1.9 Image illustrating the PoF when the subject is not parallel to the lens plane.Only a small region of the image is 
in focus with elliptical blurred areas surrounding it (Photo D. Booysen) (Wegener and Laser-Junga, 2009; Erdkamp, 2012) 
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Figure 1.10 When the image (film) plane and the lens plane are parallel, the depth of field extends between parallel 
planes on either side of the PoF rendering the entire image in focus(Photo D. Booysen) (Wegener and Laser-Junga, 2009; 
Erdkamp, 2012) 
 
Figure 1.11 Scheimpflug’s original eight piece panoramic camera, rear view(Photo reproduced with written permission – 
Bundesampt –für Eich- und Verwessungwesen, Vienna [Appendix 2.2]) 
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Figure 1.12 Eight images from the panoramic camera, perspective corrected and merged into a panorama with a 
recording angle of ± 140 degrees(Photo reproduced with written permission  – Bundesampt –für Eich- und 
Verwessungwesen, Vienna  [Appendix 2.2]) 
 
Corneal topography using a computer-aided system was developed in the 1980s and can be used to 
display an undistorted image of the curved corneal surface. However, the camera is placed at the 
centre of the imaging instrument (placido disc) resulting in a central 1 to 2 mm area of the cornea not 
being measured. Individual tear film characteristics can also influence the accuracy of the images. 
The rotating Scheimpflug camera overcomes these inadequacies by scanning the entire cornea with 
the same precision independent of the individual tear film (Neuhann, 2007). The Pentacam (Oculus, 
Wetzlar, Germany) generates real-time images of the actual eye segments, creating a precise three-
dimensional view of the anterior segment including the central cornea. The instrument measures the 
anterior and posterior surface of the cornea by taking single slit images within one scan in less than 
two seconds while rotating from 0 - 180° to maximize the measured area of the cornea. Five hundred 
measurement points from each slit image is recorded, totalling twenty-five thousand (25000) true 
elevation points (HR model one hundred-and-thirty-eight-thousand [138000] real data 
measurements). The centre of the cornea is finely measured during the rotation while the pupil 
camera detects eye motion which is corrected for in the calculation process. An exact three-
dimensional model of the anterior eye is then created. The topography and pachymetry of the entire 
anterior and posterior surface of the cornea, from limbus to limbus, are displayed and calculated. 
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Unlike placido curvature measurements systems, topography maps are generated by true elevation 
data. The analysis also includes a calculation of the anterior chamber angle; chamber volume; 
chamber height; lens densitometry; and manual measurements at any location in the anterior 
chamber of the eye. The Pentacam further calculates a quality specificity score (QS), which takes into 
account the analysed area of the cornea front and back curves, alignment, and ocular motion. This 
helps the clinician to assess the validity of the data in each examination (Neuhann, 2007; Wegener 
and Laser-Junga, 2009). (Figure 1.13 and figures 1.14, 1.15). 
 
 
Figure 1.13 Pentacam HR.(Photo D. Booysen) 
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Figure 1.14 Pentacam Quality Score (QS)information indicating an acceptable measurement in this patient with Pellucid 
Marginal degeneration (not part of the study population) (Photo D Booysen) 
 
Figure 1.15 Pentacam display of the anterior float, posterior float, sagittal front curvature, and corneal thickness.The 
Arrows show the arithmetic mean corneal radius (RM 6.27 mm), quality score (QS OK), and thinnest corneal thickness 
(Thinnest local 517 µm) values recorded in this study. (Photo D Booysen) 
Although Scheimpflug photography provides images of the anterior segment with minimal distortion, 
the distortion of the cornea and lens itself distort the image. Therefore biometrical measurements in 
the anterior segment such as corneal curvature, changes in lens curvature during accommodation, 
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depth of anterior chamber angle, always have to be corrected by specific algorithms. The amount of 
correction depends on the depth of the layer in question, meaning that each refractive zone adds a 
small amount of distortion to the path of the light rays (Wegener and Laser-Junga, 2009). 
Furthermore traditional anterior surface power maps, whether axial (sagittal) or meridional 
(tangential), are produced using the keratometric refractive index (n = 1.3375). Posterior corneal 
topography is calculated using the true refractive indices for the tissue-fluid interface (1.376 for the 
cornea and 1.336 for the aqueous) (Shankar et al., 2008). 
In conclusion, for many anterior cornea measurements of normal healthy corneas, the Scheimpflug 
imaging system showed reasonable repeatability that was comparable to that of the Placido-based 
videokeratoscope. However, certain higher order aberrations (HOA’s) derived from corneal elevation 
data from the Scheimpflug system such as trefoil and tetrafoil showed poor reliability compared to 
videokeratoscope results (Read et al., 2009). 
Ultrasound pachymetry (UP) is widely regarded as the gold standard for measuring central corneal 
thickness (CCT) due to its superiority to older mechanical pachymeters (Thornton, 1984; Al-Mezaine 
et al., 2008). However, although UP has good intraobserver reproducibility it has a high degree of 
interobserver variability (Wheeler et al., 1992; O'Donnell and Maldonado-Codina, 2005). An 
ultrasound pachymeter uses the principles of A-scan ultrasonography to measure corneal thickness. 
The ultrasonic beam is aligned perpendicular to the central corneal surface and ultrasonic echoes are 
obtained from the anterior and posterior surfaces of the cornea. The time interval between the 
echoes can be used to determine the corneal thickness if the ultrasonic speed of propagation in the 
cornea is known. Ultrasound pachymetry (UP) could not be used in this study to measure corneal the 
thickness with contact lenses in situ as only the contact lens thickness would be measured due to the 
ultrasonic echo reflection from the lens surfaces.  
Pentacam pachymetry yields high intraobserver reproducibility as well as low interobserver 
variability indicating that a reliable measurement of CCT can be obtained in a single reading and that 
the measurement is practically operator independent (Barkana et al., 2005). Pentacam pachymetry 
overestimates the CCT slightly (by 8.2 µm on average) compared with UP - probably due to the slight 
applanation force created when the UP probe displaces the 7 − 30 µm-thick tear film and compresses 
the epithelium (Al-Mezaine et al., 2008), thus agreeing with previous studies by Ucakhan et al. (2006) 
and Lam and Chen (2007) (Ucakhan et al., 2006; Lam and Chen, 2007). However, O’Donnell and 
Maldonado-Codina (2005) found the Pentacam slightly (by 2.4%) underestimated the CCT when 
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compared to UP (O'Donnell and Maldonado-Codina, 2005). The finding of Lackner et al (2005) agrees 
with that of O’Donnell and Maldonado-Codina (2005) in that, compared to UP, Pentacam 
pachymetry can be expected to err on the lower side of CCT by 11 – 15 µm on a 99% limit of 
agreement basis. In other words, as Lackner et al. (2005) observe, only one in 100 patients will have 
Pentacam CCT measurements > 11 − 15 µm lower than it would have been with UP (Lackner et al., 
2005). 
Pentacam corneal curvature measurements showed good repeatability, anteriorly (simulated 
keratometry mean (COR ±0.28 D; RR = 0.64%) and posteriorly (COR ±011 D; RR = 1.85%) as did 
anterior chamber parameters, but pupil measurements had poor repeatability (Shankar et al., 2008). 
According to McAlinden et al. (2011) the repeatability limits of the anterior keratometry readings 
with the fine scan were 0.04 D (r = 0.11 D) for both K1 and K2. Pachymetry maps, corneal maps, 
anterior chamber depth maps, corneal volume, topometric Q values and indices were also found to 
be precise. Poor precision was found for estimates of axis (astigmatic and progression index), pupil 
centre pachymetry, and single points on corneal maps, refractive power maps, and equivalent K-
readings (McAlinden et al., 2011). 
Scheimpflug or Pentacam corneal tomography was used in this study to measure the corneal 
curvature, central corneal thickness, and to determine whether the subject had any corneal disease 
such as keratoconus which would result in him or her being excluded from the study. 
1.8 Measuring IOP over soft contact lenses 
Although the diagnosis of glaucoma relies on many clinical tests, accurate IOP measurements form a 
pivotal part of the diagnosis and, more importantly, the treatment of glaucoma (Quigley and Addicks, 
1981; Lusky et al., 1993; Cartwright and Anderson, 1998; Quigley, 2001; Maier et al., 2005; Heijl et 
al., 2008). In certain clinical situations it may be necessary to measure the IOP with a soft contact 
lens on the eye. Examples include patients wearing bandage contact lenses for the treatment of 
corneal injuries, after corneal surgery such as LASIK, PRK, and corneal crosslinking (Arora et al., 2004; 
Blackmore, 2010; Markoulli et al., 2012). Also, in situations where patients wear extended wear 
contact lenses, and it may not be possible to remove the lenses for the measurement of IOP.  
More recent developments include the use of soft contact lenses for sustained drug delivery to the 
eye. The soft lenses are impregnated with the drug required for therapy which is then released into 
the eye over a period of time to treat the specific disease such as glaucoma, microbial keratitis, and 
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ocular inflammation (Braga et al., 2011; Peng and Chauhan, 2011; Gupta and Aqil, 2012; Peng et al., 
2012; Tieppo, Pate, et al., 2012; Tieppo, White, et al., 2012). Several studies have demonstrated that 
contact lenses can be used as drug delivery systems for the treatment of chronic and acute eye 
disease (Morgan, 1971; Maddox and Bernstein, 1972; Maurice, 1972). Therapeutic contact lenses 
consist of pHEMA with or without silicone which are impregnated with drugs through various 
techniques such as soaking in a drug solution, colloidal particle laden lenses, molecular imprinting, 
and micro-emulsion gels (Carvalho et al., 2015). The drugs diffuse into the post-lens tear film and 
then into the cornea leading to increased retention of the drug on the surface of the cornea, 
increased bioavailability, increased therapeutic efficacy, and a reduction in the amount of drugs 
administered as well as preservatives used (Carvalho et al., 2015). Although commercially available 
contact lenses soaked in a drug solution is the most simplistic it has many limitations including poor 
uptake or release of the drug, poor retention of the drug within the lens and therefore lack of 
sustained delivery to the eye (Carvalho et al., 2015). Of concern is that these authors draw attention 
to the fact that no studies showed prolonged drug release exceeding two hours (Carvalho et al., 
2015), however it is not clear if the studies were conducted in-vivo or in-vitro as the former may have 
more ideal slower release properties due to the drug being retained by the ocular surface barrier 
(Mahomed et al., 2016).     
Modified medicated contact lenses use a barrier to prevent molecular diffusion of the drug from the 
lens matrix prolonging its action. Creation of these barriers can affect lens transparency as well as 
oxygen permeability. One way to create a barrier is to soak the lenses in vitamin E before drug 
incorporation (Peng et al., 2010). Lotrafilcon A (Focus Night & Day) contact lenses are especially 
suited for this type of drug delivery system (Peng et al., 2010). Depending on the concentration of 
the vitamin E, the release time can be manipulated from 5.5 to 192 hours for 16% and 74% vitamin E 
respectively (Carvalho et al., 2015). Imprinted medicated contact lenses involve the formation of 
macromolecular memory sites during the contact lenses polymerization process to accommodate the 
drug. The degree of polymer crosslinking plays an important role in the stability of the imprinted 
cavities; however, high polymer crosslinking affects the hydrogel’s transparency, optical 
performance, flexibility, and water content making the lenses unsuitable for ocular use (Carvalho et 
al., 2015).  
Additional strategies to overcome the limitations of eye drops as a dosage form involve the use of 
nanoparticles and their ability to include several drugs and control their release within the contact 
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lenses (Carvalho et al., 2015). The nanoparticles are incorporated during the production of the lens 
ensuring a high concentration in the lens matrix and therefore drug loading capacity (Jung et al., 
2013). Drug release is affected by the specific nanoparticles used and in the case of polymeric 
nanoparticles the release of timolol can be sustained for two to four weeks in a temperature 
dependent manner (Jung and Chauhan, 2013).  
It is important to evaluate the accuracy and repeatability of IOP measurements with the ICare 
tonometer and the Reichert ORA compared to measurements without contact lenses on the eye to 
validate clinical decisions based on IOP measurements with these instruments.  
The following section gives an overview of the studies found in a recent literature search dealing with 
the measurements of IOP with contact lenses on the eye. Although comparative data are available 
for the ICare tonometer, only two studies, those of Lam and Tse (2014) and Sapkota et al. (2014), 
were found where the Reichert ORA was used to measure IOP with contact lenses on the eye (Lam 
and Tse, 2014; Sapkota et al., 2014). Both studies were published well after the commencement of 
the current study. The ORA also provides instrument specific measurements of corneal biomechanics 
(CH & CRF) which can be used to measure the effect of contact lenses on this corneal property (Luce, 
2005; Kotecha, 2007; Reichert, 2013). The accuracy of IOP measured with different tonometers over 
various soft contact lens materials and powers has been extensively studied over the years (Table 
1.7)  
As early as 1976, Polse et al. used a Mackay-Marg and Schiotz tonometer to measure the IOP with 
and without a -8.00 D Softlens (Bausch & Lomb) on the eye, concluding that there appeared to be 
little, if any, significant difference in IOP caused by the lens as long as the lens remained fully 
hydrated and was approximately 0.16 mm thick (Polse et al., 1976). These researchers suggested that 
thicker or less pliable lenses would result in less accurate readings (Polse et al., 1976). In 1977, Janoff 
studied the effect of contact lens wear on IOP and found no significant difference between pre-fit 
IOP and those measured after six months of lens wear. The results provided the first evidence that 
continued contact lens wear does not adversely affect IOP (Janoff, 1977).  
In 1986, McMonnies obtained reliable IOP measurements over soft contact lenses using a non-
contact tonometer as long as the centre thickness of the lens was not more than 0.15 mm 
(McMonnies, 1986). The following year, Insler and Robbins (1987) compared the accuracy of IOP 
measurements over soft contact lenses using non-contact tonometry with positive and negative 
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power contact lenses and concluded that the difference in IOP was highly correlated with lens power 
(Insler and Robbins, 1987). The findings of the Insler and Robbins study indicated the difference in 
IOP was greater for positive power hyperopic lenses, with IOP measuring higher over these lenses 
(Insler and Robbins, 1987). Their results correlated well with the earlier findings of Draeger (1980) 
who performed Goldmann applanation tonometry over high water content contact lenses. He 
observed that the power of the lens had a highly significant effect on the IOP readings measured and 
produced a correction table for this effect when measuring IOP over high water content soft contact 
lenses (Draeger, 1980).  
Panek et al. (1990) reported there was no significant difference in the TonoPen measurements of 
tonometry readings on cadaver eyes with plano-T bandage contact lenses in situ (Panek et al., 1990). 
These results were recently corroborated by Klein et al. (2011) who used the TonPen (Reichert 
instruments) and two other portable tonometers (the Phosphene tonometer [Bausch & Lomb] and 
TERT or Through Eyelid Russian Tonometer [Rjazan State Instrument Making] to measure IOP with 
and without soft contact lenses (Klein et al., 2011). Sugimoto-Takeuchi et al. (1991) found similar 
results with the plano-T and plano-B4 therapeutic lenses using a non-contact tonometer (NCT) 
(Sugimoto-Takeuchi et al., 1991).  
Mark et al. (1992) measured IOP through bandage contact lenses on cadaver eyes with both NCT and 
TonoPen tonometry. They concluded that NCT could accurately measure IOP with and without a 
therapeutic contact lens, but that TonoPen was equally inaccurate with and without lenses, giving 
false low measurements (Mark et al., 1992). Scibilia et al. (1996) compared the IOP measurements 
with and without contact lenses using the TonPen and NCT. The lenses used were O4 (Bausch & 
Lomb), Acuvue (Johnson & Johnson), and Permalens (Cooper Vision). Although the lenses used in 
their study varied in water content and central thickness, no statistically significant differences were 
identified, suggesting that these variables did not affect the IOP measurements. However, the study 
did mention that the lenses used were relatively new and were all thinner than 0.45 mm (Scibilia et 
al., 1996).  
Lim et al. (1997) compared the IOP measurements in 40 normal eyes with and without a low minus 
power daily disposable contact lens (-1.00 D SeeQuence [Bausch & Lomb]) using GAT and the 
TonoPen. The TonoPen consistently measured higher IOP than the GAT by ±4 mmHg, but the findings 
were not affected by the presence of a low minus power soft contact lens (Lim et al., 1997). GAT 
without fluorescein consistently underestimated the IOP by M = 2.15, SD = 1.97 mmHg. These were 
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similar to GAT measurements over low minus soft contact lenses which also underestimated IOP by 
M = 2.90, SD = 2.37 mmHg. The study suggested that practitioners who do not have access to topical 
anaesthesia may use a low minus power soft contact lens when performing GAT without fluorescein 
as long as a correction factor of +2.0 mmHg is applied (Lim et al., 1997). Aditionally, Schollmayer and 
Hawlina (2003) compared IOP measurements over different power soft silicone hydrogel contact 
lenses (Focus Night & Day [Ciba Vision]) with an NCT. The measurements over low minus lenses were 
accurate but measurements were considerably higher over positive power lenses with increased 
centre thickness. The conclusion was that IOP could be reliably measured with NCT in patients 
wearing minus power and low positive power soft contact lenses (Schollmayer and Hawlina, 2003).  
Touboul (2008) also found that NCT over soft contact lenses was only accurate if the lenses had low 
minus power. It was his stance that this practice was only acceptable for glaucoma screening and 
that standard GAT should remain the gold standard for IOP measurements (Touboul, 2008). Allen et 
al. (2007) measured IOP using GAT with fluorescein and topical anaesthesia over low minus silicone 
hydrogel lenses (-0.50 D Pure Vision [Bausch & Lomb]) and found IOP could be accurately measured 
through the lenses (Allen et al., 2007). Zeri et al. (2007) measured IOP using GAT through a daily 
disposable contact lens (-1.50 D Softlens One Day [Bausch & Lomb]) and concluded that IOP 
measurements by GAT of over a thin, low minus power daily lens compared favourably with the 
standard GAT procedure within the normal IOP range in patients with low levels of astigmatism (Zeri 
et al., 2007). Nosch et al. (2010) found no statistically significant difference regarding the accuracy 
and repeatability of IOP measurements with or without a thin soft contact lens on the eye. A Pascal 
dynamic contour tonometer (DCT) and a -0.50 D Filcon IV hydrogel lens (Bioclear One Day [Sauflon]) 
was used in this study (Nosch et al., 2010).  
With respect to high power myopic lenses, Patel and Illahi (2004) reported no significant change in 
IOP with or without lenses ranging from -15.00 to +3.00 D when measuring IOP with an NCT. The 
study concluded that as long as the lens thickness was not more than 0.30 mm and the power no 
more than +3.00 D, NCT could be performed accurately over a soft contact lens (Patel and Illahi, 
2004). In another study by Liu et al. (2011) NCT was performed through three different types of 
minus power soft contact lenses. The powers selected were -3.00, -6.00, and -9.00 D and the lenses 
used were hilafilcon A (Softlens One Day [Bausch & Lomb]) in 8.60 base curve and etafilcon A (1- Day 
Acuvue [Johnson & Johnson]) in 8.5 and 9.0 base curves. IOP readings through higher power minus 
lenses decreased, especially with lens powers above -6.00 D. The reduction in the measured IOP may 
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be associated with the change in the front surface curvature of the lenses and not the centre 
thickness of the lenses, as the centre thickness of higher power minus lenses remains constant in 
contrast to the increased centre thickness of higher power plus lenses. The researchers concluded 
that low power minus lenses could be left on the eye when measuring IOP with an NCT, but caution 
should be exercised with lens powers over -6.00 D due to underestimation of IOP (Liu et al., 2011).  
In another study Patel and Stevenson (2009) used an NCT to measure the IOP over a low water 
content silicone hydrogel lens of relatively high modulus (Focus Night & Day, modulus 1.20 MPa [Ciba 
Vision]) as well as a high water content daily disposable lens with low modulus (Focus Dailies, 
modulus 0.91 MPa [Ciba Vision]). The lens powers varied between -7.50 D and +6.00 D. The 
measured difference in IOP was related to both lens power, material modulus and, to a lesser extent, 
IOP (Patel and Stevenson, 2009).  
Zeri et al. (2011) evaluated the effect of hydrogel and silicon hydrogel lenses on the accuracy of the 
rebound tonometer (RBT). An Acuvue 2 hydrogel and an Acuvue Oasys silicone hydrogel lens (both 
Johnson & Johnson) were used. IOP was measured with and without the lenses on the eye with the 
ICare RBT. The results were interesting in that they unexpectedly found the RBT tended to 
underestimate IOP measured through low (+2.00 D) hydrogel and silicone hydrogel contact lenses. 
The reasons for this “inversion” of previous studies results are not clear and the researchers posit 
that it may be due to biomechanical characteristics with the low plus lenses on the eye. The study 
concluded that RBT can be reliably performed over silicone hydrogel contact lenses, but that 
measurements with hydrogel lenses were lower than those without contact lenses. However, despite 
the fact that these differences were statistically significant, their clinical significance is negligible (Zeri 
et al., 2011).  
Firat et al. (2012) evaluated the influence of silicone hydrogel contact lenses on IOP measurements 
with NCT and Pascal dynamic contour tonometry (DCT). A Focus Night & Day (Ciba Vision) contact 
lens with 24% water content, 1.1 MPa modulus of elasticity and plano refractive power was used. 
Results showed the mean IOP measured with NCT without and with the contact lens on the eye was 
respectively M = 14.5, SD = 2.95 mmHg and M = 13.92, SD = 2.58 mmHg (difference was not 
statistically significant). The mean IOP measured with DCT without and with the contact lens was 
respectively M = 16.26, SD = 2.33 mmHg and M = 15.19, SD = 2.40 mmHg (difference was statistically 
significant). The study concluded that silicone hydrogel contact lens use does not significantly affect 
IOP measured with the NCT, but it does affect IOP values measured with DCT (Firat et al., 2012).  
 
 
 
 
 
 
 
62 
 
The influence of a bandage contact lens on the IOP measured by NCT and RBT was evaluated by 
Anton et al. (2013). In their study a Pure Vision 2 HD (Bausch & Lomb) silicone hydrogel lens with a 
36% water content, 1.5 MPa modulus of elasticity and plano prescription was used. NCT and RBT 
were performed with and without the lenses on the eye and the results compared. With the NCT IOP 
without and with the lens were respectively M = 15.6, SD = 2.6 mmHg and M = 15.3, SD = 2.6 mmHg 
(difference was not statistically significant), and with the RBT, the IOP without and with the lens was 
respectively M = 17.5, SD = 4.3 mmHg and M = 16.4, SD = 3.5 mmHg (difference was not statistically 
significant but correlated well with corneal thickness – 0.03 mmHg per µm corneal thickness change). 
It was concluded that the NCT and RBT tonometer appeared to measure the IOP with a silicone 
hydrogel lens on the eye with sufficient accuracy for routine clinical practice (Anton et al., 2013).   
In a study by Lam and Tse (2014) IOP and OPA were measured using the DCT over silicone hydrogel 
lenses of different modulus. The lenses used were Focus Night and Day (Ciba Vision) with a modulus 
of 1.5 MPa and Acuvue Advance (Johnson & Johnson) with a modulus of 0.43 MPa. Corneal 
biomechanics were also measured with and without lenses using the ORA CH and CRF metrics. 
Results showed IOP was slightly higher when measured through the higher modulus lenses than 
without or through the low modulus lenses. OPA was also significantly lower when measured 
through the contact lenses, and the corneal biomechanical metrics CH and CRF clinically measured 
the same with and without lenses on the eye. In contrast to the findings of Firat et al. (2012) which 
showed that IOP measurements with silicone hydrogel lenses in situ was possible with an NCT but 
not an DCT, Lam and Tse concluded it was feasible to measure IOP with DCT over low modulus 
silicone hydrogel lenses (Lam and Tse, 2014).  
Using a -3.00 D Silicone hydrogel one day lens (Acuvue True Eye [Johnson & Johnson]) and hydrogel 
one day lens (Daily Aqua Comfort Plus [Ciba Vision]), Sapkota et al. (2014) measured both ORA IOPg 
and IOPcc with and without the lenses on the eyes of 28 subjects with normal corneas. Both IOPg 
and IOPcc when measured with contact lenses in situ were statistically lower than without contact 
lenses (p<0.05). With Acuvue True Eye (Johnson & Johnson), the IOPg and IOPcc were lower by M = 
0.88, SD = 2.04 and M = 1.55, SD = 2.16 mmHg respectively, and with Daily Aqua Comfort (Ciba 
Vision) the values were M = 1.03, SD = 1.93 mmHg and M = 1.62, SD = 3.12 mmHg respectively. The 
study concluded that to measure IOP accurately with the ORA, contact lenses should be removed 
(Sapkota et al., 2014).  
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Rimayati et al. (2014) studied the ocular surface displacement with and without contact lenses during 
noncontact tonometry and made two interesting findings. Firstly, they discovered that GAT IOP 
without lenses was similar to NCT IOP without lenses. The second finding was that with higher plus 
powered thicker lenses NCT overestimated IOP while with higher minus powered thinner lenses NCT 
underestimated IOP. The authors concluded that changes in NCT IOP depend on lens power and that 
the radius of ocular surface curvature affects the ocular surface displacement and IOP readings with 
lenses in situ (Rimayanti et al., 2014).  
Kumar, et al. (2015) compared IOP measured with and without a daily disposable hydrogel contact 
lens on the eye with the Corvis ST Scheimpflug non-contact tonometer and found the measurements 
were similar, M = 13.80, SD = 2.70 mmHg and M = 13.79, SD = 2.54 mmHg with and without lenses 
respectively. The difference of M = 0.01, SD = 0.16 mmHg was not statistically significant (Kumar et 
al., 2015).  
After the completion of this present study on tonometry and biomechanics of the cornea in contact 
lens wear, Zeri et al. (2015) studied the accuracy of ICare RBT through Acuvue 2 hydrogel (Johnson & 
Johnson) plus lenses. They measured the IOP with and without a +2.00 D and a +6.00 D lens on the 
eye and found that the ICare RBT significantly underestimated IOP with the lenses in situ: without 
lenses M = 19.0, SD = 4.1 mmHg; with +2.00 M = 17.6, SD = 4.6 mmHg, and with +6.00 D M = 17.8, SD 
= 4.1 mmHg) (Zeri et al., 2015). Surmising that the reasons for the lower IOP measurement with the 
lenses could be attributed to the lower resistance to deformation of the high water content etafilcon 
A material, the authors’ conclusion was that the corneal thickness (combined lens and corneal 
thickness) does not affect the value of the IOP measured with the ICare RBT (Zeri et al., 2015).  
In a study by Takenaka et al. (2015), using GAT measurements without lenses as a baseline, 
compared it to measurements through Acuvue 2 (Johnson & Johnson) lenses (-5.00D, -0.50D and 
+5.00D) with GAT, NCT, ICare RBT, and Tono-Pen XL. Although the authors found no significant 
differences in IOP measured with and without minus lenses using NCT, GAT, and ICare RBT, there was 
an exception with GAT through the -5.00 D lenses. IOP measurements with the Tono-Pen XL were 
significantly higher than baseline GAT IOP without lenses on the eye. The conclusion was that IOP 
obtained through contact lenses with the NCT exhibited the highest correlation with GAT without 
lenses. NCT and ICare RBT are more accurate than the other instruments used in the study to 
measure IOP through soft lenses (Takenaka et al., 2015). 
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Study Methods/Subjects Lenses used Results 
Polse et al. (1976)  Mackay-Marg & Schiotz 
tonometers 
5 eyes of albino rabbits 
-8.00 D Softlens (Bausch & 
Lomb), hydrogel 
Fully hydrated, 
approximately 0.16 mm 
thick lenses = little or any 
effect on measurements 
Draeger (1980)  GAT 
Not known 
High water content 
hydrogel lenses 
Measured IOP was highly 
correlated with lens power 
 Mc Monnies (1986)  NCT 
20 eyes 
Hydrogel lathe cut lenses, 
 -5.00 and 38% water 
content; CT (0.057-0.219 
mm) Spun cast U3 & B4 
(Bausch & Lomb) hydrogel 
lenses; CT (0.071 & 0.152 
mm)  
No effect on IOP as long as 
the CT < 0.15 mm 
Insler and Robbins (1987)  NCT 
23 subjects and 43 eyes 
Plus and minus powered 
hydrogel lenses 
Measured IOP was highly 
correlated with lens power. 
Plus lenses = higher 
measured IOP 
Panek et al. (1990)  TonoPen 
20 subjects and 40 eyes 
Plano-T bandage hydrogel 
lenses on cadaver eyes 
No effect on IOP 
Sugimoto-Takeuchi et al. 
(1991)  
NCT 
18 subjects and 29 eyes 
Plano-T & Plano B4 
therapeutic hydrogel lenses 
No effect on IOP 
Mark et al. (1992)  TonoPen and NCT  
9 cadaver eyes 
Bandage hydrogel lenses 
on cadaver eyes 
NCT accurate with and 
without a therapeutic 
contact lens. TonoPen 
equally inaccurate with and 
without a therapeutic 
contact lens  
Scibilia et al. (1996)  TonoPen and NCT 
20 eyes 
 
Hydrogel lenses, O4 
(Bausch & Lomb); Acuvue 
(Johnson & Johnson); 
Permalens (Coopervision) 
No statistically significant 
differences with or without 
the lenses 
Lim et al. (1997)  GAT and TonoPen 
20 subjects and 40 eyes 
Daily disposable hydrogel 
low minus lens (-1.00 
SeeQuence (Bausch & 
Lomb) 
TonoPen consistently 
measured higher than GAT 
by ±4 mmHg but the findings 
were not affected by the 
contact lens 
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Schollmayer and Hawalina 
(2003)  
NCT 
80 subjects and 120 eyes 
Silicone hydrogel lenses of 
different power (Focus 
Night & Day [Ciba Vision]) 
Lower measured IOP over 
low minus lenses but higher 
IOP measured with plus 
power lenses 
Study Methods/Subjects Lenses used Results 
Patel and Illahi (2004)  NCT 
8 subjects and 8 eyes 
-15.00 to +3.00 D hydrogel 
lenses 
With CT < 0.30 mm and 
power < +3.00 D, accurate 
measurements could be 
obtained with NCT 
Allen et al. (2007)  GAT 
10 subjects and 20 eyes 
Low minus silicone 
hydrogel lenses (-0.50 Pure 
Vision [Bausch & Lomb]) 
Accurate measurements 
were possible 
Zeri et al. (2007)  GAT 
68 subjects and 136 eyes 
Low minus hydrogel lens (-
1.50 Softlens One Day 
[Bausch & Lomb]) 
Measurements compared 
favourably to standard GAT 
measurements 
Touboul (2008)  NCT 
Not known 
Hydrogel lenses Measurements only 
accurate with low power 
minus lenses 
Patel and Stevenson (2009)  NCT 
25 subjects and 50 eyes 
Low water content silicone 
hydrogel lenses (Focus 
Night & Day [Ciba Vision]) 
and high water content 
hydrogel lens (Focus Dailies  
[Ciba Vision]). Power varied 
between -7.50 to +6.00 D) 
Lens power, modulus, and 
IOP affect the accuracy of 
the measurements 
Nosch et al. (2010)  DCT 
46 subjects and 46 eyes 
Hydrogel low minus lens (-
0.50 D Bioclear One Day  
[Saflon]) 
No statistically significant 
difference regarding the 
accuracy and repeatability 
with or without lenses 
Liu et al. (2011)  NCT 
32 subjects and 32 eyes 
-3.00, -6.00, and -9.00 D, 
Soflens One Day [Bausch & 
Lomb]; 1 day Acuvue 
[Johnson & Johnson] in 8.5 
and 9.0 base curves 
Lower IOP measured 
through higher power minus 
lenses; low power minus 
lenses did not affect IOP 
measurements 
Klein et al. (2011)  TonoPen, Phosphene, and 
TERT tonometers 
66 eyes 
Therapeutic soft contact 
lenses 
The presence of a 
therapeutic contact lens 
does not affect the IOP 
measurements obtained by 
the three instruments. 
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Zeri et al. (2011)     RBT 
68 subjects and 136 eyes 
Hydrogel (Acuvue 2 
[Johnson & Johnson]) and 
silicone hydrogel (Acuvue 
Oasys  [Johnson & 
Johnson]) 
RBT can be accurately 
performed over silicone 
hydrogel lenses. However, 
measurements with low 
power plus and hydrogel 
lenses were lower than 
without them.  
Study Methods/Subjects Lenses used Results 
Firat et al. (2012)  NCT and DCT 
40 subjects and 40 eyes 
Silicone hydrogel plano 
power lens (Focus Night & 
Day  [Ciba Vision]) 
Statistically insignificant 
difference with NCT. 
Statistically significant 
difference with DCT. 
Anton et al. (2013)  NCT and RBT 
NCT 16 subjects 
RBT 23 subjects 
Silicone hydrogel plano 
powered lens (Pure Vision 
2 HD [Bausch & Lomb]) 
Statistically insignificant 
difference with both NCT 
and RBT, but RBT correlated 
well with corneal thickness 
changes. 
Lam and Tse (2014)  DCT and ORA CH and CRF 
74 subjects and 148 eyes 
Silicone hydrogel lenses’ 
high (Focus Night and Day - 
Ciba Vision) and low 
(Acuvue Advance [Johnson 
& Johnson]) modulus. 
No significant difference in 
CH and CRF measured 
through the lenses. High 
modulus silicone hydrogel 
lenses demonstrated greater 
effect on IOP (95% LoA 2.73 
mmHg) than low modulus 
lenses (95 % LoA 1.0 mmHg). 
DCT can be performed 
reliably over low modulus 
silicone hydrogel lenses. 
Sapkota et al. (2014)   ORA IOPcc and IOPg 
28 subjects and 56 eyes 
Silicone hydrogel one day 
lens (Acuvue True Eye 
[Johnson & Johnson]) and 
hydrogel one day (Daily 
Aqua Comfort Plus [Ciba 
Vision]). Power used was a 
-3.00 D lens on 28 subjects 
without ocular pathology 
Both IOPg and IOPcc when 
measured with contact 
lenses were statistically 
lower than without contact 
lenses (p < 0.05). With True 
Eye IOPg and IOPcc was M = 
0.88, SD = 2.04 and M = 
1.55, SD = 2.16 mmHg lower 
respectively. With Aqua 
Comfort the values were M 
= 1.03, SD = 1.93 mmHg and 
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M = 1.62, SD = 3.12 mmHg 
respectively. To measure 
IOP accurately with the ORA 
contact lenses should be 
removed.   
Study Methods/Subjects Lenses used Results 
Rimayanti et al. (2014)  GAT and NCT 
21 subjects and 21 eyes 
Acuvue 2 (Johnson & 
Johnson), etafilcon A, 58% 
water content, 8.70 mm 
base curve, 14.00 mm 
diameter, 40 Dk/t, 0.084 
mm CT, modulus 0.25 MPa, 
power -5.00, -0.50, and 
+5.00 D 
GAT without lenses was 
similar to NCT. With higher 
plus powered thicker lenses 
NCT overestimated IOP; with 
higher minus powered 
thinner lenses NCT 
underestimated IOP. 
Changes in IOP depend on 
lens power and the radius of 
ocular surface curvature 
affects the ocular surface 
displacement and IOP 
readings. 
Kumar et al. (2015)  Corvis ST 
88 subjects and 88 eyes 
Dailies-nelfilcon A (Ciba 
Vision), 69% water content, 
8.70 mm base curve, 14.00 
mm diameter, 0.10 mm 
centre thickness, hydrogel 
lenses 
IOPs with and without the 
contact lenses were M = 
13.80, SD = 2.70 and M = 
13.79, SD = 2.54 mmHg. 
Mean difference M = 0.01, 
SD = 0.16mmHg. Statistically 
there was no difference 
between the measurements 
with and without contact 
lenses with the Corvis ST 
tonometer. 
Zeri et al. (2015)  ICare RBT 
28 subjects and 26 eyes 
Acuvue 2 (Johnson & 
Johnson), etafilcon A, 58% 
water content, 8.70 mm 
base curve, 14.00 mm 
diameter, 40 Dk/t, 0.084 
mm CT, modulus 0.25 MPa, 
and power +2.00 and +6.00 
D 
IOP’s with and without the 
positive power etafilcon A 
lenses were significantly 
different: 
 +2.00 t =-4.37, p = 0.0002 
and  
+6.00 t =-3.95, p = 0.0005. 
ICare RBT measured over 
positive hydrogel lenses was 
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significantly lower than IOP 
measured without the 
lenses. 
Study Methods/Subjects Lenses used Results 
Takenaka et al. (2015)  NCT, GAT, ICare RBT, 
Tono-Pen XL 
26 subjects 
Acuvue 2 (Johnson & 
Johnson), etafilcon A, 58% 
water content, 8,70 mm 
base curve, 14.00 mm 
diameter, 40 Dk/t, 0.084 
mm CT, modulus 0.25 MPa, 
power -5.00, -0.50, and 
+5.00 D  
GAT without lenses was 
used as the standard against 
which the measurements 
with lenses were tested.  
NCT with -5.00 lenses 
showed a -0.50 mmHg 
difference (p = 0.42); with -
0.50 lenses +0.30 mmHg p = 
0.70, and with +5.00 lenses 
+2.00 mmHg (p < 0.01). Gat 
with -5.00 lenses showed a 
difference of -1.50 mmHg (p 
= 0.03); with -0.50 lenses -
0.60 p = 0.36, and +5.00 +2.3 
mmHg (p < 0.01). ICare RBT 
showed difference with -
5.00 of +0.50 mmHg (p = 
0.49); with -0.50 lenses -
0.20mmHg p = 0.75 and with 
+5.00 lenses +1.1 mmHg (p= 
0.18). Tono-Pen XL showed a 
differences with -5,00 lenses 
of +2.6 mmHg p < 0.01 and 
with -0.50 lenses +2.5 
mmHg (p < 0.01) and with 
+5.00 +4.8 mmHg (p < 0.01). 
The authors concluded that 
the NCT and ICare RBT gave 
the most accurate IOP 
measurements with contact 
lenses in situ. 
Table 1.7 Summary of the studies that have examined the validity of measuring IOP with contact lenses  in 
situ with different tonometers.(Accurate IOP measurement with contact lenses in situ is possible with a variety of 
instruments. It is generally accepted that as long as the lens thickness does not exceed 0.15 mm - 0.30 mm, the lens is 
fairly new, well hydrated and has a low prescription, the accuracy of the measurements is not significantly different from 
measurements without the contact lenses on the eye) 
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It is evident that accurate measurement of IOP with contact lenses in situ may be possible with a 
variety of instruments. However, factors such as lens prescription or power; lens modulus or 
stiffness; lens thickness; lens anterior curvature; and hydration seem to affect the accuracy of the 
measurements. It is generally accepted that as long as the lens thickness does not exceed 0.15 − 0.30 
mm, the lens is fairly new, well hydrated and has a low prescription, the accuracy of the 
measurements is not significantly different from measurements without the contact lenses on the 
eye. Higher power plus lenses lead to overestimation, and higher power minus lenses to 
underestimation of intraocular pressure. 
1.9 Aims of this programme of research 
 According to the South African agent for the ICare rebound tonometer, it is possible to accurately 
measure the IOP while a patient is wearing soft contact lenses. Although this assurance is not 
corroborated by the parent company, it nonetheless intrigued me into prompting an investigation 
which led to this study. An exhaustive literature review revealed a number of studies (Table 1.7) 
dealing with tonometry over disposable soft contact lenses. According to the 2001 International 
Standards Organization (ISO), GAT measurements corrected for CCT remains the main reference 
instrument for clinical measurements of  IOP; in other words, the gold standard for tonometry (ISO, 
2001). However, the ICare RBT is a popular screening device in ophthalmic practice and many studies 
have demonstrated that it compares favourably with GAT and NCT (Table 1.5). Therefore, GAT 
measurements were not taken in this study. Only two studies comparing the ICare and ORA (Table 
1.6) and only one study on the accuracy of ORA measurements with soft lenses in situ (Table 1.7) 
could be found. In the current programme of research ICare and ORA measurements with and 
without contact lenses on the eye were compared.  
Although the general consensus suggests that it is possible to measure IOP with various instruments 
and soft lenses in situ, some questions remain unanswered. More information is needed on which 
specific lens characteristics such as lens material; refractive power; modulus of elasticity; water 
content; centre thickness; and base curve affect the accuracy of the IOP measurements. The ORA 
measures instrument-specific corneal biomechanical metrics (CH and CRF) which is used to calculate 
corneal compensated IOP as well as Goldmann-correlated IOP. The fact that the biomechanical 
metrics can be measured in vivo created further opportunity to study the effects of soft contact 
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lenses on these measurements which are known to influence the measurements of IOP with the 
ICare RBT and other tonometers.  
Hence, this research will examine the accuracy of ICare RBT and ORA IOP measurements with four 
commonly used soft disposable contact lenses (in South Africa) in situ and evaluated the physical and 
physiological factors that influenced the accuracy of IOP measurement with the lenses on the eye. 
Corneal thickness and corneal curvature are also known to affect IOP measurements and therefore 
the Pentacam corneal analysis system was used to measure the differences between corneal 
thickness and corneal curvature without and with lenses in situ, enabling the study of the differences 
on the accuracy of IOP measurements with the ICare RBT and ORA instruments. Repeatable and 
reproducible measurements are prerequisites for any ophthalmic measurement instruments. The 
research was designed to evaluate the repeatability and reproducibility of the ICare RBT and 
repeatability of the ORA with and without soft contact lenses in situ. At the time of writing no studies 
could be found examining repeatability and reliability of the ICare RBT and ORA with soft contact 
lenses on the eye.  
Research on the use of contact lenses as drug delivery systems to the cornea and eye are continuing 
and soft disposable lenses are often used as bandage lenses to treat corneal injuries, abrasions and 
dry eye problems. If it is possible to accurately measure IOP with contact lenses in situ with popular 
tonometers such as the ICare RBT, patient care will be enhanced and valuable chair time saved. 
Knowledge of the physical contact lens properties which influence the measurements of IOP with 
lenses in situ will benefit manufactures of bandage and drug delivery contact lenses enabling the 
design of lenses which have a minimal influence on the accuracy tonometry.   
1.9.1 Supporting publications  
The following papers have been published or presented at conference from the literature review.  
 Progression of Ocular Hypertension: Lessons from the Literature (Booysen, 2012). 
 In Vivo Measurement of Corneal Biomechanics: A Discussion on the Relevance of these 
Measurements in Refractive Surgery (Booysen, 2013). 
 Corneal Biomechanics: Clinical Insights and Applications (Booysen, 2013; Booysen, 2013). 
 Tonometry (Booysen, 2015). 
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Chapter 2 
Methodology and analysis 
2.1 Subjects 
Fifty healthy subjects comprising 15 males and 35 females between 18 to 55 years (M = 38.90, SD = 
9.23 years) without ocular pathology, adapted to soft disposable contact lens wear were enrolled in 
this programme of research. All subjects were healthy volunteers visiting a private optometry 
practice for routine eye care. The principles contained in the Declaration of Helsinki (Williams, 2008) 
and the South African Department of Health Clinical Trial and Ethics in Health Research Guidelines 
(DOH, 2015) were complied with throughout this research process. In addition, the study was 
reviewed by Aston University Research Ethics Committee (UK) and the South African Pharma-Ethics 
Committee (Appendix 1). Written informed consent was obtained from the subjects after explaining 
the procedures and reasons for the study (Appendix 4). Inclusion criteria were: healthy subjects with 
healthy eyes (no pathology or medication that might influence the measurement of IOP or corneal 
biomechanics), having normal corneas free of scarring, and having no corneal pathology and/or prior 
surgery as assessed by slit lamp biomicroscopy and Scheimpflug (Oculus Pentacam) corneal analysis.  
It is well known that corneal astigmatism affects the accuracy of GAT (Whitacre and Stein, 1993). 
With-the-rule astigmatism over 4.00 DC results in underestimation and against-the-rule astigmatism 
in overestimation of the IOP by 1 mmHg − it is statistically significant, but not clinically significant 
(Whitacre and Stein, 1993; Akram et al., 2009; Hamilton-Maxwell, 2014; Townsend and McSoley, 
2015). Although research shows the accuracy of IOP measurements with ICare RBT and NCT is not 
affected by corneal astigmatism (De Moraes et al., 2008; Johannesson et al., 2008; Hamilton-
Maxwell, 2014; Townsend and McSoley, 2015), subjects with more than 2.50 Dioptres of corneal 
astigmatism were excluded from this study. Figure 2.2 shows the range and frequency distribution of 
corneal astigmatism in the study population. All subjects had to achieve unaided or aided visual 
acuity of 6/6 or better in each eye. 
Contact lens wear, soft as well as rigid gas permeable lenses, results in lower IOP measurements 
after the lenses have been removed. This effect is most probably due to a variation in the properties 
of the cornea which includes biomechanics and corneal swelling caused by the lens wear (Xu et al., 
2008; Hamilton-Maxwell, 2014; Mahjoob et al., 2014). In this study all subjects were long-term soft 
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lens wearers resulting in lower IOP and corneal biomechanical properties being measured upon lens 
removal compared to values measured after lens wear was discontinued. Recent research show 
these values to be still decreased more than two weeks after discontinuing lens wear (Xu et al., 
2008). Although it is important to consider the long-term effect of contact lenses on the cornea and 
the accuracy of these measurements, the differences are relatively small (Xu et al., 2008; Hamilton-
Maxwell, 2014; Mahjoob et al., 2014). It is impractical to discontinue lens wear for an extended 
period in order to measure the “correct” IOP and biomechanical properties in soft contact lens 
wearers in a clinical setting. Other technical and clinical factors that may affect the accuracy of IOP 
measurements include: possible reading errors; calibration issues; Valsalva manoeuvre; nervousness 
or forced eyelid closure; and the effects of variation in corneal stiffness (Bao et al., 2015). 
All participants in this study removed their contact lenses at least 24 hours before any measurements 
were taken and data collected. According to the ISO (2001), GAT corrected for CCT remains the 
reference instrument for clinical measurement of IOP; in other words, the gold standard for 
tonometry (ISO, 2001). IOP measurements with both instruments used in this study had previously 
been compared to the gold standard and these studies as well as their results are listed in Tables 1.4 
and 1.5. The instruments had also been compared to each other and Table 1.6 lists these studies and 
their results. The aim of this programme of research was to evaluate the accuracy of the ICare RBT 
and ORA instruments with contact lenses on the eye and therefore no GAT measurements with or 
without contact lenses in situ were taken during the course of this research.  
2.2 Materials and procedure 
The contact lens materials used in this programme of research included silicone hydrogel (Pure 
Vision [Bausch & Lomb]; Acuvue Oasys [Johnson & Johnson]) and hydrogel lenses (Frequency XC 
[Coopervision], and Acuvue 1-Day Moist [Johnson & Johnson]). Euromcontact data for South Africa 
indicate these brands are commonly and routinely used by South African eye care practitioners 
(Euromcontact, 2013). The properties of the contact lenses are listed in Table 2.1. Contact lens 
powers ranged between -6.00 and +6.00 D and Figure 2.2 shows the range and frequency 
distribution of the mean spherical equivalent refractive error in the study population.   
 
 
 
 
 
 
 
 
 
73 
 
Material A.Balafilcon 
(Pure Vision)  
B. Omafilcon A 
(Frequency XC) 
C. Etafilcon A 
(Acuvue 1-Day 
Moist) 
D. Senofilicon A  
(Acuvue Oasys) 
Base curve (mm) 8.6 8.5 8.5 & 8,9* 
*Only 8.5 used in 
this study 
8.4 & 8,8* 
* Only 8.4 used in this 
study 
Overall diameter (mm) 14.00 14.20 14.50 14.00 
Modulus (MPa) 1.1 0.3-0.4 0.26 0.75 
Dk/t (x10
-9
) 101 44 25.5 147 
Water content (%) 36 60 58 38 
Central thickness (-3.00 
in μm) 
90 75 84 70 
Table 2.1 Lens materials and specifications used in the study  
 
 
Figure 2.1 Range and frequency distribution of mean spherical equivalent refractive error in the study population, n = 
50.(MSE = mean spherical equivalent refractive error) 
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Figure 2.2 Range and frequency distribution of the subjects with corneal astigmatism in the study population, n = 26. 
Very high plus (≥ +12.00 D) silicone aphakic lenses (Silsoft [Bausch & Lomb]) were initially included in 
the study as it seemed it may be beneficial to measure IOP with lenses in situ for patients wearing 
these lenses on a long-term extended wear basis. However, neither the ICare RBT nor the ORA could 
measure IOP with these lenses in situ, and the decision was made to limit the plus powers to +6.00 D. 
The sale of Silsoft (Bausch & Lomb) lenses were discontinued during the course of this study and no 
other of-the-shelf silicone aphakic lenses were and are currently available for commercial use in 
South Africa.  
Astigmatic prescriptions were converted to best spherical equivalent when recorded (sphere + ½ 
cylinder = spherical equivalent). Each subject was fitted consecutively and randomly with each of the 
four brands of contact lenses. Only new lenses stored in saline fresh from blister packs were used.  
The average MSE refractive error or lens prescription in the group was (M = -0.95, SD = 2.69D, range -
6.00 to +6.00 D). (Figure 2.1 and figure 2.2). All rebound tonometry measurements were carried out 
with a recently calibrated rebound tonometer (ICare TA01i, Tiolat Oy, Helsinki, Finland) in the 
manner recommended by the manufacturer (Tiolat, 2006). The ICare tonometer is pre-programmed 
for six measurements and the IOP measured is displayed for each measurement. The software 
discards the highest and lowest values to calculate the average IOP from the remaining 
measurements (Kontiola and Puska, 2004). The software can also detect erroneous measurements 
that may occur when the probe speed was too high or too low, if the probe did not move, the probe 
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hit the lid, or the probe did not hit the central cornea. In these cases the tonometer displays an error 
message and does not accept the measurement as correct (Kontiola and Puska, 2004). The software 
also considers the relationship between all the measures taken by estimating the standard deviation 
to ensure a coherent final result. If the instrument detects a discrepancy an error sign, (‘-‘), is 
displayed. If the standard deviation of the measurements is higher than normal the ‘P’ blinks, ‘P_’ (P 
bottom) indicates a slightly higher than normal standard deviation but the effect will most likely not 
affect the final result. ‘P-’ (P middle) indicates the standard deviation is clearly higher than normal, 
but a new measurement is only recommended if the IOP is higher than 19 mmHg. ‘P¯’ (P top) 
indicates the standard deviation of the measurements is large and a new set of measurements is 
recommended (Fernandes et al., 2005) (Figure 1.7).   
The position and alignment of the ICare tonometer can affect the measurement accuracy of IOP 
(Fernandes et al., 2005). In normal healthy subjects the ICare tonometer is relatively insensitive to 
misalignments; even with the probe deviated 10˚ nasally, Beasley et al. (2013) found the ICare 
underestimated the IOP by less than 1 mmHg which is statistically but not clinically significant 
(Beasley et al., 2013). Extreme care was taken during operation of the button to prevent the 
instrument from shaking and ensure that the tip of the probe hit the centre of the cornea.  
The two experienced optometrists (DJB and GHK) independently carried out two measurements with 
the ICare tonometer on each subject. The repeated measurement design was used and a period of at 
least two minutes was allowed between successive measurements to ensure the tonometry 
measurements were as accurate as possible (Recep et al., 1998). With the ICare tonometer this 
design includes six consecutive measurements of the right eye followed by six consecutive 
measurements of the left eye, repeated in the left eye and then again repeated in the right eye 
(R.L.L.R), first with the contact lenses on the eye and then without the contact lenses on the eye 
(Pekmezci et al., 2011). The order of measurement with or without lenses was randomised. A ten 
minute or longer interval after lens insertion was allowed before measurements were taken (Tonnu 
et al., 2005). The interval ensured proper hydration and optimal fit and allowed for recovery after 
lens removal or insertion.  
An experienced optometric assistant (MLG) checked the position of the tonometer during 
measurements. To reduce between observer biases, the assistant then recorded the second IOP 
measurement on the left eye if no errors were displayed, blinding the two optometrists. The two 
optometrists and assistant remained the same for the entire study period. Only measurements for 
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the left eye were recorded mainly due to the fact that the optometric assistant was positioned on 
the right of the optometrist taking the measurements making it easy to see the subjects left eye 
(Pekmezci et al., 2011). The contact lens centration, fit, and surface hydration were evaluated by slit-
lamp biomicroscopy. In cases of poorly centring lenses (low riding, temporal or nasal decentration) 
with excessive movement (more than 1.5 mm) and obvious dry spots, the lenses were discarded and 
a new lens fitted. 
Additional tonometry and corneal biomechanical measurements were carried out with a recently 
calibrated ocular response analyser (ORA, Reichert Inc., Depew, NY) in the manner described by the 
Reichert Inc. (Reichert, 2013). The current recommended protocol for the Reichert ORA requires that 
one image with the highest waveform score be selected among four measurements for analysis 
(Reichert, 2013). It is well known that the ocular pulse amplitude (OPA) as well as “aqueous 
massage” significantly affects the ORA measurement repeatability (Moreno-Montanes et al., 2008; 
Sullivan-Mee et al., 2009; Kotecha et al., 2010; Wang et al., 2013). Endeavouring to alleviate this 
effect in the current study, four measurements per eye were taken by one optometrist (DJB) and the 
average values of the four measurements (IOPg, IOPcc, CH, and CRF) were recorded. The graphic 
representation of the corneal response after each measurement was examined to ensure that the 
force-in and force-out applanation signal peaks were fairly symmetrical in height and similar between 
repeated measurements ensuring good quality readings. Only measurements with a waveform score 
(WS) of more than six were considered and images with scores lower than this were repeated 
(Kotecha et al., 2010; Lau and Pye, 2011) (Figure 1.6). A lower WS increases the variability of 
repeated ORA measures and thus intrasession variability. Hence, it is important to record only good 
quality ORA measurements when assessing patients (Kotecha et al., 2010). As with the ICare RBT, at 
least two minutes were allowed between successive measurements to ensure the tonometry 
measurements were as accurate as possible (Recep et al., 1998). Only measurements for the left eye 
were recorded (Pekmezci et al., 2011).  
In addition to the ICare and ORA tonometry, a recently calibrated Oculus Pentacam (Oculus, Wetzlar, 
Germany) corneal analysis system was used on each patient to screen for corneal pathology and to 
record central corneal thickness at the thinnest location on the corneal thickness map as well as RM 
corneal curvature (RM – arithmetic mean of the simulated keratometry readings – corneal curvature 
[Ks]) with and without contact lenses. Only one experienced optometrist (DJB) took the Pentacam 
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measurements which were recorded by the optometric assistant if the QS (quality score) was 
acceptable. (Figures 1.14 and 1.15).  
IOP tends to be higher in the morning and lower in the afternoon. This diurnal variation is typically ≤5 
mmHg in normal eyes but higher in ocular hypertensive and glaucomatous eyes. The cause of this 
variation is not clear but may be related to the diurnal variation of plasma cortisol (Harper and 
Henson, 2007; Spry and Harper, 2010). To minimise the effects of diurnal variation in IOP in this 
study, all measurements were taken between 13h00 and 17h00 on the days subjects visited the 
practice. In order to control accommodation which may influence IOP during repeated 
measurements (Read et al., 2010), subjects were instructed to view a distance target consisting of a 
6/24 Snellen letter.  
Finally, in an attempt to alleviate the possible effects of the Valsalva manoeuvre, nervousness and 
forced eyelid closure on the accuracy of IOP measurements, care was taken to explain the 
procedures to the subjects and they were asked to breathe normally (not hold their breath) while the 
measurements were being taken. 
 
2.3 Statistical analysis 
The data recorded included: age, gender, contact lens brand, contact lens power, ICare IOP with and 
without contact lenses by each of the two optometrists, ORA: CH, CRF, IOPcc, and IOPg with and 
without contact lenses as well as Pentacam CCT and K-readings with and without contact lenses 
measured by one optometrist. Data were analysed using the statistical package SPSS v. 22.0, and 
Microsoft Excel (Microsoft Corporation, Redmond, WA) with Analyse-it v 4.10.2 (Analyse-it Software, 
Ltd.). G*Power 3.0.10 (Franz Faul, Universität Kiel, Germany) was used for sample size analysis. A 
comprehensive discussion of the statistics used will be discussed in each experimental chapter. What 
follows is a summary of the statistics used throughout the thesis. Table 2.2 gives the descriptive 
statistics for each of the variables measured. 
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Variable n Minimum Maximum  M SD Variance 
AGE (years) 50 19 55 38.90 9.23 85.23 
Rx (diopters) 50 -6.00 +6.00 -0.95 2.96 8.77 
ICare IOP (mmHg) 50 9.00 24.5 14.58 3.38 11.46 
Corneal hysteresis (mmHg) 50 7.15 13.38 9.68 1.41 2.01 
Corneal resistance factor (mmHg) 50 6.83 13.40 9.57 1.65 2.72 
Corneal corrected IOP (mmHg) 50 10.10 23.68 16.02 3.50 12.22 
Goldmann equivalent IOP (mmHg) 50 9.00 24.40 14.64 3.58 12.84 
CCT without C/L (µm) 50 469 613 531.46 35.51 1260.91 
K-reading Without C/L (mm) 50 7.30 8.33 7.80 0.28 0.08 
ICare with Pure Vision (mmHg) 50 10.8 33.50 18.49 5.43 29.45 
ICare with Frequency XC (mmHg) 50 8.80 22.50 14.08 3.15 9.93 
ICare with 1-Day Moist (mmHg) 50 7.80 20.80 13.12 3.11 9.68 
ICare with Oasys (mmHg) 50 8.50 22.50 13.74 3.24 10.50 
CH with  Pure Vision (mmHg) 50 5.78 24.18 14.56 3.38 11.45 
CH with Frequency XC (mmHg) 50 7.10 12.88 10.08 1.34 1.80 
CH with 1-Day Moist (mmHg) 50 5.98 12.45 9.80 1.39 1.94 
CH with Oasys (mmHg) 50 7.70 14.25 10.59 1.64 2.70 
CRF with Pure Vision (mmHg) 50 9.73 23.45 14.21 3.40 11.53 
CRF with Frequency XC (mmHg) 50 6.90 14.93 9.60 1.64 2.70 
CRF with 1-Day Moist (mmHg) 50 6.80 12.68 9.34 1.53 2.35 
CRF with Oasys (mmHg) 50 6.90 16.00 9.99 2.05 4.20 
IOPcc with Pure Vision (mmHg) 50 4.63 18.15 11.72 3.18 10.09 
IOPcc with Frequency XC (mmHg) 50 9.85 22.25 14.83 3.09 9.52 
IOPcc with 1-Day Moist (mmHg) 50 9.38 21.00 15.06 2.61 6.84 
IOPcc with Oasys (mmHg) 50 8.78 19.70 14.00 2.68 7.17 
IOPg with Pure Vision (mmHg) 50 9.48 26.33 15.79 3.75 14.04 
IOPg with Frequency XC (mmHg) 50 7.23 23.90 13.55 3.48 12.12 
IOPg with 1-Day Moist (mmHg0) 50 7.13 19.93 13.62 2.86 8.18 
IOPg with Oasys (mmHg) 50 6.73 23.18 13.48 3.33 11.10 
CCT with Pure Vision (µm) 50 493 669 569.14 43.89 1926.37 
CCT with Frequency XC (µm) 50 502 721 599.98 56.10 3147.78 
CCT with 1-Day Moist (µm) 50 471 652 551.92 41.16 1694.40 
CCT with Oasys (µm) 50 497 694 590.92 49.50 2450.52 
K-reading with Pure Vision (mm) 50 6.56 8.79 7.79 0.42 0.18 
K-reading with Frequency XC (mm) 50 6.82 8.76 7.93 0.44 0.19 
K-reading with 1-Day Moist (mm) 50 6.73 8.53 7.88 0.39 0.15 
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Variable n Minimum Maximum  M SD Variance 
K-reading with Oasys (mm) 50 6.84 8.71 7.90 0.43 0.18 
Valid N (list wise) 50 
     
Table 2.2 Descriptive statistics. (M = mean and SD = standard deviation) 
 
The parametric statistical tests used in this study demand normal distribution of the data. 
Researchers recommend the Shapiro-Wilk normality test as the best choice for testing the normality 
of the data. This test is based on the correlation between the data and the corresponding normal 
scores (assesses the data against a normal population) providing better power than the Kolmogorov-
Smirnov test even after the Lilliefors correction has been applied (Ghasemi and Zahediasl, 2012). If 
the data are not normally distributed, the value of the statistical tests will still be correct but the 
significance levels will not be accurate. However, Sawilowsky and Hillman (1992) found that even 
with a radically non-normal distribution of the data, significance levels are accurate except when the 
sample sizes are small and the groups differ in sample size (Sawilowsky and Hillman, 1992). The 
Shapiro-Wilk test and Q-Q plots confirmed a normal distribution of all the data (Appendix 6); p < 0.05 
was considered significant.  
In ophthalmic research, inter-eye correlations need to be considered when attempting statistical 
analyses. It has been shown that the correlation between the right and left eye intraocular pressure 
measurements is on the order of 0.9, indicating strong inter-eye correlation (Ray and O'Day, 1985). 
Positive inter-eye correlation leads to artificially low estimates of the standard error of the 
differences between experimental groups which overstate precision and produce falsely significant 
results. Only data from the left eye of all subjects were therefore used for statistical analysis in this 
study (Ray and O'Day, 1985; Newcombe and Duff, 1987; McAlinden et al., 2011).  
It was observed from the work of Walter et al. (1998) that the required number of subjects as well as 
the optimal number of observers had to be calculated for the reliability part of the study (Walter et 
al., 1998). Considering an expected ICC of 90% and the lowest acceptable ICC of 70%, nineteen 
subjects were needed based on α = 0.05 and β = 0.20. The number of observers based required to 
test the hypotheses were two. The results of this reliability and agreement study were reported in 
accordance with the Guidelines for Reporting Reliability and Agreement Studies (GRRAS) (Kottner et 
al., 2011). Intraclass correlation coefficients (ICCs) were specifically designed to examine reliability; 
thus, to provide a reliability index to indicate measurement error (Bartko, 1966). ICCs are calculated 
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from the results obtained from analysis of variance (ANOVA) for repeated measures. ICC in isolation 
cannot give a true picture of reliability (ICC is dependent on the range of values measured – the 
greater the variability between subjects, the greater the value of ICC) and should be complemented 
by Bland and Altman 95% limits of agreement tests as these tests are independent (unlike ICCs) of 
true variability in the observations (Rankin and Stokes, 1998; Patton et al., 2006). ICC is measured on 
a scale of 0 to 1. Perfect reliability is represented by a value of 1 which indicates no measurement 
error whereas 0 indicates no reliability and lots of measurement errors (Patton et al., 2006). 
According to Spitzer and Endicott (1980), any ICC > 0.75 can be classified as “good” (Spitzer and 
Endicott, 1980).  
Several paired two-tailed t-tests were performed to test the hypotheses that ICare RBT and ORA 
measurements were not significantly different. Additionally, Bland-Altman scatter plots were used to 
assess the agreement and confidence intervals in the clinical comparison of the ICare RBT and 
Reichert ORA measurements. The mean of the differences and the standard deviation of the 
differences were also calculated. The closer the mean of the differences or bias is to zero and the 
smaller the value of the standard deviation of the differences the better the agreement between 
measures (Bland and Altman, 1986). The Bland Altman plot only defines the intervals of agreement, 
it does not give information whether the limits are acceptable or not. Acceptable limits must be 
defined based on clinical necessity, biological considerations or other goals. Ninety-five per cent 
(95%) confidence intervals were plotted and p < 0.05 was considered statistically significant 
(Armstrong et al., 2011; McAlinden et al., 2011).  
To test the hypothesis that IOP measurements with the ICare RBT and ORA are not affected by the 
presence of a soft contact lens on the eye, different statistical methods of analysis were employed, 
including Pearson’s correlation coefficients, paired two-tailed t-tests, 1-way ANOVA tests and Bland-
Altman plots. 1-way ANOVA tests provide an exact test of the hypothesis for multiple groups and in 
combination with planned comparisons is an exact and elegant (the only) alternative to multiple t-
tests (Norman and Streiner, 2008). 
In order to evaluate the effects of corneal thickness, corneal curvature, and refractive error on ICare 
RBT and Reichert ORA measurements, multiple regression analyses were used with ICare IOP and 
ORA metrics designated as the dependent or response variables and corneal curvature, corneal 
thickness, and refractive error the independent or predictor variables. Pearson’s r and Spearman’s rs 
as well as standard errors between variables were used to estimate the strength of the relationship 
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between the dependent and the predictor variables, and regression lines were used to predict the 
response variable from the predictor variables. Significance levels were evaluated by the paired two-
tailed t-test and p < 0.05 was considered statistically significant (Armstrong et al., 2011; McAlinden et 
al., 2011). 
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Chapter 3 
Reproducibility and repeatability of the ICare RBT and repeatability of 
the Reichert ocular response analyser (ORA) in a population of normal 
subjects measured with and without soft disposable contact lenses in 
situ 
3.1 Introduction 
IOP is currently the only modifiable risk factor for prevention of glaucoma development and 
progression (Weih et al., 2001). Precise IOP measurements are therefore crucial for proper 
management of glaucoma patients. The ideal tonometer needs to be accurate, repeatable, 
reproducible, and minimally influenced by factors such as corneal properties and different 
examiners. It is also important when following-up patients on glaucoma treatment and when 
switching from one tonometer to another to consider expected limits of IOP errors and differences in 
measurements between the different instruments.  
Reliability can be defined as “the degree to which a measurement technique can secure consistent 
results upon repeated measuring on the same subjects either by multiple clinicians or test-retest 
trials by one clinician at different time points on the same subjects” (Patton et al., 2006). In other 
words; are the measurements recorded by the instrument reproducible at different time intervals 
(test-retest reliability), and are the clinicians making the measurements under similar assessment 
conditions producing repeatable or consistent results, both for the same observer over a period of 
time (intraobserver reliability) and between different observers on the same subject (interobserver 
reliability)? Reliability can also be used to assess the agreement between different methods of 
measuring (method comparison or parallel reliability) (Patton et al., 2006). Therefore, information 
regarding reliability as well as sensitivity and specificity is a prerequisite to using any instrumentation 
of measurement and forms a major component of ophthalmic research (Margo et al., 2002).  
Inter- and intraobserver reliability and agreement have been examined for both the ICare RBT as well 
as the ORA (Table 3.1). Depending on the way results of reliability and agreement studies are 
reported the information provided is often insufficient to understand how the study was designed, 
conducted, and how the results were obtained (Bland and Altman, 1986; Patton et al., 2006). 
Reliability and agreement estimates are affected by various sources of variability in the measurement 
setting (e.g., observer and sample characteristics, type of instrument, administration process, and 
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the statistical approach). These reliability estimates are not fixed properties of measurement but 
rather reflect interactions between the tools/instruments, the subjects, clinicians/technicians, and 
the context of measurement). Information about sample selection, study design, and statistical 
analysis is often incomplete making interpretation of results difficult (Kottner et al., 2011). Study 
results are therefore only interpretable when the sources of variability are sufficiently described 
(Kottner et al., 2011). It is worthwhile noting that regardless of which reliability test is selected, 
comparison of reliability results between studies are not possible unless the size and attributes of the 
samples tested in each case is virtually identical (Rankin and Stokes, 1998). Furthermore, when using 
ICCs, the choice of equation, study design and intended application need to be defined clearly 
(Rankin and Stokes, 1998). Table 3.1 highlights the interobserver and intraobserver reliability of some 
of the different tonometers commonly used in practice. The following section describes the studies 
relating to the ICare RBT and ORA in more detail. 
Asrani et al. (2011) compared the reliability readings obtained by inexperienced users (patients) with 
trained ophthalmic technicians using the ICare tonometer as well as GAT. The patients repeated the 
measurement three times and the technician took one measurement. The interclass correlation 
coefficient (ICC) was 0.88 (95% CI [0.82 to 0.92]) and mean deviation 0.60 mmHg, p = 0.50 indicating 
excellent agreement between the patients and the technician. The ICCs between measurements by 
the patients were 0.69 (95% CI [0.45 to 0.84]), mean deviation -0.05 mmHg p = 0.61 for 
measurements 1 and 2, 0.71 (95% CI [0.47 to 0.85]), mean deviation 0.62 mmHg p = 0.18 for 
measurements 1 and 3, and 0.81 (95% CI [0.64 to 0.90]), mean deviation 0.67 mmHg p = 0.33 for 
measurements 2 and 3 indicating a high degree of reproducibility of the measurements (Asrani et al., 
2011).  
Sahin et al. (2007) conducted a study on 152 healthy schoolchildren to establish the intra- and 
interobserver reliability of the ICare RBT tonometer. Two experienced ophthalmologists made three 
consecutive measurements on 304 eyes. The intraobserver correlation coefficient for the examiner 1 
was: right eye r = 0.97 (95% CI [0.955 to 0.979]), left eye r = 0.97 (95 % CI [0.962 to 0.983]) p < 
0.0001. For examiner 2 it was: right eye r = 0.96 (95% CI [0.947 to 0.975]), left eye r = 0.97 (95% CI 
[0.956 to 0.980]) p < 0.0001. Interobserver correlation coefficients were r = 0.80 for the right eye and 
r = 0.86 for the left eye (p < 0.0001). The study concluded that the ICare RBT tonometer offers highly 
reproducible IOP measurements in school children showing high intra- and interobserver correlation 
coefficients (Sahin, Basmak, et al., 2007).  
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Martinez-de-la-Casa et al. (2005) established the reproducibility of the ICare RBT tonometer in 12 
healthy adult subjects. Three ophthalmologists undertook three consecutive measurements. 
Intraobserver correlation coefficients were 0.82 (95% CI [0.62 to 0.94]) for the first examiner; 0.73 
(95% CI [0.46 to 0.90]) for the second examiner, and 0.87 (95% CI [0.72 to 0.96]) for the third 
examiner. The interobserver correlation coefficient was 0.82 (95% CI [0.62 to 0.94]). All three 
examiners concluded the ICare RBT tonometer offers reproducible IOP measurements in adult 
humans (Martinez-de-la-Casa et al., 2005). Davies et al. (2006) found intersessional measurements 
made with the ICare RBT tonometer were less repeatable than those made with GAT, but are 
comparable or better than other non-GAT type tonometers. The mean difference between 
measurements was: M = 0.46, SD = 2.61 mmHg (Davies et al., 2006). In another study Detry-Morel et 
al. (2006) examined the intra- and interobserver variability of the ICare IOP measurements and their 
correlations with GAT and CCT. Their results show the interobserver variation coefficient was 6.4% 
and the intraobserver variation coefficients ranged from 5 to 5.4%, close to those of GAT (Detry-
Morel et al., 2006).  
In a study by Wang et al. (2013) the intraoperator variability of the Pascal dynamic contour 
tonometer (DCT), ocular response analyser (ORA), and the Goldmann applanation tonometer (GAT) 
was evaluated in a single population of 26 normal individuals. The intraobserver reliability of the DCT 
(CV = 3.7, ICC = 0.89) was significantly lower than that of GAT (CV = 9.7, ICC = 0.79), IOPg (CV = 7.0, 
ICC = 0.79), and IOPcc (CV = 9.8, ICC = 0.57). All the tonometers showed good repeatability with ICC 
values above 0.75 except the IOPcc with an ICC of 0.57. IOPcc had the poorest test-retest 
reproducibility and was the most variable for intraoperator assessment. IOPcc is calculated from CRF 
and IOPg which could explain the poor repeatability. CRF intraobserver reliability was ICC = 0.76. GAT 
and IOPg had similar ICCs but GAT had a larger coefficient of variation (CV) than IOPg (Wang et al., 
2013). Moreno-Montanes et al. (2008) found the intraobserver reliability ICC ranged from 0.78 to 
0.93 (“good” to “excellent”) for the ORA biomechanical metrics. CH and CRF were also slightly more 
reliable than the ORA IOPg and IOPcc readings possibly due to the fact that IOP varies with the 
cardiac cycle while corneal biomechanical properties remain fairly constant (Moreno-Montanes et 
al., 2008). Sullivan-Mee et al. (2009) found the ORA derived parameters (IOPcc and IOPg) were 
almost twice as variable when compared to GAT and DCT; however, the repeatability and 
reproducibility of the ORA was still clinically acceptable. Mean difference between measurements for 
intraobserver reliability were M = 0.48, SD = 1.66 mmHg for examiner 1, and M = 0.10, SD = 1.75 
mmHg for examiner 2. Interobserver reliability was M = 0.04, SD = 1.73 mmHg. The two examiners 
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concluded that the ocular pulse amplitude (OPA) fundamentally affects repeatability of the ORA 
IOPcc and IOPg measurements (Sullivan-Mee et al., 2009). Kotecha et al. (2010) also found the 
intraobserver variability of the ORA measurements was significantly associated with OPA and, to a 
lesser degree, with the quality of the ORA waveform. ORA measurements were dependent on the 
magnitude of the OPA. Eyes with larger OPA displayed more intraobserver or intrasession variability 
in ORA measurements. Measurements with lower waveform scores also displayed greater 
intrasession variability. Interobserver repeatability among observers 1, 2, and 3 measured as mean 
difference between measurements was M = 0.30 mmHg 95% LoA [-4.2 to 3.6]. Intraobserver 
repeatability of the ORA were 4.3 mmHg for observers 2 and 3 and 4.4 mmHg for observer 1 and this 
was calculated as the within-subject-standard-deviation (wsSD x 2.77) (Kotecha et al., 2010). 
Comparing DCT, GAT, and ORA the DCT showed the best measurement precision, repeatability and 
reproducibility of the three instruments (Kotecha et al., 2010). 
Although the reproducibility and the reliability of the measurements provided by the ICare RBT have 
been evaluated in humans, it has not been evaluated with contact lenses on the eye. It might be 
expected that reproducibility and reliability are negatively impacted by the presence of a contact lens 
on the eye and therefore the present study was designed to evaluate the intra- and interobserver 
reliability of the ICare RBT in a group of healthy subjects not only with but also without soft 
disposable contact lenses on the eye. The intraobserver reliability of the ORA was evaluated without 
the contact lenses in situ. 
Because of inadequate information about sample selection, study design, and statistical analyses in 
reliability and agreement studies, the interpretation and synthesis of study results are often difficult 
(Kottner et al., 2011). The Guidelines for Reporting Reliability and Agreement Studies (GRRAS) 
published in 2011 aims to improve the quality of reporting results of reliability and agreement 
studies in the health care and medical field. The results of this reliability and agreement study were 
reported in accordance with the GRRAS guidelines (Kottner et al., 2011).  
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Study Examiner 
number/type/cohort 
Number of 
measurements 
Interobserver 
reliability 
Intraobserver 
reliability 
Comments 
DCT 
Kaufmann et 
al. (2004)  
DCT: four examiners  
GAT: four examiners 
 
150 healthy normal 
eyes and 228 
enucleated eyes 
DCT: 3 measurements 
GAT: 3 measurements 
DCT: 0.65 mmHg 
residual variance 
estimate 
GAT: 1.10 mmHg 
residual variance 
estimate 
DCT: 0.40 mmHg 
investigation 
plus interaction 
variance 
estimate 
GAT: 1.28 mmHg 
investigator plus 
interaction 
variance 
estimate 
ANOVA model 
with examiner, 
subject and 
examiner–
subject 
interaction as 
factors. 
Doyle & 
Lachkar 
(2005)  
DCT: two 
ophthalmologists 
GAT: Not recorded 
 
25 subjects 
DCT: 2 
measurements; if 
reading ≥ 2 mmHg a 
third measurement 
was taken 
GAT: 2 
measurements; if ≥ 2 
mmHg of difference a 
third measurement 
was taken 
 DCT: 0.62 mmHg  
GAT: 0.52 mmHg  
 
 
Kotecha et 
al. (2005)  
DCT: one of two 
technicians  
GAT: one optometrist 
 
130 subjects and 130 
eyes 
DCT: 3 measurements  
GAT: 2 measurements 
DCT: mean 
difference of .2 
(95% LoA  [−4.9 
to 5.3]) mmHg. 
Based only on 
measurements 2 
and 3 
GAT: average 
readings between 
clinician and 
technician was 
mean difference 
of 0.4 (95% LoA  
[−3.5 to 4.2]) 
mmHg 
Technician: 
 DCT: RC 4.2 
mmHg and 3.2 
mmHg 
respectively for 
measurements 1 
and 2, and 2 and 
3  
GAT: 
corresponding 
RC 1.6 mmHg 
Clinician:  
DCT: RC 3.3 
mmHg and 2.6 
mmHg, 
respectively  
GAT: 
corresponding 
RC 1.7 mmHg 
 
Pourjavan et 
al. (2007)  
DCT: one 
ophthalmologist GAT: 
one ophthalmologist 
 
28 subjects and 52 
eyes 
DCT: 4 measurements  
GAT: 2 measurements 
 DCT: ICC 0.78 
(one 
measurement) 
and 0.91 (mean 
of three 
measurements) 
 
Herdener et 
al. (2008)  
DCT: one experienced 
ophthalmologist; 
GAT: not recorded 
 
50 subjects and 50 
eyes 
DCT: not recorded 
GAT: not recorded 
 DCT: short-term 
(same day) and 
long-term (2 – 8 
days) 
reproducibility 
was 1.2 and 1.5 
mmHg, 
respectively 
GAT: short-term 
(same day) and 
Sensitivity 
analyses 
excluding 
lower-quality 
DCT readings 
showed greater 
intraobserver 
reliability. 
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long-term (2–8 
days) 
reproducibility 
was 1.1 and 1.2 
mmHg, 
respectively 
Study Examiner 
number/type/Cohort 
Number of 
measurements 
Interobserver 
reliability 
Intraobserver 
reliability 
Comments 
Johannesson 
et al. (2008)  
DCT: one student 
GAT: one clinician 
 
150 eyes 
DCT: 6 measurements 
GAT: 6 measurements 
 95% CI (may be 
LoA) for RC  
DCT: ±1.7 mmHg 
(n = 149)  
GAT: ±1.9 mmHg 
(n = 150) 
IOP appeared 
to decrease 
(aside from 
tonometer) as 
multiple 
measurements 
were taken. 
Sullivan-Mee 
et al. (2009)  
DCT: two 
optometrists  
GAT: two 
optometrists 
 
60 subjects and 120 
eyes 
DCT: 2 measurements  
GAT: 2 measurements 
DCT: mean 
difference of 
0.34, SD = 1.16 
(95% LoA [−1.9 to 
2.6]) mmHg; CoV 
6.6%; CCC 0.92 
(95% CI [ 0.88 to 
0.96]) (n = 60 
eyes) 
GAT: mean 
difference of 
0.83, SD = 1.14 
(95% LoA [−1.4 to 
3.1]) mmHg; CoV 
7.8%; CCC 0.93 
(95% CI [ 0.90 to 
0.96]) 
Examiner 1: (n = 
30 eyes) 
DCT: mean 
difference 1.18, 
SD = 1.33 (95% 
LoA  [−1.4 to 
3.8]) mmHg, CoV 
8.0%, CCC 0.92 
(95% CI [0.86 to 
0.97]);  
GAT: mean 
difference 0.67, 
SD = 1.54 (95% 
LoA  [−2.4 to 
3.7]) mmHg, CoV 
11%, CCC 0.95 
(95% CI  [0.91 to 
0.98]) 
Examiner 2: (n = 
30 eyes) 
DCT: mean 
difference 0.06, 
SD = 1.62 (95% 
LoA  [−3.1 to 
3.2]) mmHg, CoV 
9.3%, CCC 0.84 
(9 % CI  [0.75 to 
0.94]);  
GAT: mean 
difference 0.64, 
SD = 1.45 (95% 
LoA [−2.2 to 3.5]) 
mmHg, CoV 10%, 
CCC 0.85 (95% CI 
[0.75 to 0.95]) 
Both examiners: 
DCT: RC of 2.0; 
GAT: RC of 2.5 
RC calculated 
using 
measurements 
on both eyes. 
Roszkowska 
et al. (2009)  
DCT: one observer 
GAT: not recorded 
 
35 subjects and 70 
eyes 
DCT: 2 measurements 
GAT: 2 measurements 
 DCT: 1.4 mmHg  
GAT: 0.8 mmHg 
(coefficient 
uncertain, 
probably RC) 
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Fogagnolo et 
al. (2010)  
DCT: one experienced 
investigator per site  
GAT: not recorded 
 
350 subjects 
DCT: measurements 
were repeated if Q > 
3; this occurred in 8% 
of the readings and 
twice for 2% of the 
time 
GAT: 2 
measurements: if ≥ 2 
mmHg of difference a 
third measurement 
was taken 
DCT: ICC 0.96 (n = 
350 eyes) and 
test–retest 
variability was 
significant (p = 
0.01, F = 2.86 > 
2.12, 6 df) 
DCT: CoV 5.0%; 
RC 3.24 mmHg 
 
Study Examiner 
number/type/cohort 
Number of 
measurements 
Interobserver 
reliability 
Intraobserver 
reliability 
Comments 
Kotecha et 
al. (2010)  
DCT: one optometrist 
and two others (non-
ophthalmologists) 
GAT: not recorded 
 
100 subjects 
DCT: 3 measurements 
GAT: 2 measurements 
DCT: −0.20 (95% 
LoA ± 2.8) mmHg 
(between 
observer 1 and 
observers 2 and 
3) 
GAT: mean 
difference of − 
0.80 (95% LoA ± 
3.9) mmHg 
Observer 1:  
DCT: 1.8 mmHg 
GAT: 2.2 mmHg 
 
Observers 2 and 
3:  
DCT: 2.0 mmHg 
GAT: 2.3 mmHg  
(n = 100, all RC) 
Only good-
quality 
measurements 
accepted (DCT) 
– value 1 or 2. 
NCT 
Hansen 
(1995)  
NCT: one examiner 
GAT: one examiner 
 
130 subjects and 130 
eyes 
NCT: 3 measurements 
GAT: 3 measurements 
 NCT: 2.90 
(Varmid), mean 
difference 0.10 
(95% LoA  [−4.88 
to 5.08]) mmHg 
GAT: 0.98 
(Varmid), mean 
difference 0.36 
(95% LoA  [−2.76 
to 3.48]) mmHg 
 
Mackie et al. 
(1996)  
NCT: one optometrist  
GAT: one of three 
ophthalmologists 
 
45 subjects and 89 
eyes 
NCT: 4 measurements 
GAT: 2 measurements 
 NCT: SDs of 
measurements 
from individual 
patients range 
from 2 to 
6.7mmHg 
 
Lam et al. 
(2004)  
NCT: possibly a 
consultant 
ophthalmologist but 
paper is unclear  
GAT: not recorded 
 
31 subjects and 31 
eyes 
NCT: 3 measurements 
GAT: 3 measurements 
 NCT: mean CoV 
4.5%, SD = 3.4% 
GAT: mean CoV 
3.7%, SD = 1.8% 
 
Tonnu et al. 
(2005)  
NCT: one examiner  
GAT: one examiner 
 
105 subjects and 105 
eyes 
NCT: 3 measurements  
GAT: 3 measurements 
 NCT: RC 3.2 
mmHg 
GAT: RC 2.2 
mmHg 
 
Ogbuehi. 
2006   
NCT: one examiner  
GAT: one 
ophthalmologist 
 
60 subjects and 60 
NCT: 4 measurements 
(only last three 
readings were 
averaged)  
GAT: 3 
 NCT: mean 
difference 
between both 
sessions of 0.1, 
SD = 1.3 (95% 
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eyes measurements. 
Readings taken in 
four sessions, two 
each for GAT and NCT 
LoA [−2.5 to 2.7]) 
mmHg 
GAT: mean 
difference 
between both 
sessions of 0.2, 
SD = 1.4 (95% 
LoA [−2.54 to  
2.94]) mmHg 
Study Examiner 
number/type/cohort 
Number of 
measurements 
Interobserver 
reliability 
Intraobserver 
reliability 
Comments 
Regine et al. 
(2006)   
NCT: two 
ophthalmologists 
GAT: not recorded 
 
10 subjects 
NCT: 3 measurements 
GAT: 3 measurements 
 NCT: RC 3.59 
mmHg (right 
eye) 
GAT: RC 3.98 
mmHg (right 
eye) 
Mean difference 
of 1.94 mmHg 
Only 10 
subjects 
Lafaut et al. 
(2007)  
NCT: one examiner  
GAT: one examiner 
 
78 subjects and 148 
eyes 
NCT: 3 measurements 
GAT: 3 measurements 
 NCT: within-
session mean 
difference 1.2, 
SD = 0.7 mmHg 
GAT: within-
session mean 
difference 0.1, 
SD = 0.2 mmHg 
Pertains to 
subgroup only. 
Similar results 
for the other 
participants 
were also 
reported. 
AlMubrad 
and Ogbuehi 
(2008)  
NCT: not recorded 
GAT: not recorded 
 
65 subjects and 65 
eyes 
NCT: 4 
measurements(mean 
of last three used) 
GAT: 3 measurements 
 NCT: within-
session mean 
difference 0.1, 
SD = 1.) and 0.2, 
SD = 1.3 mmHg 
for the first two 
sessions, 
respectively 
(95% LoA [−2.3 
to 2.5] and [−2.4 
to 2.8] mmHg 
respectively). 
Between-session 
95% LoA [−2.6 to 
3.0] mmHg 
GAT: within-
session mean 
difference 0.1, 
SD = 1.1 and .0, 
SD = 1.0 mmHg 
respectively 
(95% LoA [−2.2 
to 2.3] and [−2.0 
to 2.0] mmHg 
respectively). 
Between-session 
95% LoA [−2.2 to 
2.8] mmHg 
Intraobserver 
repeatability 
within session 
taken from 
second and 
third 
measurements 
(for both GAT 
and NCT) and 
between 
sessions 1 
week apart. 
Unclear if a 
single observer 
or not. 
Ogbuehi and 
AlMubrad 
(2008)  
NCT: one 
ophthalmologist; 
GAT: one of three 
NCT: 3 measurements  
GAT: 3 measurements 
 NCT: within-
session RC (first 
session) 1.8 
 
 
 
 
 
 
 
 
90 
 
clinicians 
 
72 subjects and 72 
eyes 
mmHg and 
(second session) 
1.7 mmHg; test–
retest 
reproducibility 
3.1 mmHg 
GAT: 1.7 (first 
session) and 1.9 
(second session); 
test–retest 
reproducibility 
2.5 mmHg 
Study Examiner 
number/type/cohort 
Number of 
measurements 
Interobserver 
reliability 
Intraobserver 
reliability 
Comments 
Ocuton S 
Marchini et 
al. (2002)  
Ocuton S: two 
operators and patient 
for self-tonometry 
GAT: not recorded 
 
80 subjects and 80 
eyes 
Ocuton S: 3 
measurements; if 
there was a 
difference ≥ 5 mmHg 
between one and the 
other two, a fourth 
measurement was 
taken 
GAT: not recorded 
Ocuton S: first 
measurement 
between two 
observers 0.61 
(95% CI [0.30 to 
0.93]) mmHg; 
second 
measurement 
between two 
observers 0.41 
(95% CI[0.02 to 
0.80]) mmHg 
First observer: 
Ocuton S: 0.66 
(95% CI  [0.31 to 
1.00]) mmHg; 
Second 
observer: 
Ocuton S: 0.42 
(95% CI [0.06 to 
0.78])mmHg  
Self-tonometry: 
Ocuton S: mean 
difference 0.6, 
SD = 2.1  (95% 
LoA [−3.6 to 4.8]) 
mmHg 
Each 
measurement 
was the mean of 
three 
consecutive 
readings 
 
Wells (2003)  Ocuton S: patient 
GAT: 1 researcher 
 
Not known 
Ocuton S: 3 
measurements  
GAT: not recorded 
 Ocuton S: RC 
9.17 mmHg 
 
ORA 
Kotecha et 
al. (2006)   
ORA: one optometrist 
GAT: Not recorded 
 
105 subjects and 144 
eyes 
ORA: 3 
measurements 
GAT: 2 measurements 
 Appear to be 
intra (not 
explicitly stated). 
ORA: CoV 8.9% 
(n = 144) 
 
Moreno-
Montanes et 
al. (2008)  
ORA: Two 
independent 
examiners/not 
recorded 
 
30 eyes 
ORA: 3 repeated 
readings (each 
measurement the 
average of three good 
quality readings) by 
two examiners n = 30 
eyes 
The mean 
difference 
between 
examiners were 
0.06 95% LoA [-
1.07, 1.19] mmHg 
for CH; -0.023 
95% LoA [-1.38 to 
1.34] mmHg for 
CRF; 0.05 95% 
LoA [-2.68 to 
2.79] for IOPcc; 
wsSD was 1.45 
mmHg for CH; 
1.95 mmHg for 
CRF; 2.3 8mmHg 
for IOPcc; and 
3.33 mmHg for 
IOPg. ICCs were 
0.84 95% CI 
[0.67 to 0.92] for 
CH; 0.93 95% CI 
[0.84to 0.96] for 
CRF; 0.78 95% CI 
Intra and 
interobserver 
reliability was 
better for the 
biomechanical 
metrics than 
ORA IOP 
readings. 
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and 0.05 95% LoA 
[-2.87 to 2.97] for 
IOPg. CCCs were 
0.92 95% CI [0.87 
to 0.98] for CH; 
0.93 95% CI [0.89 
to 0.98] for CRF; 
0.81 95% CI [0.68 
to 0.94] for 
IOPcc; and 0.89 
95% CI  [0.82 to 
0.97] for IOPg. 
[0.48 to 0.89] for 
IOPcc, and 0.93 
95% CI [0.87 to 
0.95] for IOPg.  
 
 
     
Study Examiner 
number/type/cohort 
Number of 
measurements 
Interobserver 
reliability 
Intraobserver 
reliability 
Comments 
Kynigopoulos 
et al. (2008)  
ORA: one 
experienced 
technician  
GAT: not recorded 
 
Not known 
ORA: 4 
measurements 
GAT:  not recorded 
 ORA: RC 2.22 
mmHg; CoV 
6.5%; ICC 0.89 
(lower 95% CI 
[0.82]  
(n = 49) 
 
Ehongo et al. 
(2009)  
ORA: not recorded  
GAT: not recorded 
  
23 subjects and 46 
eyes 
ORA: 2 
measurements (8 
readings) 
 GAT: 2 
measurements 
 ORA: before and 
after 
anaesthetised 
right eye were 
1.44 and 1.11 
(RE) mmHg 
 
Sullivan-Mee 
et al. (2009)  
 
ORA: two 
optometrists  
GAT: two 
optometrists  
DCT: two 
optometrists  
 
60 subjects and 120 
eyes 
ORA: 2 
measurements (8 
readings)  
GAT: 2 consecutive 
readings 
DCT: 2 consecutive 
readings 
ORA: mean 
difference 0.04, 
SD = 1.73 (95% 
LoA [−3.4 to 3.4]) 
mmHg; CoV 9.6%; 
ICC 0.89 (95% CI 
[0.84 to 0.94])  
(n = 60 eyes) 
Examiner 1: (n = 
30 eyes): 
ORA: mean 
difference 0.48, 
SD = 1.66 (95% 
LoA [−2.8 to 3.7]) 
mmHg; CoV 
9.9%; CCC 0.92 
(95% CI [0.86 to 
0.98]) 
Examiner 2:  
(n = 30 eyes) 
ORA: mean 
difference 0.10, 
SD = 1.75 (95% 
LoA [−3.3 to 3.5]) 
mmHg; CoV 
10.1%; CCC 0.91 
(95% CI [0.71 to 
0.96]) 
Both examiners: 
ORA: RC 3.9  
GAT: RC 2.0 
RC calculated 
using 
measurements 
on both eyes. 
Kotecha et 
al. (2010)  
ORA: one optometrist 
and two others (non-
ophthalmologists) 
GAT: not recorded 
 
100 subjects 
ORA: 3 
measurements 
GAT: 2 measurements 
ORA: mean 
difference of 0.30 
(95% LoA [−4.2 to 
3.6]) mmHg 
(between 
observer 1 and 
observers 2 and 
ORA:  
Observer 1:  
RC 4.4 mmHg; 
Observers 2 and 
3:  
RC 4.3 mmHg  
(n = 100 eyes) 
Only good-
quality 
measurements 
accepted 
(ORA). 
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3) 
Wang et al. 
(2013)  
Three experienced 
examiners/ possibly 
ophthalmologists but 
not recorded as such 
 
26 subjects and 52 
eyes 
One operator 
measured IOP 3 times 
with each tonometer 
(GAT, DCT, and ORA). 
Two additional 
operators measured 
IOP with each 
instrument once only 
(n = 52 eyes) 
DCT: CV=6.1, 
ICC=0.73 
GAT: CV=9.0, 
ICC=0.82 
IOPg: CV=10.8, 
ICC=0.63 
IOPcc: CV=11.7, 
ICC=0.49 
DCT: CV = 3.7, 
ICC  = 0.89  
GAT: CV = 9.7, 
ICC = 0.79 
IOPg: CV = 7.0, 
ICC = 0.79 
IOPcc: CV = 9.8, 
ICC = 0.57 
GAT and IOPg 
ICCs were 
similar but CVs 
differed. 
IOPg and IOPcc 
both showed 
more variability 
than GAT and 
DCT. 
 
 
RBT 
Martinez-de-
la-Casa et al.  
(2005) 
 
RBT: three 
experienced 
ophthalmologists 
GAT: not recorded 
 
12 subjects and 12 
eyes 
RBT: 3 measurements  
GAT: 3 measurements 
RBT: ICC 0.82 
(range 0.62 – 
0.94) (n = 12 
eyes)  
CoV 8.9% 
RBT:  
First examiner: 
ICC 0.82 (range 
0.62 – 0.94) 
Second 
examiner:  
ICC 0.73 (range 
0.46 – 0.90) 
Third examiner: 
ICC 0.87 (range 
0.72 – 0.96) 
‘Intra-subject 
variation 
coefficient’: 8.9% 
Only 12 
observations. 
Study Examiner 
number/type/cohort 
Number of 
measurements 
Interobserver 
reliability 
Intraobserver 
reliability 
Comments 
Davies et al. 
(2006) 
RBT: not recorded 
GAT: one of two 
optometrists 
 
42 subjects 
RBT: 2 measurements  
GAT: 2 measurements 
 RBT: mean 
difference 0.46, 
SD = 2.61 95% 
LoA [±5.11] 
mmHg 
 
Detry-Morel 
et al. (2006)  
RBT: three 
ophthalmologists 
GAT: one 
ophthalmologist 
 
138 subjects 
RBT: 3 consecutive 
measurements 
GAT: 3 consecutive 
measurements  
Interobserver 
variation 
coefficient of 
6.4% 
Intraobserver 
correlation 
coefficient of 5 -
6% 
 
Sahin et al. 
(2007) 
RBT: two experienced 
ophthalmologists 
 
152subjects and 304 
eyes 
RBT: 3 consecutive 
readings on 304 eyes 
RBT: r = 0.798 for 
the right eye and 
r = 0.858 for the 
left eye, p < 
0.0001 
RBT:  
First examiner:  
r = 0.970 for the 
right and 0.974 
for the left eye, p 
< 0.0001 
Second 
examiner: 
r = 0.963 for the 
right and 0.970 
for the left eye, p 
< 0.0001 
The use of 
correlation 
coefficients (r) 
is questionable. 
Abraham et 
al. (2008)  
RBT: two 
ophthalmologists 
GAT: two 
ophthalmologists 
 
100 subjects 
RBT: 6 measurements 
(highest and lowest 
discarded)  
GAT: 2 measurements 
 RBT: RC 2.38 
mmHg 
Unclear if RC 
based on data 
for one or both 
examiners. 
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Johannesson 
et al. (2008) 
RBT: one student 
GAT: one student 
 
150 eyes 
RBT: 6 measurements 
GAT: 6 measurements 
 RBT: ±2.0 mmHg 
(n = 150) 95% CI 
(may be LoA) for 
repeatability 
GAT: ±1.9 mmHg 
(n = 150) 95% CI 
(may be LoA) for 
repeatability 
IOP appeared 
to decrease 
(aside from 
tonometer) as 
multiple 
measurements 
were taken. 
Asrani et al. 
(2011)  
RBT: two -  
inexperienced user 
(patient) and trained 
ophthalmic 
technician 
GAT: second trained 
ophthalmic 
technician 
 
100 subjects and 100 
eyes 
RBT: 2 measurements 
(n =100); 30 patients 
repeated the 
measurement 3x 
GAT: 1 measurement 
All 
measurements: 
RBT: ICC 0.80 
95% CI [0.85 to 
092] 
Patient: 
RBT & GAT: ICC 
0.81 95% CI [0.73 
to 0.87], mean 
difference -0.17 
mmHg p = 0.501 
Technician:  
RBT & patient 
RBT: ICC 0.88 
95% CI [0.82 to 
0.92], mean 
difference 0.06 
mmHg p = 0.497 
Technician:  
RBT & GAT: ICC 
0.85 95% CI [0.79 
to 0.90], mean 
difference 0.23 
mmHg p = 0.671 
RBT: Patient 
Measurement 1-
2 ICC 0.69 95% CI 
[0.45 to 0.84], 
mean difference 
-0.05 mmHg, p = 
0.614 
Measurement 1-
3 ICC 0.71 95% CI 
[0.47 to 0.85], 
mean difference 
0.62 mmHg, p = 
0.184 
Measurement 2-
3 ICC 0.81 95% CI  
[0.64 to 090], 
mean difference 
0.67 mmHg, p = 
0.333 
 
 
Study Examiner 
number/type/cohort 
Number of 
measurements 
Interobserver 
reliability 
Intraobserver 
reliability 
Comments 
TonoPen 
Bafa et al.  
(2001)  
TonoPen: one 
examiner  
GAT: one examiner 
 
99 eyes 
TonoPen: 4 
mmeasurements  
GAT: 1measurement 
 TonoPen:  
CoV 5% to < 10% 
(n = 2); CoV < 5% 
(n = 97) 
 
Horowitz et 
al. (2004)  
TonoPen: two 
ophthalmologists 
GAT: not recorded 
 
138 subjects and 138 
eyes 
TonoPen: 2 
measurements  
GAT: 2 measurements 
 TonoPen:  
mean difference 
0.74, SD = 1.50 
(95% LoA [−2.26 
to 3.74]) mmHg; 
ICC 0.97 
GAT:  
mean difference 
0.13, SD =−1.75 
(95% LoA [−3.34 
to 3.63]) mmHg; 
ICC 0.95 
 
Tonnu et al. 
(2005)  
TonoPen: one 
examiner 
GAT: one examiner 
 
105 subjects and 105 
eyes 
TonoPen: 3 
measurements 
GAT: 3 measurements 
 TonoPen:  
4.3 (RC) mmHg 
GAT:  
2.2 (RC)mmHg 
Only 
measurement < 
5% accepted 
for TonoPen. 
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Transpalpebral 
Alvarez et al. 
(2004)  
Transpalpebral: 
patient  
GAT: one trained 
clinician 
 
137 subjects 
Transpalpebral: each 
subject tried 5 
different Proview 
devices; thus 5 
measurements with 
each device (25 total). 
Up to 10 attempts per 
device were 
permitted to achieve 
5 successful 
measurements 
GAT: 2 or 3 if > 2 
mmHg difference for 
first 2 
 Transpalpebral: 
within-subject 
and within-
device variance 
was 3.4 mmHg 
(620 means 
considered = 
means of each of 
five devices for 
each of 124 
subjects) (18.2% 
of variation). RC 
of 5.11 mmHg 
Five devices 
were all 
Proview which 
varied in a 
minor way.  
Lam et al. 
(2004)  
Transpalpebral: 
patient  
GAT: two of the 
investigators 
 
Not known 
 
Transpalpebral: 3 
measurements  
GAT: 3 
measurements. 
 
Two different visits 1 
week apart. Patients 
requested to practice 
at home 
 Transpalpebral: 
CoV 7.3% (n = 
194) 
GAT: CoV 4.4% 
(unclear if 
intraobserver) 
Median of the 
three readings 
was used for 
comparison 
among 
tonometers. 
Random order. 
Masked 
investigators. 
Brigatti and 
Maguluri  
(2005)  
Transpalpebral: 
patient 
GAT: one physician 
 
36 subjects and 72 
eyes 
Transpalpebral: 3 
measurements 
GAT: 2 sets of 3 
readings 
 Transpalpebral: 
mean difference 
1.76, SD = 1.76 
mmHg; 0.71 (CC) 
for first and third 
readings 
GAT: mean 
difference 1.73, 
SD = 1.4 mmHg; 
0.94 (CC) 
 
Study Examiner 
number/type/cohort 
Number of 
measurements 
Interobserver 
reliability 
Intraobserver 
reliability 
Comments 
Naruse et al. 
(2005)  
Transpalpebral: 
patient  
GAT: one 
ophthalmologist 
 
101 eyes 
Transpalpebral: 3 
(sets of five 
consecutive readings) 
GAT: 3 measurements 
 Transpalpebral: 
mean difference 
0.2, SD = 0.50 
(95% LoA [−0.83 
to 1.27]) mmHg 
(n = 26); RC 1.07 
mmHg 
Second and 
third 
measurements 
compared 
Rai et al. 
(2005)  
Transpalpebral: 
patient and 
technician 
GAT: one examiner 
 
135 subjects 
Transpalpebral: 3 
measurements 
GAT: not recorded 
 Transpalpebral: 
0.83 (CC) patient 
GAT: 0.78 (CC) 
examiners 
 
Troost et al. 
(2005)  
Transpalpebral: two 
examiners GAT: one 
examiner 
 
20 subjects and 40 
eyes 
Transpalpebral: 3 
measurements 
GAT: 3 measurements 
Transpalpebral: 
mean difference 
of −1 (95% LoA [ 
−8 to 6]) mmHg 
  
Herse et al.  
(2005)  
Transpalpebral: 
patient  
GAT: one 
Transpalpebral: 3 
measurements 
GAT: 3 measurements 
 Transpalpebral: 
4.21 (RC) mmHg; 
mean difference 
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experienced clinician 
 
107 subjects 
0.1, SD = 2.1 
mmHg 
GAT: 0 .96 (RC) 
mmHg; mean 
difference 0.1, 
SD = 0.60 mmHg 
Morledge-
Hampton et 
al.(2006)  
Transpalpebral: one 
ophthalmologist 
GAT: not recorded 
 
30 subjects 
Transpalpebral: 2 
measurements  
GAT: 3 
measurements.  
 
First and second 
measurements used 
in main analysis 
 Transpalpebral: 
0.82 (CC) for first 
and second 
readings 
GAT: 0.97 (CC) 
for first and 
second readings 
 
May not be 
intraobserver as 
number of 
observers not 
reported. 
The third GAT 
reading was 
compared with 
the first two, 
which showed 
evidence of a 
tonometry 
effect (i.e. 
lowering of 
IOP). 
Table 3.1 Inter and intraobserver reliability of different tonometers used in practice.(From the table it is 
evident that many different techniques of data analysis are employed making it difficult to interpret the results of the 
studies. This is especially true for studies conducted prior [as well as some after] to 2011 when the GRRAS guidelines 
were introduced) (ICC = intraclass correlation coefficient, RC = reliability coefficient, CC = correlation coefficient, LoA = 
limits of agreement, SD = standard deviation, CoV = coefficient of variation, VARMID = variance of difference between 
middle reading and the average of the first and last readings, df = degrees of freedom, and CCC = concordance 
correlation) (Burr et al., 2012) 
3.2 Subjects and methods 
Chapter two gave a complete description of the subjects, materials and methodology used in this 
specific study. To evaluate the inter- and intraobserver reliability of the ICare RBT with and without 
different disposable lenses on the eye, two optometrists (DJB and GHK) independently took two 
ICare RBT measurements on the left eye (of each and every subject enrolled in this study) with and 
without each of the four contact lens in situ in accordance with the protocol established for the 
study. The two measurements for the left eye were recorded by an experienced optometric assistant 
effectively blinding the optometrist taking the measurements and thereby reducing observer bias.  
To evaluate intraobserver reliability of the ORA, four measurements were taken by one experienced 
optometrist (DJB) without the contact lenses on the eye. The measurements were taken according to 
the protocol established for the study and recorded by an experienced optometric assistant (MLG), 
blinding the optometrist and reducing observer bias. Measurements 1 and 2, 1 and 3, and 1 and 4 
were compared to establish intraobserver reliability of the ORA. 
3.3 Statistical analysis 
Previously Pearson’s correlation coefficient, paired t-tests, and correlation of variation (CV) have 
been used to calculate reliability (Rankin and Stokes, 1998) (Table 3.1). Pearson’s correlation 
coefficient was considered inappropriate because it measures the strength of linear association and 
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not agreement (it is possible to have a high degree of correlation when agreement is poor) (Rankin 
and Stokes, 1998; McAlinden et al., 2011). Paired t-tests assess whether the two sets of 
measurements agree on average (Rankin and Stokes, 1998; Norman and Streiner, 2008) but it is the 
difference between within-subject scores that was of interest in this study.  
Intraclass correlation coefficients (ICCs) were specifically designed to examine reliability, providing a 
reliability index to indicate measurement error (Bartko, 1966). ICCs are calculated from the results 
obtained from ANOVA for repeated measures. Several formulas for ICCs exist and can give quite 
different results when applied to the same data. Each formula is appropriate for specific situations 
which are defined by the experimental design and the potential use of the results (Rankin and 
Stokes, 1998). ICC in isolation cannot give a true picture of reliability (ICC is dependent on the range 
of values measured – the greater the variability between subjects, the greater the value of ICC) and 
should be complemented by the Bland and Altman 95% limits of agreement tests because these tests 
are independent (unlike ICCs) of true variability in the observations (Rankin and Stokes, 1998; Patton 
et al., 2006). ICC is measured on a scale of 0 to 1; 1 represents perfect reliability with no 
measurement error whereas 0 indicates no reliability (Patton et al., 2006).  
According to Spitzer and Endicott any ICC >0.75 can be classified as “good” (Spitzer and Endicott, 
1980). In this study the same observers measured IOP in each case, therefore a “Two-Way Random” 
model (ICC 2,1) was used as it models both an effect of observer and subject (two effects). Both 
observers and subjects are drawn randomly from larger representative populations, professional 
optometrists and the public (random effects model). The reliability of a single observer was 
calculated for consistency with a 95% confidence interval. The Bland and Altman analysis were 
performed with the differences between the two measurements plotted against the mean of the two 
measurements. The mean of the differences and the standard deviation of the differences were also 
calculated. The closer the mean of the differences or bias was to zero and the smaller the value of 
the standard deviation of the differences, the better the agreement was between measures. The bias 
could be a constant or an average result arising from problems for specific values. It is therefore 
important to evaluate the differences at different magnitudes of the measured variable. Hence, 95% 
limits of agreement as well as 95% confidence intervals for these limits of agreement were also 
calculated (Bland and Altman, 1986).   
The wsSD (within-subject-standard-deviation) is calculated by taking the square root of the residual 
mean square (also known as the within subject variance) from the ANOVA table (Bland and Altman, 
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1996). wsSD represents the measurement error or the variation between measurements (in this case 
IOP) on the same subject. It is important to ensure that the SD is unrelated to the magnitude of the 
IOP measurement. Analytically this can be done by calculating a rank correlation coefficient – 
Kendall’s τ. From the wsSD it is then possible to calculate repeatability which is the √2 x 1.96wsSD, or 
2.77wsSD (Bland and Altman, 1996). 
Equation 3.1 Repeatability 
 
𝑹𝒆𝒑𝒆𝒂𝒕𝒂𝒃𝒊𝒍𝒊𝒕𝒚 =  √𝟐𝒙𝟏. 𝟗𝟔𝒘𝒔𝑺𝑫  (Bland and Altman, 1996) 
 
 
 
From the work of Walter et al. (1998) the required number of subjects as well as the optimal number 
of observers was calculated for this reliability study. Considering an expected ICC of 90% and the 
lowest acceptable ICC of 70%, nineteen (19) subjects were needed based on α = 0.05 and β = 0.20. 
The number of observers required for the same parameters was two (Walter et al., 1998). The 
Shapiro-Wilk test confirmed a normal distribution of the data (Ghasemi and Zahediasl, 2012) 
(Appendix 6) and p < 0.05 was considered significant.  
3.4 Results 
3.4.1 Intraobserver reliability of ICare Rebound tonometer measurements 
To investigate the intraobserver reliability or test-retest reliability of the ICare RBT, the first and 
second measurements of each of the two observers were compared, first with and then without 
contact lenses in situ. 
 ICC 2.1  Bland Altman analyses 
Observer DJB   
Without contact lenses 
N = 50 
0.95 95% CI (0.905 to 0.968) M = 0.30, SD = 1.3 mmHg 
95% LoA  (-2.1 to -2.8) 
With contact lenses 
N = 250 
0.95 95% CI (0.925 to 0.954) M = -0.1, SD = 1.50 mmHg 
95% LoA (-3.0 to 2.9) 
Observer GHK   
Without contact lenses 
N = 50 
0.88 95% CI (0.795 to 0.929) M = 0.1, SD = 1.7 mmHg 
95% LoA (-3.20 to 3.50) 
With contact lenses 
N = 250 
0.92 95% CI (0.902 to 0.939) M = 0.1, SD = 1.6 mmHg 
95% LoA (-3.1 to 3.3) 
Table 3.2 Intraobserver reliability of the ICare RBT. Summary of findings ..(ICC – Interclass correlation 
coefficient, M = Mean, SD – Standard deviation, LoA  -  Limits of agreement, DJB – observer 1, GHK – observer 2)  
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For observer DJB the first measurements without contact lenses (n = 50) was slightly higher than the 
second measurement, M = 14.78, SD = 3.81 and M = 14.46, SD = 3.75 mmHg respectively. Similar 
results were obtained for observer GHK with the first and second measurements (n = 50) being, M = 
14.60, SD = 3.49 and M = 14.46, SD = 3.51 mmHg respectively. ICCs (2.1 for consistency and single 
measures) were 0.95 (95% CI [0.905 to 0.968]) and 0.88 (95% CI [0.795 to 0.929]) for DJB and GHK 
respectively. When all the measurements (with and without contact lenses) were combined (n = 
250), the findings were as follows. For observer DJB the mean of the second measurement was 
slightly higher than the first measurement, M = 14.99, SD = 4.44 and M = 15.04, SD = 4.04 mmHg 
respectively. For GHK the mean of the first measurement was slightly higher than the second 
measurement, M = 14.66, SD = 4.12 and M = 14.60, SD = 4.16 mmHg respectively. ICCs (2.1 for 
consistency and single measures) were 0.94 (95% CI [0.925 to 0.954]) and 0.92 (95% CI [0.902 to 
0.939]) for DJB and GHK respectively (Table 3.2).  
The Bland-Altman analyses revealed differences between observer DJB’s first and second 
measurement without lenses (n = 50) was M = 0.30, SD = 1.3 mmHg (95% CI [-0.04 to 0.68]) and the 
95% LoA (-2.1 to 2.8) (Figure 3.2). There was a strong linear relationship between the two 
measurements, r = 0.95, p < 0.001. For observer GHK the difference between the two measurements 
without contact lenses (n = 50) was M = 0.1, SD = 1.7 mmHg (95% CI [-0.34 to 0.62]) and the 95% LoA 
(-3.2 to 3.5) (Figure 3.1). There was a strong linear relationship between the two measurements, r = 
0.90, p < 0.001. 
ICare RBT DJB – Repeatability and 
measurement error  
GHK – Repeatability  and 
measurement error  
Without contact lenses (n = 50) wsSD = 0.89 mmHg  
Repeatability = 2.45 mmHg 
ME = 1.74 mmHg 
wsSD = 1.20 mmHg  
Repeatability = 3.31 mmHg 
ME = 2.35mmHg  
All measurements with and 
without contact lenses (n = 250) 
wsSD = 1.08 mmHg 
Repeatability = 2.98 mmHg 
ME = 2.12 mmHg 
wsSD = 1.15 mmHg 
Repeatability = 3.19 mmHg 
ME = 2.54 mmHg 
Table 3.3 Intraobserver repeatability (variability) and measurement error (variation bet ween 
measurements) of the ICare RBT.(The difference between the subject’s measurement and the true value would be 
expected to be < 1.96 x wsSD for 95% of observations and the difference between the two measurements for the same 
subject would be expected to less than < 2.77 x wsSD for 95% of pairs of observations) (Bland and Altman, 1996).  (wsSD 
= within-subject-standard-deviation. ME = Measurement error). 
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Figure 3.1 Bland-Altman plot of observer GHK’s first and second ICare RBT measurement without contact lenses in situ. 
Bias was consistent for different magnitudes of the measured variable. (GHKRBT (1&2) = Observer GHK rebound 
tonometry measurements 1 & 2). 
 
 
Figure 3.2 Bland-Altman plot of observer DJB’s first and second ICare RBT measurement without contact lenses in 
situ.Bias was consistent for different magnitudes of the measured variable.(DJBRBT (1&2) = Observer DJB rebound 
tonometry measurements 1 & 2). 
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When all the measurements (with and without contact lenses) of the two observers were combined 
the results of the Bland-Altman analyses were as follows: the difference between observer DJB’s first 
and second measurements (n = 250) with lenses was M = -0.1, SD = 1.5 mmHg (95% CI [-0.25 to 
0.13]) and the 95% LoA (-3.0 to 2.9) (Figure 3.3). There was a strong linear relationship between the 
two measurements: r = 0.94, p < 0.001. For observer GHK the difference between the two 
measurements with contact lenses (n = 250) was M = 0.1, SD = 1.6 mmHg 95% CI [-0.14 to 0.27] and 
the 95% LoA (-3.1 to 3.3) (Figure 3.4). There was a strong linear relationship between the two 
measurements:  r = 0.92, p < 0.001.    
 
 
Figure 3.3 Bland-Altman plot of observer DJB’s first and second ICare RBT measurement with and without contact lenses 
in situ.Bias was consistent for different magnitudes of the measured variable. (DJBRBT (1&2) = Observer DJB rebound 
tonometry measurements 1 & 2). 
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Figure 3.4 Bland-Altman plot of observer GHK’s first and second ICare RBT measurement with and without contact lenses 
in situ. Bias was consistent for different magnitudes of the measured variable (GHKRBT (1&2) = Observer GHK’s rebound 
tonometry measurements 1 & 2). 
3.4.2 Interobserver reliability and agreement of the ICare Rebound tonometer 
measurements 
Two measurements per observer were recorded: first, without contact lenses and then with each of 
the four different brands of contact lenses (as listed in Table 2.1) on the eye. The measurement 
process was standardised and an independent observer recorded the IOP measurements blinding the 
observers. In order to investigate the interobserver reliability and agreement of the ICare RBT, the 
measurements of each of the two observers were compared, first without and then with the 
different contact lenses in situ. 
Observers DJB & GHK ICC 2.1 Bland Altman analyses 
Without contact lenses 
N = 100 
0.81 95% CI (0.724 to 0.865) M = 0.1, SD = 2.2 mmHg 
95% LoA (-4.3 to 4.5) 
With contact lenses 
N = 500 
0.88 95% CI (0.577 to 0.897) M = 0.40, SD = 2.1 mmHg 
95% LoA (-3.8 to 4.5) 
Table 3.4 Interobserver reliability of the ICare RBT. Summary of findings. (ICC – Interclass correlation 
coefficient, M = Mean, SD – Standard deviation, LoA  -  Limits of agreement)  
 
Without the contact lenses on the eye observer DJB’s mean measurement (n = 100) was slightly 
higher (M = 14.62, SD = 3.77 mmHg) than that of observer GHK (M = 14.53, SD = 3.41 mmHg). ICC 
(2.1 for consistency and single measures) was 0.81 (95% CI [0.724 to 0.865]). When all the 
measurements (with and without contact lenses, [n = 500]) were considered, observer DJB’s mean 
measurements (M = 14.96, SD = 4.14 mmHg) were once again slightly higher than that of observer 
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GHK (M = 14.59, SD = 4.13 mmHg). ICC (2.1 for consistency and single measures) was 0.88 (95% CI 
[0.857 to 0.897]). The Bland-Altman analyses revealed a difference of M = 0.1, SD = 2.2 mmHg (95% 
CI [-0.35 to 0.53]) and the 95% LoA (-4.3 to 4.5) (Figure 3.5). There was a strong linear relationship 
between the two measurements without contact lenses (n = 100): r = 0.81, p < 0.001. When all the 
measurements (n = 500) are considered, there was a difference of M = 0.4, SD = 2.1 mmHg (95% CI 
[0.18 to 0.55]) and the 95% LoA (-3.8 to 4.5) (Figure 3.6 and table 3.4). There was a strong linear 
relationship between the two measurements:  r = 0.88, p < 0.001.  
ICare RBT DJB vs GHK – Repeatability 
Without contact lenses (n = 100) wsSD = 1.59 mmHg 
Repeatability = 4.39 mmHg 
With contact lenses (n = 500) wsSD = 1.49 mmHg 
Repeatability = 4.12 mmHg 
Table 3.5 Interobserver repeatability and measurement error (variation bet ween measurements) of the 
ICare RBT.(The difference between the two measurements for the same subject would be expected to less than < 
2.77xwsSD for 95% of pairs of observations) (Bland and Altman, 1996). (wsSD = within-subject-standard-deviation) 
 
 
 
Figure 3.5 Bland-Altman plot of observers DJB and GHK’s ICare RBT measurement without contact lenses in situ. Bias was 
consistent for different magnitudes of the measured variable. (DJBRBT & GHKRBT = Observer DJB & GHK rebound 
tonometry measurements) 
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Figure 3.6 Bland-Altman plot of observers DJB and GHK’s ICare RBT measurements with and without contact lenses in 
situ.Bias was consistent for different magnitudes of the measured variable. (DJBRBT & GHKRBT = Observer DJB & GHK 
rebound tonometry measurements) 
 
3.4.3 Intraobserver reliability of the Reichert ocular response analyser (ORA) without 
contact lenses in situ 
An experienced optometrist (DJB) performed tonometry and corneal biomechanical measurements 
with a recently calibrated ocular response analyser (ORA, Reichert Inc., Depew, NY) in the way 
described in chapter two (section 2.2). To measure ORA test-retest reliability and intraobserver 
reliability, ICCs and Bland-Altman analyses were calculated for measurements 1 and 2, 
measurements 1 and 3, and measurements 1 and 4 without contact lenses in situ. 
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Observer DJB ICC 2.1 Bland Altman analyses 
CH 
N = 50 
0.63 95% CI (0.499 to 0.753)  
Measurement 1 & 2 M = 0.21, SD = 1.63 mmHg 
95% LoA (-2.99 to 3.41) 
Measurement  1 & 3 M = 0.04, SD = 1.21 mmHg 
95% LoA (-2.33 to 2.42) 
Measurement 1 & 4 M = 0.013, SD = 1.33 mmHg 
95% LoA (-2.5 to 2.61) 
CRF 
N = 50 
0.79 95% CI (0.694 to 0.859)  
Measurement 1 & 2 M = 0.18, SD = 1.31 mmHg 
95% LoA (2.38 to 2.74) 
Measurement  1 & 3 M = 0.25, SD = 1.21 mmHg 
95% LoA (-2.11 to 2.62) 
Measurement 1 & 4 M = 0.008, SD = 1.35 mmHg 
95% LoA (-2.64 to 2.66) 
IOPcc 
N = 50 
0.77 95% CI (0.679 to 0.851)  
Measurement 1 & 2 M = 0.21, SD = 2.27 mmHg 
95% LoA (-4.23 to 4.66) 
Measurement  1 & 3 M = 0.45, SD = 2.27 mmHg 
95% LoA (-3.99 to 4.88) 
Measurement 1 & 4 M = 0.42, SD = 2.18 mmHg 
95% LoA (-0.2 to 1.04) 
IOPg  
N = 50 
0.87 95% CI (0.810 to 0.918)  
Measurement 1 & 2 M = 0.41, SD = 1.87 mmHg 
95% LoA (-3.25 to 4.07) 
Measurement  1 & 3 M = 0.65, SD = 2.10 mmHg 
95% LoA (-0.06 to 1.25) 
Measurement 1 & 4 M = 0.57, SD = 1.99 mmHg 
95% LoA (-3.33 to 4.66) 
Table 3.6 Intraobserver reliability of the ORA metrics. Summary of findings. (ICC – Interclass correlation 
coefficient, M = Mean, SD – Standard deviation, LoA  -  Limits of agreement, CH – Corneal hysteresis, CRF – Corneal 
resistance factor, IOPcc – Corneal compensated IOP, IOPg – Goldman correlated IOP)  
Corneal hysteresis (CH) 
CH is one of the two instrument specific metrics of corneal biomechanics measured by the ORA 
(Equation 1.2). Of the four measurements recorded by DJB the means of the first, third and fourth 
measurements were all higher than that of the second measurement: M = 9.56, SD = 1.68 mmHg for 
the first; M = 9.55, SD = 1.52 mmHg for the second; M = 9.72, SD = 1.60 mmHg for the third; and M = 
9.74, SD = 1.94 mmHg for the fourth measurements (n = 50). ICC (2.1 for consistency and single 
measures) was 0.63 (95 %CI [0.499 to 0.743]). Bland-Altman analyses were performed and plotted. 
The difference between measurements 1 and 2 was M = 0.21, SD = 1.63 mmHg (95% CI [-0.26 to 
0.67]) and the 95% LoA (-2.99 to 3.41) (Table 3.6). There was a poor linear correlation between the 
measurements r = 0.49, p < 0.001. The difference between measurement 1 and 3 was M = 0.04, SD = 
1.21 mmHg (95% CI [-0.30 to 0.39]) and the 95% LoA (-2.33 to 2.42). The linear correlation between 
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the measurements was slightly better than between measurements 1 and 2: r = 0.73, p < 0.001. The 
difference between measurement 1 and 4 was M = 0.013, SD = 1.33 mmHg (95% CI [-0.36 to 0.39]) 
and the 95% LoA (-2.58 to 2.61). The linear correlation between measurements was: r = 0.74 p < 
0.001. The Bland-Altman plots are presented in Figure 3.7. 
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Figure 3.7 Bland-Altman plots of ORA CH measurements. Bias was consistent for different magnitudes of the measured 
variable (First is the difference between measurement 1 and 2 plotted against the mean of the two measurements. 
Second represent plots for measurements 1 and 3, and last for measurements 1 and 4) (CH = Corneal hysteresis) 
Corneal resistance factor (CRF) 
CRF is the other instrument specific metric of corneal biomechanics measured by the ORA (Equation 
1.4, page 35). It is calculated from a formula which includes a constant derived from an empirical 
analysis of the relationship between P1, P2 and CCT (Lau and Pye, 2011). Of the four measurements 
recorded by DJB the means of the second and third measurements were lower than that of the first 
and fourth measurement: M = 9.66, SD = 1.90 mmHg for the first; M = 9.48, SD = 1.74 mmHg for the 
second; M = 9.41, SD=1.78 mmHg for the third; and M = 9.66, SD = 2.13 mmHg for the fourth 
measurements (n = 50). ICC (2.1 for consistency and single measures) was 0.79 (95% CI [0.694 to 
0.859]). The Bland-Altman analyses were calculated and plotted. The difference between 
measurements 1 and 2 was M = 0.18, SD = 1.31 mmHg (95% CI [-0.19 to 0.56]) and the 95% LoA (-
2.38 to 2.74). There was a good linear correlation between the measurements: r = 0.75, p < 0.001. 
The difference between measurements 1 and 3 was M = 0.25, SD = 1.21 mmHg (95% CI [-0.09 to 
0.59]) and the 95% LoA (-2.11 to 2.62) (Table 3.6). The linear correlation between the measurements 
was: r = 0.79, p < 0.001. The difference between measurements 1 and 4 was M = 0.008, SD = 1.35 
mmHg (95% CI [-0.38 to 0.39]) and the 95% LoA (-2.64 to 2.66). The linear correlation between 
measurements was:  r = 0.78 p < 0.001. The Bland-Altman plots are represented in Figure 3.8. 
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Figure 3.8 Bland-Altman plots of ORA CRF measurements.Bias was consistent for different magnitudes of the measured 
variable (First is the difference between measurement 1 and 2 plotted against the mean of the two measurements. 
Second represent plots for measurements 1 and 3, and last for measurements 1 and 4) (CRF = Corneal resistance factor) 
Cornea compensated IOP (IOPcc) 
IOPcc is calculated from individual corneal elasticity and viscosity information and is therefore less 
affected by corneal thickness and other corneal characteristics thus giving more accurate IOP 
measurements. The formula once again includes empirically derived constants as well as the P1 and 
P2 measurements (Lau and Pye, 2011) (Equation 1.3). Of the four measurements recorded by DJB the 
means of the first and second measurements were higher than that of the third and fourth 
measurements: M = 16.24, SD = 3.72 mmHg for the first; M = 16.03, SD = 3.63 mmHg for the second; 
M = 15.79, SD = 3.94 mmHg for the third; and M = 15.82, SD = 3.64 mmHg for the fourth 
measurements (n = 50). ICC (2.1 for consistency and single measures) was 0.77 (95% CI [0.679 to 
0.851]). Bland-Altman analyses were calculated and plotted. The difference between measurements 
1 and 2 was M = 0.21, SD = 2.27 mmHg (95% CI [-0.43 to 0.86]) and the 95% LoA (-4.23 to 4.66). 
There was good linear correlation between the measurements: r = 0.81, p < 0.001. The difference 
between measurements 1 an 3 was M = 0.45, SD = 2.27 mmHg (95% CI [-0.20 to 1.09]) and the 95% 
LoA (-3.99 to 4.88) (Table 3.6). The linear correlation between the measurements was good: r = 0.83, 
p < 0.001. The difference between measurements 1 and 4 was M = 0.42, SD = 2.18 mmHg (95% CI [-
0.20 to 1.04]) and the 95% LoA (-3.86 to 4.70). The linear correlation between measurements was:  r 
= 0.83 p < 0.001. The Bland-Altman plots are represented in Figure 3.9. 
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Figure 3.9 Bland-Altman plots of ORA IOPcc measurements.Bias was consistent for different magnitudes of the measured 
variable. (First is the difference between measurement 1 and 2 plotted against the mean of the two measurements. 
Second represent plots for measurements 1 and 3, and last for measurements 1 and 4) (IOPcc = Corneal corrected IOP) 
Goldmann correlated IOP (IOPg) 
IOPg is the average of measurement P1 and P2 (Lau and Pye, 2011) (Equation 1.1). Of the four 
measurements recorded by DJB the means of the first measurements were slightly higher than that 
of the second, third and fourth measurements: M = 15.06, SD = 4.04 mmHg for the first; M = 14.66, 
SD = 3.78 mmHg for the second; M = 14.41, SD = 3.82 mmHg for the third; and M = 14.49, SD = 3.38 
mmHg for the fourth measurements (n = 50). ICC (2.1 for consistency and single measures) was 0.87 
(95% CI [0.810 to 0.918]). The Bland-Altman analyses were calculated and plotted. The difference 
between measurements 1 and 2 was M = 0.41, SD = 1.87 mmHg (95% CI [-0.13 to 0.94]) and the 95% 
LoA (-3.25 to 4.07). There was good linear correlation between the measurements: r = 0.89, p < 
0.001. The difference between measurements 1 and 3 was M = 0.65, SD = 2.10 mmHg (95% CI [-0.06 
to 1.25]) and the 95% LoA (-3.47 to 4.78) (Table 3.6). The linear correlation between the 
measurements was: r = 0.86, p < 0.001. The difference between measurements 1 and 4 was M = 
0.57, SD = 1.99 mmHg (95% CI [-0.002 to 1.13]) and the 95% LoA (-3.33 to 4.46). The linear 
correlation between measurements was: r = 0.87, p < 0.001. The Bland-Altman plots are represented 
in Figure 3.10.  
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Figure 3.10 Bland-Altman plots of ORA IOPg measurements.Bias was consistent for different magnitudes of the 
measured variable. (First is the difference between measurement 1 and 2 plotted against the mean of the two 
measurements. Second represent plots for measurements 1 and 3, and last for measurements 1 and 4) (IOPg = Goldmann 
equivalent IOP) 
 
ORA Intraobserver repeatability and measurement error or variation 
between measurements   
CH (n = 50) wsSD = 1.03 mmHg  
Repeatability = 2.86 mmHg 
ME = 2.12 mmHg 
CRF (n = 50) wsSD = 0.88 mmHg  
Repeatability = 2.44 mmHg 
ME = 1.73 mmHg 
IOPcc (n = 50) wsSD = 1.78 mmHg  
Repeatability = 4.94 mmHg 
ME = 3.5 mmHg 
IOPg (n = 50) wsSD = 1.35 mmHg  
Repeatability = 3.75 mmHg 
ME = 2.65 mmHg 
Table 3.7 Intraobserver repeatability (test-retest reliability) of the ORA measurements. (The difference 
between the subject’s measurement and the true value would be expected to be < 1.96 x wsSD for 95% of observations 
and the difference between the two measurements for the same subject would be expected to less than < 2.77xwsSD for 
95% of pairs of observations) (Bland and Altman, 1996). ( wsSD = within subject standard deviation. ME = Measurement 
error) (Bland and Altman, 1996) 
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3.5 Discussion  
Information regarding reliability as well as sensitivity and specificity is a prerequisite for using any 
instrumentation of measurement and forms a major component of ophthalmic research (Margo et 
al., 2002). Because studies on the reproducibility and reliability of the ICare RBT and ORA have 
previously been done on human subjects (Table 3.1), it can be postulated de facto that the 
reproducibility and reliability would be expected to be negatively impacted by the presence of a 
contact lens on the eye due to the induced biomechanical, thickness and curvature changes with the 
lens in situ. Therefore, the present study was designed according to the GRRAS guidelines to evaluate 
the intra- and interobserver reliability of the ICare RBT in a group of healthy subjects not only with 
but also without soft disposable contact lenses on the eye. Intraobserver reliability of the ORA was 
evaluated without contact lenses on the eye. 
3.5.1 Intraobserver reliability of the ICare RBT 
Without contact lenses the ICCs were 0.95 and 0.88 for DJB and GHK respectively. When considering 
all the measurements, with and without contact lenses on the eye, the ICCs remained high: 0.94 and 
0.92 for DJB and GHK respectively. Intraobserver repeatability of ICare RBT in this group of patients 
by the two experienced optometrists was excellent according to Spitzer and Endicott’s criteria 
(Spitzer and Endicott, 1980). This compares well to previous published data by Asrani et al. (2011), 
Sahin et al. (2007), and Martinez-de-la-Casa et al. (2005) who all found the ICare RBT produced 
repeatable measurements by the same examiner (Martinez-de-la-Casa et al., 2005; Sahin, Basmak, et 
al., 2007; Asrani et al., 2011). The Bland-Altman analyses confirmed the results obtained by ICC with 
mean differences between measurements without lenses of M = 0.30, SD = 1.3 mmHg and M = 0.10, 
SD = 1.7 mmHg for DJB and GHK respectively. When considering all the measurements, with and 
without contact lenses by the two observers, the mean differences between measurements were M 
= -0.1, SD = 1.5 mmHg and M = 0.1, SD = 1.6 mmHg for DJB and GHK respectively. Clinically, IOP 
measurement variation within ±3 mmHg is considered acceptable (Mackie et al., 1996; Choudhari et 
al., 2009). Most tonometers measure in increments of 1 mmHg (Doughty and Zaman, 2000). 
Differences > 1 mmHg was considered clinically significant in this study and therefore the small 
differences between measurements by each observer were considered clinically insignificant with 
the ICare RBT. 
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Bland and Altman also proposed that measurement error as well as repeatability of measurements 
can be calculated from wsSD (Bland and Altman, 1996). In this study the measurement error for the 
measurements taken without contact lenses was 1.74 mmHg and 2.35 mmHg for DJB and GHK 
respectively. The measurement error for all the measurements was 2.12 mmHg and 2.45 mmHg for 
DJB and GHK respectively. This means that for 95% of the measurements the true value would be 
expected to be less than the measurement errors indicated here. Repeatability without lenses was 
2.45 mmHg and 2.98 mmHg for DJB and GHK respectively and with all measurements 2.98 mmHg 
and 3.19 mmHg for DJB and GHK respectively. Therefore, for 95% of the measurements the 
difference between the two measurements would be expected to be less than these values (Table 
3.3). Compared to GAT with repeatability of 1.7 – 2.0 mmHg the ICare RBT intraobserver 
repeatability was poor (Thorburn, 1978; Dielemans et al., 1994; Kotecha et al., 2005).  However, for 
clinical IOP screening purposes the intraobserver repeatability of the ICare RBT is as good, if not 
better, than comparative noncontact tonometers (Hansen, 1995; Mackie et al., 1996; Tonnu et al., 
2005; Ogbuehi, 2006; Regine et al., 2006; Lafaut et al., 2007; AlMubrad and Ogbuehi, 2008; Ogbuehi 
and Almubrad, 2008). Intraobserver measurement repeatability was not affected by the presence of 
the disposable contact lenses on the eye.   
3.5.2 Interobserver reliability of the ICare RBT 
Without contact lenses (n = 100) the ICC was 0.81 and the mean difference determined by the Bland-
Altman analyses between observer DJB and GHK was M = 0.10, SD = 2.2 mmHg. When all the 
measurements were considered (n = 500) the ICC was 0.88 and the mean difference by the Bland-
Altman analyses between observer DJB and GHK was M = 0.4, SD = 2.1 mmHg. Clinically these small 
measurement differences were not significant. Repeatability calculated from wsSD was 4.39 mmHg 
without lenses and 4.12 mmHg with all measurements considered. Therefore, for 95% of the 
measurements the difference between the two observers’ measurements was expected to be < 4.39 
mmHg (Table 3.5). This study found that the interobserver measurement reliability with the ICare 
RBT was as good without contact lenses on the eye as it was with the four different disposable lenses 
on the eye. The interobserver reliability values determined in this study also compared well with 
previous studies for the same instrument (Martinez-de-la-Casa et al., 2005; Detry-Morel et al., 2006; 
Sahin, Basmak, et al., 2007; Asrani et al., 2011).  
Independent experienced clinicians making IOP measurements under similar conditions with the 
ICare RBT produced repeatable and consistent results. 
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3.5.3 Intraobserver reliability of the Reichert ORA without contact lenses in situ 
It is well know that the OPA affects the accuracy of IOP measurements with the NCT. Several studies 
have shown that the OPA affects the intraobserver repeatability of the ORA, IOPcc and IOPg 
measurements and to a lesser extent the instrument specific biomechanical measurements CH and 
CRF (Sullivan-Mee et al., 2009; Kotecha et al., 2010). In this study, four measurements taken by the 
same observer with the ORA revealed the following results. ICCs (n = 50) were 0.63 for CH; 0.79 for 
CRF; 0.77 for IOPcc; and 0.87 for IOPg. The best test-retest reproducibility results were derived from 
IOPg followed by CRF, IOPcc and CH. This contrasted with the results of Wang et al. (2013) who found 
the IOPcc to have the poorest test-retest reproducibility (Wang et al., 2013). However, except for CH, 
the ORA measurements performed well considering Spitzer and Endicott’s criteria (all ICCs > 0.70). 
The Bland-Altman analysis revealed that the differences between measurements for CH ranged from  
M = 0.013, SD = 1.21 mmHg to M = 0.21, SD = 1.63 mmHg depending on which measurements were 
compared.  
Using the wsSD the measurement error for CH was calculated at 2.12 mmHg and the repeatability at 
2.86 mmHg. This means that for 95% of the measurements the true value would be within 2.12 
mmHg and the difference between the measurements would be less than 2.86mmHg (Table 3.7). The 
differences between measurements for CRF ranged from M = 0.08, SD = 1.35 mmHg to M = 0.25, SD 
= 1.21 mmHg. Using the wsSD, the measurement error for CRF was calculated at 1.73 mmHg and the 
repeatability at 2.44 mmHg. This means for 95% of the measurements the true value would within 
1.72 mmHg and the difference between the measurements would be less than 2.44 mmHg (Table 
3.7). Clinically IOP measurement variation within ±3 mmHg is considered acceptable (Mackie et al., 
1996; Choudhari et al., 2009). The test-retest repeatability for the two corneal biomechanical metrics 
(CH and CRF) measured by the ORA was therefore excellent.  
The Bland-Altman analyses revealed the differences between measurements for IOPcc ranged from 
M = 0.45, SD = 2.18 mmHg to M = 0.21, SD = 2.27 mmHg. Using the wsSD, the measurement error for 
IOPcc was calculated at 3.5 mmHg and the repeatability at 4.94 mmHg. This means that for 95% of 
the measurements the true value would be within 3.5 mmHg and the difference between the 
measurements would be less than 4.94 mmHg (Table 3.7). The differences between measurements 
for IOPg ranged from M = 0.41, SD = 1.87 mmHg to M = 0.65, SD = 2.10 mmHg. Measurement error 
for IOPg was 2.65 mmHg and the repeatability 3.75 mmHg. This means that for 95% of the 
measurements the true value would be within 2.65 mmHg and the difference between the 
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measurements would be less than 3.75 mmHg (Table 3.7). These findings agree with those of Wang 
et al. (2013), Moreno-Montanes et al. (2008), and Kotecha et al. (2010) who found intraobserver 
reliability for the IOPcc and IOPg was not as good as that of the two biomechanical metrics CH and 
CRF (Moreno-Montanes et al., 2008; Kotecha et al., 2010; Wang et al., 2013). Reasons for this 
difference were attributed to the OPA as well as the fact that the two IOP values were calculated 
from the biomechanical metrics. The repeatability of < 4.94 mmHg found in this study also compared 
well to the 4.3 mmHg found by Kotecha et al. (2010). As mentioned before, most tonometers 
measure in increments of 1 mmHg (Doughty and Zaman, 2000) and clinically IOP measurement 
variation within ±3 mmHg is considered acceptable (Mackie et al., 1996; Choudhari et al., 2009). 
Although in this study the repeatability of IOPg and IOPcc was not as good as that of CH and CRF the 
mean differences were slight and therefore clinically not significant.  
Intraobserver reliability of the ORA was therefore considered good for all the parameters measured. 
3.6 Conclusion 
It is clear that although the intraobserver reliability of the ICare RBT is not as good as that of GAT. It 
compared well with that of the NCT and outperformed the ORA IOPcc and IOPg test-retest reliability 
in this study. The ORA biomechanical metrics, CH and CRF, had the best test-retest reliability. In both 
instruments the mean differences between repeated measurements were > 1 mmHg and < 5 mmHg. 
Intraobserver reliability was not affected by the presence of a contact lens on the eye. For both the 
ICare RBT and ORA test re-test reliability was good. 
Independent experienced clinicians making IOP measurements under similar conditions with the 
same ICare RBT produced repeatable and consistent results. The interobserver repeatability was not 
affected by the presence of a contact lens on the eye and the mean differences between 
measurements were < 1 mmHg. 
3.7 Summary of findings 
 The intraobserver repeatability (test-retest reliability) of the ICare RBT was not as good as 
that of GAT, but it compared favourably with comparative non-contact tonometers. 
 Interobserver repeatability with the ICare RBT was good with and without contact lenses on 
the eye. Repeated IOP measurements by independent experienced clinicians with the ICare 
RBT produced repeatable and consistent results. 
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 The intraobserver repeatability (test-retest reliability) of the ORA was excellent for the CH 
and CRF metrics, but not as good for the IOPg and IOPcc measurements. The difference could 
be attributed to the OPA and the fact that the two IOP values were calculated from the 
biomechanical metrics 
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Chapter 4 
Clinical comparison of ICare rebound tonometry and Reichert ocular 
response analyser (ORA) measurements in a population of normal 
subjects with and without soft disposable contact lenses in situ 
4.1 Introduction 
This chapter clinically compares the ICare IOP measurement with the ORA CH, CRF, IOPcc and IOPg 
measurements with and without soft disposable contact lenses in situ. Although previous studies 
have been done to compare the two instruments, no published studies comparing the two 
instruments with soft disposable contact lenses in situ were identified. The results between the 
measurements with and without lenses had also not been compared previously. Chapter three 
showed for both the ICare RBT and ORA the test-retest reliability is excellent and, furthermore, if 
independent experienced clinicians make IOP measurements under similar conditions with the same 
ICare RBT, it is very likely that repeatable and consistent results would be produced.  
Although GAT IOP has a significant association with CCT, the IOPcc produced by the ORA was found 
to have no significant association with ocular variables such as CCT, corneal curvature, and axial 
length (Medeiros and Weinreb, 2006; ElMallah and Asrani, 2008). Studies of the ORA have produced 
conflicting results: two studies in untreated glaucoma patients showed promising results with the 
ORA, IOPcc seeming to compensate for corneal factors (Kotecha et al., 2006; Medeiros and Weinreb, 
2006). In another study of glaucoma patients undergoing therapy with topical medication, the ORA 
IOPcc and IOPg consistently overestimated GAT IOP by 8.3 mmHg and 7.2 mmHg respectively. In this 
group of patients the ORA IOP measurements were not independent of CCT (Martinez-de-la-Casa, 
Garcia-Feijoo, Fernandez-Vidal, et al., 2006). Medeiros and Weinreb (2006) reported a difference of 
M = 0.07, SD = 2.77 mmHg between ORA IOPcc and GAT.  The difference was significantly influenced 
by CCT. Thicker CCT resulted in higher GAT compared to ORA IOPcc and thinner CCT resulted in lower 
GAT compared to ORA IOPcc (Medeiros and Weinreb, 2006). Kotecha et al. (2006) reported that ORA 
IOPcc overestimated GAT by 1.7 mmHg (Kotecha et al., 2006). In their study Lam et al. (2007) found 
80% of the subjects (100 of 125 eyes) in IOPg and seventy nine percent (99 of 125 eyes) in IOPcc 
could achieve ±3 mmHg agreement with GAT. The 95% limits of agreement with GAT were similar for 
IOPg and IOPcc respectively. Good agreement was found between GAT and ORA. The mean 
difference was only 0.33 mmHg between IOPg and GAT, and 0.24 mmHg between IOPcc and GAT.  
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The conclusion reached in the Lam et al. (2007) study indicated when IOP was in the teens, ORA 
measurements are comparable with GAT measurements in normal subjects (Lam et al., 2007). 
Vandewalle et al. (2009) found that although the ORA overestimated IOP compared to GAT, 41.8% of 
ORA IOPg and 35.2% of IOPcc measurements were within ±3 mmHg of GAT measurements 
(Vandewalle et al., 2009). Studies by Carbonaro et al. (2010) and Kotecha et al. (2010) confirmed that 
the ORA IOPg and IOPcc overestimated GAT by ±2 mmHg and that the differences were independent 
of CCT (Carbonaro et al., 2010; Kotecha et al., 2010). Ehrlich et al. (2010) reported that the ORA IOPg 
overestimated GAT by 0.1 mmHg and that 53.9% of the ORA IOPg measurements were within 2 
mmHg and 92.3% within 5 mmHg of GAT (Ehrlich et al., 2010). Lau and Pye (2011) also found that the 
ORA IOPg and IOPcc overestimated GAT IOP by 3.2 - 3.7 mmHg (Lau and Pye, 2011). In a more recent 
systematic review of agreement between different tonometers and GAT, 42% of the measurements 
with the ORA were estimated to be within ±2 mmHg of the GAT measurements (Cook et al., 2012). 
However, it is not clear from the review if the ORA’s corneal corrected IOP (IOPcc) or Goldmann 
equivalent IOP (IOPg) were used in the comparison (Cook et al., 2012). Differences within ±3 mmHg 
of GAT measurements for any other tonometers are clinically acceptable.  
In summary, it is obvious that the ORA (IOPg and IOPcc) tend to overestimate GAT IOP (Table 1.4). 
The exact magnitude of this difference is not clear and depends on the CCT and biomechanical 
properties of the cornea. However, differences of more than 3 mmHg are rare. The suitability of the 
NCT process used by the ORA for determining corneal biomechanics and the “true” IOP have up to 
date not yet been demonstrated with traditional biomechanical testing and manometry in human 
subjects. Validation of the ORA IOP measurements using manometric data therefore needs to be 
performed (Lau and Pye, 2011). 
Currently the studies comparing the IOP measured with GAT and RBT have somewhat divergent 
results (Table 1.5). ICare tonometry measurements were similar to GAT measures in pathologic 
corneas, and in some cases could obtain measurements where GAT could not (Moreno-Montanes et 
al., 2007). It seems as if the ICare RBT was able to estimate IOP within a range of ±3 mmHg in more 
than 80% of the population (Fernandes et al., 2005; Iliev et al., 2006; Munkwitz et al., 2008) and was 
influenced by CCT, corneal curvature, and corneal biomechanics (Brusini et al., 2006; Nakamura et 
al., 2006; Sahin, Niyaz, et al., 2007; Chui et al., 2008; Jorge, Gonzales-Meijome, et al., 2008; Salvetat 
et al., 2011). Although The RBT measurements were highly correlated with GAT measurements, they 
were not interchangeable (Salvetat et al., 2011). 
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Jorge, Gonzales-Meijome et al. (2008) examined the correlations between the corneal biomechanical 
properties measured with the ORA and the IOP measured with the ICare RBT. They found that ICare 
RBT and ORA IOPg was strongly positively correlated (R² = 0.64 p < 0.001) but ORA IOPcc less so (R² = 
0.32 p < 0.001). Regarding the two biomechanical measurements, ORA CRF correlated well with the 
ICare RBT (Spearman correlation coefficient rs = 0.70 p < 0.001) and ORA CH less so (Spearman 
correlation coefficient rs = 0.23 p = 0.012). According to these investigators, the significant positive 
correlation between ICare RBT and ORA CRF − and to a lesser extent ORA CH − indicates that 
individual physiologic variations in the corneal material properties (elastic and viscoelastic responses) 
may be more important than CCT in determining the ICare RBT measurements (Jorge, Gonzales-
Meijome, et al., 2008).   
Previous research showed the corneal modulus of elasticity (Young’s modulus) significantly affected 
the accuracy of IOP measurement (Liu and Roberts, 2005). In some studies it was found that CCT and 
corneal curvature significantly affected ICare RBT measurements (Brusini et al., 2006; Nakamura et 
al., 2006; Sahin, Niyaz, et al., 2007; Avitabile et al., 2010; Salvetat et al., 2011). The biomechanical 
properties CH and CRF measured by the ORA are composite measurements characterising the 
structural response of the eye to the ORA tonometer and they can therefore not be seen as intrinsic 
elastic or viscoelastic properties of the cornea (Jorge, Gonzales-Meijome, et al., 2008; Lau and Pye, 
2011). Currently Young’s modulus of elasticity of the cornea can only be measured ex vivo (Kerautret 
et al., 2008; Lau and Pye, 2011). According to the manufacturer, CH represents ocular resistance due 
to the combined effects of CCT, ocular rigidity as well as the cornea’s elastic properties – CH is 
therefore a function of the energy absorbed by the cornea. CRF is dominated by the combined 
effects of the viscous and elastic properties of the cornea and appears to be an indicator of the 
overall resistance of the cornea (Luce, 2005; Kotecha, 2007; Jorge, Gonzales-Meijome, et al., 2008; 
Kniestedt et al., 2008; Reichert, 2013).  
To summarise, Jorge, Gonzales-Meijome et al. (2008) found that the ICare RBT overestimated ORA 
IOPg and IOPcc while other researchers such as Vandewalle et al. (2009) found the opposite  (Table 
1.6, page 48). Theoretically, due to ICare RBT’s dependence on the corneas biomechanics, IOP 
measurement with this instrument should correlate well with ORA IOPg and poorly with IOPcc (Chui 
et al., 2008; Jorge, Gonzales-Meijome, et al., 2008).   
The aim of this experimental chapter is to clinically compare the ICare RBT and ORA IOP 
measurements with and without four different disposable contact lenses in situ. 
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4.2 Subjects and methods 
Chapter two gives a complete description of the subjects, materials and methodology used in this 
study. The four different contact lenses used remained the same for the entire study period and their 
individual properties are listed in Table 2.1. To compare the ICare RBT and ORA measurements, two 
experienced optometrists (DJB and GHK) took two ICare RBT measurements on every one of the 
subjects enrolled in the study according to the established study protocol: of each subject’s left eye 
with and without each and every contact lens in situ. One of these experienced optometrists (DJB) 
took four ORA measurements according to the protocol established for the study of each subject’s 
left eye with and without the contact lenses in situ. The measurements were recorded by an 
experienced optometric assistant (MLG) blinding the optometrists and reducing observer bias. The 
ICare RBT measurements were compared to each of the ORA metrics (CH, CRF, IOPcc, and IOPg). 
4.3 Statistical analysis 
The methods used to analyse the data included Pearson’s correlation coefficient, paired t-tests, 1-
way ANOVA tests as well as Bland-Altman plots. Pearson’s correlation coefficient describes the 
closeness of the linear relationship between two variables. The test is potentially misleading as there 
may be a strong correlation between the two variables but poor agreement (Patton et al., 2006; 
Armstrong et al., 2011; McAlinden et al., 2011). Several two-sample paired t-tests were performed to 
test the hypotheses (with and without the contact lenses in situ) (Armstrong et al., 2011), Table 4.1.  
The t-test is the easiest way to compare two means and it estimates both the means and SD which 
introduces a dependency on sample size. It is not appropriate when there are more than two groups 
or when individuals in one group are matched to individuals in another group (Norman and Streiner, 
2008).    
Ho: RBT ≈ CH 
Ho: RBT ≈ CRF 
Ho: RBT ≈ IOPcc 
Ho: RBT ≈ IOPg 
Table 4.1 Ho − null hypothesis 
 
 
Additionally 1-way ANOVA tests were performed to test the hypothesis Ho : RBT ≈ CH ≈ CRF ≈ IOPcc ≈ 
IOPg (without as well as with each of the lenses on the eye) (Armstrong et al., 2011). The 1-way 
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ANOVA provides an exact test of the hypotheses of multiple groups, and in combination with 
planned comparisons is the only alternative to multiple t-tests (Norman and Streiner, 2008). 
Finally, Bland-Altman analyses were used to measure agreement between the IOP measurements 
without and with contact lenses in situ for both the ICare RBT and ORA. Bland and Altman tests have 
two distinct advantages compared to the other methods: the power of visual representation of the 
degree of agreement, and easy identification of bias by 95% confidence intervals, outliers, and any 
relationship between the variance in measures with the size of the mean (Bland and Altman, 1986). 
The 95% limits of agreement can also relate to clinical acceptability (Rankin and Stokes, 1998). All 
tests demanded normal distribution of the data. The Shapiro-Wilk test confirmed a normal 
distribution of the data (Appendix 6) and p < 0.05 was considered significant (Ghasemi and Zahediasl, 
2012).  
4.4 Results 
Descriptive statistics for the parameters measured in the study are presented in  Table 2.2. 
In Table 4.2 the means, standard deviations, and range of the relevant measurements from 
this study compared to published values are shown. 
Pearson’s correlations indicate strong positive correlations  (changes in one variable will 
correlate with changes in the other) between the variables without as well as with contact 
lenses in situ. The only exceptions are between ICare RBT and ORA CH without lenses (r = 
0.13, p = 0.37), ICare RBT and ORA CH with Acuvue 1-Day Moist lenses (r = 0.27, p = 0.06), 
as well as ICare RBT and ORA IOPcc with Pure Vision lenses (r = 0.24, p = 0.10) which show 
weak correlations (indicating that changes in one variable will  not correlate with changes 
in the other). In Chapter 3 it was shown that the intraobserver reliability of the ICare RBT 
and ORA was excellent with differences between measurements < 0.30 mmHg , except for 
ORA IOPg with differences of 0.65 mmHg. Likewise, Interobserver reliability was < 0.40 
mmHg. Although these variations in measurements are not clinically significant, they must 
be considered when comparing the two instruments.  
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 Results from this study Mean (M), 
standard deviation(SD), 
Range (min to max) 
N = 50 
Published normal values Mean (M), standard 
deviation (SD) 
 
Mean ICare IOP M = 14.58, SD = 3.38 mmHg 
9.0 to 24.5 mmHg 
M = 15-16, SD = 2.5 mmHg (Harper and Reeves, 
1999) 
Mean ORA IOPg M = 14.64, SD = 3.58 mmHg 
9.0 to 24.4 mmHg 
M = 15-16, SD = 2.5 mmHg (Harper and Reeves, 
1999) 
Mean ORA IOPcc M = 16.02, SD = 3.50 mmHg 
10.10 to 23.68 mmHg 
M = 15-16, SD = 2.5 mmHg (Harper and Reeves, 
1999) 
CCT Pentacam  
M = 531.46, SD = 35.51 µm 
469 to 613 µm 
UP  
M = 537-567 µm,  SD not available (Argus, 1995; 
Bron et al., 1999; Shah et al., 1999; La Rosa et al., 
2001; Nemesure et al., 2003) 
Mean ORA CH M = 9.68, SD = 1.42 mmHg 
7.15 to 13.38 mmHg 
M = 9.6-12 mmHg, SD not available (Ortiz et al., 
2007; Shehadeh-Mashor et al., 2012) 
Mean ORA CRF M = 9.57, SD = 1.65 mmHg 
6.83 to 13.40 mmHg 
M = 9.5-12 mmHg, SD not available (Ortiz et al., 
2007; Shehadeh-Mashor et al., 2012) 
Mean corneal curvature 
(K) 
Pentacam  
M = 7.80, SD = 0.28 mm 
7.30 to 8.33 mm 
M = 7.80 mm, SD not available (Pepose and 
Ubels, 1992) 
Table 4.2 Means and standard deviations of the relevant results (without lenses) from this study compared 
to published population values .(UP = ultrasound pachymetry, CCT = central corneal thickness, CH = corneal 
hysteresis, CRF = corneal resistance factor, IOPcc = corneal compensated IOP, IOPg = Goldmann equivalent IOP) 
4.4.1Without lenses 
Hypotheses testing by 1-way ANOVA: Ho : RBT ≈ CH ≈ CRF ≈ IOPcc ≈ IOPg for data without lenses were 
overwhelmingly rejected: f = 132.55, p < 0.0001. The results were also supported by the means and 
standard deviations of the variables (Table 4.3). Results for paired t-tests for the different hypotheses 
tested in Table 4.4 show that without lenses the ICare RBT and ORA IOPg measurement were 
comparable and the differences between the two were not clinically nor statistically significant. 
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Means and SD of ICare RBT and ORA CH,CRF, IOPcc and IOPg without lenses 
Variable RBT (mmHg) CH (mmHg) CRF (mmHg) IOPcc (mmHg) IOPg (mmHg) 
Mean (M), 
standard 
deviation (SD) 
M = 14.58, SD = 
3.38 
M = 9.68, SD = 
1.42 
M = 9.57, SD = 
1.65 
M = 16.02, SD = 
3.50 
M = 14.64, SD = 
3.58 
Means and SD of ICare RBT and ORA CH,CRF, IOPcc and IOPg with Pure Vision lenses 
Variable RBTPure Vision 
(mmHg) 
CHPure Vision 
(mmHg) 
CRFPure Vision 
(mmHg) 
IOPcc Pure Vision 
(mmHg) 
IOPgPure Vision 
(mmHg) 
Mean (M), 
standard 
deviation (SD) 
M = 18.49, SD = 
5.43 
M = 14.56, SD = 
3.38 
M = 14.22, SD = 
3.40 
M = 11.72, SD = 
3.18 
M = 15.79, SD = 
3.75 
Means and SD of ICare RBT and ORA CH,CRF, IOPcc and IOPg with Frequency XC lenses 
Variable RBTFreq.XC (mmHg) CHFreq.XC (mmHg) CRFFreq.XC (mmHg) IOPccFreq.XC 
(mmHg) 
IOPgFreq.XC 
(mmHg) 
Mean (M), 
standard 
deviation (SD) 
M = 14.09, SD = 
3.15 
M = 10.08, SD = 
1.34 
M = 9.60, SD = 
1.64 
M = 14.83, SD = 
3.09 
M = 13.55, SD = 
3.48 
Means and SD of ICare RBT and ORA CH,CRF, IOPccC and IOPgC with Acuvue 1-Day Moist lenses 
Variable RBTMoist (mmHg) CHMoist (mmHg) CRFMoist (mmHg) IOPccMoist 
(mmHg0 
IOPgMoist (mmHg) 
Mean (M), 
standard 
deviation (SD) 
M = 13.12, SD = 
3.11 
M = 9.81, SD = 
1.40 
M = 9.34, SD = 
1.53 
M = 15.06, SD = 
2.61 
M = 13.62, SD = 
2.86 
Means and SD of ICare RBT and ORA CH,CRF, IOPcc and IOPg with Acuvue Oasys lenses 
Variable RBTOasys (mmHg) CHOasys (mmHg) CRFOasys (mmHg) IOPccOasys (mmHg) IOPgOasys (mmHg) 
Mean (M), 
standard 
deviation (SD) 
M = 13.74, SD = 
3.24 
M = 10.59, SD = 
1.64 
M = 9.99, SD = 
2.05 
M = 14.00, SD = 
2.68 
M = 13.48, SD = 
3.33 
Table 4.3 Means, and SD of ICare RBT and ORA CH, CRF, IOPcc and IOPg without lenses .(Shaded cells indicate 
small differences in the means between the different measurements – these differences are not significant). 
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Hypothesis Paired t-tests  df = 49 
Ho: RBT ≈ CH t = 9.924, p = 0.000 (reject 0H ) 
Ho: RBT ≈ CRF t = 13.25, p = 0.000  (reject 0H )  
Ho: RBT ≈ IOPcc t = -3.946, p = 0.000 (reject 0H ) 
Ho: RBT ≈ IOPg t =-0.224, p = 0.823  (cannot reject 0H )* 
With Pure Vision lenses 
Ho: RBT ≈ CH 
t = 6.459, p = 0.000 (reject  0
H
)  
Ho: RBT ≈ CRF 
t = 9.408, p = 0.000 (reject  0
H
)  
Ho: RBT ≈ IOPcc 
t = 8.537, p = 0.000 (reject   0
H
) 
Ho: RBT ≈ IOPg 
t = 6.115, p = 0.000 (reject  0
H
) 
With Frequency XC lenses 
Ho: RBT ≈ CH t = 9.572, p = 0.000 (reject  0H )  
Ho: RBT ≈ CRF t = 14.759, p < 0.000 (reject  0H )  
Ho: RBT ≈ IOPcc t = -2.053, p = 0.045 (reject   0H ) 
Ho: RBT ≈ IOPg t = 1.837, p = 0.072 (cannot reject  0H )* 
With Acuvue 1-Day Moist lenses 
Ho: RBT ≈ CH t = 7.687, p = 0.0000 (reject  0H )  
Ho: RBT ≈ CRF t = 11.698, p = 0.000 (reject  0H )  
Ho: RBT ≈ IOPcc t = -5.703, p = 0.000 (reject   0H ) 
Ho: RBT ≈ IOPg t = -2.225, p = 0.031(reject  0H ) 
With Acuvue Oasys lenses 
Ho: RBT ≈ CH 
t = 7.560, p = 0.000 (reject  0
H
)  
Ho: RBT ≈ CRF 
t = 11.750, p = 0.000 (reject  0
H
)  
Ho: RBT ≈ IOPcc 
t = -0.729, p = 0.469 (cannot reject   0
H
)* 
Ho: RBT ≈ IOPg 
t = 1.140, p = 0.260 (cannot reject  0
H
)* 
 
Table 4.4 Results of the t-tests for the hypotheses tested, with and without lenses in situ.  
(* - grey shaded cells indicate hypotheses that cannot be rejected) 
4.4.2 With Pure Vision lens   
Hypotheses testing by 1-way ANOVA: H0: RBTA ≈ CHA ≈ CRFA ≈ IOPccA ≈ IOPgA for data 
with Pure Vision lenses were overwhelmingly rejected: f = 34.25, p < 0.0001. The results 
were also supported by the means and standard deviations  of the variables (Table 4.3). 
Results for the paired t-tests (Table 4.4) showed that with Pure Vision lenses the ICare RBT 
and ORA measurements (CH, CRF, IOPcc, and IOPg) were not comparable and the 
differences between the two was clinically and statistically significant. The modulus of Pure 
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Vision (1.1 Mpa) significantly affected the accuracy of IOP measurement with the ICare 
RBT. 
4.4.3 With Frequency XC lens   
Hypotheses testing by 1-way ANOVA: H0: RBTB ≈ CHB ≈ CRFB ≈ IOPccB ≈ IOPgB for data 
with Frequency XC lenses were overwhelmingly rejected: f = 102.56, p < 0.0001. The results 
were also supported by the means and standard deviations of the variables ( Table 4.3). 
Results for the paired t-tests (Table 4.4) showed that with Frequency XC lenses the ICare 
RBT and ORA IOPg measurements were comparable and the differences between the two 
were neither clinically nor statistically significant. The lower modulus of Frequency XC 
(0.3–0.4 MPa) was similar to the modulus of the cornea (M = 0.29, SD = 0.06 MPa) 
(Hamilton and Pye, 2008) and therefore affected the accuracy of IOP measurement with 
the ICare RBT less. 
4.4.4 With Acuvue 1-Day Moist lens 
Hypotheses testing by 1-way ANOVA: H0: RBTC ≈ CHC ≈ CRFC ≈ IOPccC ≈ IOPgC for data with 
Acuvue 1-day Moist lenses were overwhelmingly rejected: f = 116.84, p < 0.0001. The 
results were also supported by the means and standard deviations of the variables (Table 
4.3). Results for the paired t-tests for the different hypotheses tested (Table 4.4) showed 
that with Acuvue 1-day Moist lenses the ICare RBT and ORA measurements (CH, CRF, IOPcc, 
and IOPg) were not comparable and the differences between the two were clinically and 
statistically significant. The lower modulus of Acuvue 1-Day Moist (0.26 MPa) was similar 
to the modulus of the cornea (M = 0.29, SD = 0.06 MPa) (Hamilton and Pye, 2008) and 
therefore affected the accuracy of IOP measurements with the ICare RBT less. 
4.4.5 With Acuvue Oasys lens  
Hypotheses testing by 1-way ANOVA: H0: RBTD ≈ CHD ≈ CRFD ≈ IOPccD ≈ IOPgD for data 
with Acuvue Oasys lenses were overwhelmingly rejected: f = 64.37, p < 0.0001. The results 
were also supported by the means and standard deviations of the variables ( Table 4.3). 
Results for the paired t-tests for the different hypotheses tested (Table 4.4) showed that 
with Acuvue Oasys lenses the ICare RBT and ORA IOPcc, and the IOPg were comparable and 
the differences between the two were neither clinically nor statistically significant. 
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4.4.6 Bland-Altman analyses 
Figure 4.1 (page 125) shows a Bland-Altman plot of the difference between ICare RBT and ORA CH 
without lenses (n = 50), while figure 4.2) shows the Bland Altman plot for all measurements (n = 250) 
including measurements with and without lenses. 
 
Figure 4.1 Bland-Altman plot of the difference or bias between ICare RBT and ORA CH without lenses (n = 50). Note the 
tendency of the bias to increase with higher IOP measurements. 
 
 
 
Figure 4.2 Bland-Altman plot of the difference or bias between ICare RBT and ORA CH for all measurements (n = 250) 
including measurements with and without lenses. Note the tendency of the bias to increase with higher IOP 
measurements. 
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The difference between RBT and CH without lenses was M = 4.91, SD = 3.46 mmHg (95% CI [3.91 to 
5.89]). Visual examination of the scatter plot revealed two outliers. There was a poor linear 
correlation between the measurements: r = 0.13. The difference between RBT and CH for all 
measurements was M = 3.86, SD = 3.42 (95% CI [3.43 to 4.283). The scatter plot revealed a few 
outliers and the linear correlation between the measurements was poor: r = 0.58. The differences 
between these two measurements were clinically as well as statistically significant. 
Figure 4.3 (page 126) shows a Bland-Altman plot of the difference between ICare RBT and ORA CRF 
without lenses (n = 50), while figure 4.4 shows the Bland Altman plot for all measurements (n = 250) 
including measurements with and without lenses. 
 
 
Figure 4.3 Bland-Altman plot of the difference or bias between ICare RBT and ORA CRF without lenses (n = 50). Note the 
tendency of the bias to increase with higher IOP measurements. 
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Figure 4.4 Bland-Altman plot of the difference or bias between ICare RBT and ORA CRF for all measurements (n = 250) 
including measurements with and without lenses. Note the tendency of the bias to increase with higher IOP 
measurements. 
The difference between RBT and CRF without lenses was M= 5.02, SD = 2.68 mmHg (95% CI [4.25 to 
5.77]). Visual examination of the scatter plot revealed two outliers. There was a poor linear 
correlation between the measurements: r = 0.63. The difference between RBT and CRF for all 
measurements was M = 4.26, SD = 2.57 (95% CI [3.93 to 4.58]). The scatter plot revealed a few 
outliers and the linear correlation between the measurements was good: r = 0.80. The differences 
between these two measurements were clinically as well as statistically significant. 
Figure 4.5 (page 128) shows a Bland-Altman plot of the difference between ICare RBT and ORA IOPcc 
without lenses (n = 50), while figure 4.6 shows the Bland Altman plot for all measurements (n = 250) 
including measurements with and without lenses. 
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Figure 4.5 Bland-Altman plot of the difference or bias between ICare RBT and ORA IOPcc without lenses (n = 50). 
 
Figure 4.6 Bland-Altman plot of the difference or bias between ICare RBT and ORA CRF for all measurements (n = 250) 
including measurements with and without lenses. 
The difference between RBT and IOPcc without lenses was M = -1.45, SD = 2.59 mmHg (95 % CI [-2.18 
to -0.71]) with the ORA IOPcc significantly overestimating ICare RBT. Visual examination of the 
scatter plot revealed two outliers. There was a fairly good linear correlation between the 
measurements: r = 0.717. The difference between RBT and IOPcc for all measurements was M = 
0.476, SD = 4.627 (95% CI [-0.10 to 1.05]). The scatter plot revealed a few outliers and the linear 
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correlation between the measurements was poor: r = 0.262. The differences between these two 
measurements were neither clinically nor statistically significant. 
Figure 4.7 (page 129) shows a Bland-Altman plot of the difference between ICare RBT and ORA IOPg 
without lenses (n = 50), while Figure 4.8 shows the Bland Altman plot for all measurements (n = 250) 
including measurements with and without lenses. 
 
 
Figure 4.7 Bland-Altman plot of the difference or bias between ICare RBT and ORA IOPg without lenses (n = 50). 
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Figure 4.8 Bland-Altman plot of the difference or bias between ICare RBT and ORA IOPg for all measurements (n = 250) 
including measurements with and without lenses. 
The difference between RBT and IOPg without lenses was M = -0.06, SD = 1.89 mmHg (95% CI [-0.60 
to 0.48]). Visual examination of the scatter plot revealed one outlier. There was excellent linear 
correlation between the measurements: r = 0.85. The difference between RBT and IOPg for all 
measurements was M = 0.59, SD = 2.39 (95% CI [0.290 to 0.885]). The scatter plot revealed a few 
outliers and the linear correlation between the measurements was excellent: r = 0.82. The 
differences between these two measurements (with and without lenses) were neither clinically nor 
statistically significant. 
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Figure 4.9 Box plots indicating the medians, upper and lower quartiles of the variables measured(ICare – yellow boxes, 
ORA IOPcc – purple boxes, and IOPg – orange boxes). Outliers are indicated by circles. The data represents 
measurements with and without contact lenses in situ in mmHg. The blue line indicates mean RBT without lenses. The 
means and confidence intervals show some overlap indicating that the groups are fairly similar. Further analyses are 
needed to reveal statistically significant differences between the groups (RBT = rebound tonometry, IOPcc = corneal 
compensated IOP, IOPg =  Goldmann equivalent IOP) 
4.5 Discussion  
This experimental chapter aimed to add more information to the clinical comparison between ICare 
RBT and ORA IOP measurements. In the case of the ICare RBT, literature shows that corneal 
biomechanical properties (CH and CRF) play a major role in the accuracy of the IOP measurements, 
more so than CCT (Chui et al., 2008; Jorge, Gonzales-Meijome, et al., 2008; Salvetat et al., 2011). The 
other variables important to consider include CCT, corneal curvature, and refractive error (Detry-
Morel et al., 2006; Lopez-Caballero et al., 2007; Avitabile et al., 2010; Salvetat et al., 2011; Hohmann 
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et al., 2012; Rao et al., 2012). With regard to the ORA, many of the same variables influence the 
accuracy of the measurements but not all of them influence each one of the four measurements. 
Age, corneal curvature, CCT, and corneal biomechanics are important variables which can affect the 
accuracy of the ORA measurements (Luce, 2005; Kotecha et al., 2006; Kniestedt et al., 2008; Kotecha 
et al., 2010). Individually, different measurements are affected differently by the variables − CRF is 
closely associated with CCT; IOPcc is not significantly associated with CCT; and IOPg is associated with 
CCT, corneal curvature as well as axial length (Moreno-Montanes et al., 2008; Sullivan-Mee et al., 
2009; Kotecha et al., 2010; Terai et al., 2012; Wang et al., 2013). The ORA employs the same 
principles as the NCT and it was therefore was significantly affected by the OPA while the ICare RBT 
was not affected by the OPA (Moreno-Montanes et al., 2008; Sullivan-Mee et al., 2009; Kotecha et 
al., 2010; Wang et al., 2013). Jorge et al. (2008) evaluated the correlations between the corneal 
biomechanical properties with the IOP obtained with the ICare RBT. They found that the ICare RBT 
displayed higher and more variable results than the ORA with the IOPg and IOPcc being more 
reliable. ICare RBT had a strong positive correlation with IOPg, less so with IOPcc and CRF, and a poor 
correlation with CH. From their results they postulated the strong correlation with CRF indicates that 
ICare RBT has a higher correlation with the biomechanical properties of the cornea than CCT (Jorge, 
Gonzales-Meijome, et al., 2008). The ORA IOPcc and IOPg tend to overestimate IOP (results varied 
between 3 – 7 mmHg depending on the study) compared to GAT (Martinez-de-la-Casa, Garcia-Feijoo, 
Fernandez-Vidal, et al., 2006; Lau and Pye, 2011; Cook et al., 2012). Although the ICare RBT was able 
to estimate IOP within a range of ±3 mmHg in more than 80% of the population (Fernandes et al., 
2005; Iliev et al., 2006; Munkwitz et al., 2008), most studies show it overestimates GAT IOP 
measurements (Table 1.5). 
The results of the current study showed the ICare RBT and ORA IOPg measurements were 
comparable. Most tonometers measure in increments of 1 mmHg (Doughty and Zaman, 2000). Also, 
studies have shown that calibration errors of 2 mmHg are common (Choudhari et al., 2009). 
Therefore, for the purposes of this study differences of more than 1 mmHg were considered clinically 
significant. Without lenses the RBT measurement was M = 14.58, SD = 3.35 mmHg and IOPg M = 
14.64, SD = 3.58 mmHg. The difference between the two measurements, according to the Bland-
Altman analyses was M = -0.06, SD = 0.59 mmHg and a strong linear relationship existed between the 
two measurements: r = 0.85. ANOVA and t-tests confirmed the hypothesis that the two 
measurements were not significantly different: t = -0.04, p = 0.96. With the Pure Vision lenses the 
ICare RBT and ORA metrics did not compare well and the RBT significantly overestimated the IOP 
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when compared to the ORA. Pure Vision has a high modulus of elasticity (1.1 MPa) which might have 
affected the biomechanics of the cornea/lens combination and therefore the ICare RBT 
measurement.  
With the Frequency XC lens the RBT measurement was M = 14.09, SD = 3.15 mmHg and IOPg M = 
13.55, SD = 3.48 mmHg. Although the ANOVA showed the RBT and ORA metrics were not 
comparable the t-test showed the RBT and IOPg values were comparable (t = 2.06, p = 0.045) with 
the differences between them clinically and statistically insignificant. Although the hypothesis that 
RBT and IOPcc was comparable was rejected by the ANOVA and t-tests (t = -2.28, p= 0.03) the mean 
measurement for IOPcc (M = 14.83, SD = 3.09) was statistically significant: however, clinically it was 
not significantly different from the RBT mean (M = 14.09, SD = 3.15). 
With the Acuvue 1-Day Moist lens the RBT measurement was M = 13.62, SD = 2.86 mmHg and IOPg 
M = 13.12, SD = 3.11 mmHg. The ANOVA showed RBT and IOPg values were comparable (f = 1.44, p = 
0.2365), the t-tests rejected this hypothesis (t = -2.47, p < 0.017). But, although the difference 
between the means was statistically significant, clinically it was not significant.  
With the Acuvue Oasys lens the RBT measurement was M = 13.74, SD = 3.24 mmHg, IOPcc M =14.00, 
SD = 2.68 mmHg, and IOPg M = 13.48, SD = 3.33 mmHg. The ANOVA confirmed the hypothesis that 
the RBT, IOPcc and IOPg measurements were comparable (f = 1.17, p = 0.2841 for IOPcc and f = 1.72, 
p = 0.1957 for IOPg). This hypothesis was further confirmed by the t-tests which indicate that the RBT 
and ORA IOPcc and IOPg measurements were statistically and clinically comparable (t =-1.08, p = 
0.284 for IOPcc and t = 1.31, p < 0.196 for IOPg).  
Finally, Bland-Altman analyses of all the measurements with as well as without lenses indicated that 
the mean differences between RBT and IOPcc were M = 0.48, SD = 4.63 mmHg with a weak linear 
correlation (r = 0.26) between the two measurements. The difference was neither statistically nor 
clinically significant. The mean difference between RBT and IOPg was M = 0.59, SD = 2.39 mmHg with 
a strong linear correlation (r = 0.82) between the two measurements. The difference was neither 
clinically nor statistically significant. 
4.6 Conclusion 
The present study confirms that the ICare RBT and ORA IOPg pressure measurements were highly 
correlated and comparable. Clinically the differences between the two measurements were less than 
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0.60 mmHg. This difference was apparently not affected by the presence of a contact lens on the 
eye.  
With the Pure Vision lenses the ICare RBT and ORA metrics did not compare well and the RBT 
significantly overestimated the IOP compared to the ORA. Pure Vision has a high modulus of 
elasticity (1.1 MPa) which might have affected the biomechanics of the cornea/lens combination and 
therefore the ICare RBT measurements. The ICare RBT and IOPcc pressure measurements were also 
correlated and comparable but to a lesser extent than the ICare RBT and IOPg measurements. 
Clinically the difference was larger than 1 mmHg with ORA IOPcc overestimating the ICare RBT. 
However, when the measurements with contact lenses were included in the analysis, the difference 
becomes clinically insignificant (0.50 mmHg). This could be ascribed to the induced biomechanical 
differences and their effects on the ICare RBT measurements. The lower correlation with ORA IOPcc 
also suggests that ICare RBT measurements were affected by corneal biomechanical properties and 
not only the IOP or CCT of the eye which confirms previously reported findings (Jorge, Gonzales-
Meijome, et al., 2008). ORA CH and CRF measurements were neither clinically nor statistically 
comparable to ICare RBT measurements.  
All measurements in this study were collected at one specific sitting and it is therefore conceivable 
that variation in measurement may occur from one visit to the next with or without a specific lens 
which limits the clinical usefulness of the results of this study. The study should be expanded to 
collect data over a number of consecutive visits to determine the variability of the measurements 
thereby validating the clinical usefulness of the results obtained in this study.     
4.7 Summary of findings 
 ORA CH and CRF metrics were neither clinically nor statistically comparable with ICare RBT 
measurements.  
 ICare RBT and ORA IOPg were clinically and statistically comparable but the ICare RBT was 
less comparable with ORA IOPcc.  
 With the high modulus Pure Vision lens in situ the ICare RBT overestimated ORA IOPg and 
IOPcc. The difference became clinically insignificant when the data for measurements with all 
the lenses were considered (< 0.60 mmHg). 
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Chapter 5 
Intraocular pressure and corneal biomechanical metric 
measurements through soft disposable contact lenses with the ICare 
rebound tonometer and the Reichert ocular response analyser 
 
5.1 Introduction 
Chapter three showed that the intraobserver reliability (test-retest repeatability by the same 
observer) of the ICare RBT and the ORA produced repeatable and consistent results even when 
measurements were performed with disposable contact lenses on the eye. Interobserver reliability 
(test-retest repeatability between different observers) also produced repeatable and consistent 
results with the ICare RBT. Chapter four confirmed that the ICare RBT and ORA IOPg pressure 
measurements were highly correlated and comparable. Clinically the differences between the two 
measurements were less than 0.60 mmHg and this difference seemed not to be affected by the 
presence of a contact lens on the eye. ICare RBT and IOPcc pressure measurements were also 
correlated and comparable but to a lesser extent than ICare RBT and IOPg measurements. 
Although the diagnosis of glaucoma relies on many clinical tests as well as risk factor analyses, 
accurate IOP measurements form an essential part of the diagnosis and treatment of glaucoma 
(Quigley and Addicks, 1981; Lusky et al., 1993; Cartwright and Anderson, 1998; Quigley, 2001; Maier 
et al., 2005; Heijl et al., 2008). In certain clinical situations it may be necessary to measure the IOP 
with a soft contact lens on the eye. Examples include patients wearing bandage contact lenses for 
the treatment of corneal injuries after corneal surgery such as LASIK, PRK, and corneal crosslinking 
(Arora et al., 2004; Blackmore, 2010; Markoulli et al., 2012), avoiding topical anaesthesia, to 
minimise trauma, and when the corneal surface is extremely irregular (Zeri et al., 2015). In situations 
where patients wear extended wear contact lenses and it may not be possible to remove the lenses 
for IOP measurement. The latter especially applies when the patient makes use of the newer ICare 
HOME (TA022) tonometer (Liang et al., 2009; Asrani et al., 2011; Flemmons et al., 2011). This 
tonometer was specifically designed for home use by glaucoma patients who need regular IOP 
monitoring (Tiolat, 2015). The tonometer uses the same rebound technology of ICare TAO1i, but 
integrates EyeSmart eye recognition and EasyPosalignment features to improve usability. IOP is 
determined by impact duration or deceleration of a magnetic solenoid probe directed at the central 
cornea, and computed from six consecutive measurements. The ICare HOME has shown good 
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agreement with the current reference standard Goldmann Applanation Tonometer (GAT) when used 
for self-measurement by adults, and by a caregiver on a child (Dabasia et al., 2015; Mudie et al., 
2016). The device has also demonstrated good repeatability. Mudie et al. (2016) found that the ICare 
HOME and ICare TA01i (used in the this programme of research) compared well with mean 
differences M = 0.30, SD = 2.82 mmHg (Mudie et al., 2016).  
More recent developments include the use of soft contact lenses for sustained drug delivery to the 
eye. The soft lenses are impregnated with the drug required for therapy which is then released into 
the eye over a period of time to treat a specific diseases such as glaucoma, microbial keratitis, and 
ocular inflammation (Braga et al., 2011; Peng and Chauhan, 2011; Gupta and Aqil, 2012; Peng et al., 
2012; Tieppo, Pate, et al., 2012; Tieppo, White, et al., 2012). It is important to evaluate the accuracy 
and repeatability of IOP measurements with and without contact lenses using the ICare tonometer as 
well as the newer Reichert ORA to validate clinical decisions based on IOP measurements with these 
instruments. 
Literature shows that various studies have been conducted on the ICare tonometer; yet in only two 
the Reichert ORA was used to measure IOP with contact lenses on the eye (Lam and Tse, 2014; 
Sapkota et al., 2014). Conversely, the ORA is essentially a noncontact tonometer and a number of 
studies have been conducted on the accuracy of the NCT measurement with contact lenses in situ. 
These results provided the first evidence that continued contact lens wear does not adversely affect 
IOP (Janoff, 1977). In Table 5.1 the findings of the different studies dealing with IOP measurement 
with contact lenses in situ using the NCT, ICare RBT and, more recently, the ORA are summarised. 
These findings substantiate that accurate measurement of intraocular pressure with contact lenses in 
situ was possible with a variety of instruments. However, various factors seem to affect the accuracy 
of the measurements including lens prescription or power, lens modulus or stiffness, lens thickness, 
lens anterior curvature, and lens hydration. The generally accepted tenet in the literature is that as 
long as the lens thickness does not exceed 0.15 mm to 0.30 mm and it is fairly new, well hydrated, 
and has a low prescription power the accuracy of the measurements would not significantly differ 
from measurements without contact lenses on the eye. It is further accepted that higher power plus 
lenses lead to overestimation, and higher power minus lenses to underestimation of intraocular 
pressure (McMonnies, 1986; Insler and Robbins, 1987; Sugimoto-Takeuchi et al., 1991; Mark et al., 
1992; Scibilia et al., 1996; Schollmayer and Hawlina, 2003; Patel and Illahi, 2004; Kerautret et al., 
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2008; Patel and Stevenson, 2009; Liu et al., 2011; Zeri et al., 2011; Firat et al., 2012; Ogbuehi, 2012; 
Anton et al., 2013; Lam and Tse, 2014).  
 
 
Study Methods/Subjects Lenses used Results 
McMonnies, (1986)  
 
NCT 
5 eyes of albino rabbits 
Hydrogel lathe cut lenses, 
-5.00 and 38% water 
content, CT (0.057 - 0.219 
mm) 
Spun cast U3 & B4 (Bausch 
& Lomb) hydrogel lenses, 
CT (0.071 and  0.152 mm)  
No effect on IOP as long as 
the CT < 0.15 mm. 
Insler & Robbins, (1987)  NCT 
23 subjects and 43 eyes 
Plus and minus powered 
hydrogel lenses 
Measured IOP was highly 
correlated with lens power. 
Plus lenses = higher 
measured IOP. 
Sugimoto-Takeuchi et al. 
(1991)  
NCT 
18 subjects and 29 eyes 
Plano-T & Plano B4 (Bausch 
& Lomb) therapeutic 
hydrogel lenses 
No effect on IOP. 
Mark et al. (1992)  TonoPen and NCT 
9 cadaver eyes 
Bandage hydrogel lenses on 
cadaver eyes 
NCT accurate with and 
without a therapeutic 
contact lens. TonoPen 
equally inaccurate with and 
without a therapeutic 
contact lens.  
Scibilia et al. (1996)  TonoPen and NCT 
Group A 5 subjects and 10 
eyes 
Group B 10 subjects and 
10 eyes 
 
Hydrogel lenses, O4 
(Bausch & Lomb), Acuvue 
(Johnson & Johnson), 
Permalens (Coopervision) 
No statistically significant 
differences with or without 
the lenses. 
Schollmayer and Hawlina 
(2003)  
NCT 
80 subjects and 120 eyes 
Silicone hydrogel lenses of 
different power (Focus 
Night & Day – Ciba Vision) 
Lower measured IOP over 
low minus lenses, but 
higher IOP measured with 
plus power lenses. 
Patel and Illahi (2004)  NCT -15.00 to +3.00 D hydrogel With CT < 0.30 mm and 
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8 subjects and 8 eyes lenses power < +3.00 D, accurate 
measurements could be 
obtained with NCT. 
Study Methods/Subjects Lenses used Results 
Patel and Stevenson (2009)  NCT 
25 subjects and 50 eyes 
Low water content silicone 
hydrogel lenses (Focus 
Night & Day [Ciba Vision]) 
and high water content 
hydrogel lens (Focus Dailies 
[Ciba Vision]). Power varied 
between -7.50  to +6.00 D 
Lens power, modulus, and 
IOP affect the accuracy of 
the measurement. 
Zeri et al. (2011)  RBT 
68 subjects and 136 eyes 
Hydrogel (Acuvue 2 
[Johnson & Johnson]) and 
silicone hydrogel (Acuvue 
Oasys [Johnson & Johnson]) 
RBT can be accurately 
performed over silicone 
hydrogel lenses. However, 
measurement with low 
power plus and hydrogel 
lenses was lower than 
without them.  
Firat et al. (2012)  NCT and DCT 
40 subjects and 40 eyes 
Silicone hydrogel plano 
power lens (Focus Night & 
Day [Ciba Vision]) 
Statistically insignificant 
difference with NCT. 
Statistically significant 
difference with DCT. 
Ogbuehi et al. (2012)  NCT  
39 subjects and 39 eyes 
High water content 
hydrogel, Dailies – nelfilcon 
A (Ciba Vision). 69% water 
content. Two powers used, 
+6.00 and -6.00  D with CT 
0.207 and 0.085 mm 
respectively 
Statistically significant 
increase in measured IOP 
with +6.00 D lenses (3 
mmHg). Statistically 
significant decrease in IOP 
with -6.00 D lenses. 
Difference between two 
lens powers was 3.6 mmHg. 
Reliable estimates of IOP 
can be made through high 
water content minus lenses 
up to -6.00 D. CT of +0.2 
mm results in unreliable 
estimates of IOP. 
Lam and Tse (2014)  DCT and ORA CH and CRF 
74 subjects and 148 eyes 
Silicone hydrogel lenses’ 
high Modulus Focus Night 
and Day (Ciba Vision) and 
No significant difference in 
CH and CRF measured 
through the lenses. High 
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low modulus Acuvue 
Advance (Johnson & 
Johnson)  
modulus silicone hydrogel 
lenses demonstrated 
greater effect on IOP 95% 
LoA: 2.73 mmHg than low 
modulus lenses 95% LoA: 
1.0 mmHg. DCT can be 
performed reliably over low 
modulus silicone hydrogel 
lenses. 
Study Methods/Subjects Lenses used Results 
Sapkota et al. (2014)  ORA IOPcc and IOPg 
28 subjects and 56 eyes 
Silicone hydrogel one day 
lens (Acuvue True Eye 
[Johnson & Johnson]) and 
hydrogel one day (Daily 
Aqua Comfort Plus [Ciba 
Vision]). Power used was a -
3.00 D lens on 28 subjects 
without ocular pathology 
Both IOPg and IOPcc when 
measured with contact 
lenses were statistically 
lower than without contact 
lenses (p < 0.05). With True 
Eye IOPg and IOPcc were M 
= 0.88, SD = 2.04 and M = 
1.55, SD = 2.16 mmHg lower 
respectively. With Aqua 
Comfort the values were M 
= 1.03, SD = 1.93 mmHg and 
M = 1.62, SD = 3.12 mmHg 
respectively. To measure 
IOP accurately with the 
ORA, contact lenses should 
be removed.  
Rimayanti et al. (2014)  GAT and NCT 
21 subjects and 21 eyes 
Acuvue 2 (Johnson & 
Johnson), etafilcon A, 58% 
water content, 8.70 mm 
base curve, 14.00 mm 
diameter, 40 Dk/t, 0.084 
mm CT, modulus 0.25 MPa, 
power -5.00, -0.50, and 
+5.00 D 
GAT without lenses was 
similar to NCT. With higher 
plus powered thicker lenses 
NCT overestimated IOP. 
With higher minus powered 
thinner lenses NCT 
underestimated IOP. 
Differences in IOP 
measurement depend on 
lens power and the radius 
of ocular surface curvature 
affects the ocular surface 
displacement and IOP 
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readings. 
Study Methods/Subjects Lenses used Results 
Takenaka et al. 2015  
 
NCT, GAT, ICare RBT, 
TonoPen XL 
26 subjects and 26 eyes 
Acuvue 2 (Johnson & 
Johnson), etafilcon A, 58% 
water content, 8.70 mm 
base curve, 14.00 mm 
diameter, 40 Dk/t, 0.084 
mm CT, modulus 0.25 MPa, 
power -5.00, -0.50, and 
+5.00 D  
GAT without lenses was 
used as the standard 
against which the 
measurements with lenses 
were tested.  The authors 
concluded that the NCT and 
ICare RBT gave the most 
accurate IOP measurements 
with contact lenses in situ. 
Table 5.1 Summary of previous studies that  examined the validity of measuring IOP with contact lenses in 
situ with the NCT, ORA and RBT.( RBT = rebound tonometry; NCT = non-contact tonometry; DCT = dynamic contour 
tonometry) 
Statistical power calculation (G*Power 3.0.10, Franz Faul, Universität Kiel, Germany) required a 
sample size of at least 50 subjects. Four commonly prescribed disposable soft contact lenses of 
different powers (range -6.00D to +6.00 D, minus lenses n = 32 and plus lenses n = 18) and different 
materials (hydrogel and silicone hydrogel) were used (Table 2.1). This study specifically aimed to 
investigate the accuracy of IOP and biomechanical metric measurement with the contact lenses in 
situ using the ICare RBT and Reichert ORA.  
5.2 Subjects and methods 
Chapter two presented a complete description of the subjects, materials and methodology used in 
this specific study. To evaluate the accuracy of IOP and corneal biomechanical measurements with 
the ICare RBT and ORA with contact lenses in situ, two experienced optometrists (DJB and GHK) took 
two ICare RBT measurements on every single subject enrolled in the study according to the protocol 
established for the study of each subject’s left eye with and without each and every contact lens in 
situ. One experienced optometrist (DJB) took four ORA measurements according to the 
aforementioned protocol established for the study of each subjects left eye with and without each of 
the contact lenses in situ. The measurements were recorded by an experienced optometric assistant 
(MLG) blinding the optometrists and reducing observer bias. The measurements with and without 
contact lenses in situ were compared for both the ICare RBT as well as the Reichert ORA.  
5.3 Statistical analysis 
Most tonometers measure in increments of 1 mmHg (Doughty and Zaman, 2000). Interobserver 
repeatability of the ICare RBT varies by 2 − 3 mmHg (Proctor et al., 2010). The current study showed 
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that 95% of repeated measurements were within 4.39 mmHg of each other (Table 3.3), and 
interobserver reliability without lenses was M = 0.10, SD = 2.2 mmHg; with all measurements M = 
0.40, SD = 2.1 mmHg which is considerably better than previously reported values. Observer DJB’s 
measurements were consistently higher than those of observer GHK. Without lenses the difference 
was 0.09 mmHg and when all the measurements were considered, it was 0.37 mmHg which is not 
clinically significant. Intersessional measurements have limits of agreement between repeated 
readings of ±5 mmHg (Davies et al., 2006). The current study showed that 95% of the measurements 
were within ±3.5 mmHg (Table 3.2)). The repeatability and reproducibility of the ORA varies between 
4.3 to 4.7 mmHg (Kotecha et al., 2010) which is similar to previous findings with non-contact 
tonometers (Tonnu et al., 2005). This current study showed the intraobserver reliability of the 
measurements with the ORA was 2.86 mmHg for CH; 3.44 mmHg for CRF; 4.94 mmHg for IOPcc; and 
3.75 mmHg for IOPg (Table 3.4). Clinically IOP variation within 3 mmHg is considered acceptable 
(Mackie et al., 1996; Choudhari et al., 2009; Lam and Tse, 2014). Differences ≥ 1 mmHg were 
considered clinically significant. 
Data were analysed using the statistical package SPSS v. 22.0 and Microsoft Excel (Microsoft 
Corporation, Redmond, WA) with Analyse-it v 4.10.2 (Analyse-it Software, Ltd.). Researchers 
recommend the Shapiro-Wilk test as the best choice for testing the normality of the data (Ghasemi 
and Zahediasl, 2012). This test confirms a normal distribution of the data (Appendix 6).  
The Paired t-tests were performed to test the hypothesis that measurements with the ICare RBT and 
ORA and K-readings without and with contact lenses in situ were equal. The t-test is the easiest way 
to compare two means; it estimates both the means and SD which introduces a dependency on 
sample size. However, Norman and Streiner (2008) advise this test is not appropriate when there are 
more than two groups or when individuals in one group are matched to individuals in another group 
(Norman and Streiner, 2008). p < 0.05 was considered significant. Bland Altman plots were used to 
assess the differences in IOP reading without and with every kind of contact lens as function of IOP 
value. The differences between the two measurements were plotted against the mean of the two 
measurements. The mean of the differences and the standard deviation of the differences were also 
calculated. The closer the mean of the differences was to zero and the smaller the value of the 
standard deviation of the differences the better the agreement between measures. Also calculated 
were 95% limits of agreement as well as 95% confidence intervals for these limits of agreement were 
also calculated (Bland and Altman, 1986).   
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5.4 Results 
Figures 2.1 and 2.2, show the range and frequency distribution of the mean spherical equivalent 
refractive error (MSE) and corneal astigmatism in the study population. Twenty-six (26) subjects had 
cylindrical refractive errors (M = -0.94D, SD = 0.58, range -0.25 to -2.50D). Tables 5.2 to 5.4, show the 
means, SD, and p-values for the ICare and ORA measurements with and without contact lenses for 
the entire sample as well as minus and plus lenses separately. Table 2.2 gives the descriptive 
statistics for all the variables measured.  
No data was forthcoming from the manufactures on the lens thickness for the different lens powers 
used in the study. However, the Scheimpflug corneal tomography system (Pentacam) was used to 
measure not only the combined cornea contact lens thickness but also the combined cornea contact 
lens curvature. Although Scheimpflug photography provides images of the anterior segment with 
minimal distortion, the distortion of the cornea and lens itself distort the image. Therefore 
biometrical measurements in the anterior segment such as corneal curvature, changes in lens 
curvature during accommodation, depth of anterior chamber angle, always have to be corrected by 
specific algorithms. The amount of correction depends on the depth of the layer in question, 
meaning that each refractive zone adds a small amount of distortion to the path of the light rays 
(Wegener and Laser-Junga, 2009). The combined cornea contact lens thickness and curvature 
measured in this study could conceivably be affected by introduced distortion which is not corrected 
by the pre-pre-programmed algorithms. The mean CCT without lenses was M = 531.46, SD = 35.51 
µm and K was M = 7.80, SD = 0.28 mm.  
Although the corneal curvature (K) was expected to change with the contact lenses on the cornea the 
changes were neither clinically nor statistically significant. When analysing the data for the entire 
sample (plus and minus lenses), the results were: 
 K with the Pure Vision lens was M = 7.79, SD = 0.42 mm, and the difference between the K 
without the lens was M = 0.01, SD = 0.40 mm (95% CI [-0.183 to 0.122]), t = 0.285, p = 0.777.  
 With the Frequency XC lens the K was M = 7.93, SD = 0.44 mm and the mean difference 
between K without the lens was M = -0.13, SD = 0.41 mm (95% CI [-0.242 to -0.001]), t = -
2.01, p = 0.050.  
 With the Acuvue 1-Day Moist lens K was M = 7.88, SD = 0.39 mm and the mean difference 
between K without the lens was M = -0.082, SD = 0.35 mm (95% CI [-0.181 to 0.016]), t = -
1.53, p = 0.133.  
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 Lastly with the Acuvue Oasys lens K was M = 7.90, SD = 0.43 mm and the mean difference 
between K without the lens was M = -0.102, SD = 0.407 mm (95% CI [-0.218 to 0.0132]), t = -
1.652, p = 0.105. 
Splitting the data between plus and minus lenses it was apparent that the K-readings with the plus 
lenses were steeper (M = 7.60, SD = 0.45 [95% CI 7.494 to 7.704] mm) than the measurements 
without the lenses in the plus lens group (M = 7.93, SD = 0.45 [95% CI 7.79 to 8.06] mm), and with 
the minus lenses flatter (M = 8.03, SD = 0.31 [95% CI 7.954 to 8.104] mm) than the measurements 
without the lenses in the minus lens group (M = 7.73, SD = 0.26 [95% CI 7.63 to 7.82] mm) (Figures 
5.1 and 5.2). The mean difference between the K-readings with plus and minus lenses were M = -
0.43, SD = 0.52 (95% CI -0.522 to -0.307) mm which is significant t = 6.98, p < 0.0001.  
 
Figure 5.1 Corneal curvature (K) without and with minus powered contact lenses in situ – blue line indicates mean K 
without lenses 
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Figure 5.2 Corneal curvature (K) without and with plus powered contact lenses in situ – blue line indicates mean K 
without lenses 
The published parameters (based on a -3.00 D lens) for the centre thickness of the four lenses used in 
the study were: 90 µm for the Pure Vision lens; 75 µm for the Frequency XC lens; 84 µm for the 
Acuvue 1-Day Moist lens; and 70 µm for the Acuvue Oasys lens (Table 2.1). Published thickness for 
the pre-corneal tear film was 3 µm (King-Smith et al., 2000). Therefore the expected CCT with each of 
the lenses on the eye should be the baseline measured CCT without lenses + contact lens CT + pre-
corneal tear film thickness. Considering the data for both plus and minus lenses, the following was 
expected: for the Pure Vision lens the expected CCT should be M = 624.46, SD = 35.51; for the 
Frequency XC it should be M = 609.46, SD = 35.51; for the Acuvue 1-Day Moist the expected CCT 
should be M = 618.46, SD = 35.51; and for the Acuvue Oasys it should be M = 604.46, SD = 35.51. This 
relates to a difference of M = 55.3, SD = 28.1 µm (95% CI [47.33 to 63.31]) between the measured 
CCT with the Pure Vision lens in situ compared to the expected CCT. With the Frequency XC the 
difference was M = 9.5, SD = 38.8 µm (95% CI [-1.54 to 20.50]); with the Acuvue 1-Day Moist M = 
66.5, SD = 22.9 µm (95% CI [60.3 to 73.05]); and for Acuvue Oasys M = 13.5, SD = 30.3 µm (95% CI 
[4.93 to 22.15]).  
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In all cases the measured CCT with lenses in situ was lower than expected, significantly so with the 
Pure Vision and the Acuvue 1-Day Moist lenses. Reasons for this could be that the published CT was 
for -3.00 D lenses only and that this sample included lenses ranging in power from -6.00 to +6.00 D 
(M = -0.95, SD = 2.69D) as well as the measurement technique employed. However, splitting the data 
into plus and minus lenses (Figures 5.3 and 5.4) it was apparent that the measured CCT was 
significantly higher with plus power (particularly Frequency XC and Acuvue Oasys) lenses than minus 
lenses. With the plus power lenses in situ the CCT was M = 607.03, SD = 49.31 (95% CI 595.4 to 618.6) 
µm and with the minus powered lenses M = 564.0, SD = 46.5 (95% CI 553.0 to 574.90) µm. The mean 
difference between the CCT with plus and minus power lenses was M = 43.1, SD = 74.2 (95% CI 25.6 
to 60.5) µm which is significant t = -4.93, p < 0.001.  
 
Figure 5.3 Central corneal thickness (CCT) without and with the different minus powered contact lenses in situ – blue line 
indicates mean CCT without lenses 
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Figure 5.4 Central corneal thickness (CCT) without and with plus powered contact lenses in situ – blue line indicates mean 
CCT without lenses 
Considering the data for the entire cohort, all ICare RBT and ORA measurements were significantly 
affected by the presence of a contact lens on the eye, with the exception of the two ORA metrics CH 
and CRF which were not significantly affected by the presence of the Acuvue 1-Day Moist (CH p = 
0.160) and Frequency XC (CRF p = 0.757) lenses. This was confirmed by the Bland-Altman plots which 
showed it was possible to accurately measure IOP with ICare RBT while wearing Frequency XC and 
Oasys lenses as well as ORA CH and CRF with the Frequency XC, Acuvue 1-Day Moist, and Oasys 
lenses. This, however, was not the case with ORA IOPcc and ORA IOPg which were significantly 
underestimated with all of the lenses on the eye. Looking at the data for the minus lenses only, all 
the measurements with the ICare RBT and ORA were significantly affected with the exception of RBT 
with the Frequency XC lens (p = 0.093); ORA CH with the Acuvue 1-Day Moist lens (p = 0.622); and 
ORA IOPg with the pure Vision lens (p = 0.492). With the plus powered lenses on the eye, ICare RBT 
was not significantly affected by the presence of Frequency XC (p = 0.229) and Acuvue Oasys lenses 
(p = 0.128). This was not true for ORA CH with Acuvue 1-Day Moist (p = 0.086), IOPcc and IOPg with 
Frequency XC (IOPcc [p = 0.291]; IOPg [p = 0.455]) as well as Acuvue 1-Day Moist lenses (IOPcc [p = 
0.668]; IOPg [p = 0.965]). IOPg with plus powered Acuvue Oasys lenses was not statistically different 
to measurement without the lenses (p = 0.792). With the Pure Vision lenses on the eye, ICare RBT 
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significantly overestimated IOP M = 3.97, SD = 4.12 mmHg (95% CI [2.799 to 5.140]). This was even 
more evident with the plus powered Pure Vision lenses M = 5.85, SD = 6.01 mmHg (95% CI [2.859 to 
8.836]). ICare RBT significantly underestimated IOP with both minus and plus power Acuvue 1-Day 
Moist lenses in that the means were: M = -1.22, SD = 1.91 mmHg (95% CI [-1.90 to-0.53]) and M = -
1.89, SD = 2.09 mmHg (95% CI [2.93 to-0.85]) respectively.  
ORA IOPcc and IOPg were significantly underestimated in the entire cohort irrespective of lens power 
(Table 5.5, page 150). ORA IOPcc measurements with the Pure Vision lenses fared the worst 
underestimating IOPcc by M = -4.30, SD = 2.34 mmHg (95% CI [-4.964 to -3.637]). This was also the 
case with the ORA biomechanical metric measurements with Pure Vision, overestimating CH by M = 
4.89, SD = 3.29 mmHg (95% CI [3.953 to 5.822]) and CRF by M = 4.65, SD =3.18 mmHg (95% CI [3.746 
to 5.555]). ORA CH and CRF were also significantly overestimated with plus powered silicone lenses, 
especially Pure Vision CH: M =7.65, SD = 3.89 mmHg (95% CI [5.920 to 9.386]), CRF: M = 7.48, SD = 
3.74 mmHg (95% CI [5.623 to 9.346]) and, to a lesser extent, Acuvue Oasys CH: M = 1.96, SD = 1.01 
mmHg (95% CI [1.457 to 2.465]), CRF: M = 1.68, SD = 1.60 mmHg (95% CI [0.886 to 2.478]). 
 Without CL 
(mmHg) 
Pure Vision 
(mmHg)  
Frequency XL 
(mmHg) 
Acuvue 1-day 
Moist (mmHg) 
Acuvue Oasys 
(mmHg) 
Entire sample (n = 
50) 
All powers All powers All powers All powers  
RBT M = 14.58, SD = 
3.38 
 
M = 18.49, SD = 5.43 
Difference = 3.91 
p = 0.000 
M = 14.09, SD = 3.15* 
Difference = -0.49 
p = 0.036 
M = 13.12, SD = 3.11 
Difference = -1.46 
p = 0.000 
M = 13.74, SD = 3.24* 
Difference = -0.84 
p = 0.004 
ORA CH M = 9.68, SD = 1.4 
 
M = 14.56, SD = 3.38 
Difference = 4.88 
p = 0.000 
M = 10.08, SD = 1.34* 
Difference = 0.40 
p = 0.002 
M = 9.81, SD = 1.39** 
Difference = 0.13 
p = 0.160 
M = 10.59, SD = 1.64* 
Difference = 0.91 
p = 0.000 
ORA CRF M = 9.57, SD =1.65 M = 14.22, SD = 3.40 
Difference = 4.65 
p = 0.000 
M = 9.60, SD = 1.65** 
Difference = 0.03 
p = 0.757 
M = 9.34, SD = 1.53* 
Difference = -0.23 
p = 0.033 
M = 9.99, SD = 2.05* 
Difference = 0.42 
p = 0.034 
ORA IOPcc M = 16.02, SD = 
3.50 
M = 11.72, SD =3.18 
Difference = - 4.30 
p = 0.000 
M = 14.82, SD = 3.09 
Difference = -1.2 
p = 0.000 
M = 15.06, SD = 2.61* 
Difference = -0.96 
p = 0.004 
M = 14.00, SD = 2.68 
Difference = -2.02 
p = 0.000 
ORA IOPg M = 14.64, SD = 
3.58 
M = 15.79, SD = 3.75 
Difference = 1.15 
p = 0.007 
M = 13.55, SD = 3.48 
Difference = -1.09 
p = 0.003 
M = 13.62, SD = 2.86 
Difference = -1.02 
p = 0.002 
M = 13.48, SD = 3.33 
Difference = -1.10 
p = 0.000 
Table 5.2 Means, standard deviations and p values (n = 50) of the ICare RBT and ORA metrics measured 
with and without the different contact lenses on the eye .(* Differences < 1 mmHg considered clinically 
insignificant. ** Differences < 1 mmHg and p < 0.05 are considered statistically and clinically insignificant. Shaded cells 
represent differences > 1 mmHg from the non-lens condition.) (RBT = rebound tonometery; CH = corneal hysteresis; CRF 
= corneal resistance factor; IOPcc = cornea corrected IOP; IOPg = Goldman equivalent IOP) 
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Table 5.3 Means, standard deviations and p values (n = 32) of the ICare RBT and ORA metrics measured 
with and without the different minus contact lenses on the eye  (range -0.50 to -6.00 D).(* Differences < 1 
mmHg considered clinically insignificant. ** Differences < 1 mmHg and p < 0.05 were considered statistically and clinically 
insignificant. Shaded cells represent differences > 1 mmHg from the non-lens condition.) (–VE = negative power lenses; 
RBT = rebound tonometery; CH = corneal hysteresis; CRF = corneal resistance factor; IOPcc = cornea corrected IOP; IOPg = 
Goldman equivalent IOP; M = Mean; SD = Standard deviation) 
 Without CL 
(mmHg) 
Pure Vision 
(mmHg)  
Frequency XL 
(mmHg) 
Acuvue 1-day 
Moist(mmHg) 
Acuvue Oasys 
(mmHg) 
+VE only (n = 18) +VE +VE +VE +VE 
RBT M = 15.82, SD = 
3.45 
 
M = 21.67, SD = 
6.48 
Difference = 5.85 
p = 0.001 
M = 15.31, SD = 
3.06** 
Difference = -0.51 
p = 0.229 
M = 13.93, SD = 
2.93 
Difference = -1.89 
p = 0.001 
M = 14.94, SD = 
3.15** 
Difference = -0.88 
p = 0.128 
ORA CH M = 9.56, SD = 1.34 M = 17.21, SD = 
3.69 
Difference = 7.65 
p = 0.000 
M = 10.22, SD = 
1.16* 
Difference = 0.66 
p = 0.023 
M = 9.82, SD = 
1.38** 
Difference = 0.26 
p = 0.086 
M = 11.52, SD = 
1.52 
Difference = 1.96 
p = 0.000 
ORA CRF M = 9.64, SD = 1.79 M = 17.13, SD = 
3.84 
Difference = 7.48 
p = 0.000 
M = 10.21, SD = 
1.72* 
Difference = 0.56 
p = 0.042 
M = 9.72, SD = 
1.57** 
Difference = 0.17 
p  = 0.495 
M = 11.33, SD = 
2.02 
Difference = 1.68 
p = 0.000 
ORA IOPcc M = 16.57, SD = 
3.99 
M = 11.74, SD = 
3.51 
Difference = -4.83 
P = 0.000 
M =15.94, SD = 
3.22** 
Difference =- 0.63 
p = 0.291 
M = 16.28, SD = 
2.55** 
Difference = -0.28 
p = 0.668 
M = 14.37, SD = 
2.62 
Difference = -2.2 
p = 0.001 
ORA IOPg M = 14.97, SD = 
4.18 
M = 18.47, SD = 
3.88 
Difference = 3.49 
p = 0.000 
M = 15.35, SD = 
3.88** 
Difference = 0.38 
p = 0.455 
M = 15.00, SD = 
2.83** 
Difference = 0.028 
p = 0.965 
M = 15.14, SD = 
3.41** 
Difference = 0.17 
p = 0.792 
Table 5.4 Means, standard deviations and p values (n = 18) of the ICare RBT and ORA metrics measured 
with and without the different plus contact lenses on the eye  (range +0.50 to +6.00 D).(* Differences < 1 
mmHg considered clinically insignificant. ** Differences < 1 mmHg and p <  0.05 were considered statistically and 
clinically insignificant. Shaded cells represent differences  > 1 mmHg from the non-lens condition.) (+VE = positive power 
lenses; RBT = rebound tonometery; CH = corneal hysteresis; CRF = corneal resistance factor; IOPcc = cornea corrected 
IOP; IOPg = Goldman equivalent IOP; M = Mean; SD = Standard deviation) 
 Without CL 
(mmHg) 
Pure Vision 
(mmHg)  
Frequency XL 
(mmHg) 
Acuvue 1-day 
Moist 
(mmHg) 
Acuvue Oasys 
(mmHg) 
-VE only (n = 32) -VE -VE -VE -VE 
RBT M = 13.88, SD = 
3.19 
M = 16.70, SD = 
3.79 
Difference = 2.81 
p = 0.000 
M = 13.40, SD = 
3.03** 
Difference = -0.48 
p = 0.093 
M = 12.66, SD = 
3.16 
Difference = -1.22 
p  = 0.001 
M = 13.06, SD = 
3.13* 
Difference = -0.82 
p = 0.015 
ORA CH M = 9.74, SD = 1.48 M = 13.07, SD = 
2.06 
Difference = 3.33 
p = 0.000 
M = 10.04, SD = 
1.44* 
Difference = 0.26 
p = 0.038 
M = 9.80, SD = 
1.42** 
Difference = 0.059 
p = 0.622 
M = 10.07, SD = 
1.49* 
Difference = 0.33 
p = 0.004 
ORA CRF M = 9.52, SD = 1.59 M = 12.58, SD = 
1.56 
Difference = 3.05 
p = 0.000 
M = 9.27, SD = 
1.52* 
Difference = -0.26 
p = 0.016 
M = 9.13, SD = 
1.50* 
Difference = -0.39 
p = 0.001 
M = 9.24, SD = 
1.67* 
Difference = -0.28 
p = 0.000 
ORA IOPcc M = 15.72, SD = 
3.23 
M = 11.71, SD = 
3.03 
Difference = -4.00 
p = 0.000 
M = 14.20, SD = 
2.87 
Difference = -1.52 
p = 0.000 
M = 14.37, SD = 
2.43 
Difference = -1.35 
p = 0.000 
M = 13.79, SD = 
2.73 
Difference =-1.95 
p = 0.000 
ORA IOPg M = 15.72, SD = 
3.23 
M = 14.28, SD = 
2.72** 
Difference = -0.17 
p = 0.492 
M = 12.54, SD = 
2.82 
Difference = -1.92 
p = 0.000 
M = 12.84, SD = 
2.61 
Difference = -1.61 
p = 0.000 
M = 12.54, SD = 
2.94 
Difference = -1.92 
p = 0.000 
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Comparison: without and 
with lenses 
Mean difference (M) and Standard deviation 
(SD) mmHg 
95% CI 
Total sample: 
(n = 50) 
Minus 
lenses: 
(n = 32) 
Plus lenses: 
(n = 18) 
Total sample: Minus lenses: Plus lenses: 
RBTWithout . RBTPure Vision M = 3.97, SD = 
4.12* 
M = 2.81, 
SD = 1.83* 
M = 5.85, SD = 
6.01* 
2.80 to 5.14 2.15 to 3.47 2.86 to 8.84 
RBTWithout . RBTFrequency XC M = -0.43, SD 
= 1.65 
M = -0.48, 
SD = 1.58 
M = -0.51, SD 
= 1.75 
-0.90 to 0.031 -1.06 to 0.09 -1.38 to 0.36  
RBTWithout . RBT1-Day Moist M = -1.40, SD 
= 1.96* 
M =-1.22, 
SD = 1.91* 
M = -1.89, SD 
= 2.09* 
-1.95 to 0.83 -1.90 to -0.53 -2.93 to -0.85 
RBTWithout . RBTOasys M = -0.78, SD 
= 1.98 
M = -0.82, 
SD = 1.81 
M = -0.88, SD 
= 2.32* 
-1.34 to 0.21 -1.47 to -0.17 -2.03 to 0.28 
CHWithout . CHPure Vision M = 4.89, SD = 
3.29* 
M = 3.33, 
SD = 1.87* 
M = 7.65, SD = 
3.89* 
3.95 to 5.82 2.66 to 4.01 5.92 to 9.39 
CHWithout . CHFrequency XC M = 0.41, SD = 
0.88 
M = 0.26, 
SD = 0.69 
M = 0.67, SD = 
1.13 
0.16 to 0.66 0.01 to 0.51 0.11 to 1.23 
CHWithout . CH1-Day Moist M = 0.13, SD = 
0.65 
M = 0.06, 
SD = 0.67 
M = 0.26, SD = 
0.60 
-0.05 to 0.32 -0.18 to 0.30 -0.04 to 0.56 
CHWithout . CHOasys M = 0.92, SD = 
1.10 
M = 0.33, 
SD = 0.60 
M = 1.96, SD = 
1.01* 
0.61 to 1.23 0.11 to 0.55 1.46 to 2.47 
CRFWithout . CRFPure Vision M = 4.65, SD = 
3.18* 
M = 3.06, 
SD = 1.01* 
M = 7.48, SD = 
3.74* 
3.75 to 5.56 2.69 to 3.42 5.62 to 9.35 
CRFWithout . CRFFrequency XC M = 0.04, SD = 
0.88 
M = -0.26, 
SD = 0.57 
M = 0.56, SD = 
1.08 
-0.21 to 0.29 -0.46 to -0.05 0.02 to 1.10 
CRFWithout . CRF1-Day Moist M = -0.23, SD 
= 0.72 
M =-0.39, 
SD = 0.57 
M = 0.08, SD = 
0.87 
-0.43 to -0.02 -0.60 to -0.19 -0.36 to 0.51 
CRFWithout . CRFOasys M = 0.42, SD = 
1.38 
M = -0.28, 
SD = 0.40 
M = 1.68, SD = 
1.60* 
0.03 to 0.82 -0.43 to -0.14 0.89 to 2.48 
IOPccWithout . IOPccPure Vision M = -4.30, SD 
= 2.34* 
M = -4.00, 
SD = 1.83* 
M = -4.83, SD 
= 3.03* 
-4.96 to -3.63 -4.66 to -3.34 -6.33 to -3.33 
IOPccWithou . IOPccFrequency XC M = -1.20, SD 
= 2.05* 
M = -1.52, 
SD = 1.76* 
M = -0.63, SD 
= 2.45 
-1.78 to -0.62 -2.16 to -0.89 -1.84 to 0.59 
IOPccWithout . IOPcc1-Day Moist M = -0.97, SD 
= 2.51* 
M = -1.35, 
SD = 1.83* 
M = -0.29, SD 
= 2.77 
-1.61 to -0.33 -2.01 to -0.69 -1.67 to 1.10 
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Table 5.5 Bland-Altman analysis of the differences between measurements with and without lenses plotted 
against the arithmetic mean of the measurements with and without lenses for both ICare RBT and ORA 
instruments.(Values are indicated for the total sample as well as for minus and plus lenses separately. Negative values 
indicate the measurement with the contact lenses on the eye was lower than the measurement without the lenses on 
the eye. * = Clinically significant differences. Shaded blocks indicate differences of ±2.00 mmHg or more.) (RBT = rebound 
tonometery; CH = corneal hysteresis; CRF = corneal resistance factor; IOPcc = cornea corrected IOP; IOPg = Goldman 
equivalent IOP) 
5.5 Discussion  
Previous studies posit that measurement of IOP using the ICare rebound tonometer and NCT is 
possible with contact lenses in situ (Table 5.1). However, although the principles of the ORA are 
based on those of the noncontact tonometer (Luce, 2005; Kotecha, 2007; Kniestedt et al., 2008), it 
measures instrument-specific corneal biomechanics as well as IOPcc and IOPg. It is important to 
consider that the biomechanical properties CH and CRF measured by the ORA characterise the 
structural response of the eye to this specific measurement device; therefore, they cannot be seen as 
intrinsic elastic or viscoelastic properties of the cornea (Jorge, Gonzales-Meijome, et al., 2008; Lau 
and Pye, 2011). Currently Young’s modulus of elasticity of the cornea can only be measured ex vivo 
(Kerautret et al., 2008; Lau and Pye, 2011). The purpose of this study was to compare IOP 
measurements with the ICare and ORA tonometers with four commonly used disposable soft contact 
lenses in situ to IOP measurements with these instruments without lenses on the same eyes of a 
group contact lens wearers (n = 50).   
The rebound response of the ICare RBT reflects the viscoelastic properties of the cornea (Chihara, 
2008; Jorge, Gonzales-Meijome, et al., 2008). Although the CCT and corneal curvature can affect the 
ICare IOP accuracy, it seems that the biomechanical properties (in this study represented by CH and 
CRF) have the greatest influence on the instrument’s IOP measurement (Chui et al., 2008). Although 
Comparison: without and 
with lenses 
Mean difference (M) and standard deviation 
(SD) mmHg 
95% CI 
IOPccWithout . IOPccOasys M = -2.02, SD 
= 1.99* 
M = -1.93, 
SD = 1.79* 
M = -2.20, SD 
= 2.35* 
-2.59 to -1.46 -2.57 to -1.28 -3.37 to -1.03 
IOPgWithout . IOPgPure Vision M = 1.15, SD = 
2.86* 
M = -0.17, 
SD = 1.42 
M = 3.49, SD = 
3.29* 
0.33 to 1.96 -0.69 to 0.34 1.86 to 5.13 
IOPgWithout . IOPgFrequency XC M = -1.09, SD 
= 2.49* 
M = -1.91, 
SD = 2.32* 
M = 0.38, SD = 
2.11 
-1.79 to -0.38 -2.75 to -1.07 -0.67 to 1.43 
IOPgWithout . IOPg1-Day Moist M = -1.02, SD 
= 2.18* 
M = -1.61, 
SD = 1.65* 
M = 0.03, SD = 
2.64 
-1.64 to -0.40 -2.21 to -1.02 -1.29 to 1.34 
IOPgWithout . IOPgOaysys M = -1.17, SD 
= 2.20* 
M = -1.92, 
SD = 1.44* 
M = 0.17, SD = 
2.68 
-1.79 to -0.54 -2.43 to -1.40 -1.17 to 1.50 
 
 
 
 
 
 
 
153 
 
research shows the accuracy of IOP measurement with ICare RBT and NCT was not affected by 
corneal astigmatism (De Moraes et al., 2008; Johannesson et al., 2008; Hamilton-Maxwell, 2014; 
Townsend and McSoley, 2015), subjects with more than 2.50 Dioptres of corneal astigmatism were 
nonetheless excluded from this study.  
IOP measurements are significantly higher when the corneal modulus of elasticity is increased and 
the corneal curvature and CCT remains constant (Liu and Roberts, 2005). Measuring IOP with contact 
lenses in situ should therefore affect the measurement accuracy considerably. Wearing contact 
lenses during NCT tonometry alters the ocular surface behaviour (changes the amount of 
deformation) and therefore the IOP readings (Rimayanti et al., 2014). It is likely that the viscoelastic 
properties of the contact lenses and lens thickness affect the rebound response of the ICare RBT. 
Lower modulus softer lenses seem to absorb more energy leading to lower IOP measurements while 
higher modulus stiffer lenses lead to overestimation of the IOP. The Bland-Altman analyses clearly 
indicate that, with both the ICare RBT as well as the ORA, IOP measurements with and without the 
higher modulus Pure Vision lenses were statistically and clinically significantly different (Table 5.5).  
Splitting the data into plus and minus lenses, the differences became much more pronounced with 
the plus powered thicker higher modulus Pure Vision lenses having the greatest effect on the 
measurement accuracy. With the lower modulus Frequency XC, Acuvue 1-Day Moist, and Acuvue 
Oasys the ICare RBT underestimated the IOP when compared to the measurements without lenses. 
This underestimation was possibly due to the energy of the probe being absorbed by the low 
modulus material. In contrast to the findings of Zeri et al. (2011) that the ICare RBT underestimated 
IOP over moderate plus power hydrogel lenses (Zeri et al., 2011), the findings of the current study 
showed that ICare RBT underestimated IOP with minus as well as plus powered contact lenses of 
moderate modulus of elasticity. Zeri et al. (2015) measured the IOP with and without a +2.00 and a 
+6.00 D etafilcon A hydrogel lens in situ and found the ICare RBT significantly underestimated IOP 
with the lenses (Zeri et al., 2015). These authors speculate that the reasons for the lower IOP 
measurements with the lenses could be attributed to the lower resistance to deformation of the high 
water content etafilcon A material. They therefore concluded that the corneal thickness (combined 
lens and corneal thickness) did not affect the value of the IOP measured with the ICare RBT (Zeri et 
al., 2015). With the low modulus of elasticity hydrogel Acuvue 1-Day Moist lenses the difference was 
statistically as well as clinically significant (> 1 mmHg). With both plus and minus powered high 
modulus of elasticity silicone Pure Vision lenses, ICare RBT significantly overestimated IOP (> 1 
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mmHg) (Table 5.5). These findings are similar to those of previous research conducted with the NCT 
(McMonnies, 1986; Insler and Robbins, 1987; Schollmayer and Hawlina, 2003; Patel and Illahi, 2004; 
Touboul, 2008; Patel and Stevenson, 2009; Liu et al., 2011).  
In the current study the cornea/lens thickness was significantly thicker with the plus power lenses 
than with minus power lenses (70.33 and 33.32 µm respectively) than measurement of CCT without 
lenses and the corneal curvature was steeper (M = 7.60, SD = 0.45 mm compared to M = 7.93, SD = 
0.27 mm without lenses) with the plus power lenses and flatter (M = 8.03, SD = 0.31 mm compared 
to M = 7.73, SD = 0.26 mm without lenses) with the minus power lenses. Liu and Roberts (2005) 
found that IOP measurements were affected by CCT (lower with thinner corneas and higher with 
thicker corneas), corneal curvature (lower with flatter corneas and higher with steeper corneas), and 
Young’s modulus (Liu and Roberts, 2005). Although the results of the current study support these 
results, the contact lens modulus of elasticity seem to play a more significant role in the accuracy of 
IOP measurement with contact lenses in situ with the ICare RBT and ORA. 
The ORA corneal hysteresis (CH) measurement was significantly higher with the silicone lenses 
(specifically with the thicker plus lenses) compared to the measurement without lenses. The corneal 
resistance factor (CRF) was also significantly higher with the silicone Pure Vision lenses. These 
findings contradicted those of Lam and Tse (2014) which indicated the measurement of the two 
biomechanical metrics were not affected by the presence of a silicone hydrogel lens on the eye (Lam 
and Tse, 2014). The modulus of elasticity of the Pure Vision and Acuvue Oasys lenses was 1.1 and 
0.75 MPa respectively. This differs from that of the Focus Night & Day’s 1.5 MPa (Ciba Vision) and 
Acuvue Advance’s 0.43 MPa (Johnson & Johnson) that Lam and Tse (2014) used in their study. Other 
differences between the two studies include the use of only -3.00 D lenses compared to lens powers 
ranging between -6.00D to +6.00D, difference in lens thickness across the power range, and the use 
of an ORA WS score of three-and-a-half compared to the six-score used in this study. The low WS 
may affect the influence of the ocular pulse amplitude on the measurements (Lam and Tse, 2014).   
Of further interest is that the ORA IOPcc with Pure Vision as well as Frequency XC, Acuvue 1-Day 
Moist, and Acuvue Oasys measurements were significantly lower (irrespective of lens power) than 
the instrument-measured IOPcc without lenses (Tables 5.2 to 5.5). In the case of ORA IOPg, the 
measurement was significantly lower for the minus power Frequency XC, Acuvue 1-Day Moist, and 
Acuvue Oasys lenses and significantly higher for the Pure Vision plus lenses, but no significant 
difference was observed with any of the other brands of plus lenses (Tables 5.2 to 5.5, and Figure 
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4.9). The IOPcc, and to a lesser extent the IOPg calculation, takes corneal viscoelastic properties into 
consideration (Lau and Pye, 2011). As expected, these measurements were influenced by a contact 
lens which alters ocular surface behaviour, apparent corneal thickness, corneal curvature, and 
viscoelastic corneal properties; therefore altering the time needed to achieve maximal light 
detection in NCT (Liu et al., 2011). In the case of IOPcc, the measurements in this study were lower 
with lenses in situ than without the lenses; with IOPg lower measurements with minus lenses and 
significantly higher measurements with thicker plus lenses were seen. These findings concur with 
those of Sapkota et al. (2014), namely, that ORA IOPcc and IOPg measurements were lower with -
3.00 low and moderate modulus (0.66 and 0.89 MPa) daily wear contact lenses on the eye. IOPcc was 
highly affected and underestimated by more than 3 mmHg in 36% of their subjects (Sapkota et al., 
2014). In the current study IOPcc was underestimated by more than 3 mmHg with only the Pure 
Vision lenses in all subjects. Young’s modulus of the human cornea has been reported as M = 0.29, 
SD = 0.06 MPa (Hamilton and Pye, 2008) which, in this study, was similar to the modulus of 
Frequency XC and Acuvue 1-Day Moist lenses, but significantly lower than the modulus of Pure Vision 
and Acuvue Oasys lenses (Table 2.1). 
Other than the influence of the lenses on the biomechanical properties of the cornea/lens 
combination (Table 1.7), factors such as anterior corneal and lens curvature; central corneal 
thickness; lens water content; central lens thickness; oxygen transmissibility of the lenses; combined 
lens corneal thickness; and hydration may influence the accuracy of the measurements with lenses in 
situ. The effects of these factors need further study.  
All measurements in this study were collected at one specific sitting and it is therefore conceivable 
that variation in measurements may occur from one visit to the next with a specific lens, limiting the 
clinical usefulness of the results of this particular study. Hence, the study should be expanded and 
additional research be undertaken to collect data over a number of consecutive visits to determine 
the variability of the measurements validating the clinical usefulness of the results obtained in this 
study.    
5.6 Conclusion 
ICare RBT and ORA IOPg tonometry is possible with low minus power, moderate modulus of 
elasticity, thin silicone hydrogel (Acuvue Oasys) and hydrogel (Frequency XC, Acuvue 1-Day Moist) 
disposable soft contact lenses in situ. With the advent of “therapeutic” contact lenses for sustained 
 
 
 
 
 
 
 
156 
 
drug delivery to the eye as well as ICare HOME IOP measurements, this information will aid 
manufactures and clinicians in deciding which materials, centre thickness, water content, and power 
contact lenses can be used that will augment the accuracy of  IOP measurements with the lenses in 
situ.  
5.7 Summary of findings 
 In the case of ORA IOPcc, the IOP measurements were lower with lenses in situ than without 
the lenses, and with ORA IOPg the IOP measurements were lower with minus lenses and 
significantly higher with thicker and stiffer plus lenses in situ. 
 The ICare RBT underestimated IOP measurements with low modulus plus and minus lenses 
and overestimated IOP with thicker high modulus plus lenses in situ. 
 The ORA CH and CRF metrics were overestimated with thicker high modulus plus lenses in 
situ.  
 Accurate ICare RBT and ORA IOPg tonometry was possible with low minus power, moderate 
modulus of elasticity, thin silicone hydrogel, and hydrogel disposable soft contact lenses in 
situ.
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Chapter 6 
Physiological and physical factors and their impact on ICare RBT and 
ORA IOP measurements in a population of normal subjects with and 
without contact lenses in situ. 
6.1 Introduction 
Chapter three showed that the intraobserver reliability (test-retest repeatability by the same 
observer) of the ICare RBT and the ORA produced repeatable and consistent results even when 
measurements were performed with disposable contact lenses on the eye. Interobserver reliability 
(test-retest repeatability between different observers) also produced repeatable and consistent 
results with the ICare RBT. Chapter four confirmed that the ICare RBT and ORA IOPg pressure 
measurements were highly correlated and comparable. Clinically the differences between the two 
measurements were less than 0.60 mmHg and this difference seemed not to be affected by the 
presence of a contact lens on the eye. ICare RBT and IOPcc pressure measurements were also 
correlated and comparable but to a lesser extent than ICare RBT and IOPg measurements. Chapter 
five showed that ICare RBT and ORA tonometry was possible with low minus power (range -0.50 to -
6.00 D), and low modulus of elasticity (0.26 to 0.75 MPa) silicone hydrogel and hydrogel disposable 
soft contact lenses in situ. However, it is clear that further analysis of the data was needed to 
individually examine the effects of the different corneal, refractive and contact lens characteristics 
on the accuracy of the ICare and ORA measurements in more detail.  
From the literature reviewed in Chapter one it is evident that numerous physiological as well as 
physical factors affect the accuracy of the IOP measurements made with any commercially available 
tonometer. Although not all the factors discussed previously were measured during this study, care 
was taken to eliminate some of them by means of the study methodology which was carefully 
designed to exclude specific factors, namely, diurnal variation; ocular pulse amplitude,; 
accommodation; operator bias and technique; calibration issues; Valsalva manoeuvre; nervousness 
or forced eyelid closure;  as well as the influence of the pre-corneal tear film (Bao et al., 2015).  
Although NCT is affected by the same ocular sources of error including CCT, scleral rigidity, corneal 
curvature; and corneal biomechanics; and ocular surface behaviour (Kniestedt et al., 2008; Rimayanti 
et al., 2014), data have been presented showing it is more influenced by CCT than applanation 
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tonometry (Graf, 1991). Factors influencing the CH and CRF include diurnal variation; tear film (a dry 
cornea leads to false CH values); IOP (the higher the IOP the lower the CH and higher the CRF); age 
(CH and CRF decrease by between 0.24 to 0.28 mmHg and 0.31 mmHg per decade respectively); 
corneal curvature (flatter corneas have lower CH and CRF values); and corneal swelling (corneal 
thickness increases but CH decreases due to the modified matrix viscosity and reduced dampening 
capacity of the cornea) (Moreno-Montanes et al., 2008; Sullivan-Mee et al., 2009; Kotecha et al., 
2010; Terai et al., 2012; Wang et al., 2013). As mentioned, CH is dependent on IOP and measured IOP 
is dependent on CH. CH can be seen as a dynamic corneal property indicating how much energy the 
cornea can absorb under stress. A 2013 study suggest that along with IOP it is the only other known 
modifiable risk factor for glaucoma progression manifested as visual field changes and ONH damage 
with age (Medeiros et al., 2013).  Xu et al. (2008) found that long-term soft contact lens wear leads to 
changes in corneal viscoelastic properties. Lower CH and CRF was apparent the first day after contact 
lens removal as well as two weeks after discontinuing contact lens wear while CCT remained 
constant (Xu et al., 2008).  
Although GAT IOP has a significant association with CCT, as expected IOPcc produced by the ORA was 
found to have no significant association with ocular variables such as CCT, corneal curvature, and 
axial length (Medeiros and Weinreb, 2006; ElMallah and Asrani, 2008). Studies of the ORA have 
produced conflicting results: two studies showed promising results with the ORA IOPcc seeming to 
compensate for corneal factors (Kotecha et al., 2006; Medeiros and Weinreb, 2006). In the second 
study of glaucoma patients undergoing therapy with topical medication, the ORA IOPcc and IOPg 
consistently overestimated GAT IOP by 8.3 mmHg and 7.2 mmHg respectively. In second study group 
of patients the ORA IOP (both IOPcc and IOPg) measurements were not independent of CCT 
(Martinez-de-la-Casa, Garcia-Feijoo, Fernandez-Vidal, et al., 2006). Medeiros and Weinreb (2006) 
reported a difference of M = 0.068, SD = 2.77 mmHg between ORA IOPcc and GAT. The difference 
was significantly influenced by CCT. Thicker CCT resulted in higher GAT compared to ORA IOPcc and 
thinner CCT resulted in lower GAT compared to ORA IOPcc (Medeiros and Weinreb, 2006).  
ICare RBT is affected by the same physical properties of the eye that affect GAT. These properties 
include CCT, corneal curvature, corneal biomechanics as well as refractive error with ICare RBT 
overestimating GAT IOP in myopic eyes. ICare is not influenced by the OPA (Detry-Morel et al., 2006; 
Lopez-Caballero et al., 2007; Avitabile et al., 2010; Hohmann et al., 2012; Rao et al., 2012). It has 
been shown that ICare RBT may be more sensitive to CCT than GAT and that a CCT change of 10 µm 
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can result in a measurement deviation of 0.7 mmHg (Brusini et al., 2006; Nakamura et al., 2006; 
Sahin, Niyaz, et al., 2007; Avitabile et al., 2010). Salvetat et al. (2011) also found CCT in subjects with 
normal corneas significantly affected IOP measurements with GAT and RBT. An increase of 0.41 
mmHg (GAT) and 0.50 mmHg (RBT) for every 10 µm increase in CCT was observed. These authors 
further found although corneal curvature did not seem to influence GAT, it significantly affected RBT. 
RBT tends to underestimate IOP in healthy steep corneas and overestimate IOP in healthy flat 
corneas by 0.76 mmHg per 1.00 D change in corneal curvature. Steep corneas may therefore 
hypothetically decrease the probe velocity leading to the underestimation of the IOP (Salvetat et al., 
2011).  
Chui et al. (2008) found other biomechanical “corneal” (ORA specific) properties such as CH and CRF 
were more important than CCT in influencing IOP measurements with the ICare RBT (Chui et al., 
2008). Although this study considered the influence of CCT, CH and CRF on IOP measured with the 
RBT, it did not report or comment on the correlation between the RBT IOP, GAT IOP (IOPg), and the 
corneal corrected IOP (IOPcc) measured with the ORA (Chui et al., 2008). In a 2008 study by Jorge et 
al. (2008), the influence of CCT and corneal biomechanical properties of the cornea (measured by the 
ORA) on ICare tonometry was evaluated. In the study ICare tonometry and ultrasound pachymetry 
was measured centrally, nasally and peripherally and the ICare IOP measurements were correlated 
with corneal thickness as well as ORA CH, CRF, IOPg, and IOPcc (Jorge, Gonzales-Meijome, et al., 
2008). Jorge et al. (2008) found although CCT plays a role in the accuracy of RBT measurements, the 
elastic and viscous properties of the cornea seem to play a more significant role in the interaction of 
the tonometer probe with the ocular surface. CRF showed a higher correlation with ICare RBT than 
CCT or CH (Jorge, Gonzales-Meijome, et al., 2008). There was also a high correlation between ICare 
RBT and IOPg but a lower correlation with IOPcc which suggests that ICare RBT measurements are 
affected not only by the actual IOP, but also by corneal properties including viscosity and 
viscoelasticity (Jorge, Gonzales-Meijome, et al., 2008).  
It was the aim of this chapter to identify and consider the essentially important measured intrinsic 
and extrinsic variables (corneal and contact lens properties) which may affect the measurements of 
IOP with the ICare RBT and the ORA tonometer.  
6.2 Subjects and methods 
Chapter two gave a complete description of the subjects, materials and methodology used in this 
specific study. To establish which intrinsic and extrinsic factors affect the accuracy of the ICare RBT 
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and ORA, two experienced optometrists (DJB and GHK) took two ICare RBT measurements on every 
one of the subjects enrolled in the study. The measurements were taken according to the protocol 
established for the study of each subject’s left eye with and without each and every contact lens in 
situ. One experienced optometrist (DJB) took four ORA measurements according to the protocol 
established for the study of each subject’s left eye with and without the contact lenses in situ. The 
measurements were recorded by and experienced optometric assistant (MLG) blinding the 
optometrists and reducing observer bias. Additionally, a recently calibrated Oculus Pentacam corneal 
analysis system was used on each patient to screen for corneal pathology (corneal ectasia, scarring, 
and prior surgery), the amount and presence of corneal astigmatism, and to record central corneal 
thickness at the thinnest location on the corneal thickness map as well as RM corneal curvature (RM 
– arithmetic mean of the simulated Ks) with and without contact lenses in situ. The Pentacam 
measurements were taken by one experienced optometrist (DJB) and was recorded by the 
optometric assistant (MLG) if the Pentacam QS (quality score) was acceptable. All the variables 
recorded as well as those inherent to the different contact lenses were analysed to establish their 
effect on the IOP measurement accuracy with the ICare RBT and Reichert ORA.  
6.3 Statistics 
In order to evaluate the effects of corneal thickness, corneal curvature, and refractive error on ICare 
RBT and Reichert ORA measurements, regression analysis was used with ICare IOP and ORA metrics 
designated as the dependent or response variables and corneal curvature, corneal thickness, and 
refractive error the independent or predictor variables. Pearson’s r as well as standard errors 
between variables was used to estimate the strength of the relationship between the dependent and 
the predictor variables and regression lines were used to predict the response variable from the 
predictor variables. The Pearson correlation coefficients were used to assess if a linear relationship 
existed between the variables and regression analyses to determine the value of one variable in 
terms of another (McAlinden et al., 2011). Significance levels were evaluated by the paired 2-tailed t-
test and p < 0.05 was considered statistically significant (Armstrong et al., 2011; McAlinden et al., 
2011). 
Multiple scatter plots for measurements without and with lenses were used to display the 
relationships between the variables stated in the graphical matrix. To further determine the linear 
relationship between one dependent variable (ICare RBT, or ORA CH, CRF, IOPcc and IOPg) and 
multiple independent variables (age, Rx, CCT, CH, CRF, corneal curvature (K), lens modulus, Dk/t, CT, 
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and water content) multiple linear regression models were used. A linear equation involving the 
independent variables predicting the dependent variable was constructed and the goodness of fit of 
the multiple regression to the data points was carried out using ANOVA tests. Multiple regression 
analysis assumes that the predictor variables are independent of each other which is rare a rare 
situation in practice. Multiple regression should account for at least half of the variance in the data, 
in other words the multiple correlation coefficient (R) should be at least 0.7 (Coefficient of 
determination, R2 ≥ 0.49). Finally, multiple regression is probably best used in an exploratory context, 
identifying variables that might be examined by more detailed studies (Armstrong and Eperjesi, 
2007). Stepwise regression was performed to identify the strongest correlated independent 
variables. The maximum allowable p-value for an independent variable to be included with the 
stepwise algorithm was set at 0.05. If at any step a variables p-value went above 0.05, it was 
removed.  
It is impossible to estimate regression coefficients before doing the research and data collection 
study; hence, power studies are not really relevant. As a rule of thumb the number of data points 
(i.e., observations or cases) should be considerably more than 5 to 10 times the number of variables  
(Kleinbaum et al., 1988; Norman and Streiner, 2008). The number of observations recorded in the 
current study was 1 750 and the number of variables for the regression analysis 10. In order to 
perform a multiple regression analysis it is important to consider which variables are significant to 
include in the model based on previous studies. In the case of the ICare RBT the literature shows that 
corneal biomechanical properties, represented here by the metrics CH and CRF, play a major role in 
the accuracy of the IOP measurements, more so than CCT (Chui et al., 2008; Jorge, Gonzales-
Meijome, et al., 2008; Salvetat et al., 2011).  
Other variables that necessitate consideration include CCT, corneal curvature, and refractive error 
(Detry-Morel et al., 2006; Lopez-Caballero et al., 2007; Avitabile et al., 2010; Salvetat et al., 2011; 
Hohmann et al., 2012; Rao et al., 2012; Rimayanti et al., 2014). With regard to the ORA, many of the 
same variables influence the accuracy of the measurements. Age, corneal curvature, CCT, and 
corneal biomechanics are important variables to include in the analysis (Luce, 2005; Kotecha et al., 
2006; Kniestedt et al., 2008; Kotecha et al., 2010). Previous studies determined that CRF is closely 
associated with CCT but not with IOPcc. IOPg is also closely associated with CCT, corneal curvature as 
well as axial length (Moreno-Montanes et al., 2008; Sullivan-Mee et al., 2009; Kotecha et al., 2010; 
Terai et al., 2012; Wang et al., 2013). 
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6.4 Results 
Regarding the correlation between ICare RBT and ORA measurements (Table 6.1), stronger 
correlations were found between IOPg (r = 0.854, p = 0.000) than IOPcc (r = 0.717, p = 0.000). In 
terms of the biomechanical metrics CRF was also strongly correlated (r = 0.629, p = 0.000) but CH was 
not (r = 0.131, p = 0.366). Although CCT showed a strong correlation (r = 0.561, p = 0.000), corneal 
curvature did not (r = 0.129, p = 0.372). Multiple regression analyses showed that CRF significantly 
affects ICare RBT β = 2.329 (95 % CI [1.725 to 2.932]), p < 0.0001. CH also affects ICare RBT but less 
significantly β = -1.949 (95% CI [-2.542 to -1.357]), p < 0.0001. Furthermore, corneal curvature also 
affects the ICare RBT measurement β = 1.097 (95% CI [-1.021 to 3.215]), p = 0.3020); but this effect is 
not statistically significant (Figures 6.1 to 6.5). Stepwise regression (R2 = 0.72) confirmed that CRF 
significantly affects RBT β = 2.268 (95% CI [1.676 to 2.861]), p = 0.0000. CH also affects RBT but less 
significantly β = -2.001 (95% CI [-2.574 to -1.427]), p = 0.0000. Although CCT had an effect it was not 
as significant as that of CRF and CH, β = 0.0232 (95% CI [0.0016 to 0.045]), p = 0.0000.  
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 Pearson correlation 
coefficient 
r 
Statistical significance 
(2-tailed) 
p-values 
RBT vs   
CH 0.131 0.366 
CRF 0.629** 0.000 
K 0.129 0.372 
CCT 0.561** 0.000 
IOPcc 0.717** 0.000 
IOPg 0.854** 0.000 
CRF vs   
CCT 0.725** 0.000 
IOPg 0.636** 0.000 
IOPcc 0.259 0.070 
K -0.147 0.308 
CH 0.760** 0.000 
CH vs   
CCT 0.562** 0.000 
IOPg 0.022 0.880 
IOPcc -0.406** 0.003 
Rx vs   
K 0.319* 0.024 
Table 6.1 Significant correlation of biomechanical properties measured by ORA and parameters measured 
by ICare RBT and Oculus Pentacam.(Pearson correlation coefficients as well as statistical significance are indicated. * 
= Correlation is significant at p = 0.05 level (2-tailed), ** = correlation is significant at the p = 0.01 level (2-tailed), n = 50.) 
(K = corneal curvature, RBT = rebound tonometry, CCT = central corneal thickness, CH = corneal hysteresis, CRF = corneal 
resistance factor, Rx = MSE or mean spherical equivalent refractive error, IOPg = Goldmann equivalent IOP, and IOPcc = 
corneal compensated IOP) 
The ORA metric CRF is strongly correlated with CH (r = 0.760, p = 0.000), CCT (r = 0.725, p = 0.000), 
and IOPg (r = 0.636, p = 0.000) (Table 6.1). Multiple regression analyses confirmed the effect of CCT β 
= 0.024 (95% CI [0.01815 to 0.03452]), p < 0.0001 and corneal curvature β = -1.135 (95% CI [-2.255 to 
-0.01558]), p = 0.0470 on CRF. Stepwise regression (R2 = 0.96) showed that CH significantly affects 
CRF β = 0.868 (95% CI [0.803 to 0.933]), p = 0.0000. IOPg also affects CRF but less significantly β = 
0.285 (95% CI [0.259 to 0.311]), p = 0.0000. The metric CH was correlated to CCT (r = 0.562, p = 0.000, 
IOPcc r = -0.406, p = 0.003) as well as CRF (strongest correlation) as previously shown in Figure 6.2 
(page 162). Multiple regression analyses confirmed the effect of CCT β = 0.029 (95% CI [0.01815 to 
0.03995]), p < 0.0001 and IOPg β = -0.189 (95% CI [-0.0366 to -0.01234]), p =0.0366 on CH (Figures 
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6.1 to 6.5). Stepwise regression (R2 = 0.94) confirmed that CRF significantly affects CH β = 1.078 (95% 
CI [0.997 to 1.158]), p = 0.0000. IOPg also affects CH but less significantly β = -0.307 (95% CI [-0.344 
to -0.269]), p = 0.0000. 
As shown before IOPcc was strongly correlated with ICare RBT and CH. Multiple regression analyses 
confirmed the strong effects of ICare RBT β = 0.210 (95% CI [0.06073 to 0.3588]), p = 0.0069, CRF β = 
2.229 (95% CI [1.776 to 2.683]), p < 0.0001, and CH β = -3.121 (95% CI [-3.530 to -2.713]), p <0.0001 
on IOPcc. Stepwise regression (R2 = 0.94) showed that CH significantly affects IOPcc β = -3.142 (95% 
CI [-3.519 to -2.766]), p = 0.0000. CRF also affects IOPcc but less significantly β = 2.351 (95% CI [1.936 
to 2.767]), p = 0.0000. Finally RBT also affects IOPcc β = 0.1899 (95% CI [0.059 to 0.321]), p = 0.0045. 
As previously noted, IOPg was strongly correlated with ICare RBT and CRF. Multiple regression 
analyses confirmed the strong effects of ICare RBT β = 0.2312 (95% CI [0.06252 to 0.4000]), p = 
0.0084), CRF β = 2.473 (95% CI [1.960 to 2.987]), p < 0.0001, and CH β = -2.782 (95% CI [-2.782 to -
1.857]), p <0.0001 on IOPg. Stepwise regression (R2 = 0.75) showed that RBT significantly affects IOPg 
β = 0.914 (95% CI [0.762 to 1.066]), p = 0.0000. Rx also affects IOPg but less significantly β = -0.226 
(95% CI [-0.402 to -0.045]), p = 0.01205. Multiple scatter plots of the different variables and their 
correlations are shown in Figures  6.6 and 6.7. 
 
Figure 6.1 This model predicts that the ICare RBT variable is significantly affected by the CH and CRF variables, p < 
0.0001.R
2
 and R
2
 adjusted are > 0.70 indicating that the model has good predictive value. The K variable has less effect on 
the RBT variable and age, CCT, and Rx variables seem to have very little effect on the RBT variable. The ƒ statistic was 
20.72, p < 0.0001 which also indicates that the model has good statistic predictive value. (RBT = rebound tonometry, Rx = 
MSE refractive error, CCT = central corneal thickness, K = corneal curvature, CH = corneal hysteresis, and CRF = corneal 
resistance factor. R
2
 = coeffiecient of determination). 
N 50
Equation 
R² 0.743
R² adjusted 0.707
SE of fit (RMSE) 1.8564
Parameter Estimate 95% CI SE VIF t DF p-value
Constant -7.620 -26.29 to 11.05 9.2573 - -0.82 43 0.4149
AGE 0.01180 -0.04814 to 0.07174 0.029724 1.07 0.40 43 0.6933
Rx 0.1307 -0.06162 to 0.3231 0.095387 1.13 1.37 43 0.1776
CCT 0.01849 -0.004301 to 0.04129 0.011303 2.29 1.64 43 0.1091
K 1.097 -1.021 to 3.215 1.0501 1.22 1.04 43 0.3020
CH -1.949 -2.542 to -1.357 0.29388 2.47 -6.63 43 <0.0001
CRF 2.329 1.725 to 2.932 0.29914 3.46 7.78 43 <0.0001
RBT = -7.62 + 0.0118 AGE + 0.1307 Rx + 0.01849 CCT + 1.097 K - 1.949 CH + 2.329 CRF
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Do not reject the null hypothesis at the 5% significance level.
2
 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
1
1
1
1
1
2
2
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Figure 6.2 This model predicts that the CRF variable is significantly affected by the CCT and K variables, p < 0.0001 and p = 
0.0470 respectively.R
2
 and R
2
 adjusted are < 0.70 indicating that the model has fairly good predictive value. The IOPg 
variable has less effect on the CRF variable and age, as well as Rx variables seem to have very little effect on the CRF 
variable. The ƒ statistic was 14.36, p < 0.0001 which also indicates that the model has good statistic predictive value. 
(RBT= rebound tonometry, Rx = MSE refractive error, CCT = central corneal thickness, K = corneal curvature, CH = corneal 
hysteresis, IOPg = Goldmann equivalent IOP, IOPcc = corneal compensated IOP, and CRF = corneal resistance factor. R
2
 = 
coeffiecient of determination). 
 
 
Figure 6.3 This model predicts that the CH variable is significantly affected by the CCT and IOPg variables, p < 0.0001 and 
p = 0.0366 respectively.R
2
 and R
2
 adjusted are < 0.70 indicating that the model has poor predictive value. The K variable 
has less effect on the CH variable and age, as well as Rx variables seem to have very little effect on the CH variable. The ƒ 
statistic was 6.5, p < 0.0001 which also indicates that the model has poor statistic predictive value. (RBT = rebound 
tonometry, Rx = MSE refractive error, CCT = central corneal thickness, K = corneal curvature, CH = corneal hysteresis, 
N 50
Equation 
R² 0.667
R² adjusted 0.621
SE of fit (RMSE) 1.01559
Parameter Estimate 95% CI SE VIF t DF p-value
Constant 3.371 -6.840 to 13.58 5.0633 - 0.67 43 0.5091
AGE -0.01811 -0.05050 to 0.01429 0.016063 1.04 -1.13 43 0.2658
Rx 0.01555 -0.09520 to 0.1263 0.054915 1.26 0.28 43 0.7784
CCT 0.02442 0.01433 to 0.03452 5.0062 E-03 1.50 4.88 43 <0.0001
K -1.135 -2.255 to -0.01558 0.55531 1.14 -2.04 43 0.0470
RBT 0.07664 -0.1047 to 0.2580 0.089930 4.52 0.85 43 0.3988
IOPg 0.1147 -0.04895 to 0.2784 0.081160 4.02 1.41 43 0.1647
CRF = 3.371 - 0.01811 AGE + 0.01555 Rx + 0.02442 CCT - 1.135 K + 0.07664 RBT + 0.1147 IOPg
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Do not reject the null hypothesis at the 5% significance level.
2 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
1
1
1
2
2
1
1
N 50
Equation 
R² 0.476
R² adjusted 0.402
SE of fit (RMSE) 1.09618
Parameter Estimate 95% CI SE VIF t DF p-value
Constant 6.210 -4.811 to 17.23 5.4651 - 1.14 43 0.2621
AGE -0.02380 -0.05877 to 0.01116 0.017338 1.04 -1.37 43 0.1769
Rx -6.502 E-04 -0.1202 to 0.1189 0.059273 1.26 -0.01 43 0.9913
CCT 0.02905 0.01815 to 0.03995 5.4034 E-03 1.50 5.38 43 <0.0001
K -1.198 -2.407 to 0.01091 0.59938 1.14 -2.00 43 0.0520
RBT 0.07328 -0.1225 to 0.2690 0.097066 4.52 0.75 43 0.4544
IOPg -0.1890 -0.3657 to -0.01234 0.087600 4.02 -2.16 43 0.0366
CH = 6.21 - 0.0238 AGE - 0.0006502 Rx + 0.02905 CCT - 1.198 K + 0.07328 RBT - 0.189 IOPg
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Do not reject the null hypothesis at the 5% significance level.
2
 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
1
1
1
2
1
1
2
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IOPcc = corneal compensated IOP, IOPg = Goldmann equivalent IOP, and CRF = corneal resistance factor. R
2
 = coeffiecient 
of determination). 
 
 
Figure 6.4 This model predicts that the IOPcc variable is significantly affected by the CH, CRF, and RBT variables p < 
0.0001 for CH and CRF and p = 0.0069 for RBT.R
2
 and R
2
 adjusted are > 0.70 indicating that the model has excellent 
predictive value. The K variable has less effect on the IOPcc variable and the age, CCT, and Rx variables seem to have very 
little effect on the IOPcc variable. The ƒ statistic was 99.79, p < 0.0001 which also indicates that the model has excellent 
statistic predictive value. (RBT = rebound tonometry, Rx = MSE refractive error, CCT = central corneal thickness, K = 
corneal curvature, CH = corneal hysteresis, IOPcc = corneal compensated IOP, and CRF = corneal resistance factor. R
2
 = 
coeffiecient of determination). 
 
 
N 50
Equation 
R² 0.943
R² adjusted 0.934
SE of fit (RMSE) 0.89907
Parameter Estimate 95% CI SE VIF t DF p-value
Constant 20.77 11.65 to 29.89 4.5186 - 4.60 42 <0.0001
AGE -0.01423 -0.04334 to 0.01487 0.014422 1.07 -0.99 42 0.3293
Rx -0.06146 -0.1567 to 0.03379 0.047195 1.18 -1.30 42 0.2000
CCT 0.005306 -0.006080 to 0.01669 5.6420 E-03 2.43 0.94 42 0.3523
K -0.1597 -1.199 to 0.8796 0.51497 1.25 -0.31 42 0.7581
RBT 0.2098 0.06073 to 0.3588 0.073857 3.89 2.84 42 0.0069
CH -3.121 -3.530 to -2.713 0.20245 5.00 -15.42 42 <0.0001
CRF 2.229 1.776 to 2.683 0.22488 8.33 9.91 42 <0.0001
IOPcc = 20.77 - 0.01423 AGE - 0.06146 Rx + 0.005306 CCT - 0.1597 K + 0.2098 RBT - 3.121 CH + 2.229 
CRF
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
2
 Do not reject the null hypothesis at the 5% significance level.
1
2
2
2
2
1
1
1
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Figure 6.5 This model predicts that the IOPg variable is significantly affected by the CH and CRF variables, p < 0.0001 for 
both as well as the RBT variable, p = 0.0084.R
2
 and R
2
 adjusted are > 0.70 indicating that the model has excellent 
predictive value. The K variable has less effect on the IOPg and age variables, and CCT, and Rx variables seem to have 
very little effect on the IOPg variable. The ƒ statistic was 80.78, p < 0.0001 which also indicates that the model has 
excellent statistic predictive value. (RBT = rebound tonometry, Rx = MSE refractive error, CCT = central corneal thickness, 
K = corneal curvature, CH = corneal hysteresis, IOPg = Goldmann equivalent IOP, and CRF = corneal resistance factor. R
2
 = 
coeffiecient of determination). 
 
 
 
 
 
 
N 50
Equation 
R² 0.931
R² adjusted 0.919
SE of fit (RMSE) 1.01772
Parameter Estimate 95% CI SE VIF t DF p-value
Constant 7.228 -3.094 to 17.55 5.1149 - 1.41 42 0.1650
AGE -0.01516 -0.04811 to 0.01778 0.016325 1.07 -0.93 42 0.3584
Rx -0.09807 -0.2059 to 0.009745 0.053424 1.18 -1.84 42 0.0735
CCT 0.007900 -0.004989 to 0.02079 6.3866 E-03 2.43 1.24 42 0.2230
K -0.1103 -1.287 to 1.066 0.58293 1.25 -0.19 42 0.8509
RBT 0.2312 0.06252 to 0.4000 0.083604 3.89 2.77 42 0.0084
CH -2.320 -2.782 to -1.857 0.22917 5.00 -10.12 42 <0.0001
CRF 2.473 1.960 to 2.987 0.25455 8.33 9.72 42 <0.0001
IOPg = 7.228 - 0.01516 AGE - 0.09807 Rx + 0.0079 CCT - 0.1103 K + 0.2312 RBT - 2.32 CH + 2.473 CRF
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1
 Do not reject the null hypothesis at the 5% significance level.
2
 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
1
1
1
1
1
2
2
2
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Figure 6.6 Multiple scatter plots of the correlation of all ICare RBT and ORA measurements with and without lenses.ICare 
RBT is strongly correlated with ORA IOPg and CRF. The correlation with ORA IOPcc and CH is weaker. (CH = corneal 
hysteresis, CRF = corneal resistance factor, RBT = rebound tonometry, IOPg = Goldmann equivalent IOP, IOPcc = cornea 
compensated IOP). 
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Figure 6.7 Multiple scatter plots of the different variables displaying relationships from the multiple linear regression 
model. 
From the above it is evident that RBT had strong relationships with CRF, IOPcc, IOPg, and less strong with CCT. CH had 
strong relationships with CCT, and CRF. CRF had strong relationships with RBT, CCT, IOPg, and less strong with IOPcc. 
IOPcc had strong relationships with RBT and IOPg while IOPg had strong relationships with CRF, IOPcc, and less strong 
with CH. CCT had strong relationships with CH, CRF, and less strong with IOPg. K does not seem to have had strong 
relationships with these variables. (RBT = rebound tonometry, Rx =MSE Refractive error, CH = corneal hysteresis, CRF 
= corneal resistance factor, IOPcc = corneal compensated IOP, IOPg = Goldmann equivalent IOP, CCT = central corneal 
thickness, and K =corneal curvature 
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With contact lenses in situ multiple regression analyses confirmed the strong predictive effects of CH 
and CRF on ICare RBT as well as ORA IOPg and IOPcc with the four different lenses in situ.  
For ICare RBT with the Pure Vision (A) lens R2 = 0.78 and R2 adjusted = 0.75, f = 25.93, p < 0.0001 
indicating good predictability with the model including age, Rx, CHA, CRFA, CCTA, and KA as 
predicting variables. Both CHA and CRFA had significant predictive ability β = -0.59, p = 0.026 (95% CI 
[-1.098 to -0.076]), and β = 2.14, p < 0.0001 (95% CI [1.55 to 2.73]), respectively. Stepwise regression 
(R2 = 0.77) showed that KA significantly affects RBTA β = 2.239 (95% CI [0.007 to 4,470]), p = 0.0493. 
CRFA also affects RBTA but less significantly β = 2.096 (95% CI [1.634 to 2.557]), p = 0.0000. CHA’s 
effect on RBTA was the least significant β = -0.692 (95% CI [-1.165 to -0.219]), p = 0.0041. For the 
Frequency XC (B) lens R2 = 0.79 and R2 adjusted = 0.76, f = 27.15, p < 0.0001 and the predictive values 
of CHB and CRFB were β = -1.6, p < 0.0001 (95% CI [-2.15 to -1.05]), and β = 2.42, p < 0.0001 (95 % CI 
[1.904 to 2.934]), respectively. Stepwise regression (R2 = 0.77) showed that CRFB significantly affects 
RBTB β = 2.473 (95% CI [2.047 to 2.899]), p = 0.0000. CHB also affects RBTB but less significantly β = -
1.547 (95% CI [-2.070 to -1.024]), p = 0.0000. For the Acuvue 1-Day Moist (C) lens R2 = 0.80 and R2 
adjusted = 0.77, f = 28.06, p < 0.0001 and the predictive values of CHC and CRFC were β = -1.99, p < 
0.0001 (95% CI [-2.603 to -1.383]) and β = 2.896, p < 0.0001 (95 % CI [2.338 to 3.454]) respectively. 
Stepwise regression (R2 = 0.78) showed that CRFC significantly affects RBTC β = 2.904 (95% CI [2.446 
to 3.362]), p = 0.0000. CHC also affects RBTC but less significantly β = -1.982 (95% CI [-2.486 to -
1.478]), p = 0.0000. For the Acuvue Oasys (D) lens R2 = 0.80 and R2 adjusted = 0.77, f = 28.01, p < 
0.0001 and the predictive values of CHD and CRFD were β = -1.890, p < 0.0001 (95 % CI [-2.541 to -
1.239]) and β = 2.651, p < 0.0001 (95% CI [2.028 to 3.274]) respectively. Stepwise regression (R2 = 
0.78) showed that CRFD significantly affects RBTD β = 2.774 (95% CI [2.299 to 3.249]), p = 0.0000. 
CHD also affects RBTD but less significantly β = -2.038 (95% CI [-2.623 to -1.455]), p = 0.0000. Finally 
Rx also had an effect on RBTD β = -0.225 (95% CI [-0.397 to -0.052]), p = 0.01080. (Figures 6.8 to 
6.11).  
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Figure 6.8 For ICare RBT with the Pure Vision lens (designated A) R
2 
= 0.783 and R
2 
adjusted = 0.753, f = 25.93, p < 0.0001 
indicating good predictability with the model including age, Rx, CHA, CRFA, CCTA, and KA as predicting variables.Both 
CHA and CRFA had significant predictive ability with β =-0.59, p = 0.026, and β = 2.14, p < 0.0001 respectively. (RBT = 
rebound tonometry, Rx =MSE Refractive error, CH = corneal hysteresis, CRF = corneal resistance factor, IOPcc = corneal 
compensated IOP, IOPg = Goldmann equivalent IOP, CCT = central corneal thickness, and K =corneal curvature, R
2
 = 
coeffiecient of determination) 
 
Fit
N 50
Equation 
R² 0.783
R² adjusted 0.753
SE of fit (RMSE) 2.6958
Parameter Estimate 95% CI SE VIF p-value
Constant -19.85 -42.68 to 2.982 11.321 - 0.0867
AGE 0.03051 -0.05722 to 0.1182 0.043501 1.09 0.4868
Rx -0.2782 -0.7030 to 0.1465 0.21061 2.62 0.1934
CHA -0.5868 -1.098 to -0.07584 0.25337 4.96 0.0254
CRFA 2.138 1.549 to 2.727 0.29205 6.63 <0.0001
CCTA 8.741 E-04 -0.02336 to 0.02511 0.012015 1.88 0.9423
KA 1.867 -0.5183 to 4.251 1.1826 1.70 0.1218
RBTA = -19.85 + 0.03051 AGE - 0.2782 Rx - 0.5868 CHA + 2.138 CRFA + 0.0008741 CCTA + 1.867 
KA
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Do not reject the null hypothesis at the 5% significance level.
2 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
1
1
1
2
2
1
1
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Figure 6.9 For the Frequency XC lens (designated B) R
2 
= 0.791 and R
2
 adjusted = 0.762, f = 27.15, p < 0.0001 indicating 
good predictability of the model.The predictive values of CHB and CRFB were β =-1.6, p < 0.0001, and β =2 .42, p < 0.0001 
respectively. (RBT = rebound tonometry, Rx = MSE Refractive error, CH = corneal hysteresis, CRF = corneal resistance 
factor, IOPcc = corneal compensated IOP, IOPg = Goldmann equivalent IOP, CCT = central corneal thickness, and K = 
corneal curvature, R
2
 = coeffiecient of determination). 
 
Fit
N 50
Equation 
R² 0.791
R² adjusted 0.762
SE of fit (RMSE) 1.5370
Parameter Estimate 95% CI SE VIF p-value
Constant -6.201 -19.01 to 6.609 6.3522 - 0.3344
AGE 0.008511 -0.04193 to 0.05895 0.025012 1.11 0.7353
Rx -0.03079 -0.2673 to 0.2057 0.11726 2.50 0.7942
CHB -1.600 -2.151 to -1.049 0.27309 2.78 <0.0001
CRFB 2.419 1.904 to 2.934 0.25523 3.65 <0.0001
CCTB 0.006886 -0.006806 to 0.02058 6.7892 E-03 3.01 0.3162
KB 1.097 -0.2882 to 2.482 0.68693 1.90 0.1176
RBTB = -6.201 + 0.008511 AGE - 0.03079 Rx - 1.6 CHB + 2.419 CRFB + 0.006886 CCTB + 1.097 KB
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Do not reject the null hypothesis at the 5% significance level.
2 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
1
1
1
2
2
1
1
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Figure 6.10 For the Acuvue 1-Day Moist lens (designated C) R
2 
= 0.797 and R
2
 adjusted = 0.768, f = 28.06, p < 0.0001 
indicating good predictability of the model.The predictive values of CHC and CRFC were β = -1.99, p < 0.0001 and β = 
2.896,  p < 0.0001 respectively. (RBT = rebound tonometry, Rx = MSE Refractive error, CH = corneal hysteresis, CRF = 
corneal resistance factor, IOPcc = corneal compensated IOP, IOPg = Goldmann equivalent IOP, CCT = central corneal 
thickness, and K =corneal curvature, R
2
 = coeffiecient of determination). 
 
Fit
N 50
Equation 
R² 0.797
R² adjusted 0.768
SE of fit (RMSE) 1.4978
Parameter Estimate 95% CI SE VIF p-value
Constant 2.286 -12.29 to 16.87 7.2293 - 0.7533
AGE 0.01341 -0.03849 to 0.06531 0.025735 1.23 0.6050
Rx -0.1115 -0.2854 to 0.06233 0.086202 1.42 0.2027
CHC -1.993 -2.603 to -1.384 0.30234 3.88 <0.0001
CRFC 2.896 2.338 to 3.454 0.27679 3.93 <0.0001
CCTC 0.003555 -0.01201 to 0.01912 7.7198 E-03 2.21 0.6475
KC 0.09399 -1.276 to 1.464 0.67925 1.55 0.8906
RBTC = 2.286 + 0.01341 AGE - 0.1115 Rx - 1.993 CHC + 2.896 CRFC + 0.003555 CCTC + 0.09399 KC
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Do not reject the null hypothesis at the 5% significance level.
2 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
1
1
1
2
2
1
1
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Figure 6.11 For the Acuvue Oasys lens (designated D) R
2 
= 0.796 and R
2
 adjusted = 0.768,  f= 28.01, p < 0.0001 indicating 
good predictability of the model.The predictive values of CHD and CRFD were β =-1.890, p < 0.0001 and β = 2.651, p < 
0.0001 respectively. (RBT = rebound tonometry, Rx = MSE Refractive error, CH = corneal hysteresis, CRF= corneal 
resistance factor, IOPcc = corneal compensated IOP, IOPg = Goldmann equivalent IOP, CCT = central corneal thickness, 
and K = corneal curvature, R
2
 = coeffiecient of determination). 
 
ORA IOPg with the Pure Vision (A) lens R2 = 0.72 and R2 adjusted = 0.68, f = 18.42, p < 0.0001 
indicating good predictability with the model including age, Rx, CHA, CRFA, CCTA, and KA as 
predicting variables. Both CHA and CRFA had significant predictive ability β = -0.725, p = 0.0007 (95% 
CI [-1.126 to -0.323]) and β = 1,399, p < 0.0001 (95% CI [0.936 to 1.861]) respectively. Stepwise 
regression (R2 = 0.68) showed that KA significantly affects IOPgA β = 1.994 (95% CI [0.168 to 3.821]), p 
= 0.0324. CRFA also affects IOPgA but less significantly β = 1.545 (95% CI [1.167 to 1.923]), p = 
0.0000. Finally CHA also had an effect on IOPgA β = -0.685 (95% CI [-1.072 to -0.2984]), p = 0.00052. 
For the Frequency XC (B) lens R2 = 0.87 and R2 adjusted = 0.85, f = 46.75, p < 0.0001 indicating good 
predictive value values. Both CHB and CRFB had significant predictive ability β = -2.002, p < 0.0001 
(95% CI [-2.488 to -1.517]) and β = 2.802, p < 0.0001 (95% CI [2.348 to 3.256]) respectively. Stepwise 
regression (R2 = 0.86) showed that CRFB significantly affects IOPgB β = 2.969 (95% CI [2.600 to 
3.234]), p = 0.0000. CHB also affects IOPgB but less significantly β = -2.041 (95% CI [-2.494 to -1.588]), 
p = 0.0000. For the Acuvue 1-Day Moist (C) lens R2 = 0.97 and R2 adjusted = 0.97, f = 261.10, p < 
0.0001 and the predictive values of CHC and CRFC were β = -2.336, p < 0.0001 (95% CI [-2.539 to -
Fit
N 50
Equation 
R² 0.796
R² adjusted 0.768
SE of fit (RMSE) 1.5605
Parameter Estimate 95% CI SE VIF p-value
Constant -0.7285 -16.50 to 15.04 7.8207 - 0.9262
AGE 0.02476 -0.02788 to 0.07741 0.026104 1.17 0.3481
Rx -0.1550 -0.3870 to 0.07706 0.11506 2.34 0.1851
CHD -1.890 -2.541 to -1.240 0.32274 5.67 <0.0001
CRFD 2.651 2.028 to 3.274 0.30890 8.06 <0.0001
CCTD 0.001149 -0.01659 to 0.01889 8.7950 E-03 3.81 0.8967
KD 0.7871 -0.7473 to 2.321 0.76083 2.13 0.3067
RBTD = -0.7285 + 0.02476 AGE - 0.155 Rx - 1.89 CHD + 2.651 CRFD + 0.001149 CCTD + 0.7871 KD
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Do not reject the null hypothesis at the 5% significance level.
2 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
1
1
1
2
2
1
1
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2.133]) and β = 2.989, p < 0.0001 (95% CI [2.803 to 3.175]) respectively. Stepwise regression (R2 = 
0.97) showed that CRFC significantly affects IOPgC β = 3.011 (95% CI [2.853 to 3.169]), p = 0.0000. Rx 
also affects IOPgC but less significantly β = 0.069 (95% CI [0.021 to 0.118]), p = 0.00504. Finally CHC 
also had an effect on IOPgC β = -2.338 (95% CI [-2.508 to -2.168]), p =0.0000. For the Acuvue Oasys 
(D) lens R2 = 0.97 and R2 adjusted = 0.97, f = 248.90, p < 0.0001 and the predictive values of CHD and 
CRFD were β = -2.795, p < 0.0001 (95% CI [-3.043 to -2.547]) and β = 3.253, p < 0.0001 (95 % CI [3.015 
to 3.490]) respectively. Stepwise regression (R2 = 0.97) showed that CRFD significantly affects IOPgD β 
= 3.223 (95% CI [3.042 to 3.404]), p = 0.0000. CHD also affects IOPgD but less significantly β = -2.759 
(95% CI [-2.985 to -2.533]), p = 0.0000. (Figures 6.12 to 6.15).  
 
Figure 6.12 ORA IOPg with the Pure Vision lens (designated A) R
2 
= 0.720 and R
2
 adjusted = 0.681, f = 18.42, p < 0.0001 
indicating good predictability with the model including age, Rx, CHA, CRFA, CCTA, and KA as predicting variables.Both 
CHA and CRFA had significant predictive ability with β = -0.725, p = 0.0007 (95 % CI [-1.126 to -0.323]) and β = 1,399, p < 
0.0001 (95 % CI [0.936 to 1.861]) respectively. (RBT = rebound tonometry, Rx = MSE Refractive error, CH = corneal 
hysteresis, CRF = corneal resistance factor, IOPcc = corneal compensated IOP, IOPg = Goldmann equivalent IOP, CCT = 
central corneal thickness, and K = corneal curvature, R
2
 = coeffiecient of determination). 
 
Fit
N 50
Equation 
R² 0.720
R² adjusted 0.681
SE of fit (RMSE) 2.1173
Parameter Estimate 95% CI SE VIF p-value
Constant -13.84 -31.77 to 4.092 8.8921 - 0.1269
AGE 0.05898 -0.009922 to 0.1279 0.034167 1.09 0.0915
Rx 0.3119 -0.02165 to 0.6456 0.16542 2.62 0.0661
CHA -0.7247 -1.126 to -0.3233 0.19901 4.96 0.0007
CRFA 1.399 0.9362 to 1.861 0.22939 6.63 <0.0001
CCTA -0.001488 -0.02052 to 0.01754 9.4371 E-03 1.88 0.8755
KA 2.457 0.5838 to 4.330 0.92882 1.70 0.0114
IOPgA = -13.84 + 0.05898 AGE + 0.3119 Rx - 0.7247 CHA + 1.399 CRFA - 0.001488 CCTA + 2.457 
KA
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Do not reject the null hypothesis at the 5% significance level.
2 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
1
1
1
2
2
1
2
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Figure 6.13 For the Frequency XC lens (designated B) R
2 
= 0.867 and R
2
 adjusted = 0.849, f = 46.75, p < 0.0001 indicating 
good predictive value values.Both CHB and CRFB had significant predictive ability with β = -2.002, p < 0.0001 (95 % CI [-
2.488 to -1.517]) and β = 2.802, p < 0.0001 (95 % CI [2.348 to 3.256]) respectively. (RBT = rebound tonometry, Rx = 
Refractive error, CH = corneal hysteresis, CRF = corneal resistance factor, IOPcc = corneal compensated IOP, IOPg = 
Goldmann equivalent IOP, CCT = central corneal thickness, and K =corneal curvature, R
2
 = coeffiecient of determination). 
 
Fit
N 50
Equation 
R² 0.867
R² adjusted 0.848
SE of fit (RMSE) 1.3550
Parameter Estimate 95% CI SE VIF p-value
Constant 7.807 -3.486 to 19.10 5.5999 - 0.1704
AGE -0.001966 -0.04643 to 0.04250 0.022049 1.11 0.9294
Rx 0.03644 -0.1720 to 0.2449 0.10337 2.50 0.7262
CHB -2.002 -2.488 to -1.517 0.24075 2.78 <0.0001
CRFB 2.802 2.348 to 3.256 0.22500 3.65 <0.0001
CCTB 0.004083 -0.007987 to 0.01615 5.9852 E-03 3.01 0.4987
KB -0.4177 -1.639 to 0.8035 0.60558 1.90 0.4940
IOPgB = 7.807 - 0.001966 AGE + 0.03644 Rx - 2.002 CHB + 2.802 CRFB + 0.004083 CCTB - 0.4177 
KB
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Do not reject the null hypothesis at the 5% significance level.
2 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
1
1
1
2
2
1
1
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Figure 6.14 For the Acuvue 1-Day Moist lens (designated C) R
2 
= 0.973 and R
2
 adjusted = 0.970, f = 261.10, p < 0.0001 and 
the predictive values of CHC and CRFC were β = -2.336, p < 0.0001 (95% CI [-2.539 to -2.133]) and β = 2.989, p < 0.0001 (95 
% CI [2.803 to 3.175]), respectively.(RBT = rebound tonometry, Rx = Refractive error, CH = corneal hysteresis, CRF = 
corneal resistance factor, IOPcc = corneal compensated IOP, IOPg = Goldmann equivalent IOP, CCT = central corneal 
thickness, and K = corneal curvature, R
2
 = coeffiecient of determination). 
 
Fit
N 50
Equation 
R² 0.973
R² adjusted 0.970
SE of fit (RMSE) 0.4991
Parameter Estimate 95% CI SE VIF p-value
Constant 9.663 4.805 to 14.52 2.4088 - 0.0002
AGE 0.007589 -0.009704 to 0.02488 8.5748 E-03 1.23 0.3811
Rx 0.05580 -0.002127 to 0.1137 0.028723 1.42 0.0586
CHC -2.336 -2.539 to -2.133 0.10074 3.88 <0.0001
CRFC 2.989 2.803 to 3.175 0.092225 3.93 <0.0001
CCTC 5.615 E-04 -0.004626 to 0.005749 2.5722 E-03 2.21 0.8282
KC -0.2034 -0.6598 to 0.2530 0.22633 1.55 0.3738
IOPgC = 9.663 + 0.007589 AGE + 0.0558 Rx - 2.336 CHC + 2.989 CRFC + 0.0005615 CCTC - 0.2034 
KC
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
2 Do not reject the null hypothesis at the 5% significance level.
1
2
2
1
1
2
2
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Figure 6.15 For the Acuvue Oasys lens (designated D) R
2 
= 0.972 and R
2
 adjusted = 0.968, f = 248.90, p  <0.0001 and the 
predictive values of CHD and CRFD were β =-2.795, p < 0.0001 (95 % CI [-3.043 to -2.547]) and β = 3.253, p < 0.0001 (95% 
CI [3.015 to 3.490]) respectively.(RBT = rebound tonometry, Rx = Refractive error, CH = corneal hysteresis, CRF = corneal 
resistance factor, IOPcc = corneal compensated IOP, IOPg = Goldmann equivalent IOP, CCT = central corneal thickness, 
and K = corneal curvature, R
2
 = coeffiecient of determination). 
ORA IOPcc with the Pure Vision (A) lens R2 = 0.40 and R2 adjusted = 0.31, f = 4.70, p = 0.0009 
indicating poor predictability with the model including age, Rx, CHA, CRFA, CCTA, and KA as 
predicting variables. Only KA and Age had any predictive ability β = 3.084, p = 0.0107 (95% CI [0.7530 
to 5.415]) and β = 0.1018, p = 0.0210 (95% CI [0.01608 to 0.1876]) respectively. Stepwise regression 
(R2 = 0.24) showed that KA significantly affects IOPccA β = 2.856 (95% CI [0.985 to 4.727]), p = 
0.00277. Age also affects IOPccA but less significantly β = 0.1139 (95% CI [0.027 to 0.200]), p = 
0.0095. The coefficient of determination (R2) is < 0.49 which indicates that the relationships are weak 
in both the multiple and stepwise regression model. For the Frequency XC (B) lens R2 = 0.97 and R2 
adjusted = 0.97, f = 261.19, p < 0.0001 indicating good predictive value values. CHB and CRFB had a 
significant influence with β = -3.413, p < 0.0001 (95% CI [-3.605 to -3.220]) and β = 2.748, p < 0.0001 
(95% CI [2.568 to 2.928]) respectively. Stepwise regression (R2 = 0.96) showed that CHB significantly 
affects IOPccB β = -3.370 (95% CI [-3.576 to -3.164]), p = 0.0000. CRFB also affects IOPccB but less 
significantly β = 2.846 (95% CI [2.678 to 3.0149]), p = 0.0000.  For the Acuvue 1-Day Moist (C) lens R2 
= 0.94 and R2 adjusted = 0.93, f = 108.30, p < 0.0001 and the predictive values of CHC and CRFC were 
Fit
N 50
Equation 
R² 0.972
R² adjusted 0.968
SE of fit (RMSE) 0.5949
Parameter Estimate 95% CI SE VIF p-value
Constant 9.731 3.718 to 15.74 2.9814 - 0.0022
AGE -0.01418 -0.03425 to 0.005884 9.9513 E-03 1.17 0.1613
Rx -0.06135 -0.1498 to 0.02711 0.043864 2.34 0.1691
CHD -2.795 -3.043 to -2.547 0.12303 5.67 <0.0001
CRFD 3.253 3.015 to 3.490 0.11776 8.06 <0.0001
CCTD 0.002450 -0.004311 to 0.009212 3.3528 E-03 3.81 0.4689
KD -0.01192 -0.5968 to 0.5730 0.29004 2.13 0.9674
IOPgD = 9.731 - 0.01418 AGE - 0.06135 Rx - 2.795 CHD + 3.253 CRFD + 0.00245 CCTD - 0.01192 
KD
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
2 Do not reject the null hypothesis at the 5% significance level.
1
2
2
1
1
2
2
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β =-2.918, p < 0.0001 (95% CI [-3.201 to -2.635]) and β = 2.465, p < 0.0001 (95% CI [2.206 to 2.725]) 
respectively. Stepwise regression (R2 = 0.94) showed that CHC significantly affects IOPccC β = -2.928 
(95% CI [-3.164 to -2.693]), p = 0.0000. CRFC also affects IOPccC but less significantly β = 2.533 (95% 
CI [2.315 to 2.751]), p = 0.0000. Finally Rx also had an effect on IOPccC β = 0.080 (95% CI [0.014 to 
0.148]), p = 0.01798. For the Acuvue Oasys (D) lens R2 = 0.96 and R2 adjusted = 0.96 f = 178.22, p < 
0.0001 and the predictive values of CHD and CRFD were β = -3.443, p < 0.0001 (95 % CI [-3.678 to 
3.209]) and β = 2.729, p < 0.0001 (95% CI [2.504 to 2.953]) respectively. Stepwise regression (R2 = 
0.09) showed that Age significantly affects IOPccD β = 0.089 (95% CI [0.012 to 0.167]), p = 0.027. The 
coefficient of determination (R2) is < 0.49 which indicates that the relationship is weak (Figures 6.16 
to 6.19).  
 
Figure 6.16 ORA IOPcc with the Pure Vision lens (designated A) R
2 
= 0.396 and R
2 
adjusted = 0.312, f = 4.70, p = 0.0009 
indicating poor predictability with the model including age, Rx, CHA, CRFA, CCTA, and KA as predicting variables.Only KA 
and age had any predictive ability with β = 3.084, p = 0.0107 (95% CI [0.7530 to 5.415]) and β = 0.1018, p = 0.0210 (95% CI 
[0.01608 to 0.1876]) respectively. (RBT = rebound tonometry, Rx = Refractive error, CH = corneal hysteresis, CRF = 
corneal resistance factor, IOPcc = corneal compensated IOP, IOPg = Goldmann equivalent IOP, CCT = central corneal 
thickness, and K = corneal curvature, R
2
 = coeffiecient of determination). 
 
Fit
N 50
Equation 
R² 0.396
R² adjusted 0.312
SE of fit (RMSE) 2.6346
Parameter Estimate 95% CI SE VIF p-value
Constant -9.309 -31.62 to 13.00 11.064 - 0.4048
AGE 0.1018 0.01607 to 0.1875 0.042514 1.09 0.0211
Rx 0.3575 -0.05764 to 0.7726 0.20583 2.62 0.0896
CHA -0.7601 -1.259 to -0.2607 0.24762 4.96 0.0037
CRFA 0.5610 -0.01459 to 1.137 0.28542 6.63 0.0558
CCTA -0.006194 -0.02988 to 0.01749 0.011743 1.88 0.6006
KA 3.084 0.7535 to 5.415 1.1557 1.70 0.0107
IOPccA = -9.309 + 0.1018 AGE + 0.3575 Rx - 0.7601 CHA + 0.561 CRFA - 0.006194 CCTA + 3.084 KA
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Do not reject the null hypothesis at the 5% significance level.
2 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
1
2
1
2
1
1
2
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Figure 6.17 For the Frequency XC lens (designated B) R
2
=0.973 and R
2
 adjusted = 0.970, f = 261.19, p < 0.0001 indicating 
good predictive value values. CHB and CRFB had a significant influence with β = -3.413, p < 0.0001 (95 % CI [-3.605 to -
3.220]) and β = 2.748, p < 0.0001 (95% CI [2.568 to 2.928]) respectively. (RBT = rebound tonometry, Rx = Refractive error, 
CH= corneal hysteresis, CRF= corneal resistance factor, IOPcc = corneal compensated IOP, IOPg = Goldmann equivalent 
IOP, CCT = central corneal thickness, and K = corneal curvature, R
2
 = coeffiecient of determination).   
 
Fit
N 50
Equation 
R² 0.973
R² adjusted 0.970
SE of fit (RMSE) 0.5381
Parameter Estimate 95% CI SE VIF p-value
Constant 23.22 18.73 to 27.70 2.2240 - <0.0001
AGE 0.005642 -0.01202 to 0.02330 8.7570 E-03 1.11 0.5228
Rx -0.1462 -0.2290 to -0.06338 0.041055 2.50 0.0009
CHB -3.413 -3.606 to -3.220 0.095615 2.78 <0.0001
CRFB 2.748 2.568 to 2.928 0.089360 3.65 <0.0001
CCTB 0.006689 0.001895 to 0.01148 2.3770 E-03 3.01 0.0073
KB -0.5988 -1.084 to -0.1138 0.24051 1.90 0.0167
IOPccB = 23.22 + 0.005642 AGE - 0.1462 Rx - 3.413 CHB + 2.748 CRFB + 0.006689 CCTB - 0.5988 
KB
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
2 Do not reject the null hypothesis at the 5% significance level.
1
2
1
1
1
1
1
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Figure 6.18 For the Acuvue 1-Day Moist lens (designated C) R
2 
= 0.938 and R
2
 adjusted = 0.929, f = 108.30, p < 0.0001 and 
the predictive values of CHC and CRFC were β = -2.918, p < 0.0001 (95% CI [-3.201 to -2.635] 0 and β = 2.465, p < 0.0001         
995% CI [2.206 to 2.725] 0 respectively. (RBT= rebound tonometry, Rx = Refractive error, CH = corneal hysteresis, CRF = 
corneal resistance factor, IOPcc= corneal compensated IOP, IOPg= Goldmann equivalent IOP, CCT= central corneal 
thickness, and K = corneal curvature, R
2
 = coeffiecient of determination).   
  
Fit
N 50
Equation 
R² 0.938
R² adjusted 0.929
SE of fit (RMSE) 0.6954
Parameter Estimate 95% CI SE VIF p-value
Constant 17.87 11.10 to 24.64 3.3563 - <0.0001
AGE 0.005586 -0.01851 to 0.02968 0.011948 1.23 0.6425
Rx 0.07877 -0.001937 to 0.1595 0.040020 1.42 0.0555
CHC -2.918 -3.201 to -2.635 0.14036 3.88 <0.0001
CRFC 2.465 2.206 to 2.725 0.12850 3.93 <0.0001
CCTC 0.003452 -0.003776 to 0.01068 3.5840 E-03 2.21 0.3408
KC 0.09138 -0.5446 to 0.7273 0.31535 1.55 0.7734
IOPccC = 17.87 + 0.005586 AGE + 0.07877 Rx - 2.918 CHC + 2.465 CRFC + 0.003452 CCTC + 
0.09138 KC
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
2 Do not reject the null hypothesis at the 5% significance level.
1
2
2
1
1
2
2
 
 
 
 
 
 
 
182 
 
 
Figure 6.19 For the Acuvue Oasys lens (designated D) R
2 
= 0.961 and R
2
 adjusted = 0.956 f = 178.22, p < 0.0001 and the 
predictive values of CHD and CRFD were β = -3.443, p < 0.0001 (95% CI [-3.678 to 3.209]) and β = 2.729, p < 0.0001 (95% CI 
[2.504 to 2.953]) respectively. (RBT = rebound tonometry, Rx = Refractive error, CH = corneal hysteresis, CRF = corneal 
resistance factor, IOPcc = corneal compensated IOP, IOPg = Goldmann equivalent IOP, CCT = central corneal thickness, 
and K = corneal curvature, R
2
 = coeffiecient of determination).   
The above regression analyses included analysis of the data of all the measurements with each of the 
four lenses (plus and minus) in situ. From Chapter 5 it was evident that the K-readings with the plus 
lenses were steeper (M = 7.60, SD = 0.45 [95% CI 7.494 to 7.704] mm) than the measurements 
without the lenses in the plus lens group (M = 7.93, SD = 0.45 [95% CI 7.79 to 8.06] mm), and with 
the minus lenses flatter (M = 8.03, SD = 0.31 [95% CI 7.954 to 8.104] mm) than the measurements 
without the lenses in the minus lens group (M = 7.73, SD = 0.26 [95% CI 7.63 to 7.82] mm).(Figures 
5.1 and 5.2, pages 143 and 144). The mean difference between the K-readings with plus and minus 
lenses were M = -0.43, SD = 0.52 (95% CI -0.522 to -0.307) mm which is significant t = 6.98, p < 
0.0001. Salvetat et al. (2011) found that 1.00 D of corneal curvature change could influence IOP 
measurement by 0.76 mmHg. Therefore, the IOP measurements with the lenses could be affected by 
1.41 mmHg and 1.25 mmHg for plus and minus lenses respectively due to the changes in corneal 
curvature (Salvetat et al., 2011).  
Multiple regression analyses of the results of measurements with all the plus lenses confirmed the 
predictive effects of both CH: β = -1.46, p < 0.0001 (95% CI [-2.000 to -0.913]) and CRF: β = 2.53, p < 
Fit
N 50
Equation 
R² 0.961
R² adjusted 0.956
SE of fit (RMSE) 0.5617
Parameter Estimate 95% CI SE VIF p-value
Constant 22.05 16.37 to 27.72 2.8149 - <0.0001
AGE -0.01341 -0.03236 to 0.005540 9.3957 E-03 1.17 0.1608
Rx -0.08981 -0.1733 to -0.006291 0.041416 2.34 0.0357
CHD -3.444 -3.678 to -3.209 0.11616 5.67 <0.0001
CRFD 2.729 2.505 to 2.953 0.11118 8.06 <0.0001
CCTD 0.005149 -0.001235 to 0.01153 3.1656 E-03 3.81 0.1112
KD -0.1810 -0.7333 to 0.3713 0.27385 2.13 0.5122
IOPccD = 22.05 - 0.01341 AGE - 0.08981 Rx - 3.444 CHD + 2.729 CRFD + 0.005149 CCTD - 0.181 KD
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
2 Do not reject the null hypothesis at the 5% significance level.
1
2
1
1
1
2
2
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0.0001 (95% CI [1.998 to 3.054]); however, K: β = -0.173, p = 0.827 (95% CI [-1.743 to 1.397]) had 
little predictive effect on ICare RBT measurements. Stepwise regression (R2 = 0.86) showed that CRF+ 
significantly affects RBT+ β = 2.535 (95% CI [2.061 to 3.009]), p = 0.0000. CH+ also affects RBT+ but 
less significantly β = -1.461 (95% CI [-1.955 to -0.966]), p = 0.0000.  With IOPcc both CH: β = -3.18., p < 
0.0001 (95% CI [-3.540 to -2.812]) and CRF: β = 2.624, p < 0.0001 (95% CI [2.271 to 2.978]) were 
strongly predictive but K: β = -0.11, p = 0.8330 (95% CI [-1.161 to 0.9388]) had little predictive effect. 
Stepwise regression (R2 = 0.86) showed that CH+ significantly affects IOPcc+ β = -3.215 (95% CI [-
3.548 to -2.880]), p = 0.0000. CRF+ also affects IOPcc+ but less significantly β = 2.685 (95% CI [2.365 
to 3.005]), p = 0.0000.  With IOPg both CH: β = -2.80, p < 0.0001 (95% CI [-2.985 to -2.609]) and CRF: 
β = 3.27, p < 0.0001 (95% CI [3.088 to 3.453]) were strongly predictive but K: β = -0.3490, p = 0.2036 
(95% CI [-0.8916 to 0.1937]) had little predictive effect. Stepwise regression (R2 = 0.97) showed that 
CRF+ significantly affects IOPg+ β = 3.263 (95% CI [3.097 to 3429]), p = 0.0000. CH+ also affects IOPg+ 
but less significantly β = -2.781 (95% CI [-2.954 to -2.607]), p = 0.0000.    
The multiple regression analyses of the results with the minus lenses for RBT confirmed the 
predictive effects of CH: β = -0.76, p < 0.0001 (95% CI [-1.051 to -0.4605]) and CRF: β = 1.79, p < 
0.0001 (95% CI [1.484 to 2.099]). Interestingly Age: β = 0.082, p = 0.0001 (95% CI [0.0404 to 0.1229]) 
and more importantly K: β = 2.09. p = 0.0002 (95% CI [1.002 to 3.185]) also had predictive effects in 
the model. Stepwise regression (R2 = 0.77) showed that K- significantly affects RBT- β = 2.524 (95% CI 
[1.525 to 3.522]), p = 0.0000. CRF- also affects RBT- but less significantly β = 1.879 (95% CI [1.596 to 
2.161]), p = 0.0000. CH- also affects RBT- β = -0.820 (95% CI [-1.108 to -0.532]), p = 0.0000. Finally 
Age also had an effect on RBT- β = 0.090 (95% CI [0.050 to 0.129]), p = 0.0001. With IOPcc the results 
were similar with CH: β = -1.18, p < 0.0001 (95% CI [-1.495 to -0.8624]); CRF: β = 0.57, p = 0.2260, 
(95% CI [0.2425 to 0.9005]); Age: β = 0.12, p < 0.0001 (95% CI [0.0745 to 0.1629]), and K: β = 1.81, p = 
0.0027 (95% CI [0.6368 to 2.974]) also having predictive effects in the model. Stepwise regression (R2 
= 0.60) showed that K- significantly affects IOPcc- β = 1909 (95% CI [0.852 to 2.968]), p = 0.0040. CH- 
also affects RBT- but less significantly β = -1.181 (95% CI [-1.486 to -0.876]), p = 0.0000. CRF- also 
affects IOPcc- β = 0.634 (95% CI [0.335 to 0.934]), p = 0.0003. Finally Age also had an effect on IOPcc- 
β = 0.123 (95% CI [0.081 to 0.166]), p = 0.0000. In terms of IOPg the results were similar with CH: β = 
-0.82, p < 0.0001 (95% CI [-1.088 to -0.5576]); CRF: β = 1.39, p < 0.0001 (95% CI [1.116 to 1.668]); age: 
β = 0.095, p < 0.0001 (95% CI [0.0576 to 0.1317]), and K: β = 1.183, p = 0.0183 (95% CI [0.2035 to 
2.162]) having predictive effects in the model. Stepwise regression (R2 = 0.70) showed that K- 
significantly affects IOPg- β = 1,261 (95% CI [0.371 to 2.150]), p = 0.00548. CRF- also affects IOPg- β = 
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1.450 (95% CI [1.198 to 1.701]), p = 0.0000. CH- also affects IOPg- β = -0.821 (95% CI [-1.077 to -
0.564]), p = 0.0000. Finally Age also had an effect on IOPg- β = 0.099 (95% CI [0.063 to 0.135]), p = 
0.0000. 
To establish which of the inherent properties of the contact lenses influence the accuracy of the 
measured IOP all the measurements were grouped together; in other words the data for age, Rx, 
RBT, CH, CRF, CCT, IOPcc, IOPg, CCT, K, modulus, water content, Dk/t, and CT included measurements 
without lenses as well as measurements with each of the lenses in situ (n = 250).  
With ICare RBT R2 = 0.79 and R2 adjusted = 0.78, f = 90.39, p < 0.0001 indicating good predictability 
with the model including age, Rx, CH, CRF, CCT, K, modulus, water content, Dk/t, and CT as predicting 
variables. Both CH and CRF had significant predictive ability β = -1.198, p < 0.0001 (95% CI [-1.438 to -
0.9579]), and β = 2.323, p < 0.0001 (95% CI [2.073 to 2.573]) respectively. K also had significant 
predictive ability and influence β = 1.368, p = 0.0003 (95 % CI [0.6313 to 2.105]) but age less so β = 
0.03131, p = 0.0271 (95 % CI [0.0036 to 0.0590]). Stepwise regression (R2 = 0.79) showed that CRF 
significantly affects RBT β = 2.330 (95% CI [2.115 to 2.545]), p = 0.0000. CH also affects RBT but less 
significantly β = -1.224 (95% CI [-1.454 to -0.994]), p = 0.0000. K affects RBT β = 1.302 (95% CI [0.640 
to 1.964]), p = 0.00012.  Age had a smaller effect β = 0.032 (95% CI [0.005 to 0.059]), p = 0.02236 as 
did CT β = -0.0087 (95% CI [-0.0167 to -0.001]), p = 0.03371. (Figure 6.20, page 181).  
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Figure 6.20 This model predicts that ICare RBT is significantly affected by CH and CRF, p<0.0001 for both as well as K, p = 
0.0003. R
2
 and R
2
 adjusted are > 0.70 indicating that the model has excellent predictive value.Age has less influence on 
ICare RBT. The ƒ statistic was 90.39, p < 0.0001 which also indicates that the model has excellent statistic predictive 
value. (RBT= rebound tonometry, Rx = refractive error, CCT = central corneal thickness, K = corneal curvature, CH = 
corneal hysteresis, IOPg = Goldmann equivalent IOP, CT = contact lens centre thickness, water = contact lens water 
content, Dk/t = oxygen transmissibility of the contact lens, modulus = modulus of elasticity of the contact lens, and CRF =  
corneal resistance factor, R
2
 = coeffiecient of determination). 
With ORA IOPg R2 = 0.79 and R2 adjusted = 0.76, f = 91.84, p < 0.0001 indicating good predictability 
with the model including age, Rx, CH, CRF, CCT, K, modulus, water content, Dk/t, and CT as predicting 
variables. Both CH and CRF had significant predictive ability with β = -1.658, p < 0.0001 (95 % CI [-
1.857 to -1.459]), and β = 2.316, p < 0.0001 (95 % CI [2.109 to 2.523]) respectively. Lens modulus also 
had significant predictive ability and influence β = -2.953, p = 0.0360 (95 % CI [-5.711 to -0.1943]). 
Stepwise regression (R2 = 0.78) showed that CRF significantly affects IOPg β = 2.425 (95% CI [2.249 to 
2.599]), p = 0.0000. CH also affects IOPg but less significantly β = -1.736 (95% CI [-1.927 to -1.544]), p 
= 0.0000. Modulus also affects IOPg β = -1.604 (95% CI [-2.402 to -0807]), p = 0.00008 (Figure 6.21).  
N 250
Equation 
R² 0.791
R² adjusted 0.782
SE of fit (RMSE) 1.9621
Parameter Estimate 95% CI SE VIF p-value
Constant -8.368 -15.66 to -1.073 3.7030 - 0.0247
AGE 0.03131 0.003578 to 0.05904 0.014076 1.07 0.0271
Rx 0.01106 -0.08895 to 0.1111 0.050768 1.44 0.8278
CH -1.198 -1.438 to -0.9579 0.12195 7.03 <0.0001
CRF 2.323 2.073 to 2.573 0.12686 8.38 <0.0001
CCT 7.057 E-04 -0.006835 to 0.008247 3.8280 E-03 2.55 0.8539
K 1.368 0.6313 to 2.105 0.37413 1.43 0.0003
Modulus 1.874 -1.457 to 5.205 1.6909 27.93 0.2688
Water 0.04756 -0.02142 to 0.1165 0.035015 37.12 0.1757
Dk/t -0.005147 -0.01651 to 0.006212 5.7664 E-03 6.15 0.3729
CT -0.04712 -0.1050 to 0.01079 0.029398 59.81 0.1103
2
 Do not reject the null hypothesis at the 5% significance level.
RBT = -8.368 + 0.03131 AGE + 0.01106 Rx - 1.198 CH + 2.323 CRF + 0.0007057 CCT + 1.368 K + 1.874 
Modulus + 0.04756 Water - 0.005147 Dk/t - 0.04712 CT
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
1
1
2
1
1
2
1
2
2
2
2
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Figure 6.21 This model predicts that ORA IOPg is significantly affected by CH and CRF, p<0.0001 for both as well as 
Modulus, p = 0.00360. R
2
 and R
2
 adjusted are > 0.70 indicating that the model has excellent predictive value.The ƒ 
statistic was 91.84, p < 0.0001 which also indicates that the model has excellent statistic predictive value. (Rx = refractive 
error, CCT = central corneal thickness, K = corneal curvature, CH = corneal hysteresis, IOPg = Goldmann equivalent IOP, CT 
= contact lens centre thickness, water = contact lens water content, Dk/t = oxygen transmissibility of the contact lens, 
modulus=modulus of elasticity of the contact lens, and CRF= corneal resistance factor. R
2
 = coeffiecient of 
determination). 
With ORA IOPcc R2 = 0.68 and R2 adjusted = 0.67, f = 50.57, p < 0.0001 indicating good predictability 
with the model including age, Rx, CH, CRF, CCT, K, modulus, water content, Dk/t, and CT as predicting 
variables. Both CH and CRF had significant predictive ability with β = -2.082, p < 0.0001 (95 % CI [-
2.318 to -1.846]), and β = 1.785, p < 0.0001 (95 % CI [1.539 to 2.031]) respectively. Lens modulus also 
had significant predictive ability and influence β = -3.311, p = 0.0476 (95 % CI [-6.586 to -0.0349]) but 
age less so β = 0.03065, p = 0.0277 (95 % CI [0.003386 to 0.05792]). Stepwise regression (R2 = 0.69) 
showed that CH significantly affects IOPcc β = -2.131 (95% CI [-2.361 to -1.901]), p = 0.0000. CRF also 
affects IOPcc but less significantly β = 1.799 (95% CI [1.589 to 2.011]), p = 0.0000. Modulus also 
affects IOPcc β = -2.327 (95% CI [-3.269 to -1.386]), p = 0.0000. Finally Age also affects IOPcc β = 
0.030 (95% CI [0.003 to 0.057]), p = 0.02848 (Figure 6.22). 
 
N 250
Equation 
R² 0.794
R² adjusted 0.785
SE of fit (RMSE) 1.62481
Parameter Estimate 95% CI SE VIF p-value
Constant 2.611 -3.430 to 8.651 3.0664 - 0.3954
AGE 0.01543 -0.007537 to 0.03839 0.011656 1.07 0.1870
Rx 0.06474 -0.01808 to 0.1476 0.042040 1.44 0.1249
CH -1.658 -1.857 to -1.459 0.10098 7.03 <0.0001
CRF 2.316 2.109 to 2.523 0.10505 8.38 <0.0001
CCT 0.004250 -0.001994 to 0.01049 3.1698 E-03 2.55 0.1813
K 0.4003 -0.2100 to 1.011 0.30981 1.43 0.1976
Modulus -2.953 -5.711 to -0.1943 1.4002 27.93 0.0360
Water -0.03006 -0.08718 to 0.02706 0.028995 37.12 0.3009
Dk/t 0.005425 -0.003982 to 0.01483 4.7750 E-03 6.15 0.2571
CT 0.02344 -0.02452 to 0.07139 0.024344 59.81 0.3366
2
 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
IOPg = 2.611 + 0.01543 AGE + 0.06474 Rx - 1.658 CH + 2.316 CRF + 0.00425 CCT + 0.4003 K - 2.953 
Modulus - 0.03006 Water + 0.005425 Dk/t + 0.02344 CT
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Do not reject the null hypothesis at the 5% significance level.
1
1
1
2
2
1
1
2
1
1
1
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Figure 6.22 This model predicts that ORA IOPcc is significantly affected by CH and CRF, p < 0.0001 for both as well as 
Modulus, p = 0.00476 and less significantly by age p = 0.0277.R
2
 and R
2
 adjusted are < 0.70 indicating that the model has 
poor predictive value. The ƒ statistic was 50.57, p < 0.0001 which also indicates that the model has fair statistic predictive 
value. (Rx = refractive error, CCT = central corneal thickness, K = corneal curvature, CH = corneal hysteresis, IOPg = 
Goldmann equivalent IOP, CT = contact lens centre thickness, water = contact lens water content, Dk/t = oxygen 
transmissibility of the contact lens, modulus = modulus of elasticity of the contact lens, and CRF = corneal resistance 
factor, R
2
 = coeffiecient of determination). 
 
6.5 Discussion  
Biomechanical properties of the cornea have a significant impact on IOP measurement error (Liu and 
Roberts, 2005) which may vary depending on the instrumentation used to measure the IOP. In fact, 
all tonometers that measure IOP through the application of stress to the corneal tissue are subject to 
the effects of corneal resistance which is an ‘effective’ rather than an intrinsic mechanical property 
such as Young’s modulus. Relatively recently the ORA, an in vivo method to measure the 
biomechanical properties of the cornea in the form of two metrics, CH and CRF, became available. CH 
can be considered a dynamic corneal property indicating how much energy the cornea absorbs and is 
the difference between the two pressure measurements made by the ORA. Corneal resistance is a 
composite characteristic which incorporates the material as well as geometric properties of the 
N 250
Equation 
R² 0.679
R² adjusted 0.666
SE of fit (RMSE) 1.92959
Parameter Estimate 95% CI SE VIF p-value
Constant 13.15 5.979 to 20.33 3.6416 - 0.0004
AGE 0.03065 0.003386 to 0.05792 0.013843 1.07 0.0277
Rx 0.07970 -0.01865 to 0.1781 0.049926 1.44 0.1117
CH -2.082 -2.318 to -1.846 0.11993 7.03 <0.0001
CRF 1.785 1.539 to 2.031 0.12475 8.38 <0.0001
CCT 5.199 E-04 -0.006896 to 0.007936 3.7645 E-03 2.55 0.8903
K 0.5833 -0.1415 to 1.308 0.36793 1.43 0.1142
Modulus -3.311 -6.586 to -0.03487 1.6629 27.93 0.0476
Water -8.219 E-04 -0.06866 to 0.06701 0.034434 37.12 0.9810
Dk/t 0.008676 -0.002495 to 0.01985 5.6707 E-03 6.15 0.1274
CT 0.003983 -0.05297 to 0.06093 0.028910 59.81 0.8905
2
 Do not reject the null hypothesis at the 5% significance level.
IOPcc = 13.15 + 0.03065 AGE + 0.0797 Rx - 2.082 CH + 1.785 CRF + 0.0005199 CCT + 0.5833 K - 3.311 
Modulus - 0.0008219 Water + 0.008676 Dk/t + 0.003983 CT
H0: β = 0
The parameter is equal to 0.
H1: β ≠ 0
The parameter is not equal to 0.
1 Reject the null hypothesis in favour of the alternative hypothesis at the 5% significance level.
1
1
2
1
1
2
2
1
2
2
2
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corneal tissue (Luce, 2005; Jorge, Gonzales-Meijome, et al., 2008; Lau and Pye, 2011). Although CH 
and CRF represent biomechanical properties of the cornea, it is prudent to keep in mind that they are 
composite measures which characterise the structural response of the eye to the measurement 
device rather than intrinsic properties of the corneal tissue (Jorge, Gonzales-Meijome, et al., 2008; 
Lau and Pye, 2011). In other words, these so-called biomechanical properties represent the response 
of the entire corneal tissue to the measurement principle of the ORA (Jorge, Gonzales-Meijome, et 
al., 2008; Lau and Pye, 2011). Considering that the ORA uses the delay in corneal response after the 
applanation process to determine the viscoelastic properties of the cornea, it can be assumed that 
the absorbed energy could also delay the corneal response when an impact is applied to the cornea 
to measure IOP (Jorge, Gonzales-Meijome, et al., 2008). The ICare RBT should therefore be affected 
by the corneal biomechanical properties. Previous studies show this is indeed the case and that ICare 
RBT is correlated with CRF and CH (Chui et al., 2008; Jorge, Gonzales-Meijome, et al., 2008). Other 
studies also found correlations between ICare RBT and CCT, corneal curvature, and refractive error 
(Detry-Morel et al., 2006; Lopez-Caballero et al., 2007; Avitabile et al., 2010; Hohmann et al., 2012; 
Rao et al., 2012). The purpose of this experimental chapter was to identify from the measured, 
intrinsic and extrinsic variables (corneal and contact lens properties) the significant ones which may 
affect the measurement of IOP with the ICare RBT and the ORA tonometers with and without 
disposable soft contact lenses on the eye.  
Multiple linear regression analyses of the results of this study showed that CRF was correlated to and 
significantly affected ICare RBT. This was also the case with CH and CCT although the effect was less.  
Although corneal curvature also affects ICare RBT, it was not statistically significant. CCT was strongly 
correlated to and affected CRF. CCT, IOPg and ICare RBT were strongly correlated to CH and CRF. As 
shown before, IOPcc was strongly correlated with and predicted ICare RBT and was affected by CH 
and CRF. IOPg was strongly correlated with and predicted ICare RBT and was affected by CH, CRF and 
Rx.  
These results agreed with those of previous studies which showed that ICare RBT was strongly 
correlated to CRF, more so than with CCT. Although CCT was correlated with CH, CH did not 
demonstrate as strong a correlation with ICare RBT as CRF did (Jorge, Gonzales-Meijome, et al., 
2008). Corneas with higher values of CH and CRF have a longer delay in response to stress and 
relaxation forces which means it absorbs more energy when impacted by the probe resulting in 
higher IOP measurements with the ICare RBT (Chui et al., 2008; Jorge, Gonzales-Meijome, et al., 
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2008). The strong correlation between CRF and ICare RBT indicated that the RBT measurements were 
affected by viscoelastic properties of the cornea rather than just by CCT or elastic (CH) properties. 
This was in agreement with the findings of Jorge et al. (2008). Other as yet unknown and 
unmeasured tissue properties of the cornea may also affect the ICare RBT measurements. In contrast 
to previous studies (Detry-Morel et al., 2006; Lopez-Caballero et al., 2007; Avitabile et al., 2010; 
Hohmann et al., 2012; Rao et al., 2012), the present study did not find significant correlations 
between age, refractive error, and corneal curvature with the ICare RBT IOP measurements without 
contact lenses on the eye. Reasons for this difference may be due to the relatively narrow age range 
(18 to 55 years, M = 38.90, SD = 9.23 years) of the study participants and the fact that they were all 
Caucasian and long-term soft contact lens wearers. Although the participants removed their lenses at 
least 24 hours before data collection, the effects of long-term contact lens wear on the cornea − and 
therefore IOP measurements − cannot be ruled out (Xu et al., 2008; Hamilton-Maxwell, 2014; 
Mahjoob et al., 2014).  
The multiple regression analyses confirmed the strong predictive effects of CH and CRF on ICare RBT 
as well as ORA IOPg and IOPcc with the different lenses in situ. For ICare RBT both CH and CRF had 
significant predictive ability and therefore influence with all four lenses. For ORA IOPg, both CH and 
CRF had significant predictive ability and influence with all four lenses. For ORA IOPcc, CH and CRF 
had significant predictability and influence with the four lenses tested. However, when splitting the 
data for the plus and minus lenses, corneal curvature (K) and age also had a small predictive effect on 
the IOP measurements with the three instruments in the minus lens group only. This may be due to 
the fact that the combined cornea/lens thickness was less with the minus lenses (M = 561.66, SD = 
44.78 µm) than with the plus lenses (M = 607.03, SD = 49.31 µm) or the differences in sample size 
between the two groups (minus 32 subjects and plus 18 subjects). 
Multiple and stepwise regression analysis of the variables including contact lens properties 
confirmed the significant predictive effects of CRF, CH and modulus on ICare RBT, ORA IOPg and ORA 
IOPcc. Corneal curvature (K) and age also had predictive ability with the ICare RBT and ORA IOPcc.    
The results indicate that the biomechanical properties of the cornea/lens combination were more 
important in predicting or influencing the measurements of IOP with the ICare RBT and ORA IOPg 
and IOPcc than CCT, corneal curvature, age, and refractive error.  
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6.6 Conclusion 
The present study showed that although central corneal thickness, age and corneal curvature had 
some influence on the accuracy of IOP measurements with the ICare RBT and ORA, the 
biomechanical properties (represented by CH and CRF) of the cornea were more important to 
consider as it had a greater influence on the accuracy of the measurements with these two 
instruments. ICare RBT was significantly influenced by the biomechanical properties and corneal 
curvature and to a lesser extent by age. For IOPg the results were similar in that it was significantly 
influenced by biomechanical properties and lens modulus. In the case of IOPcc, the most significant 
influence was from biomechanical properties, modulus and − to a lesser extent − from age. Modulus 
is a viscoelastic property of the contact lens and it is therefore not unexpected that it would have 
some influence on the IOP measurements, similar to that of the two biomechanical metrics CH and 
CRF. Although the ICare RBT and ORA IOPcc do not correlate well, it may be possible to calibrate the 
ICare RBT to more closely approximate the ORA IOPcc measurements rather than the ORA IOPg 
measurements if future studies validate that ORA IOPcc is, in fact, a more accurate representation of 
the “true IOP” of the eye. The ICare RBT is a versatile, cost-effective instrument which is simple to 
use, accurate for clinical use, and adaptable to different clinical situations.   
6.7 Summary of findings 
 ICare RBT was influenced by the biomechanical properties (CH and CRF), lens modulus of 
elasticity, corneal curvature, and age. 
 ORA IOPg was influenced by the biomechanical properties (CH and CRF), lens modulus of 
elasticity, and ocular surface behaviour. 
 ORA IOPcc was influenced by the biomechanical properties (CH and CRF), lens modulus of 
elasticity, and age.  
 Although central corneal thickness and corneal curvature had some influence on the 
accuracy of IOP measurements with the ICare RBT and ORA, the biomechanical properties of 
the cornea and ocular surface behaviour were more important to consider; and a greater 
influence on the accuracy of the measurements with these two instruments was observed. 
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Chapter 7  
Final discussion, conclusion, and recommendations for future work 
 
This programme of research examined the reproducibility and repeatability of ICare RBT 
measurements and the repeatability of the ORA measurements with and without contact lenses on 
the eye. IOP measurements with the two instruments were clinically compared and by using four 
different disposable lenses (commonly used by South African practitioners) with different material 
and physical characteristics. The effect on the accuracy of IOP measurements with contact lenses in 
situ with both the ICare and ORA tonometers were evaluated. Additionally, the physiological as well 
as physical factors that influence IOP measurement with and without contact lenses on the eye when 
using these two instruments were examined.  
7.1 Reproducibility and repeatability of the ICare RBT and repeatability of 
the Reichert ORA in a population of normal subjects measured with and 
without soft disposable contact lenses in situ 
7.1.1 Intraobserver reliability of the ICare RBT 
Without contact lenses the ICCs were 0.95 and 0.88 for DJB and GHK respectively. When considering 
all the measurements with and without contact lenses on the eye, the ICCs remained high: 0.94 and 
0.92 for DJB and GHK respectively. In other words, taking into account Spitzer and Endicott’’s criteria, 
the ±90% intraobserver repeatability of ICare RBT by the two experienced optometrists in this group 
of patients was excellent (Spitzer and Endicott, 1980). This compares well to previous published data 
by Asrani et al. (2011), Sahin et al. (2007), and Martinez-de-la-Casa et al. (2005) who all found that 
the ICare RBT produced repeatable measurements by the same examiner (Martinez-de-la-Casa et al., 
2005; Sahin, Basmak, et al., 2007; Asrani et al., 2011). Bland-Altman analyses confirmed the results 
obtained by ICC with mean differences between measurements without lenses (M = 0.30 mmHg, SD 
= 1.3 mmHg and M = 0.10 mmHg, SD = 1.7 mmHg for DJB and GHK respectively).  
When considering all the measurements, with and without contact lenses by the two observers the 
mean differences between measurements were M = -0.1 mmHg, SD = 1.5 mmHg and M = 0.1 mmHg, 
SD = 1.6 mmHg for DJB and GHK respectively. Clinically these small measurement differences are not 
significant.  
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In this study the measurement error for the measurements taken without contact lenses was 1.74 
mmHg and 2.35 mmHg for DJB and GHK respectively. Measurement error for all the measurements 
was 2.12 mmHg and 2.45 mmHg for DJB and GHK respectively. This means for 95% of the 
measurements the true value would be expected to be less than the measurement errors indicated 
here. Repeatability without lenses was 2.45 mmHg and 2.98 mmHg for DJB and GHK respectively and 
with all measurements 2.98 mmHg and 3.19 mmHg for DJB and GHK respectively. Hence, for 95% of 
the measurements the difference between the two measurements would be expected to be less 
than these values. Compared to GAT with repeatability of 1.7 – 2.0 mmHg the ICare RBT 
intraobserver repeatability was poor (Thorburn, 1978; Dielemans et al., 1994; Kotecha et al., 2005).  
However, for clinical IOP screening purposes the intraobserver repeatability of the ICare RBT was as 
good if not better than comparative noncontact tonometers (Hansen, 1995; Mackie et al., 1996; 
Tonnu et al., 2005; Ogbuehi, 2006; Regine et al., 2006; Lafaut et al., 2007; AlMubrad and Ogbuehi, 
2008; Ogbuehi and Almubrad, 2008). Intraobserver measurement repeatability was not affected by 
the presence of the disposable contact lenses on the eye.   
7.1.2 Interobserver reliability of the ICare RBT 
Without contact lenses the ICC was 0.81 and the mean difference determined by Bland-Altman 
analyses between observer DJB and GHK was M = 0.10 mmHg, SD = 2.2 mmHg. When all the 
measurements were considered the ICC was 0.88 and the mean difference by Bland-Altman analyses 
between observer DJB and GHK was (M = 0.4 mmHg, SD = 2.1 mmHg). Clinically, these small 
measurement differences were not significant. Repeatability was 4.39 mmHg without lenses and 
4.12 mmHg with all measurements considered. Therefore for 95% of the measurements the 
difference between the two observers was expected to be < 4.39 mmHg. In this study the results 
showed that the interobserver measurement reliability with the ICare RBT was as good without 
contact lenses on the eye as it was with the four different disposable lenses on the eye. The 
interobserver reliability values determined in this study also compared well with previous studies for 
the same instrument (Martinez-de-la-Casa et al., 2005; Detry-Morel et al., 2006; Sahin, Basmak, et 
al., 2007; Asrani et al., 2011).  
Therefore, independent experienced clinicians making IOP measurements under similar conditions 
with the same ICare RBT would produce repeatable and consistent results even when contact lenses 
are worn. 
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7.1.3 Intraobserver reliability of the Reichert ORA without contact lenses in situ  
It is well known that the OPA affects the accuracy of IOP measurements with the NCT. Several studies 
showed that the OPA affects the intraobserver repeatability of the ORA IOPcc and IOPg 
measurements and to a lesser extent the instrument specific biomechanical measurements CH and 
CRF. In this study four measurements taken by the same observer with the ORA revealed the 
following results: ICCs were 0.63 for CH, 0.79 for CRF, 0.77 for IOPcc and 0.87 for IOPg.  IOPg gave the 
best test-retest reproducibility followed by CRF, IOPcc and CH. This contrasted with the results found 
by Wang et al. (2013) which indicated the IOPcc had the poorest test-retest reproducibility. However, 
except for CH, the ORA measurements performed well considering Spitzer and Endicott’s criteria (all 
ICCs >0.70). Bland-Altman analyses revealed the mean differences between measurements for CH 
ranged from Ms = 0.013 mmHg to 0.21 mmHg with SDs = 1.21 mmHg to 1.63 mmHg depending on 
which measurements were compared.  
The measurement error for CH was calculated at ME = 2.12 mmHg and the repeatability at 2.86 
mmHg. This means that for 95% of the measurements the true value would be within 2.12 mmHg 
and the difference between the measurements would be less than 2.86 mmHg. The mean 
differences between measurements for CRF ranged from Ms = 0.08 mmHg to 0.25 mmHg with SDs = 
1.35 mmHg to 1.21 mmHg. The measurement error for CRF was calculated at 1.73 mmHg and the 
repeatability at 2.44 mmHg. This means for 95% of the measurements the true value would within 
1.72 mmHg and the difference between the measurements would be less than 2.44 mmHg. These 
values were clinically insignificant, studies have shown that calibration errors of up to 2 mmHg are 
frequently encountered with GAT tonometers and measurements are made in 1 mmHg increments 
(Doughty and Zaman, 2000; Choudhari et al., 2009). Test-retest repeatability for the two corneal 
biomechanical metrics (CH and CRF) measured by the ORA was excellent.  
Bland-Altman analyses revealed the mean differences between measurements for IOPcc ranged from 
Ms = 0.45 mmHg to 0.21 mmHg with SDs = 2.18 mmHg to 2.27 mmHg. The measurement error for 
IOPcc was calculated at 3.5 mmHg and the repeatability at 4.94 mmHg. This means for 95% of the 
measurements the true value would within 3.5 mmHg and the difference between the 
measurements would be less than 4.94 mmHg. Mean differences between measurements for IOPg 
ranged from Ms = 0.41 mmHg to 0.65 mmHg with SDs = 1.87 mmHg to 2.10 mmHg. The 
measurement error for IOPg was 2.65 mmHg and the repeatability 3.75 mmHg indicating that for 
95% of the measurements the true value would be within 2.65 mmHg and the difference between 
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the measurements would be less than 3.75 mmHg. These findings agreed with those of Wang et al. 
(2013), Moreno-Montanes et al. (2008), and Kotecha et al. (2010) who found that the intraobserver 
reliability for the IOPcc and IOPg was not as good as that of the two biomechanical metrics (CH and 
CRF). Reasons for this difference were attributed to the OPA as well as the fact that the two IOP 
values were calculated from the biomechanical metrics. The repeatability of < 4.94 mmHg found in 
this study also compared well to the 4.3 mmHg found by Kotecha et al. (2010). Although the 
repeatability was not as good as that of CH and CRF the mean differences were small and therefore 
clinically not significant. Intraobserver reliability of the ORA can thus be considered good for all the 
parameters measured. 
7.2 Clinical comparison of the ICare RBT and ORA with and without contact 
lenses in situ 
Intraocular pressure measurements with the rebound tonometer (ICare) and the Reichert ocular 
response analyser (ORA) were compared in this population of healthy subjects with and without 
contact lenses on the eye. 
In the case of the ICare RBT, the literature as well as this study showed that corneal biomechanical 
properties (CH and CRF) play a major role in the accuracy of the IOP measurements, more so than 
CCT (Chui et al., 2008; Jorge, Gonzales-Meijome, et al., 2008; Salvetat et al., 2011). The other 
variables important to consider include CCT, corneal curvature, and refractive error (Detry-Morel et 
al., 2006; Lopez-Caballero et al., 2007; Avitabile et al., 2010; Salvetat et al., 2011; Hohmann et al., 
2012; Rao et al., 2012). With regard to the ORA, many of the same variables influenced the accuracy 
of the measurements but not all of them influenced each one of the four measurements. Age, 
corneal curvature, CCT, and corneal biomechanics are important variables which can affect the 
accuracy of the ORA measurements (Luce, 2005; Kotecha et al., 2006; Kniestedt et al., 2008; Kotecha 
et al., 2010).  
Individually different measurements are affected differently by the variables; CRF is closely 
associated with CCT; IOPcc is not significantly associated with CCT; and IOPg is associated with CCT, 
corneal curvature, ocular surface behaviour as well as axial length (Moreno-Montanes et al., 2008; 
Sullivan-Mee et al., 2009; Kotecha et al., 2010; Terai et al., 2012; Wang et al., 2013; Rimayanti et al., 
2014). The ORA employs the same principles as the NCT and is therefore significantly affected by the 
OPA while the ICare RBT is not affected by the OPA (Moreno-Montanes et al., 2008; Sullivan-Mee et 
al., 2009; Kotecha et al., 2010; Wang et al., 2013). Jorge et al. (2008) evaluated the correlations 
 
 
 
 
 
 
 
195 
 
between the corneal biomechanical properties with the IOP obtained with the ICare RBT. They found 
the ICare RBT displayed higher and more variable results than the ORA with IOPg and IOPcc being 
more reliable. ICare RBT had a strong positive correlation with IOPg, less so with IOPcc and CRF and a 
poor correlation with CH. From their results they postulated that the strong correlation with CRF 
indicated that ICare RBT has a higher correlation with the biomechanical properties of the cornea 
than with CCT (Jorge, Gonzales-Meijome, et al., 2008). The present study showed that although CCT 
and K had some influence on the accuracy of IOP measurements with the ICare RBT and ORA, the 
biomechanical properties of the cornea were more important to consider since it had a greater 
influence on the accuracy of the IOP measurements with these two instruments.  
 
Figure 7.1 Comparison between ICare RBT and ORA IOPcc and IOPg measurements without lenses. RBT and IOPg 
measurements were well correlated and comparable.(Yellow = RBT, purple = IOPcc, and orange = IOPg). 
The results of this study further showed that ICare RBT and ORA IOPg measurements were 
comparable (Figure 7.1). For the purposes of this study differences of more than 1mmHg were 
considered clinically significant as most tonometers measure in increments of 1mmHg. Without 
lenses the mean RBT measurement were M = 14.58, SD = 3.35 mmHg and IOPg M = 14.64, SD = 3.58 
mmHg. The mean difference between the two measurements, according to the Bland-Altman 
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analyses was M = -0.06, SD = 0.59 mmHg and a strong linear relationship existed between the two 
measurements: r = 0.854. The ANOVA and t-tests confirmed the hypothesis that the two 
measurements were the same t = -0.04, p = 0.956. With the Pure Vision lenses the ICare RBT and 
ORA metrics did not compare well at all and the RBT significantly overestimated the IOP compared to 
the ORA. Pure Vision has a high modulus of elasticity (1.1 MPa) which may have affected the 
biomechanics of the cornea/lens combination and therefore the ICare RBT measurements.  
With the Frequency XC lens the mean ICare RBT measurement was M = 14.09, SD = 3.15 mmHg and 
IOPg M = 13.55, SD = 3.48 mmHg. Although the ANOVA showed that the RBT and ORA metrics were 
not comparable, the t-tests showed that the RBT and IOPg values were comparable (t = 2.06, p = 
0.0449) with the differences between them clinically and statistically insignificant. Although the 
hypothesis that ICare RBT and IOPcc were comparable was rejected, and the difference between the 
means were statistically significant it was not clinically significant (RBT M =14.09, SD = 3.15 mmHg 
and IOPcc M = 14.83, SD = 3.09 mmHg) (Table 4.3).  
With the Acuvue 1-Day Moist lens the mean ICare RBT measurement was M = 13.62, SD = 2.86 
mmHg and IOPg M = 13.12, SD = 3.11 mmHg. The ANOVA showed that RBT and IOPg values were 
comparable (f = 1.44, p = 0.2365), but the t-tests rejected this hypothesis (t = -2.47, p < 0.017). 
However, despite the fact that the difference between the means was statistically significant, 
clinically it was not significant (Table 4.3).  
With the Acuvue Oasys lens the mean RBT measurement was M = 13.74, SD = 3.24 mmHg, IOPcc M = 
14.00, SD = 2.68 mmHg, and IOPg M = 13.48, SD = 3.33 mmHg. The ANOVA confirmed the hypothesis 
that the RBT, IOPcc and IOPg measurements were comparable (f = 1.17, p = 0.2841 for IOPcc and f = 
1.72, p = 0.1957 for IOPg). This hypothesis was further confirmed by the t-tests which indicated that 
the RBT and ORA IOPcc and IOPg measurements were statistically and clinically comparable (t = -
1.08, p = 0.2841 for IOPcc and t = 1.31, p < 0.1957 for IOPg). Finally, the Bland-Altman analyses of all 
the measurements with as well as without lenses indicated that the mean differences between RBT 
and IOPcc was M = 0.48, SD = 4.63 mmHg with a weak linear correlation r = 0.262 between the two 
measurements. The difference was not clinically significant. The mean differences between RBT and 
IOPg were M = 0.59, SD = 2.39 mmHg with a strong linear correlation between the two 
measurements. The difference was neither clinically nor statistically significant. 
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In conclusion, this study confirmed that the ICare RBT and ORA IOPg pressure measurements were 
highly correlated and comparable. Clinically the difference between the two measurements was less 
than 0.60 mmHg and this difference seemed not to be affected by the presence of a contact lens on 
the eye. ICare RBT and IOPcc pressure measurements were also correlated and comparable but to a 
lesser extent than ICare RBT and IOPg measurements. Clinically, when compared to the ICare RBT 
measurements, the ORA IOPcc measurements showed a difference larger than 1 mmHg. This 
overestimation was not unexpected. However, when the measurements with contact lenses were 
included in the analysis the difference became clinically insignificant (0.50 mmHg). This may be due 
to the contact lens induced biomechanical differences and their effects on the ICare RBT 
measurements. The lower correlation with ORA IOPcc also suggests that the ICare RBT 
measurements were affected by corneal biomechanical properties and not only the IOP or CCT of the 
eye. The aforementioned confirms previously reported results by Jorge, Gonzales-Meijome, et al. 
(2008) as well as those of this study.  The ORA CH and CRF were neither clinically nor statistically 
comparable to ICare RBT measurements.  
7.3 Accuracy of the ICare RBT and ORA with disposable silicone hydrogel 
and hydrogel lenses in situ 
The primary goal of this study was to evaluate the accuracy of intraocular pressure measurement 
with the ICare RBT and the ORA with four commonly used soft disposable contact lenses in situ, and 
to establish whether it is at all feasible to measure intraocular pressure with lenses in situ during a 
normal clinical ophthalmic evaluation. Although contact lenses are normally removed during a 
comprehensive ophthalmological examination and therefore tonometry, certain circumstances may 
require measurement of IOP with the lenses remaining on the eye. These circumstances include 
situations where contact lenses are used in the treatment of corneal injuries; post surgically and, 
more recently, as drug delivery devices to the cornea and anterior segment of the eye for the 
treatment of diseases such as chronic glaucoma, anterior segment inflammation, recurrent corneal 
erosions and keratoconjunctivitis sicca. It is therefore important to know how and which of the 
physical characteristics of the contact lens influence the accuracy of IOP measurements with these 
two instruments commonly used in clinical practice.  
The rebound response of the ICare RBT reflects the viscoelastic properties of the cornea (Chihara, 
2008; Jorge, Gonzales-Meijome, et al., 2008). Although the CCT and corneal curvature can affect the 
ICare IOP accuracy, it is apparent that the biomechanical properties (in this study represented by CH 
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and CRF) have the greatest influence on the instrument’s IOP measurements (Chui et al., 2008). IOP 
measurements are significantly increased when the corneal modulus of elasticity is increased and the 
corneal curvature and CCT remains constant (Liu and Roberts, 2005). Measuring IOP with contact 
lenses in situ should therefore affect the measurement accuracy considerably. It is likely that the 
viscoelastic properties, lens thickness and water content of the contact lenses affect the rebound 
response of the ICare RBT. Lower modulus, thinner, and/or softer lenses seem to absorb more 
energy leading to lower IOP measurements while higher modulus, thicker, and/or stiffer  lower water 
content lenses lead to overestimation of the IOP. The Bland-Altman analysis clearly indicated that 
with both the ICare RBT as well as the ORA, IOP measurements with and without the higher modulus 
Pure Vision lenses were statistically and clinically significantly different.  
Splitting the data into plus and minus lenses, the differences became much more pronounced with 
the plus powered Pure Vision lenses having the greatest effect on the measurement accuracy. With 
the lower modulus Frequency XC, Acuvue 1-Day Moist, and Acuvue Oasys, the ICare RBT 
underestimated the IOP when compared to the measurements without lenses. This underestimation 
was possibly due to the energy of the probe being absorbed by the low modulus material. In contrast 
to the findings of Zeri et al. (2011, 2015) that the ICare RBT underestimated IOP over moderate plus 
power hydrogel lenses, the results of this study showed that ICare RBT underestimated IOP with 
minus as well as plus powered contact lenses of moderate modulus of elasticity (Zeri et al., 2011; Zeri 
et al., 2015). With the low modulus of elasticity hydrogel Acuvue 1-Day Moist lenses, the differences 
were statistically as well as clinically significant (> 1 mmHg). With both plus and minus powered high 
modulus of elasticity silicone Pure Vision lenses, ICare RBT significantly overestimated IOP (> 1 
mmHg). These findings were similar to those of previous research conducted with the NCT 
(McMonnies, 1986; Insler and Robbins, 1987; Schollmayer and Hawlina, 2003; Patel and Illahi, 2004; 
Touboul, 2008; Patel and Stevenson, 2009; Liu et al., 2011).  
 The ORA corneal hysteresis (CH) measurement was significantly higher with the silicone hydrogel 
lenses, (specifically with the plus lenses) when compared to the measurements without lenses. The 
corneal resistance factor (CRF) was also significantly higher with the silicone hydrogel Pure Vision 
lenses. These current results contrast with those of Lam and Tse (2014) which indicated the 
measurement of the two biomechanical metrics were not affected by the presence of a silicone 
hydrogel lens on the eye (Lam and Tse, 2014). The modulus of elasticity of the Pure Vision and 
Acuvue Oasys lenses were 1.1 and 0.75 MPa respectively. This differed from that of the Focus Night 
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& Day’s 1.5 MPa (Ciba Vision) and Acuvue Advance’s 0.43 MPa (Johnson and Johnson) used by Lam 
and Tse (2014) in their study. Other differences between the two studies included the use of only -
3.00 D lenses compared lens powers that ranged between -6.00 to +6.00 D in this study, and the use 
of an ORA WS score of 3.5 compared to the 6 used in this study. The low WS may have affected the 
influence of the ocular pulse amplitude on the measurements (Lam and Tse, 2014).   
Of further interest is that ORA IOPcc with Pure Vision as well as Frequency XC, Acuvue 1-Day Moist, 
and Acuvue Oasys measurements were significantly lower (irrespective of lens power) than the 
instrument-measured IOPcc without lenses. In the case of ORA IOPg, the measurement was 
significantly lower for the minus power Frequency XC, Acuvue 1-Day Moist, and Acuvue Oasys lenses 
and significantly higher for the Pure Vision plus lenses, but no significant difference was observed 
with any of the other brands of plus lenses. The IOPcc, and to a lesser extent the IOPg calculation, 
takes corneal viscoelastic properties into consideration (Lau and Pye, 2011). As expected, these 
measurements were influenced by a contact lens which altered ocular surface behaviour (Rimayanti 
et al., 2014) and viscoelastic corneal properties; therefore, altering the time needed to achieve 
maximal light detection in NCT (Liu et al., 2011). In the case of IOPcc, the measurements were lower 
with lenses in situ than without the lenses, and with IOPg lower measurements with minus lenses 
and significantly higher measurements with plus lenses were seen. These results concur with those 
of Sapkota et al. (2014), namely, that ORA IOPcc and IOPg measurements were lower with a -3.00 D,  
moderate modulus (0.66 and 0.89 MPa) daily wear contact lens on the eye. IOPcc was highly affected 
and underestimated by more than 3 mmHg in 36% of their subjects (Sapkota et al., 2014). In the 
current study IOPcc was underestimated by more than 3 mmHg only with the Pure Vision lenses in all 
subjects. It seems the closer the lens modulus of elasticity is to the corneal modulus of elasticity, the 
less the effect is on the measurements of IOP with the lens in situ. 
Other than the influence of the lenses on the biomechanical properties of the cornea/lens 
combination, factors such as anterior corneal and lens curvature; central corneal thickness; lens 
water content; central lens thickness; oxygen transmissibility of the lenses; and hydration may 
influence the accuracy of the measurements with lenses in situ (Table 1.7).   
7.4 Impact of corneal and contact lens characteristics on the measurement 
of IOP with the ICare RBT and ORA 
The effect of corneal thickness, corneal curvature, and refractive error on the intraocular pressure 
measurements with the ICare RBT and Reichert ORA in a population of normal subjects with and 
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without contact lenses on the eye was examined. By using the contact lenses to change the corneal 
thickness, corneal curvature, and corneal biomechanics this study examined the role of corneal 
characteristics as well as the contact lens modulus of elasticity, power, transmissibility (Dk/t), water 
content, and centre thickness on the accuracy of the intraocular pressure measurements with the 
ICare RBT and the ORA.  
Biomechanical properties of the cornea have a significant impact on IOP measurement errors (Liu 
and Roberts, 2005) which may vary depending on the instrumentation used to measure the IOP. All 
tonometers that measure IOP through the application of stress to the corneal tissue are subject to 
the effects of corneal resistance which is an ‘effective’ rather than an intrinsic mechanical property 
such as Young’s modulus. Corneal resistance is a composite characteristic that incorporates material 
as well as geometric properties of the corneal tissue (Luce, 2005; Jorge, Gonzales-Meijome, et al., 
2008). Relatively recently an in vivo method in the form of the ORA has become available to measure 
the biomechanical properties of the cornea in the form of two metrics, CH and CRF (Luce, 2005). 
Both CH and CRF are influenced by viscoelastic properties because they are both linear combinations 
of inward and outward applanation pressure signals in ORA measurement. CH describes the damping 
nature of the cornea (e.g. collagen structure, hydration state) or the corneal dynamic resistance 
component. CRF emphasises inward applanation pressure and is influenced more heavily by elasticity 
(Jorge, Gonzales-Meijome, et al., 2008). In other words, these so-called biomechanical properties 
represent the response of the entire corneal tissue to the measurement principal of the ORA (Jorge, 
Gonzales-Meijome, et al., 2008).  
Considering that the ORA uses the delay in corneal response after the applanation process to 
determine the viscoelastic properties of the cornea, it can be assumed that the absorbed energy 
could also delay the corneal response when an impact is applied to the cornea to measure IOP 
(Jorge, Gonzales-Meijome, et al., 2008). The ICare RBT could therefore be affected by the corneal 
biomechanical properties. In fact, some previous studies confirmed the aforementioned in that ICare 
RBT correlated with CRF and CH (Chui et al., 2008; Jorge, Gonzales-Meijome, et al., 2008). Other 
studies found correlations between ICare RBT and CCT, corneal curvature, and refractive error 
(Detry-Morel et al., 2006; Lopez-Caballero et al., 2007; Avitabile et al., 2010; Hohmann et al., 2012; 
Rao et al., 2012).  
Multiple linear regression analyses of the results of the current study showed that CRF was 
correlated to and significantly affected ICare RBT as well as CH; although not as strongly. Corneal 
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curvature also seemed to affect ICare RBT; yet, it was not statistically significant. CCT was strongly 
correlated to and affected CRF. Central corneal thickness (CCT), IOPg and ICare RBT were strongly 
correlated to and was affected by CH and CRF. As shown before IOPcc was strongly correlated with 
and predicted ICare RBT and was affected by CH. IOPg was strongly correlated with and predicted 
ICare RBT and was affected by CH and CRF.  
The above confirmed previous study results which showed that ICare RBT was strongly correlated to 
CRF, more so than with CCT. Although CCT was correlated with CH, CH did not demonstrate as strong 
a correlation with ICare RBT as CRF did (Jorge, Gonzales-Meijome, et al., 2008). Corneas with higher 
values of CH and CRF have a longer delay in response to stress and relaxation forces which means it 
absorbs more energy when impacted by the probe resulting in higher IOP measurements with the 
ICare RBT (Jorge, Gonzales-Meijome, et al., 2008). The strong correlation between CRF and ICare RBT 
signifies that the RBT measurements were affected by viscoelastic properties of the cornea rather 
than just by CCT or elastic (CH) properties, which agrees with the results of Jorge et al. (2008).  
Other as yet unknown and unmeasured tissue properties of the cornea may also affect the ICare RBT 
measurements. In contrast to previous studies (Detry-Morel et al., 2006; Lopez-Caballero et al., 2007; 
Avitabile et al., 2010; Hohmann et al., 2012; Rao et al., 2012; Rimayanti et al., 2014), the present 
study did not find significant correlations between age, refractive error, and corneal curvature with 
the ICare RBT IOP measurements without contact lenses on the eye. Reasons for this difference may 
be due to the relatively narrow age range (18 to 55 years, M = 38.90, SD = 9.23 years) of the study 
participants and the fact that the participants were all Caucasian and long-term soft contact lens 
wearers. Although the participants removed their lenses at least 24 hours before data collection, the 
effects of long-term contact lens wear on the cornea and therefore IOP measurements cannot be 
ruled out (Xu et al., 2008; Hamilton-Maxwell, 2014; Mahjoob et al., 2014).  
The CCT and corneal curvature can be changed by fitting disposable contact lenses on the eye. 
Measurements of the new parameters and IOP with the lenses in situ will theoretically make it 
possible to study the effects of these changes on the measured IOP with the ICare RBT as well as the 
ORA. The results of this study show with the contact lenses on the eye the CCT was statistically and 
clinically significantly thicker than without the lenses on the eye. Logically and according to the 
literature it is expected that the measured IOP should be accordingly higher due to the increase in 
CCT.   
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However,  it was interesting to note that the predicted changes in CCT, calculated from the CCTWithout 
lenses +published contact lens thickness +3 µm tear film thickness, was also significantly higher than 
the CCT measured with each of the lenses on the eye. In all instances the measured CCT with lenses 
in situ was lower than expected, significantly so with the Pure Vision and the Acuvue 1-Day Moist 
lenses. Reasons for this could be that the published CT was for -3.00 D lenses only and that this 
sample included lenses ranging in power from -6.00 to +6.00 D (M = -0.95, SD = 2.69 D) as well as the 
Scheimplug measurement technique employed. Although Scheimpflug photography provides images 
of the anterior segment with minimal distortion, the distortion of the cornea and lens itself distort 
the image. Therefore biometrical measurements in the anterior segment such as corneal curvature, 
changes in lens curvature during accommodation, depth of anterior chamber angle, always have to 
be corrected by specific algorithms. The amount of correction depends on the depth of the layer in 
question, meaning that each refractive zone adds a small amount of distortion to the path of the light 
rays (Wegener and Laser-Junga, 2009).  
Splitting the data into plus and minus lenses (Figures 5.3 and 5.4), the measured CCT was significantly 
higher with the plus powered (particularly Frequency XC and Acuvue Oasys) lenses than minus 
lenses. With the plus powered lenses in situ the CCT was M = 607.03, SD = 49.31 µm and with the 
minus powered lenses M = 561.66, SD = 44.78 µm. This is equal to a difference of +70.03 µm and 
+33.32 µm without lenses for the plus and minus lenses respectively.   
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Figure 7.2 Differences in CCT measured without and with the four different contact lenses on the eye.CCT is significantly 
higher with the Pure Vision, Frequency XC, and Acuvue Oasys lenses in situ. CCT = central corneal thickness 
Although the corneal curvature (K) is also expected to change due to the presence of the lenses on 
the eye, it was found in this study that these changes were neither clinically nor statistically 
significant. On the other hand, when considering the data for plus and minus powered lenses 
separately, two readings were notable: the K-reading with the plus lenses was steeper (M = 7.60, SD 
= 0.45 mm) than the K-reading measured without lenses (M = 7.93, SD = 0.27 mm) and with the 
minus lenses flatter (M = 8.03, SD = 0.31 mm) than that measured without the lenses (M = 7.73, SD = 
0.26 mm) (Figures 5.1 and 5.2). This equates to a difference of -0.33 mm and +0.30 mm for plus and 
minus lenses respectively which may influence the IOP measurements with the two instruments.  
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Figure 7.3 Corneal curvature with and without the four different lenses on the cornea.K = corneal curvature 
Using multiple linear regression models the relationship between the dependent variables ICare RBT, 
ORA IOPcc and IOPg, and multiple independent variables (age, Rx, CCT, CH, CRF, and K) were used to 
determine which of the variables influenced the dependent variable the most. The multiple 
regression analyses confirmed the strong predictive effects of CH and CRF on ICare RBT as well as 
ORA IOPg and IOPcc with the different lenses in situ. For the ICare RBT both CH and CRF had 
significant predictive ability and therefore influence with all four lenses and, similarly, for the ORA 
IOPg both the CH and CRF had significant predictive ability and influence with all four lenses. For the 
ORA IOPcc CH and CRF had significant predictability and influence with the four lenses tested. These 
results seem to indicate that the biomechanical properties of the cornea/lens combination were 
more important in predicting or influencing the measurements of IOP with the ICare RBT and ORA 
IOPg and IOPcc than CCT, corneal curvature, age, and refractive error.  
Further multiple linear regression analyses including all the data as well as the contact lens specific 
parameters revealed that ICare RBT was significantly influenced by CH, CRF, K and − to a lesser extent 
− by age. For IOPcc the results were similar in that it was significantly influenced by CH, CRF, and lens 
modulus. In the case of IOPg significant influence was from CH, CRF, modulus and to a lesser extent 
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from age. Modulus is an elastic property of the contact lens and it is therefore not unexpected that it 
would have some influence on the IOP measurements similar to that of the two biomechanical 
metrics CH and CRF.  
In conclusion, the present study showed that although CCT and K do have some influence on the 
accuracy of IOP measurements with the ICare RBT and ORA, the biomechanical properties of the 
cornea are more important to consider and have a greater influence on the accuracy of the IOP 
measurements with these two instruments. This finding differs with that of Rimayanti et al. (2014) 
who found that the radius of ocular surface curvature is associated with changes in ocular surface 
displacement and therefore NCT IOP readings with contact lenses in situ (Rimayanti et al., 2014). 
Although the ICare RBT and ORA IOPcc do not correlate well, it may be possible to calibrate the ICare 
RBT to more closely approximate the ORA IOPcc measurements rather than the ORA IOPg 
measurements if future studies validate that ORA IOPcc do, in fact, provide an accurate 
representation of the “True IOP” of the eye. The ICare RBT is a versatile cost-effective instrument 
which is simple to use, accurate for clinical use, and highly adaptable to different clinical situations.  
7.5 Limitations of this study 
Several limitations were associated with this study. It comprised of a moderate yet adequate sample 
size and the investigation was performed using only Caucasian subjects with good general health and 
no ocular pathology. For this reason it was not possible to assess the influence of ethnicity and the 
effects of maladies such as glaucoma, corneal abnormalities or other eye disease on the results.  
In addition, although the subjects all removed their lenses one day prior to the data collection, they 
were, however, all long-term soft contact lens users. This means the effects of long-term lens wear 
on the cornea which can affect the accuracy of IOP measurements cannot be ignored. It is well 
known that age affects corneal biomechanics with corneas becoming stiffer as the years advance. 
Due to ethical constraints the age of the subjects in this study ranged from 18 to 55 years (M = 38.90, 
SD = 9.23 years), which means there is a lack of evidence-based data on the effects of natural corneal 
biomechanical changes for subjects older than 55 years. Future studies should include subjects older 
than 55 years to study the effects of natural corneal biomechanical changes on the results.   
All measurements in this study were collected at one specific sitting and it is therefore conceivable 
that variations in measurements may occur from one visit to the next with a specific lens, limiting the 
clinical usefulness of the results of the study. The study should be expanded to collect data over a 
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number of consecutive visits to determine the variability of the measurements validating the clinical 
usefulness of the results obtained in this study.  
According to the International Standards Organization (2001), GAT corrected for CCT remains the 
reference instrument for clinical measurements of IOP; in other words, the gold standard for 
tonometry (ISO, 2001). The IOP measurements with both instruments used in this study were 
compared to the gold standard and these studies as well as their results are listed in Tables 1.4 and 
1.5 (pages 25 and 41). GAT with contact lenses in situ was not investigated. This limitation might 
elicit interest in researchers to explore GAT with contact lenses in situ.  
Finally, therapeutic (bandage) contact lenses and lenses designed specifically for drug delivery to the 
eye differ significantly (Chapter 1) from contact lenses used to correct refractive error. Similar studies 
using these specific lenses need to be conducted to examine the effects on IOP measurement with 
theses lenses in situ.  
7.6 Importance of this work 
Although therapeutic contact lenses have been used for many years to treat corneal injuries, post 
surgically and in keratoconjunctivitis sicca, their use as drug delivery systems to the diseased eye is in 
its infancy. The ocular surface is readily available for the administration of drugs making the 
preferred route it to treat ocular disorders, however the use of eye drops as a dosage form suffer 
from some major limitations. These limitations include the short residence time in the cornea due to 
its rapid clearance and dilution by the tears, and the fact that most of the drug is drained through the 
nasolacrimal ducts leading to unwanted systemic absorption and adverse effects (Kompella et al., 
2010). Consequently topical drugs have a low bioavailability (< 5%) and reduced residence time in the 
tear film (< 3 minutes) (Kearns and Williams, 2009; Gaudana et al., 2010). This necessitates frequent 
high doses to achieve therapeutic levels in the eye. The stance of Stone et al. (2009) is that the lack 
of manual dexterity in the geriatric population and noncompliance with eye drop treatment regimens 
are two major limitations in eye drop administration (Stone et al., 2009).  
To overcome the limitations of eye drops as a dosage form, various strategies have been employed 
which include permeation enhancers; viscous and adhesive polymers; collagen shields; nanoparticles; 
colloidal carriers; ocular implants; and contact lenses (Carvalho et al., 2015). Several studies have 
demonstrated that contact lenses can be used as drug delivery systems for the treatment of chronic 
and acute eye disease (Morgan, 1971; Maddox and Bernstein, 1972; Maurice, 1972).  
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The present study as well as other research studies has shown it is possible to accurately measure 
IOP through soft disposable lenses. However, more work is needed to understand which specific lens 
characteristics affect the accuracy of the IOP measurements and contemporary-specific studies need 
to be conducted on the modified medicated contact lenses which would include vitamin E-sustained 
release lenses, imprinted medicated lenses, and medicated lenses with nanoparticles. Lens designers 
and manufactures can then make use of the information to manufacture medicated therapeutic 
lenses specifically designed not to interfere with IOP measurements while delivering the active drug 
to the eye as required.  
Since the 1950s when Goldmann first described the current the gold standard for intraocular 
pressure (IOP) measurements, it has been recognised that the biomechanical characteristics of the 
cornea, especially central corneal thickness (CCT), play a role in the accuracy of IOP measurements. 
In 2002 particularly, when the Ocular Hypertension Treatment Study (OHTS) (Gordon et al., 2002) 
once again drew attention to CCT, research studies and ophthalmic discourse once again turned to 
the role that CCT has on the risk for glaucoma development or progression (Medeiros, Sample, 
Zangwill, et al., 2003; Chauhan et al., 2005; Congdon et al., 2006; Hong et al., 2007; Rogers et al., 
2007). A central issue imbedded in these speculations was that the biomechanical characteristics of 
the cornea might somehow reflect vulnerability of the optic nerve head to glaucoma while a further 
aspect generating interest was the well-described discrepancies between measured and true IOP 
(Wells et al., 2008).  
Corneal tissue properties may or may not be directly related to lamina cribrosa tissue properties 
given that their embryological derivation is different, but there are also plausible connections. Firstly, 
corneal thickness may be associated with structural characteristics of the sclera and adjacent tissues 
as well as the optic disc (Pakravan et al., 2007). According to these authors, there does seem to be a 
correlation between thinner corneas and larger optic discs (Pakravan et al., 2007). Larger optic disc 
diameters may be associated with increased vulnerability to pressure-induced deformation (Sigal et 
al., 2004). Secondly, the corneal tissue characteristics themselves, for example their ability to resist 
deformation, may reflect the constitution of the extracellular matrix (ECM) (Pakravan et al., 2007). 
Confirming the aforementioned are suggestions that corneal hysteresis (CH) is lower in patients with 
Marfan syndrome, keratoconus, Fuchs endothelial dystrophy, high myopia and in pregnancy which 
has hormonally mediated systemic effects on connective tissues (Luce, 2005; Kotecha, 2007; Ortiz et 
al., 2007; Shen et al., 2008).  Given that the cornea, sclera, peripapillary ring, and lamina cribrosa in 
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an individual eye are essentially made from ECM constituents coded for by the same genes, it is 
plausible, but as yet unproven, that their biomechanical characteristics may be similar. It has been 
surmised that an eye with a more deformable cornea, or one with less viscous damping, may also 
have an optic disc that is more vulnerable to glaucoma damage from raised IOP (Wells et al., 2008). 
Both the cornea and the lamina cribrosa tend to become more rigid with age and therefore stiffer, 
less resilient structures (Albon et al., 2000; Kotecha et al., 2006). Age related stiffening of connective 
tissues is possibly similar in the cornea and lamina cribrosa, and, because CH declines with age, 
(Kotecha et al., 2006) it is possible that the lamina cribrosa and peripapillary sclera behave similarly.    
In the biomechanical paradigm of glaucomatous optic neuropathy, IOP acts on the tissues of the eye, 
producing stress, deformations and strain within these tissues which eventually leads to an IOP-
related cascade of cellular events that culminate in damage to the RGC (retinal ganglion cell) axons 
(Burgoyne et al., 2005). This mechanical response is a function of the individual eye’s anatomy 
(geometry) and composition (mechanical properties) which therefore contribute to determine the 
individual’s susceptibility to IOP. The mechanical and vascular mechanisms of glaucomatous injury 
are inseparably intertwined: IOP-related mechanics determine the biomechanical environment 
within the ONH via mediating blood flow and cellular responses through various pathways. 
Reciprocally, the biomechanics depend on tissue anatomy and composition which are subject to 
change through cellular activities such as remodelling (Burgoyne et al., 2005).  
The current study adds to the understanding of corneal biomechanics, its accurate in vivo 
measurement and its role in glaucoma diagnosis and effect on IOP measurement.   
7.7 Recommendations for future work 
Sigal et al. (2005) identified the five most important determinants of ONH biomechanics as follows: 
the compliance of the sclera; the size of the eye; IOP; the compliance of the lamina cribrosa; and the 
thickness of the sclera. The Sigal et al. (2005) study was the first to quantify the important role of 
scleral properties on ONH biomechanics.  
Results from a study by Wells et al. (2008) suggest that optic disc surface compliance may have a 
relationship with corneal hysteresis, a parameter of ocular biomechanics that is easily and 
noninvasively measurable at the front of the eye with the ORA. These authors did not find that optic 
disc compliance was associated with CCT (Wells et al., 2008). If optic disc compliance, as measured by 
the amount of deepening of the optic cup during an acute rise in pressure, is associated with 
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increased risk for glaucoma, it is possible that CH might provide further information about glaucoma 
risk and pathogenesis. It is possible that CH had a relationship to change in mean optic disc depth in 
this study because it represents properties of the rest of the eye rather than just the cornea (Wells et 
al., 2008). In a clinic-based retrospective observational study, Congdon et al. (2006) found lower CH 
values were associated with progression of glaucomatous visual fields independent of CCT (Congdon 
et al., 2006).  
The importance of measureable biomechanical properties of the cornea, such as CH and CRF, and 
their relationship to the biomechanics of the sclera and the lamina cribosa, needs further 
investigation. The morphological signal or waveform produced by the Ocular Response Analyser is a 
unique “signature” for the eye being measured. The waveform signal is complex and stores 
considerably more information than just the interrelation of the inward and outward applanation 
pressure conveyed by CH and CRF (Galletti et al., 2015). The ORA software provides 37 additional 
descriptors that further describe each signal (Mikielewicz et al., 2011). Multivariate waveform and 
descriptor analysis can and should be used to improve not only the diagnostic capability of the ORA, 
but also to improve our understanding of corneal and ocular biomechanics. Furthermore the use and 
adaptation of existing technology such as the ICare RBT to measure not only IOP but also 
biomechanical properties of the cornea deserves further exploration and study.  
More work needs to be done to investigate the accuracy of IOP measurements with specialised 
therapeutic contact lenses (bandage lenses and lenses designed for drug delivery to the eye) in situ, 
not only at one sitting but during multiple visits to validate the clinical significance of the 
measurements. Studies should be larger with more diverse ethnicity and include subjects with known 
eye diseases such as glaucoma and corneal diseases in order to examine the effects of these factors 
on the accuracy of IOP measurements with the different instruments used in this study.  
Finally, future studies should include measurements with GAT which is considered the gold standard 
reference instrument for tonometry.  
7.8 Conclusion 
The biomechanical properties of the cornea (viscoelasticity and elasticity) are influenced by corneal 
geometric parameters such as CCT, corneal diameter, corneal curvature, and astigmatism (Bao et al., 
2015). It is also influenced by age [stiffness increases with age (Elsheikh et al., 2007)], corneal 
 
 
 
 
 
 
 
210 
 
hydration, disease (such as keratoconus, Fuch’s endothelial dystrophy, glaucoma, and high myopia), 
and intraocular pressure. Following a period in which attention has been limited to the importance of 
CCT when measuring IOP, there is currently growing appreciation and renewed interest among 
researchers regarding the role of corneal biomechanics in IOP measurements. It seems there is a 
widespread realisation that corneal stiffness or biomechanics more than the parameters affecting it 
should be considered when improving the accuracy of IOP measurements.   
The main purpose of the current programme of research was to determine whether it would be 
possible to accurately measure IOP with soft contact lenses in situ. The results showed that IOP could 
be measured accurately (within 2 mmHg) with thin minus power, low or moderate modulus of 
elasticity hydrogel and silicone hydrogel lenses while the subjects were wearing the lenses. Further 
analyses of the data revealed that although CCT and corneal curvature had some influence on the 
IOP measurements with the ICare RBT and ORA, the biomechanical properties of the cornea and 
ocular surface behaviour were more important to consider and have a greater influence on the 
accuracy of the IOP measurements with these two instruments. Furthermore, neither the ICare RBT 
nor the ORA could measure IOP with high plus (≥ +12.00 D), high modulus of elasticity, thick (0.32 to 
0.49 mm) silicone aphakic lenses (Silsoft – etafilcon A [Bausch & Lomb]) in situ. 
The results of the research further showed that the ICare RBT and ORA IOPg measurements were 
clinically as well as statistically comparable (differences < 0.6 mmHg) but the difference seemed not 
to be affected by the presence of a contact lens on the eye. Although the test-retest reliability of the 
ICare RBT was not as good as that reported for GAT, it compared favourably with noncontact 
tonometers. It was also determined that the OPA does affect the test-retest reliability of the ORA 
IOPcc and IOPg, but the CH and CRF repeatability was excellent. Finally, repeated measurements by 
independent experienced clinicians with the same ICare RBT produced repeatable and consistent 
results. 
__________________________________________________________________________________ 
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A hyper-text must be included to the Elsevier homepage at http://www.elsevier.com . All 
content posted to the web site must maintain the copyright information line on the bottom of 
each image. You are not allowed to download and post the published electronic version of 
your chapter, nor may you scan the printed edition to create an electronic version. 
Central Storage: This license does not include permission for a scanned version of the 
material to be stored in a central repository such as that provided by Heron/XanEdu. 
19. Website (regular and for author): A hyper-text must be included to the Homepage of the 
journal from which you are licensing at 
http://www.sciencedirect.com/science/journal/xxxxx.  or for books to the Elsevier homepage 
at http://www.elsevier.com 
20. Thesis/Dissertation: If your license is for use in a thesis/dissertation your thesis may be 
submitted to your institution in either print or electronic form. Should your thesis be 
published commercially, please reapply for permission. These requirements include 
permission for the Library and Archives of Canada to supply single copies, on demand, of the 
complete thesis and include permission for UMI to supply single copies, on demand, of the 
complete thesis. Should your thesis be published commercially, please reapply for permission.  
21. Other Conditions:  
v1.6 
If you would like to pay for this license now, please remit this license along with your 
payment made payable to "COPYRIGHT CLEARANCE CENTER" otherwise you will 
be invoiced within 48 hours of the license date. Payment should be in the form of a check 
or money order referencing your account number and this invoice number 
RLNK501160922. 
Once you receive your invoice for this order, you may pay your invoice by credit card. 
Please follow instructions provided at that time. 
 
Make Payment To: 
Copyright Clearance Center 
Dept 001 
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P.O. Box 843006 
Boston, MA 02284-3006 
 
For suggestions or comments regarding this order, contact RightsLink Customer 
Support: customercare@copyright.com or +1-877-622-5543 (toll free in the US) or +1-
978-646-2777. 
Gratis licenses (referencing $0 in the Total field) are free. Please retain this printable 
license for your reference. No payment is required. 
2.2 Licence agreement from BEV – Bundesamt für Eich- und Vermessungswesen  
Dear Mr. Booysen, 
The use of the two photographs you requested is free of charge for you. 
For further information please see chapter 2.2.2 of our Standard charges and licensing 
conditions (see link). 
Please use the BEV-logo in your publication which you also find a link below. 
  
http://www.bev.gv.at/pls/portal/docs/PAGE/BEV_PORTAL_CONTENT_ALLGEMEIN/020
0_PRODUKTE/BESTELLFORMULARE/STANDARD_CHARGES_AND_LICENSING_C
ONDITIONS_2015.PDF 
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Appendix 3  
Data collection table 
  
Table 8.1 Study data collection sheet indicating clinicians and observer information .ICare – rebound 
tonometry, CH – Corneal hysteresis, CRF – corneal resistance factor, IOPcc – corneal corrected IOP, IOPg – Goldmann 
equivalent IOP, CCT – central corneal thickness, K-Read – corneal curvature, Sc – without contact lenses, Cc – with 
contact lenses, C/L – contact lens, A – Pure Vision, B – Frequency XC, C – Acuvue 1-Day Moist, D – Acuvue Oasys, Px – 
Patient reference 
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Appendix 4 
Consent form  
Invitation. 
You are invited to take part in a research study. This document is needed to help you to decide if you 
would like to participate. Before you decide, it is important for you to understand, why the research is 
being done and what it will involve. If you have any questions that are not fully explained in this 
document, do not hesitate to ask the Mr Dirk Booysen the principal researcher. You should not agree 
to take part unless you are completely happy about all the procedures involved and possible risks. 
Please take time to read the following information carefully. 
 
Research project title. 
Tonometry and Biomechanics of the Cornea in Contact Lens Wear. 
 
Research workers, school and subject area responsible. 
Dr Amy Sheppard, Life &Health Sciences, Vision Sciences, Aston University. 
A.sheppard@aston.ac.uk  
Dr Leon Davies, Life &Health Sciences, Vision Sciences, Aston University. L.n.davies@aston.ac.uk  
Mr Dirk J. Booysen, Life & Health Sciences, Vision Sciences, Aston University. 
dirk@dirkbooysen.co.za  
 
What is the purpose of the study? 
Glaucoma is a potentially blinding eye disease; early diagnosis relies on effective screening for the 
disease in a variety of clinical settings. One popular method of screening involves the measurement of 
intraocular pressure with a device called a tonometer. 
The purpose of this study is to investigate if intraocular pressure can be accurately measured in a 
subject wearing soft disposable contact lenses with the ICare® rebound tonometer and the Ocular 
Response Analyser (ORA®). The ICare® tonometer is a portable, clinically approved, simple, safe to 
operate and effective screening device to measure the intraocular pressure. The ORA® is a clinically 
approved non-contact tonometer, which is safe to operate and an effective device to measure 
intraocular pressure as well as corneal biomechanics (viscoelastic properties) of the eye. Although 
other types of tonometer’s accuracy have been evaluated in subjects wearing soft disposable contact 
lenses, the ICare® tonometer and ORA® accuracy and factors that may influence their accuracy still 
needs further evaluation. This research study aims to address this. 
 
Where will the study be conducted? 
The study will be entirely conducted at the Dirk Booysen Eye Care Centre™, located at 248 
Voortrekker road, Monument, Krugersdorp, South Africa. 
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Why have I been chosen? 
You have been chosen to take part in the research project because you have normal healthy eyes and 
are a successful disposable contact lens wearer aged between 18 to 55 years. 
 
What will happen to me if I take part? 
The ICare® rebound tonometer and the Reichert Ocular Response Analyser (ORA®) will be used to 
measure the intraocular pressure on each of your eyes. In addition to the intraocular pressure 
measurement, Oculus Pentacam® corneal analysis will be carried out on each of your eyes. All 
procedures will first be done with the contact lenses in your the eyes, and then repeated directly after 
contact lens removal. Four (4) different soft disposable lenses will be used. The information recorded 
will include the type of disposable lens, its prescription, the intraocular pressure, corneal curvature, 
corneal thickness, corneal hysteresis, and corneal resistance factor, with and without the lenses on the 
eye for each eye separately. Your gender, age, and contact lens prescription will also be recorded. All 
the information will be recorded in a single clinical session which will take approximately 30 minutes 
per research participant. 
 
What is the procedure if a medical problem is discovered while participating in the study? 
In the event discovering a medical condition affecting the eye such as glaucoma during the course of 
the study, you will immediately be referred to an appropriate medical specialist for evaluation and 
treatment. The information recorded as part of the study procedures will not be used but kept 
anonymous and stored on site in a secure database. 
     
Are there any potential risks in taking part in the study? 
All the clinical procedures forming part of this study are clinically approved and routinely performed 
in eye care practice. ICare® tonometry is routinely performed to measure the intraocular pressure. No 
topical anaesthesia is required. Six measurements are taken at 0.1s intervals with the amount of force 
applied by the probe so minimal that it does not elicit the blink response. The Ocular Response 
Analyser (ORA®) developed by Reichert, measures the cornea’s response to indentation by a rapid air 
pulse. The principles of the ORA® are based on those of the non-contact tonometer. With the ORA® 
a metered air pulse is directed at the cornea until an applanation event is reached. The ORA® makes 
four measurements of the corneal response to the pulse of air, corneal hysteresis (CH), corneal 
resistance factor (CRF), Goldmann intraocular pressure (IOPg), and corneal corrected intraocular 
pressure (IOPcc). The Oculus Pentacam® is a non-contact corneal analysis system that makes use of 
Scheimpflug photography to analyse various corneal characteristics such as corneal thickness and 
topography. 
I do not anticipate that you will have any physical or other discomfort during the procedures which 
should not take more than 30 minutes to complete.  
 
Do I have to take part? 
Your participation is totally voluntary and you can refuse to participate or you can stop at any time 
without stating any reasons whatsoever. Your refusal to participate in or your withdrawal from this 
clinical trial will not affect your access to other medical or eye care. The principal researcher (Mr Dirk 
Booysen), however, retains the right to withdraw you from the study if it is considered to be in your 
best interest, in which event reasons will be provided for withdrawing you from the study.  
 
Will I have any additional expenses or be remunerated for participation? 
Other than routine screening of intraocular pressure and corneal characteristics, you will receive no 
direct benefit from this research project. There will be no costs to you or your medical scheme for the 
procedures performed during this study and you will not be remunerated to take part in the study. 
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Insurance and compensation? 
In the unlikely event of study related injuries adequate insurance for you and the principal researcher 
has been obtained. The researcher assumes no obligation to pay for the medical treatment of other 
injuries or illnesses not related to the studies. Further detailed information on the payment of medical 
treatment and compensation due to injury can be obtained from Mr Dirk Booysen should you wish to 
review it.   
  
Will my taking part in the study be kept confidential? 
Your participation in the research project will be fully confidential. Mr Dirk Booysen will be 
personally responsible for maintaining your privacy and confidentiality. A slight risk of breaching 
privacy and confidentiality in terms of clinical results will be minimised by keeping your information 
anonymous and stored on site in a secure database. There will be no way to link any research 
information to any individual participant. All information (digital and hard copies) will be 
permanently deleted and disposed of 12 months after completion of the study. Data that may be 
reported in scientific journals will not include any information that identifies you as a patient in this 
research study. However, in connection with this study it may be important for domestic and foreign 
health authorities, such as the Department of Health, the National Health Research Ethics Council, the 
Food and Drug Administration of the USA, the South African Medical Association Research Ethics 
Committee (SAMAREC), the Medicines Control Council (MCC), Aston University’s School of Life 
& Health Sciences Research Ethics Committee (AOREC), as well as other authorised persons to be 
able to review your records pertaining to this trial. Therefore, by signing this document, you authorise 
Mr Dirk Booysen to release your records in appropriate circumstances to the appropriate authorities 
mentioned above. You understand that these records will be used within reason by these authorities 
only in connection with carrying out their obligations relating to this research study. 
The information collected during this study may also be added to research databases and used in the 
future to develop a better understanding of the procedures used in this study, and to improve the 
efficiency, study design and study methods of future research. Such information will not identify you 
by name.  
Finally, although privacy and confidentiality will be protected vigorously to the extent permissible by 
law, we cannot, however, absolutely guarantee privacy or confidentiality. 
 
What will happen to the results of the research project? 
We intend to present and publish the findings of this study at meetings and in academic and 
professional journals. Only anonymous information will be used for analysis and publication 
protecting your privacy and confidentiality. A copy of the published research findings will be 
available at our practice as soon as the project is completed.  
 
Who is organising and funding the research? 
Dr Amy Sheppard assisted by Dr Leon Davies will lead the research project, which constitutes part 
of Mr Dirk Booysen’s postgraduate research. Mr Booysen is a qualified optometrist currently enrolled 
in the Ophthalmic Doctorate programme at Aston University (UK). 
There is no funding for the research project. 
 
Who has reviewed and granted ethics approval for the research study? 
The protocol of this research study was submitted to Aston University’s School of Life & Health 
Sciences Research Ethics Committee (AOREC) in the United Kingdom, as well as to the South 
African Medical Association Research Ethics Committee (SAMAREC), a research ethics committee 
registered with the National Health Research Ethics Council. Written approval has been granted by 
both AOREC and SAMAREC for the conduct of the research study. The study has been structured in 
accordance with the Guidelines on Clinical Trials and Ethics in Health Research, published by the 
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Department of Health and the Declaration of Helsinki (last updated October 2008), adopted by the 
World Medical Association (WMA), which deals with the recommendations guiding health care 
professionals in biomedical research involving human participants. Copies of these documents may be 
obtained from Mr Dirk Booysen should you wish to review them. 
 
Whom do I contact if something goes wrong or I need further information? 
Please feel free to contact Mr Dirk Booysen (e-mail: dirk@dirkbooysen.co.za , or telephone 011 954 
1000). 
 
Whom do I contact if I wish to make a complaint about the way in which the research is being 
conducted? 
If you have any concerns about the way in which the research has been conducted, you should contact 
the Secretary of Aston University’s School of Life & Health Sciences Research Ethics Committee 
(AOREC) (e-mail: j.g.walter@aston.ac.uk or telephone 0044 121 204 4665), or the head of the 
SAMAREC secretariat, Ms M Otto (e-mail: maureeno@samedical.org or telephone +27124812046). 
 
 
Consent Form. 
 
Title of Project:  
Tonometry and Biomechanics of the Cornea in Contact Lens Wear. 
 
Name of Chief Researcher:  
Mr Dirk J Booysen 
 
  Initial 
1 I confirm that I have read and understand the information sheet for the above 
study. I have had the opportunity to consider the information, ask questions and 
have had these answered satisfactorily. 
 
2 I am aware that the results of the study, including personal details regarding my 
sex, age, date of birth, and diagnosis will be anonymously processed into a 
research report, but that some of my eye health information may be reasonably 
disclosed to authorities under certain circumstances 
 
3 I understand that my participation is voluntary and that I am free to withdraw at 
any time without giving any reason, without my medical care or legal rights being 
affected. 
 
4  I have had sufficient opportunity to ask questions and (of my own free will) 
declare myself prepared to participate in the above study. 
 
5 I understand that I shall receive a signed copy of this document  
 
_______________    _______________ ___________________ 
Name of volunteer Date Signature 
________________ ________________ ___________________ 
Researcher Date Signature 
________________ ________________ ___________________ 
Name of Person taking                      Date Signature 
Consent (if different from researcher) 
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Appendix 5 
Indemnity insurance  
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Appendix 6  
Tests of normality 
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Appendix 7  
Raw data spread sheet with rebound tonometry measurements averaged  
 
 
Tests of normality 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
AGE 0.121 50 0.064 0.965 50 0.145 
Refraction 0.154 50 0.004 0.952 50 0.042 
ICare IOP 0.173 50 0.001 0.945 50 0.021 
Corneal hysteresis 0.066 50 0.200* 0.979 50 0.510 
Corneal resistance factor 0.106 50 0.200* 0.954 50 0.049 
Corneal corrected IOP 0.121 50 0.066 0.953 50 0.046 
Goldmann equivalent IOP 0.122 50 0.060 0.961 50 0.101 
CCT without C/L 0.094 50 0.200* 0.958 50 0.077 
K-reading Without C/L 0.067 50 0.200* 0.970 50 0.241 
ICare with C/L A 0.174 50 0.001 0.908 50 0.001 
ICare with C/L B 0.153 50 0.005 0.946 50 0.024 
ICare with C/L C 0.097 50 0.200* 0.971 50 0.243 
ICare with C/L D 0.177 50 0.000 0.940 50 0.013 
CH with C/L A 0.157 50 0.003 0.904 50 0.001 
CH with C/L B 0.069 50 0.200* 0.981 50 0.578 
CH with C/L C 0.083 50 0.200* 0.973 50 0.294 
CH with C/L D 0.103 50 0.200* 0.969 50 0.216 
CRF with C/L A 0.163 50 0.002 0.854 50 0.000 
CRF with C/L B 0.076 50 0.200* 0.961 50 0.095 
CRF with C/L C 0.102 50 0.200* 0.950 50 0.034 
CRF with C/L D 0.086 50 0.200* 0.948 50 0.028 
IOPcc with C/L A 0.087 50 0.200* 0.983 50 0.664 
IOPcc with C/L B 0.103 50 0.200* 0.944 50 0.019 
IOPcc with C/L C 0.070 50 0.200* 0.990 50 0.948 
IOPcc with C/L D 0.087 50 0.200* 0.975 50 0.373 
IOPg with C/L A 0.101 50 0.200* 0.952 50 0.042 
IOPg with C/L B 0.083 50 0.200* 0.967 50 0.172 
IOPg with C/L C 0.083 50 0.200* 0.985 50 0.762 
IOPg with C/L D 0.092 50 0.200* 0.971 50 0.256 
CCT with C/L A 0.081 50 0.200* 0.977 50 0.432 
CCT with C/L B 0.083 50 0.200* 0.971 50 0.250 
CCT with C/L C 0.077 50 0.200* 0.980 50 0.550 
CCT with C/L D 0.144 50 0.011 0.944 50 0.020 
K-reading with C/L A 0.099 50 0.200* 0.977 50 0.421 
K-reading with C/L B 0.084 50 0.200* 0.977 50 0.447 
K-reading with C/L C 0.118 50 0.081 0.939 50 0.013 
K-reading with C/L D 0.077 50 0.200* 0.982 50 0.631 
Table 8.2 Tests of normality. 
* This is a lower bound of the true significance. Although several of the variables have p values that indicate significant 
differences to the normal distribution the Q-Q plots show that these variables data points are close to the normality line. 
If the data is not normally distributed the value of the statistical tests will still be correct but the significance levels will 
not be accurate. However, Sawilowsky and Hillman, 1992 found that even with a radically non-normal distribution of the 
data, significance levels are accurate except when the sample sizes are small and the groups differ in sample size, which 
is not the case in this study (Sawilowsky and Hillman, 1992) 
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Appendix 8  
Editors Report 
 
Suzette M. Swart 
 
FULL MEMBER: Professional Editors’ Guild 
 
12 April 2016 
 
TO WHOM IT MAY CONCERN 
 
 
I, Suzette Marié Swart (ID 5211190101087), confirm that I have edited the noted Doctor of 
Optometry (by Research) thesis, Tonometry and Biomechanics of the Cornea in Contact 
Lens Wear. The accuracy of the final work is still the student’s own responsibility.  
 
STUDENT:   
DIRK JOHAN BOOYSEN 
 
TITLE:   
TONOMETRY AND BIOMECHANICS OF THE CORNEA IN CONTACT LENS WEAR  
 
Thank you 
 
Suzette M Swart (not signed – sent electronically) 
0825533302 
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smswart@vodamail.co.za 
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